data_1bb8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bb8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 42.4 p-10 -91.35 -177.08 4.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 109.772 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -63.09 -9.47 10.72 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.506 -0.746 . . . . 0.0 109.698 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -101.3 -71.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.994 -1.066 . . . . 0.0 110.02 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 169.09 7.08 0.03 OUTLIER Glycine 0 N--CA 1.497 2.703 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.949 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.566 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 67.0 mtm180 -87.98 136.49 32.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.644 -1.503 . . . . 0.0 109.066 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.3 mt -82.61 111.72 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.42 149.85 22.78 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -86.04 -179.71 6.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.803 -1.186 . . . . 0.0 110.97 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t -58.63 145.62 39.03 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.691 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.02 -40.1 2.81 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.328 -0.857 . . . . 0.0 111.189 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 27' ' ' TYR . 46.5 mp0 -72.07 152.18 42.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.709 -1.465 . . . . 0.0 109.997 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -154.67 142.38 19.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -110.27 132.43 54.18 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -89.5 169.87 11.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.313 -0.867 . . . . 0.0 109.347 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -12.6 41.79 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.534 -0.729 . . . . 0.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -87.65 -18.41 29.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.272 -0.893 . . . . 0.0 109.831 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.54 -23.85 25.46 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -64.86 137.89 58.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.424 . . . . 0.0 109.569 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.566 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -82.8 171.41 13.97 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.643 -0.661 . . . . 0.0 110.115 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tt -154.56 127.23 8.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.511 ' CE1' ' OE2' ' A' ' 17' ' ' GLU . 75.9 t80 -132.78 163.19 29.6 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.249 -0.907 . . . . 0.0 109.058 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -131.52 137.05 48.35 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.323 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.72 133.13 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 33' ' ' PHE . 34.6 p30 -88.31 174.61 8.08 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.667 -0.646 . . . . 0.0 110.319 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 t -62.11 6.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 0.0 110.555 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.512 ' H ' ' C ' ' A' ' 31' ' ' ASP . 19.9 m-85 -100.69 -16.31 17.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.98 -1.075 . . . . 0.0 108.432 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.61 -4.86 85.11 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.26 149.88 59.46 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.072 -1.252 . . . . 0.0 108.717 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.96 137.41 24.21 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.405 1.403 . . . . 0.0 109.786 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -135.21 137.63 42.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.915 -1.116 . . . . 0.0 109.274 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.61 145.23 40.74 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.518 -0.739 . . . . 0.0 110.172 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.0 157.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.527 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 55.6 m-85 -127.53 155.73 43.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -170.78 136.5 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.85 -1.156 . . . . 0.0 110.868 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -86.62 5.99 33.14 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -131.76 131.73 43.22 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.615 0.722 . . . . 0.0 110.098 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 tp -86.18 -42.78 13.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.6 OUTLIER -118.75 174.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.93 -16.74 59.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.086 -1.008 . . . . 0.0 110.6 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.5 p -88.39 -4.91 58.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.849 -1.157 . . . . 0.0 110.596 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.546 ' CG ' HH12 ' A' ' 11' ' ' ARG . 73.2 m-20 -70.01 177.31 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.595 -1.316 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -139.6 138.08 35.88 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.08 144.07 50.32 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.49 -0.756 . . . . 0.0 111.044 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.0 143.92 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.449 2.099 . . . . 0.0 112.912 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.79 130.6 17.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -0.775 . . . . 0.0 110.072 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.84 59.71 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -92.22 135.24 34.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.013 -1.286 . . . . 0.0 109.061 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -75.24 161.27 29.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.314 -0.867 . . . . 0.0 110.189 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.55 158.86 3.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.57 -0.706 . . . . 0.0 110.23 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 9.3 t -147.31 158.0 43.8 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 87.1 mt -83.09 124.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.872 -1.143 . . . . 0.0 109.306 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 19.8 m -58.41 153.9 14.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.206 -0.934 . . . . 0.0 109.543 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.86 -53.45 57.8 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.611 -0.835 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -48.88 -44.65 40.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.885 -1.135 . . . . 0.0 109.043 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -72.33 -39.06 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 40' ' ' TYR . 11.0 ttmt -67.32 -49.86 62.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.977 -1.077 . . . . 0.0 109.444 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -50.34 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.27 -49.26 74.73 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 110.42 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -68.87 -39.75 79.66 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 111.701 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.31 -48.59 49.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.699 -1.251 . . . . 0.0 111.305 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.123 -0.985 . . . . 0.0 110.44 -178.61 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 37.6 p-10 -95.24 -170.81 2.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.371 -0.831 . . . . 0.0 109.59 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.444 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 70.1 m-80 -68.18 -11.57 59.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.849 . . . . 0.0 110.789 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -103.47 -23.27 13.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.028 -1.045 . . . . 0.0 109.907 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 109.41 19.27 8.48 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 24.3 mtt180 -84.71 124.59 31.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.131 -1.217 . . . . 0.0 109.47 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mm -75.45 101.73 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.835 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.24 150.62 20.04 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -87.48 -171.81 3.63 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.0 111.45 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.431 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 66.2 p -54.06 149.95 8.68 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.0 -45.25 2.48 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 1.4 mp0 -69.22 131.84 45.55 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.563 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.3 m -152.7 152.35 31.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.287 -0.883 . . . . 0.0 108.775 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.444 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.1 tt0 -95.92 141.59 29.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.042 -1.037 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -88.11 163.03 16.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.718 -0.613 . . . . 0.0 109.376 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -62.71 -19.82 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.018 -1.051 . . . . 0.0 108.571 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.91 -13.59 44.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.913 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.31 -26.83 19.02 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 121.258 -0.901 . . . . 0.0 111.075 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -61.99 135.92 57.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.694 -1.474 . . . . 0.0 110.237 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH1' ' A' ' 11' ' ' ARG . 74.1 m-85 -80.57 168.28 19.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -161.04 147.38 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.0 -1.062 . . . . 0.0 109.298 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.537 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 84.6 t80 -139.16 168.05 20.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 65.5 tttt -127.06 138.99 53.32 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.433 -0.792 . . . . 0.0 109.437 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -138.39 170.7 15.55 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mm -108.47 136.57 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.405 -0.809 . . . . 0.0 110.123 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.4 m-20 -78.47 161.82 26.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.22 -0.925 . . . . 0.0 108.649 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 t -59.79 -2.82 0.42 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 109.317 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.4 m-85 -101.53 -18.46 15.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.335 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 2.4 51.5 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 121.227 -0.921 . . . . 0.0 111.237 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -86.26 148.15 46.57 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.78 -1.424 . . . . 0.0 110.191 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 87.2 Cg_endo -76.99 128.32 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 122.94 2.427 . . . . 0.0 113.213 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.524 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -131.29 163.45 27.79 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -131.73 156.2 46.35 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.282 -0.886 . . . . 0.0 109.892 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.41 147.04 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -125.79 151.57 46.58 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.783 0.801 . . . . 0.0 109.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -172.27 145.47 1.72 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -87.79 23.79 1.92 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.951 -1.093 . . . . 0.0 108.281 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -137.37 137.56 38.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.593 -0.692 . . . . 0.0 110.539 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.0 tp -95.18 -42.33 8.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 47' ' ' THR . 18.2 m -126.86 147.49 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.15 -7.04 0.17 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 45' ' ' VAL . 30.8 p -89.82 -4.74 57.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.998 -1.064 . . . . 0.0 110.184 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.21 164.18 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.142 -0.974 . . . . 0.0 110.801 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -134.86 121.03 20.04 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.3 150.69 64.61 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.75 150.52 44.84 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.491 2.128 . . . . 0.0 111.69 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.83 147.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.83 -38.36 3.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -95.17 131.21 41.45 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.307 -1.114 . . . . 0.0 108.485 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -77.76 153.4 32.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.839 -1.163 . . . . 0.0 109.689 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.02 163.31 22.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.45 -0.781 . . . . 0.0 110.128 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 29.6 t -157.16 169.71 24.17 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.589 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.7 mt -82.42 136.82 22.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 94.5 p -55.85 154.31 7.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.149 -0.969 . . . . 0.0 109.311 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 61' ' ' ARG . 78.6 mt -62.01 -49.61 75.37 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.308 -0.87 . . . . 0.0 110.272 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 60' ' ' LEU . 30.5 mtt180 -46.65 -47.53 20.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.786 -1.196 . . . . 0.0 109.787 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -72.18 -34.83 68.72 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -68.71 -41.57 78.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 108.913 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.26 -52.54 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.45 -34.45 72.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -70.85 -35.33 72.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.424 -0.798 . . . . 0.0 111.535 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.61 -39.93 95.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.821 -1.174 . . . . 0.0 110.658 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 . . . . . 0 C--N 1.293 -1.88 0 O-C-N 120.538 -1.351 . . . . 0.0 111.352 -177.881 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 6' ' ' ARG . 35.9 mtm-85 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -95.69 -163.88 1.1 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.082 -1.012 . . . . 0.0 109.85 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 13.4 p30 -67.07 -23.54 65.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -100.03 5.02 45.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 110.637 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.43 49.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -87.19 134.86 33.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.137 -1.214 . . . . 0.0 110.205 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.4 mm -84.44 97.1 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 108.773 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.78 146.02 24.47 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.039 -1.038 . . . . 0.0 109.708 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.79 178.59 6.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.122 -0.986 . . . . 0.0 109.732 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -57.26 147.02 26.61 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.532 0.682 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.55 -45.23 1.76 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 24.3 mp0 -72.41 156.62 38.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.106 -1.232 . . . . 0.0 109.802 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.8 m -157.75 140.91 15.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.534 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.4 tt0 -94.85 142.18 27.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -92.25 169.08 10.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.631 0.729 . . . . 0.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -63.48 -23.1 67.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.701 -0.624 . . . . 0.0 110.553 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -88.1 -17.49 30.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 0.0 110.133 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.39 -32.21 6.02 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -60.4 135.15 57.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.736 -1.449 . . . . 0.0 109.558 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.68 170.18 16.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 111.192 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.3 tp -152.03 121.66 6.93 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 82.3 t80 -125.14 174.66 7.91 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.236 -0.915 . . . . 0.0 108.57 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.576 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 75.1 tttt -128.06 121.77 30.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 109.779 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -124.3 158.47 32.49 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.96 150.02 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.467 ' CG ' ' NE2' ' A' ' 37' ' ' GLN . 69.1 m-20 -80.9 170.44 16.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 108.937 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.7 m -68.07 -2.64 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -96.96 -17.51 20.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.132 -0.98 . . . . 0.0 109.389 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.59 -4.41 32.71 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 20.9 pt-20 -85.34 145.67 43.08 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.882 -1.363 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 86.2 Cg_endo -78.57 146.97 21.94 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.645 2.23 . . . . 0.0 113.44 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.469 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.8 mp0 -142.3 178.35 7.63 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -133.95 152.9 52.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 0.0 109.531 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.92 158.58 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.451 -0.781 . . . . 0.0 109.33 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -128.95 149.96 50.58 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.277 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -168.37 142.28 3.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 0.0 109.949 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -90.37 11.63 20.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -139.87 153.48 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 0.0 110.442 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 59' ' ' SER . 42.9 tp -99.25 -43.61 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.95 170.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.15 -15.58 59.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 0.0 110.886 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.2 p -86.57 -13.76 44.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.588 -1.32 . . . . 0.0 110.069 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -71.17 178.94 3.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.389 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.8 147.73 46.78 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.92 149.66 74.09 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.976 -1.077 . . . . 0.0 109.553 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -51.7 147.64 23.72 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.337 1.358 . . . . 0.0 111.432 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.24 141.18 11.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 -24.64 29.14 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -96.81 140.74 30.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.313 . . . . 0.0 109.356 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -74.45 153.28 39.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.807 -1.183 . . . . 0.0 109.148 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.31 163.32 0.41 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.181 -0.949 . . . . 0.0 110.09 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -148.38 160.12 43.33 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 99.0 mt -84.84 134.26 27.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 44.3 t -58.47 153.87 15.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.661 -0.65 . . . . 0.0 110.052 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -60.82 -53.13 61.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -49.87 -45.74 50.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.935 -1.103 . . . . 0.0 109.845 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.9 -29.9 66.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 108.675 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -72.39 -45.54 59.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.459 -0.775 . . . . 0.0 109.204 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.35 -55.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 0.0 110.252 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.06 93.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 0.0 110.647 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -68.74 -35.16 76.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 111.803 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.03 -41.78 86.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.569 -1.332 . . . . 0.0 111.755 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 . . . . . 0 C--N 1.293 -1.874 0 O-C-N 120.239 -1.538 . . . . 0.0 111.335 -177.383 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -70.34 175.24 4.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 0.0 110.264 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.5 HD21 ' CD ' ' A' ' 19' ' ' GLN . 79.9 m-20 -66.81 -12.4 58.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.476 -0.765 . . . . 0.0 109.931 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.418 ' NH1' ' HG3' ' A' ' 9' ' ' ARG . 7.7 mmm-85 -95.57 -77.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 0.0 109.349 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.96 3.7 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.216 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 55.9 mtm180 -88.14 125.27 34.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.732 -1.452 . . . . 0.0 108.869 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.3 mt -77.79 110.95 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.07 -1.019 . . . . 0.0 109.832 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.2 156.71 18.12 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -88.79 -176.84 5.36 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.816 -1.178 . . . . 0.0 110.775 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 17' ' ' GLU . 73.2 p -54.63 161.65 1.42 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.801 0.81 . . . . 0.0 112.068 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.34 -19.26 1.89 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 40.4 mt-10 -86.92 150.03 24.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.266 . . . . 0.0 110.295 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.0 p -157.5 134.05 9.83 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.5 ' CD ' HD21 ' A' ' 8' ' ' ASN . 47.9 tt0 -99.2 125.8 44.86 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.452 HH11 ' CG ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -85.57 -174.13 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.816 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -72.48 -22.9 60.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 109.937 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.67 -10.97 57.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.89 -21.94 43.42 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -61.33 138.05 58.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.847 -1.384 . . . . 0.0 109.294 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 67.3 m-85 -80.54 166.72 20.9 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.252 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.3 tp -150.24 119.07 6.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 109.623 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -125.44 162.27 25.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -131.44 138.13 48.92 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.25 -0.906 . . . . 0.0 110.736 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.2 p90 -142.82 164.51 29.9 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.62 138.85 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.94 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.456 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 52.8 m-20 -87.37 -178.35 6.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.949 . . . . 0.0 110.4 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 p -66.91 -1.37 3.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.321 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 47.9 m-85 -98.58 -10.63 23.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.951 . . . . 0.0 108.713 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.45 -8.52 76.88 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -81.37 145.2 54.99 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.5 148.22 42.27 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.94 1.76 . . . . 0.0 112.717 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.1 mp0 -135.67 170.71 15.54 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.28 145.89 39.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.346 -0.846 . . . . 0.0 110.383 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.85 146.49 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -128.91 151.11 50.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.597 -0.69 . . . . 0.0 109.596 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -171.66 146.19 2.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -88.83 11.42 17.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 108.51 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -123.57 140.99 52.44 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.555 -0.716 . . . . 0.0 110.226 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.79 -44.95 6.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.38 172.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -19.41 62.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.2 p -86.7 -1.98 58.15 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.703 -1.248 . . . . 0.0 110.788 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' OD1' ' NH1' ' A' ' 11' ' ' ARG . 76.0 m-20 -70.6 -174.22 0.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.585 -1.322 . . . . 0.0 109.334 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -148.75 130.53 15.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.043 -1.035 . . . . 0.0 109.454 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 15.0 m -80.97 130.07 64.91 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.83 -1.169 . . . . 0.0 109.272 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -48.87 148.05 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.188 1.259 . . . . 0.0 111.711 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.14 135.46 13.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.112 -0.992 . . . . 0.0 109.817 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.13 -32.66 6.68 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -92.33 136.47 33.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -1.165 . . . . 0.0 108.553 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -74.59 151.78 39.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.377 -0.827 . . . . 0.0 110.439 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -55.62 169.48 0.32 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 43.6 t -165.15 166.46 19.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.131 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 71.5 mt -83.6 125.48 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.015 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -56.69 156.0 6.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.337 -0.852 . . . . 0.0 109.638 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.13 -47.85 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 17' ' ' GLU . 5.0 mmp_? -53.25 -50.6 64.47 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.013 -1.054 . . . . 0.0 110.291 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.29 -36.68 61.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.753 -1.217 . . . . 0.0 110.806 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -65.97 -44.34 85.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.747 -1.22 . . . . 0.0 110.105 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.68 -48.78 87.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.48 -42.71 74.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.93 -1.106 . . . . 0.0 109.974 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.27 -51.86 27.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 110.807 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.7 mt -68.27 -26.32 65.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 111.752 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 C--N 1.292 -1.912 0 O-C-N 120.804 -1.185 . . . . 0.0 112.745 -177.003 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 121.456 0.646 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -100.82 -176.47 3.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.732 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -66.29 -15.17 63.01 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.042 -1.036 . . . . 0.0 110.034 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.512 HH11 ' CG ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -95.39 -0.51 52.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 -178.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 0.45 86.45 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -84.57 137.04 33.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.107 -1.231 . . . . 0.0 109.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.6 mt -80.47 120.06 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.916 -1.115 . . . . 0.0 109.743 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -90.32 150.59 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 18.8 mtpp -87.09 -178.03 6.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.926 -1.109 . . . . 0.0 110.608 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 29.7 p -57.1 149.05 20.21 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 111.571 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.16 -30.37 2.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 15' ' ' THR . 43.1 mp0 -76.15 154.17 35.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.845 -1.385 . . . . 0.0 109.296 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -157.43 138.24 13.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.066 -1.022 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -99.37 134.34 42.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.464 HH11 ' HG3' ' A' ' 20' ' ' ARG . 5.2 mmm-85 -87.54 176.02 7.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -21.33 63.56 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -83.52 -7.27 59.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.618 -0.676 . . . . 0.0 110.527 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.11 -28.46 13.84 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 120.97 -1.081 . . . . 0.0 111.068 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -57.13 154.33 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.853 -1.381 . . . . 0.0 109.616 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.63 169.85 9.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 109.731 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 tt -154.83 133.3 11.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.456 -0.777 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.96 146.41 49.08 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -118.92 136.38 54.09 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.653 -0.654 . . . . 0.0 110.606 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.513 ' CD2' ' OE1' ' A' ' 37' ' ' GLN . 7.3 p90 -148.12 -171.9 3.94 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.365 -0.834 . . . . 0.0 110.287 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.7 mp -106.64 129.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.9 p30 -86.47 -171.66 3.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.189 -0.944 . . . . 0.0 109.6 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.76 19.89 0.19 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.881 -1.137 . . . . 0.0 109.291 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 10.7 m-85 -118.29 -15.05 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.337 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.21 64.56 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.6 147.94 50.6 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.183 -1.186 . . . . 0.0 109.583 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.8 140.07 34.73 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.014 1.81 . . . . 0.0 112.36 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.677 ' N ' ' NE2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.0 164.65 26.51 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 23.2 m-85 -128.65 141.41 51.35 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.17 -0.957 . . . . 0.0 109.271 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.85 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -122.52 154.89 37.26 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.702 0.763 . . . . 0.0 110.113 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -171.26 143.6 1.9 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.999 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -97.17 18.25 15.38 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.81 144.72 31.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.324 -0.86 . . . . 0.0 110.202 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 59' ' ' SER . 45.1 tp -94.25 -43.92 8.21 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.24 167.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -12.55 61.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.488 -0.757 . . . . 0.0 111.261 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.0 m -86.79 -9.6 55.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.903 -1.123 . . . . 0.0 110.098 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.28 167.19 16.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -140.2 118.85 12.34 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.92 148.24 86.88 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.38 157.1 62.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.183 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.96 150.5 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.311 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.64 -41.62 2.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -98.13 132.04 44.0 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.493 -1.004 . . . . 0.0 108.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.86 157.66 31.3 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.086 -1.009 . . . . 0.0 109.896 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -53.78 159.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.4 m -148.6 176.19 10.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 109.192 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.61 126.66 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 31.5 t -55.63 148.53 15.83 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.16 -0.963 . . . . 0.0 108.481 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 mt -58.52 -52.43 65.68 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.461 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -49.36 -37.24 24.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.704 -1.247 . . . . 0.0 108.989 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.35 -43.5 60.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.279 -0.888 . . . . 0.0 109.364 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -65.06 -44.36 89.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.494 -0.754 . . . . 0.0 109.613 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.09 -47.06 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.67 -46.58 88.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.099 -1.0 . . . . 0.0 109.851 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.47 -40.05 70.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.234 -0.916 . . . . 0.0 110.843 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.4 -45.24 80.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 112.082 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.27 -1.519 . . . . 0.0 110.263 -178.517 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.6 mtm-85 . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 43.6 p-10 -76.83 -175.08 3.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.042 . . . . 0.0 109.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.58 -6.16 3.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.65 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -104.77 -81.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 0.0 109.404 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 177.72 2.81 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 17.5 ptt180 -86.96 132.03 33.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.082 -1.246 . . . . 0.0 108.584 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 12' ' ' ILE . 96.0 mt -70.08 131.86 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.46 163.01 16.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 175.98 7.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.098 -1.001 . . . . 0.0 109.783 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -60.96 130.32 45.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.859 -0.526 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.58 -37.29 3.42 Favored Glycine 0 N--CA 1.501 2.973 0 O-C-N 121.218 -0.926 . . . . 0.0 111.892 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 59.1 mp0 -72.62 150.58 42.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.638 -1.507 . . . . 0.0 110.265 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -155.8 148.39 23.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.316 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -104.8 132.93 50.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.963 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -85.42 170.9 12.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 109.632 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -68.68 -18.49 64.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.15 -21.31 36.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 110.359 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.53 3.86 Favored Glycine 0 N--CA 1.502 3.082 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -61.06 139.64 58.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.124 -1.221 . . . . 0.0 109.191 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 86.6 m-85 -85.73 170.3 12.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.835 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.4 tp -151.46 128.15 10.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -129.88 142.95 50.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.57 142.08 47.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.569 -0.707 . . . . 0.0 110.247 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -149.09 -171.41 3.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.0 109.53 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.11 134.85 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.261 -0.899 . . . . 0.0 110.221 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' OD2' ' OE1' ' A' ' 37' ' ' GLN . 12.5 m-20 -87.05 175.25 8.2 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.862 -1.149 . . . . 0.0 110.392 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 m -70.76 -2.71 15.58 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 11.0 m-85 -98.67 -11.59 21.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.589 -0.694 . . . . 0.0 109.357 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.79 -5.88 79.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.547 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.9 pt-20 -86.75 152.08 53.54 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.159 -1.201 . . . . 0.0 109.328 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' C ' HE21 ' A' ' 37' ' ' GLN . 95.3 Cg_endo -78.25 155.1 28.92 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.137 1.891 . . . . 0.0 112.441 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -148.86 160.14 43.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.217 -0.927 . . . . 0.0 109.235 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -136.66 148.97 47.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 m -122.24 145.37 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -116.03 151.51 35.36 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 t -169.64 145.54 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.28 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.72 9.07 36.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -132.32 133.64 44.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.1 tp -88.99 -42.96 11.47 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.67 151.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.42 -7.08 3.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.109 -0.995 . . . . 0.0 111.156 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.1 p -90.34 -11.8 39.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.749 -1.22 . . . . 0.0 109.774 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.62 172.49 11.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.181 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.33 135.03 33.34 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.24 147.39 60.53 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.745 -1.222 . . . . 0.0 110.451 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.61 145.7 71.02 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.13 1.887 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.72 144.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 110.573 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.12 -32.62 7.3 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -97.07 139.11 33.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.159 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.62 151.8 34.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -0.966 . . . . 0.0 109.771 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.7 150.53 15.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.141 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.7 p -147.32 161.98 39.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.046 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.69 126.81 40.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.0 m -56.33 160.94 2.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.157 -0.964 . . . . 0.0 108.801 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.04 -47.6 73.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.748 -1.22 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -41.54 -53.01 3.58 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.401 -0.812 . . . . 0.0 110.28 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -69.01 -34.43 75.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.088 -1.008 . . . . 0.0 108.662 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -68.77 -41.87 78.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -50.15 -51.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.138 -0.976 . . . . 0.0 109.266 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.7 70.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.852 -1.155 . . . . 0.0 109.525 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.93 -44.87 60.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.91 . . . . 0.0 111.481 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.54 -44.06 71.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.23 -1.544 . . . . 0.0 110.899 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 . . . . . 0 N--CA 1.496 1.863 0 O-C-N 119.762 -1.836 . . . . 0.0 110.886 -178.513 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 121.444 0.64 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.57 -159.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.407 -0.808 . . . . 0.0 109.743 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.112 -0.992 . . . . 0.0 110.261 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -92.18 -86.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.041 . . . . 0.0 109.496 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.1 22.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.551 ' NH1' ' OD2' ' A' ' 48' ' ' ASP . 67.6 mtm180 -88.72 135.73 33.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.795 -1.415 . . . . 0.0 110.578 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.8 mm -76.37 114.46 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 140.45 33.14 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -86.39 179.01 6.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.963 -1.085 . . . . 0.0 111.028 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -52.13 155.12 2.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.418 0.628 . . . . 0.0 109.84 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.68 -44.75 2.06 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -70.28 147.17 50.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -1.231 . . . . 0.0 109.272 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -155.24 157.5 37.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.649 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.0 tp-100 -107.28 123.12 47.85 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.388 -0.82 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.539 ' NH2' ' OH ' ' A' ' 40' ' ' TYR . 18.3 mtt180 -83.62 169.49 15.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.201 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.877 . . . . 0.0 109.622 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' A' ' 24' ' ' ARG . 1.4 p30 -91.43 -26.58 18.78 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.97 -1.081 . . . . 0.0 109.98 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.42 -36.25 2.96 Favored Glycine 0 N--CA 1.505 3.295 0 O-C-N 121.268 -0.895 . . . . 0.0 111.443 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.531 ' NH2' ' OD2' ' A' ' 22' ' ' ASP . 3.3 ptt-85 -60.57 132.92 55.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.604 -1.527 . . . . 0.0 109.438 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 86.2 m-85 -87.04 168.93 12.86 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pp -147.4 138.22 23.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -125.31 156.97 37.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.662 -0.649 . . . . 0.0 109.452 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -117.68 138.97 51.64 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 16.7 p90 -148.83 -165.89 2.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.984 -1.072 . . . . 0.0 109.961 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.439 ' O ' ' CD2' ' A' ' 29' ' ' TYR . 1.4 mp -107.48 136.37 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 O-C-N 121.315 -0.866 . . . . 0.0 110.461 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.59 ' CG ' HE21 ' A' ' 37' ' ' GLN . 17.0 m-20 -80.56 173.01 13.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.006 -1.059 . . . . 0.0 109.494 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -9.59 10.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.554 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 11.5 m-85 -104.21 -6.76 20.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.471 -0.768 . . . . 0.0 110.824 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.26 -4.6 64.87 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.028 -1.045 . . . . 0.0 110.539 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.02 150.54 47.8 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.832 -1.393 . . . . 0.0 110.102 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.55 152.65 23.12 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.268 1.979 . . . . 0.0 113.554 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.59 HE21 ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -157.83 179.89 8.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.75 149.58 50.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.857 -1.152 . . . . 0.0 110.179 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.02 162.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.539 ' OH ' ' NH2' ' A' ' 20' ' ' ARG . 84.1 m-85 -137.0 153.83 50.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.256 -0.902 . . . . 0.0 110.767 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -168.23 149.75 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -86.97 3.68 44.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.337 -0.852 . . . . 0.0 109.302 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.579 ' CB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -131.95 153.13 50.61 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.392 -0.818 . . . . 0.0 109.459 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 59' ' ' SER . 19.5 tp -93.36 -51.14 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.348 0.594 . . . . 0.0 109.975 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.51 175.62 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.42 0.628 . . . . 0.0 110.5 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.86 63.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 111.095 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -85.16 -8.08 58.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.817 -1.177 . . . . 0.0 110.309 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 59.8 m-20 -74.46 174.38 9.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 109.819 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -139.68 149.51 43.76 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -80.85 138.81 49.99 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.269 -0.894 . . . . 0.0 109.934 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -46.18 140.82 10.47 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.923 1.749 . . . . 0.0 111.706 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.6 132.13 17.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.14 -30.75 6.6 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -94.54 145.5 24.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -1.083 . . . . 0.0 108.706 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.6 150.66 34.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 108.726 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -49.53 162.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.01 -1.056 . . . . 0.0 109.845 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 38.2 t -154.78 173.64 16.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.155 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.473 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 5.9 mm -92.1 132.16 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.467 -0.77 . . . . 0.0 109.317 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 45.9 t -55.78 164.11 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.283 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 mp -71.32 -57.48 4.43 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.521 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -45.82 -41.92 11.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -69.06 -41.88 77.02 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.34 -0.944 . . . . 0.0 108.877 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -67.16 -42.03 84.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.938 . . . . 0.0 109.954 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.76 -49.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.76 -1.213 . . . . 0.0 108.635 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.61 83.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.0 110.292 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -70.97 -43.12 68.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.89 . . . . 0.0 111.171 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.66 -44.06 78.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 111.545 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 C--N 1.296 -1.744 0 O-C-N 120.815 -1.178 . . . . 0.0 110.539 -178.328 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 6' ' ' ARG . 1.7 mtt-85 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -84.66 -171.66 3.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -66.96 -14.87 63.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.882 . . . . 0.0 109.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -95.04 -5.07 45.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -0.894 . . . . 0.0 108.911 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.82 58.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' CG ' ' A' ' 48' ' ' ASP . 17.9 mmt180 -90.67 142.12 28.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -1.183 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mm -82.55 119.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 108.004 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp -90.75 145.06 25.11 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -87.6 179.28 6.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.052 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -57.52 136.74 56.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.256 -0.902 . . . . 0.0 110.036 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.27 -56.48 1.23 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -49.3 148.69 2.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 110.021 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -157.13 156.84 33.39 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -99.74 145.17 27.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.027 -1.046 . . . . 0.0 110.493 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -89.59 149.72 22.72 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.594 ' CD ' ' H ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -58.36 -20.57 44.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -89.15 -11.23 44.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 110.43 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.28 -35.0 5.24 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.525 HH21 ' HE1' ' A' ' 42' ' ' TRP . 2.4 ptp180 -59.12 143.96 47.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.412 . . . . 0.0 108.738 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -90.73 162.68 14.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.915 . . . . 0.0 110.183 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.33 140.42 25.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.666 0.746 . . . . 0.0 109.509 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -134.47 151.98 51.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -120.04 142.11 49.13 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.549 -0.719 . . . . 0.0 109.286 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -140.86 163.1 33.86 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.92 138.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.153 -0.967 . . . . 0.0 109.969 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' CG ' ' NE2' ' A' ' 37' ' ' GLN . 45.3 m-20 -84.12 161.68 20.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.6 p -63.24 -3.25 1.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' ASP . 3.4 m-85 -99.75 -15.96 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.379 -0.826 . . . . 0.0 109.085 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.32 56.89 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -80.59 156.29 73.22 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.499 -1.589 . . . . 0.0 107.125 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -93.53 141.08 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.563 1.508 . . . . 0.0 111.101 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.493 ' NE2' ' CG ' ' A' ' 31' ' ' ASP . 2.8 mp0 -130.02 154.64 47.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.539 -0.726 . . . . 0.0 109.126 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.2 147.89 52.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -123.11 156.05 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.442 -0.786 . . . . 0.0 109.037 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.9 156.12 44.93 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.427 -0.795 . . . . 0.0 109.696 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -174.31 146.31 1.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.592 -0.693 . . . . 0.0 109.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.64 ' H ' ' HG ' ' A' ' 57' ' ' CYS . 54.7 m95 -90.46 3.49 53.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -123.77 142.5 51.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -92.42 -44.49 8.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.543 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 46' ' ' ALA . 2.1 t -121.7 174.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 45' ' ' VAL . . . -72.74 -15.14 61.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -92.47 -8.52 44.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.049 -1.032 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.474 ' CG ' ' NH2' ' A' ' 11' ' ' ARG . 1.1 m-20 -72.54 168.84 17.75 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.278 -0.888 . . . . 0.0 109.805 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -134.73 144.64 47.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.21 122.62 81.57 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.0 110.495 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.88 151.79 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.509 1.473 . . . . 0.0 112.025 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.85 139.58 7.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.56 -30.88 9.31 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 13.0 mptt -93.46 127.26 39.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -1.15 . . . . 0.0 108.242 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -78.01 149.74 33.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.579 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 53.1 t0 -40.06 147.03 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.789 -0.569 . . . . 0.0 109.902 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.64 ' HG ' ' H ' ' A' ' 42' ' ' TRP . 21.5 p -153.66 164.86 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG2' ' CD ' ' A' ' 62' ' ' GLU . 20.3 mt -83.29 129.3 37.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.634 0.731 . . . . 0.0 110.032 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 92.4 p -60.84 173.14 0.8 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 63' ' ' LYS . 96.6 mt -83.92 -59.71 2.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.867 -1.146 . . . . 0.0 110.071 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' LEU . 37.6 mtt180 -40.01 -35.0 0.33 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' CD ' ' CG2' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -72.9 -40.89 65.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.736 -1.227 . . . . 0.0 108.582 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 60' ' ' LEU . 46.2 mttm -63.91 -46.46 84.72 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.505 -0.747 . . . . 0.0 109.719 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.2 mp -53.44 -49.41 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.66 94.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -78.73 -44.18 24.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.06 -1.025 . . . . 0.0 112.501 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -66.71 -38.82 87.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.127 -1.608 . . . . 0.0 111.432 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--N 1.292 -1.892 0 O-C-N 120.477 -1.389 . . . . 0.0 110.612 -178.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 39.4 p-10 -80.57 -169.23 2.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.726 HD22 ' NE2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -70.24 -21.11 63.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 108.831 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.5 mmm-85 -95.81 1.89 53.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.457 -0.777 . . . . 0.0 110.42 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 82.51 20.64 61.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.543 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -86.97 149.29 24.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.344 . . . . 0.0 108.567 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 mm -90.6 119.37 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.422 -0.799 . . . . 0.0 109.174 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 1.7 mm? -89.45 136.68 32.89 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 14' ' ' LYS . 8.9 mtmp? -86.38 -174.15 4.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.876 -1.14 . . . . 0.0 110.447 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 17' ' ' GLU . 8.8 m -51.55 138.99 21.29 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.753 -0.592 . . . . 0.0 110.206 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.04 -42.18 0.76 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 15' ' ' THR . 85.7 mt-10 -66.02 140.18 58.26 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.043 -1.269 . . . . 0.0 109.845 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 92.4 p -158.22 164.47 36.47 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.726 ' NE2' HD22 ' A' ' 8' ' ' ASN . 1.5 tm0? -92.8 150.44 20.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.888 -1.132 . . . . 0.0 109.393 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.485 ' NH1' ' CZ ' ' A' ' 24' ' ' ARG . 2.2 ttt180 -89.79 161.77 15.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.336 -0.852 . . . . 0.0 109.429 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -57.36 -30.06 64.55 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.906 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -84.92 -44.22 13.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 0.0 110.16 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.53 -31.81 1.02 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.485 ' CZ ' ' NH1' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -61.26 144.61 53.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.897 -1.355 . . . . 0.0 108.985 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -85.7 164.73 17.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.32 150.94 28.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 109.708 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.502 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 63.4 t80 -134.96 169.2 17.77 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 26.8 tttm -128.09 138.74 52.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.298 -0.876 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.498 ' HH ' ' CD1' ' A' ' 67' ' ' LEU . 8.3 p90 -144.82 159.8 42.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.4 mp -100.34 136.31 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.34 -0.85 . . . . 0.0 109.165 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 33' ' ' PHE . 54.8 m-20 -81.5 166.76 20.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.164 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -60.55 1.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -1.0 . . . . 0.0 111.068 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 9.6 m-85 -101.47 -21.17 14.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.924 -1.11 . . . . 0.0 108.557 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.52 39.12 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.565 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.1 pt-20 -84.82 150.13 55.26 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.912 -1.346 . . . . 0.0 109.961 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.51 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 85.3 Cg_endo -78.7 139.66 16.0 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.78 2.32 . . . . 0.0 113.527 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.565 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -137.88 161.33 36.9 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.28 -0.888 . . . . 0.0 108.827 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -132.11 150.1 52.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.25 151.05 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -126.45 155.03 42.88 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.333 -0.854 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.1 t -170.06 152.66 4.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.657 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -93.99 16.54 14.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.553 ' CB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.14 144.24 32.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' ' OG ' ' A' ' 59' ' ' SER . 21.5 tp -96.53 -44.49 7.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.79 153.93 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 121.547 0.689 . . . . 0.0 109.261 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.45 -11.75 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.72 . . . . 0.0 110.904 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 -8.28 39.17 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.73 -1.231 . . . . 0.0 111.222 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.0 166.36 21.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.903 -1.123 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 49' ' ' ARG . 4.0 tpt180 -128.24 124.01 35.61 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.469 -0.77 . . . . 0.0 109.093 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.41 142.22 40.21 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.847 . . . . 0.0 109.971 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -48.59 147.87 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.284 1.323 . . . . 0.0 110.823 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.23 -37.3 46.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.853 -1.154 . . . . 0.0 109.595 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.25 -31.24 56.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -98.35 135.16 40.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -1.161 . . . . 0.0 108.587 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -79.04 166.55 22.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 109.74 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -65.51 159.27 24.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.193 -0.942 . . . . 0.0 110.021 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.8 p -161.54 178.34 9.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.6 mt -87.48 134.12 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 21.9 t -61.62 161.39 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 109.883 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.8 -48.72 73.4 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.948 -1.095 . . . . 0.0 109.644 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 61' ' ' ARG . 0.6 OUTLIER -48.09 -51.39 24.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.793 -1.192 . . . . 0.0 109.133 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -70.01 -38.12 75.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.59 -45.62 86.18 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.712 -1.243 . . . . 0.0 109.149 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.49 -54.29 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -30.2 69.74 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.171 -0.956 . . . . 0.0 109.687 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.91 -42.91 76.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.148 -0.97 . . . . 0.0 111.542 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.498 ' CD1' ' HH ' ' A' ' 29' ' ' TYR . 4.4 mm? -69.21 -51.24 39.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.846 -1.159 . . . . 0.0 111.418 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 . . . . . 0 C--N 1.298 -1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 112.075 -177.134 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 53.6 p-10 -87.13 -165.5 1.31 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.884 -1.135 . . . . 0.0 109.996 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -66.67 -17.92 65.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.699 -0.625 . . . . 0.0 109.403 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.495 ' CG ' HH11 ' A' ' 9' ' ' ARG . 4.4 mtt-85 -103.98 -80.13 0.53 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.382 -0.824 . . . . 0.0 109.162 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -178.92 34.7 0.07 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -90.56 130.95 36.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -1.055 . . . . 0.0 110.178 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.6 mm -79.91 107.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.29 157.49 18.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.93 -1.106 . . . . 0.0 110.481 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -87.82 170.48 11.15 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 m -52.75 138.63 28.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.141 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.73 -57.75 1.87 Allowed Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.111 -0.993 . . . . 0.0 110.74 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -51.56 141.88 15.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 110.081 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.2 m -152.21 149.81 29.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.617 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.4 tp-100 -95.26 137.99 33.56 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.256 -0.903 . . . . 0.0 109.727 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.632 ' NH1' ' NH2' ' A' ' 24' ' ' ARG . 4.7 mtp180 -81.84 -177.04 6.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -76.71 -24.97 53.09 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.825 -0.547 . . . . 0.0 110.042 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' OD2' ' NE ' ' A' ' 24' ' ' ARG . 38.6 p-10 -89.98 -28.53 19.06 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.753 -1.217 . . . . 0.0 111.407 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 19' ' ' GLN . . . 136.05 -26.24 3.13 Favored Glycine 0 N--CA 1.503 3.157 0 O-C-N 120.757 -1.214 . . . . 0.0 111.382 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.632 ' NH2' ' NH1' ' A' ' 20' ' ' ARG . 8.0 ptt180 -65.59 135.99 55.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.364 -1.668 . . . . 0.0 108.714 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.617 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 72.0 m-85 -72.67 173.55 8.84 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -152.4 126.89 9.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.5 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -129.4 151.87 49.57 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.407 ' HZ1' ' CA ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -124.55 135.03 52.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.33 -0.856 . . . . 0.0 110.055 -178.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.407 ' CA ' ' HZ1' ' A' ' 28' ' ' LYS . 17.4 p90 -139.17 164.88 28.64 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.316 -0.865 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 30' ' ' ILE . 87.1 mt -105.41 137.71 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.357 -0.84 . . . . 0.0 109.0 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 33' ' ' PHE . 5.0 p30 -83.39 175.39 9.88 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.143 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -66.2 6.06 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.936 -1.103 . . . . 0.0 110.882 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 31' ' ' ASP . 12.3 m-85 -102.36 -18.93 15.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.933 -1.105 . . . . 0.0 110.118 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.24 -9.4 45.96 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 121.11 -0.994 . . . . 0.0 110.651 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HG3' HE22 ' A' ' 37' ' ' GLN . 17.4 pt-20 -87.9 146.15 38.13 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.953 -1.322 . . . . 0.0 109.137 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.592 ' C ' HE21 ' A' ' 37' ' ' GLN . 95.2 Cg_endo -77.87 136.65 15.16 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.481 2.121 . . . . 0.0 112.679 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.639 ' N ' HE21 ' A' ' 37' ' ' GLN . 0.0 OUTLIER -122.19 174.93 6.66 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.268 -0.895 . . . . 0.0 109.073 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.95 146.32 39.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.561 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.99 143.56 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.646 -0.659 . . . . 0.0 109.273 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -124.15 160.0 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.518 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 153.8 5.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -98.09 14.81 26.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.8 146.94 38.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.089 -1.007 . . . . 0.0 109.136 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.7 tp -89.74 -49.3 6.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 109.123 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 m -118.97 171.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.95 -17.54 62.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.359 -0.838 . . . . 0.0 111.893 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.4 t -87.92 -4.86 58.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.626 -1.296 . . . . 0.0 110.629 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.7 -175.08 1.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 0.0 110.55 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -142.03 133.76 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.9 m -73.53 150.59 89.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.073 -1.017 . . . . 0.0 108.426 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.64 148.07 92.45 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.903 1.735 . . . . 0.0 111.723 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.95 143.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.411 -0.805 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.43 -29.03 10.17 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -94.87 143.08 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.317 . . . . 0.0 109.819 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 55' ' ' ARG . 8.1 ptt-85 -78.67 154.92 29.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.5 155.52 15.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.061 -1.024 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.1 m -149.11 177.85 9.24 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.0 mt -93.55 135.68 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.99 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 p -57.97 174.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 108.874 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.417 HD11 ' H ' ' A' ' 60' ' ' LEU . 4.3 mp -77.93 -54.25 6.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.868 -1.145 . . . . 0.0 110.234 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -47.01 -40.8 15.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.447 -0.783 . . . . 0.0 110.282 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -70.49 -38.46 74.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 66' ' ' GLU . 41.9 mttt -67.26 -50.52 60.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 108.767 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 63' ' ' LYS . 1.5 mp -40.0 -54.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.618 -0.676 . . . . 0.0 109.437 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.46 73.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 109.691 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 63' ' ' LYS . 11.0 tp10 -76.42 -41.66 46.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.396 -0.815 . . . . 0.0 111.738 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.79 -48.44 79.13 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.585 -1.322 . . . . 0.0 111.284 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 . . . . . 0 C--N 1.294 -1.81 0 O-C-N 121.009 -1.057 . . . . 0.0 111.045 -177.659 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 70.1 mtt180 . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 6' ' ' ARG . 67.7 m-20 -137.56 -103.72 0.19 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.363 -0.836 . . . . 0.0 112.378 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' A' ' 19' ' ' GLN . 72.9 m-20 -66.46 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -94.68 27.8 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.078 -1.014 . . . . 0.0 112.097 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.69 29.5 51.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -81.21 141.04 34.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.401 -1.058 . . . . 0.0 108.606 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.8 mm -86.21 98.36 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 109.681 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 151.5 20.7 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -89.56 -178.84 5.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.005 -1.059 . . . . 0.0 110.941 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 t -55.6 156.44 4.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.8 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.88 -36.62 3.26 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -79.65 159.76 26.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.886 -1.361 . . . . 0.0 110.174 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.585 ' HG ' ' H ' ' A' ' 19' ' ' GLN . 40.0 t -160.41 166.33 29.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.892 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.585 ' H ' ' HG ' ' A' ' 18' ' ' SER . 42.8 tt0 -104.22 148.01 26.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.517 HH21 HH11 ' A' ' 24' ' ' ARG . 9.3 mmm180 -90.76 168.59 11.63 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.713 0.768 . . . . 0.0 110.522 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -67.89 -27.51 66.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.393 -0.817 . . . . 0.0 109.606 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.5 p30 -94.99 -28.61 15.05 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.957 . . . . 0.0 110.949 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 136.5 -26.28 3.06 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.648 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.517 HH11 HH21 ' A' ' 20' ' ' ARG . 0.4 OUTLIER -60.0 145.87 44.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.375 -1.662 . . . . 0.0 109.256 -179.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -79.62 167.96 20.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.093 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.02 129.92 10.98 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.873 0.844 . . . . 0.0 110.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -136.42 154.19 50.87 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -127.3 143.62 51.2 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.007 -1.058 . . . . 0.0 110.05 -178.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.412 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 12.2 p90 -137.06 170.63 15.78 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.6 mm -99.88 135.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.15 -0.969 . . . . 0.0 109.799 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 33' ' ' PHE . 88.2 m-20 -81.71 162.98 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.187 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.1 p -64.1 0.74 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.2 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 31' ' ' ASP . 3.6 m-85 -100.66 -20.43 15.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.7 36.42 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.8 pt-20 -86.12 148.62 48.14 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.847 -1.384 . . . . 0.0 109.663 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.487 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 97.2 Cg_endo -83.65 142.45 10.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.947 1.765 . . . . 0.0 112.414 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.0 mp0 -130.2 167.78 17.88 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -134.57 143.45 47.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.394 -0.816 . . . . 0.0 110.267 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.06 156.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -133.31 147.27 51.87 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 t -172.11 148.61 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.951 . . . . 0.0 109.615 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -91.54 16.25 10.81 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.342 -0.849 . . . . 0.0 108.856 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 47.6 mtmt -134.41 143.67 47.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.351 -0.843 . . . . 0.0 110.153 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -94.2 -44.08 8.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.41 176.7 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-O 121.379 0.609 . . . . 0.0 109.438 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.53 -15.06 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 110.886 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.5 p -92.91 -14.34 27.73 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.791 -1.193 . . . . 0.0 111.453 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.17 169.73 11.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.713 -1.242 . . . . 0.0 110.481 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -123.58 147.92 46.86 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.517 0.675 . . . . 0.0 109.209 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.14 147.15 60.25 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.424 -0.797 . . . . 0.0 110.063 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.15 140.12 51.55 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.297 1.331 . . . . 0.0 110.834 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.94 149.0 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.886 -1.134 . . . . 0.0 109.588 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.17 -20.27 26.66 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.31 137.89 36.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -1.088 . . . . 0.0 108.991 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -76.22 167.8 21.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' O ' ' SG ' ' A' ' 57' ' ' CYS . 35.6 t0 -60.15 161.91 6.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.423 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 77.0 m -151.19 151.58 32.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.1 mt -81.29 134.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.87 -1.144 . . . . 0.0 109.519 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 150.73 28.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 110.655 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.59 -64.72 0.73 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -41.58 -48.35 3.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.587 . . . . 0.0 111.73 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.45 -33.12 73.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.53 -1.356 . . . . 0.0 109.9 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -68.5 -42.19 78.93 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 109.745 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.81 -56.64 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.383 -0.823 . . . . 0.0 110.51 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.76 87.49 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.318 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -75.01 -28.75 60.62 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 111.477 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -70.25 -53.13 18.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.56 -1.338 . . . . 0.0 111.585 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 C--N 1.3 -1.582 0 O-C-N 120.256 -1.528 . . . . 0.0 109.589 -178.479 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.896 0.855 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 40.7 p-10 -93.8 -168.2 1.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.627 0.727 . . . . 0.0 110.378 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -66.27 -14.91 62.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.476 -0.765 . . . . 0.0 110.481 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -99.86 -13.58 19.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.352 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.26 14.98 39.89 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 48' ' ' ASP . 30.0 mtt180 -84.07 135.3 34.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.157 . . . . 0.0 109.323 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.8 mt -84.27 111.4 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 109.192 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.94 157.33 15.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -92.26 179.04 5.67 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.018 -1.051 . . . . 0.0 109.968 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.4 m -54.01 146.23 14.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.439 -0.788 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.08 -52.67 4.75 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -52.56 149.84 5.55 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.134 -1.215 . . . . 0.0 109.28 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 t -157.1 161.72 39.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.596 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.3 tp-100 -105.17 131.41 52.69 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -89.53 162.5 15.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.373 -0.829 . . . . 0.0 109.362 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -22.3 66.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -84.75 -7.99 59.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.4 -0.813 . . . . 0.0 109.329 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.31 8.83 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -62.11 137.7 58.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.946 -1.326 . . . . 0.0 109.466 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.596 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 67.0 m-85 -80.41 173.15 12.88 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.512 -0.743 . . . . 0.0 109.548 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.43 ' CD2' ' C ' ' A' ' 26' ' ' LEU . 1.2 tt -156.07 139.24 15.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.326 -0.858 . . . . 0.0 109.874 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -136.57 155.25 50.19 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.23 -0.919 . . . . 0.0 109.275 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -119.97 138.97 53.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.474 -0.766 . . . . 0.0 110.513 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -143.14 165.0 28.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.03 134.84 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 0.0 109.378 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 33' ' ' PHE . 72.1 m-20 -80.11 164.64 23.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 108.401 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.8 t -58.9 0.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.942 -1.099 . . . . 0.0 110.536 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.7 m-85 -101.73 -19.35 15.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.052 -1.03 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.08 46.02 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.528 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 22.9 pt-20 -83.68 147.55 52.44 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.012 -1.287 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.502 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 55.7 Cg_endo -81.4 139.2 11.4 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.473 2.115 . . . . 0.0 113.249 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.7 mp0 -137.5 159.86 40.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -132.14 145.02 51.1 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 149.1 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -121.18 152.38 38.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.7 t -168.29 145.03 3.94 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 109.314 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.93 11.74 21.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.967 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -135.99 141.22 44.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.548 -0.72 . . . . 0.0 109.809 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.9 tp -89.65 -42.63 11.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.59 173.81 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.97 -14.35 59.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.047 -1.033 . . . . 0.0 110.598 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 p -91.27 -2.78 57.35 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 11' ' ' ARG . 80.5 m-20 -69.51 -174.43 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.661 -1.274 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -149.62 124.97 10.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.506 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 m -82.21 152.96 68.74 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.85 137.86 42.68 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 120.968 1.112 . . . . 0.0 109.978 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.86 -34.92 5.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.106 -0.996 . . . . 0.0 110.478 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.95 -22.27 62.23 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -99.48 140.83 33.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -1.122 . . . . 0.0 110.957 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 55' ' ' ARG . 2.0 ptt-85 -76.22 153.78 35.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.511 -0.743 . . . . 0.0 109.886 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.4 161.14 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 0.0 109.462 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.5 p -152.03 162.86 40.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.34 -0.85 . . . . 0.0 108.745 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.24 127.91 40.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.056 -1.027 . . . . 0.0 109.771 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.9 p -59.52 169.27 1.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.36 -0.837 . . . . 0.0 109.907 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -79.59 -58.53 3.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -41.45 -43.67 2.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 110.905 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -69.89 -41.38 74.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 0.0 109.433 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -67.99 -44.84 75.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 110.162 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.11 -60.69 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.914 -1.116 . . . . 0.0 109.203 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.01 63.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.942 . . . . 0.0 110.26 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -71.81 -39.04 70.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.06 -54.54 20.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.867 -1.145 . . . . 0.0 111.889 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.347 -1.471 . . . . 0.0 109.478 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.381 0.61 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 11' ' ' ARG . 8.3 p-10 -88.6 -168.33 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.783 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -67.15 -11.88 58.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.533 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.599 ' CB ' HH12 ' A' ' 11' ' ' ARG . 0.3 OUTLIER -100.2 -73.39 0.64 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.908 -1.12 . . . . 0.0 110.047 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.18 0.86 0.05 OUTLIER Glycine 0 N--CA 1.501 3.012 0 C-N-CA 118.41 -1.852 . . . . 0.0 113.03 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.599 HH12 ' CB ' ' A' ' 9' ' ' ARG . 2.4 mtm-85 -84.46 114.64 22.07 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 119.95 -1.912 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.95 113.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.444 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.91 169.47 10.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.42 -0.8 . . . . 0.0 109.716 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -89.16 -177.16 5.35 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.27 1.033 . . . . 0.0 111.054 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 t -56.75 153.62 10.37 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.39 -41.43 1.15 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.792 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.86 136.52 56.96 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.938 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -159.24 154.24 25.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.254 -0.904 . . . . 0.0 108.621 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -109.02 140.93 41.88 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.022 -1.048 . . . . 0.0 110.217 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -84.71 177.21 8.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.571 -0.706 . . . . 0.0 110.022 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -14.48 62.11 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -87.83 -20.14 26.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 109.837 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.24 -30.19 8.5 Favored Glycine 0 N--CA 1.501 3.019 0 O-C-N 121.227 -0.92 . . . . 0.0 111.204 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -63.38 140.68 58.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.546 -1.561 . . . . 0.0 109.679 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.47 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 90.8 m-85 -85.07 168.49 14.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.778 . . . . 0.0 109.87 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -150.89 127.48 10.81 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.448 0.642 . . . . 0.0 109.576 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -131.79 156.33 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -127.16 144.11 51.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -0.773 . . . . 0.0 109.861 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 12.1 p90 -144.86 161.66 38.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.201 -0.937 . . . . 0.0 108.776 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.4 mp -102.86 135.96 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.371 -0.83 . . . . 0.0 108.883 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 60.2 m-20 -81.74 174.26 11.52 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.288 -0.883 . . . . 0.0 109.186 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.4 t -65.58 -3.47 4.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 109.361 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -96.55 -11.32 25.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 108.91 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.6 -6.17 77.36 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -84.69 149.47 54.16 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.179 -1.189 . . . . 0.0 109.249 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 40.1 Cg_endo -82.89 136.51 8.22 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.589 2.193 . . . . 0.0 113.668 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.1 mp0 -125.67 164.9 19.61 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.4 149.09 51.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 109.698 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.8 142.68 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -127.43 156.99 41.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.557 -0.714 . . . . 0.0 109.795 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.5 t -170.91 150.75 3.21 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.488 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -89.38 11.07 20.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 51.7 mtmt -135.64 139.87 44.1 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.501 0.667 . . . . 0.0 110.567 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -92.51 -39.28 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.27 155.36 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.23 -7.67 10.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.181 -0.95 . . . . 0.0 110.972 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.3 p -93.76 -10.47 34.12 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.7 -1.25 . . . . 0.0 111.887 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -71.15 -171.56 0.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.488 -1.382 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -141.99 151.8 42.84 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -79.35 149.69 72.69 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.963 -1.086 . . . . 0.0 109.307 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' ALA . 32.6 Cg_endo -82.09 -112.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.56 2.174 . . . . 0.0 114.498 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.59 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -55.0 -149.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.257 -0.902 . . . . 0.0 112.954 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.97 36.1 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 52' ' ' ALA . 11.9 mptt -89.26 130.99 35.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.112 -1.228 . . . . 0.0 108.818 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.06 159.07 28.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 109.978 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 23.1 p-10 -53.71 162.19 0.93 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.677 -0.639 . . . . 0.0 109.851 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 19.8 t -162.97 161.22 25.49 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.494 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 89.3 mt -82.83 137.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.9 p -61.13 159.06 12.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.32 -0.863 . . . . 0.0 109.854 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HA ' ' HZ1' ' A' ' 63' ' ' LYS . 97.2 mt -63.53 -49.1 74.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -45.82 -46.34 15.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.115 -0.99 . . . . 0.0 110.352 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -37.43 75.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.883 -1.136 . . . . 0.0 109.781 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HZ1' ' HA ' ' A' ' 60' ' ' LEU . 2.8 mtmp? -67.61 -44.68 77.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.856 -1.153 . . . . 0.0 110.202 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.5 -53.56 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.956 -1.09 . . . . 0.0 110.145 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.62 79.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.112 . . . . 0.0 110.133 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.19 -45.47 56.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.89 -1.131 . . . . 0.0 110.177 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.29 -44.12 65.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.025 -1.047 . . . . 0.0 110.008 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--N 1.289 -2.034 0 O-C-N 120.609 -1.307 . . . . 0.0 109.646 -178.338 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 121.388 0.613 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -98.5 -164.39 1.13 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.61 -0.681 . . . . 0.0 109.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.556 HD21 ' NE2' ' A' ' 19' ' ' GLN . 22.3 p30 -68.65 -12.74 61.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.115 -0.99 . . . . 0.0 110.599 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -96.07 -5.71 40.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.0 -1.063 . . . . 0.0 109.29 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.19 -1.67 69.04 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.281 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.521 HH22 ' CG ' ' A' ' 48' ' ' ASP . 6.8 ptm180 -82.78 136.46 34.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.734 -1.451 . . . . 0.0 109.316 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.8 mt -83.97 110.6 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.149 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.79 161.72 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 77.5 mttt -88.93 -174.3 4.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.842 -1.161 . . . . 0.0 110.831 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t -55.79 162.23 1.86 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.67 -36.94 1.41 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 14' ' ' LYS . 9.5 mp0 -73.72 156.42 37.91 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.919 -1.342 . . . . 0.0 109.303 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -156.96 158.65 37.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 109.423 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.556 ' NE2' HD21 ' A' ' 8' ' ' ASN . 56.5 tt0 -97.05 134.74 40.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 108.735 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -86.47 160.99 18.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.891 -1.13 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.87 -36.49 62.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.584 -0.697 . . . . 0.0 109.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -82.14 -25.29 34.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.171 -0.955 . . . . 0.0 110.515 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.64 -26.9 5.06 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.17 -0.956 . . . . 0.0 110.744 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.666 HH21 ' HE1' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -59.74 148.5 34.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.356 -1.673 . . . . 0.0 108.307 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -87.44 164.42 16.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.232 -0.918 . . . . 0.0 109.187 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.74 137.75 22.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -131.6 161.48 32.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 29' ' ' TYR . 4.7 tmtm? -125.13 136.19 53.39 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.251 -0.906 . . . . 0.0 110.79 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 13.6 p90 -139.7 170.08 16.55 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.474 ' CD1' ' HZ3' ' A' ' 28' ' ' LYS . 5.9 mm -101.87 133.84 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.123 -0.986 . . . . 0.0 110.503 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 33' ' ' PHE . 59.5 m-20 -84.23 162.43 20.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -59.87 -3.98 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 21.8 m-85 -101.07 -15.27 17.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.03 -1.044 . . . . 0.0 109.622 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.31 0.32 58.32 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.984 -1.072 . . . . 0.0 111.064 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -83.9 150.56 59.08 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.837 -1.39 . . . . 0.0 109.682 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.503 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 88.8 Cg_endo -81.61 118.94 3.24 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.107 1.872 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.6 HE21 ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -115.05 163.02 16.21 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.72 142.03 44.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.24 150.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -122.77 151.61 41.45 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.7 t -171.77 148.62 2.41 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.666 ' HE1' HH21 ' A' ' 24' ' ' ARG . 98.7 m95 -91.91 10.6 28.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 57' ' ' CYS . 29.8 mtmt -135.64 146.74 48.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.675 0.75 . . . . 0.0 110.179 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -96.3 -40.07 9.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.15 161.23 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.61 -14.05 62.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.922 -1.111 . . . . 0.0 111.423 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -87.37 0.23 55.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.796 -1.19 . . . . 0.0 110.985 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.521 ' CG ' HH22 ' A' ' 11' ' ' ARG . 84.7 m-20 -72.49 -178.61 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.896 -1.127 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.42 121.18 13.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -75.79 146.29 79.5 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.492 -1.38 . . . . 0.0 109.957 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.82 155.58 62.16 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.031 . . . . 0.0 111.296 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.36 151.6 0.36 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 110.359 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.81 3.76 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -92.49 146.17 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -1.227 . . . . 0.0 108.913 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.493 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -78.08 -99.1 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 66.3 t0 -168.46 140.24 2.76 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.532 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 15.0 p -148.6 169.25 20.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.976 -1.077 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -82.69 139.0 18.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.497 -0.752 . . . . 0.0 110.326 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -60.72 169.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.33 -52.84 28.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -47.16 -47.76 23.7 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.724 -1.235 . . . . 0.0 110.114 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 68.3 mt-10 -71.49 -38.89 71.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.445 -1.409 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -65.75 -39.78 91.44 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 0.0 110.188 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.05 -44.41 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.377 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.19 90.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.955 -1.091 . . . . 0.0 110.782 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -71.34 -34.31 70.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.868 -1.145 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.88 -44.61 80.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.557 -1.339 . . . . 0.0 110.865 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.853 -1.154 . . . . 0.0 110.617 -178.721 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 29.3 p-10 -123.58 -169.57 1.97 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.208 -0.932 . . . . 0.0 109.936 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.687 ' ND2' HE21 ' A' ' 19' ' ' GLN . 68.9 m-80 -67.73 -21.37 65.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 110.077 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.57 -4.69 40.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.73 17.33 61.97 Favored Glycine 0 N--CA 1.497 2.738 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.07 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' A' ' 11' ' ' ARG . 3.6 mtt-85 -86.04 138.58 31.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -1.112 . . . . 0.0 108.913 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.8 mm -82.57 116.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -88.9 147.09 24.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.092 -1.005 . . . . 0.0 108.574 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -90.53 -179.73 5.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.802 -1.187 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 m -55.68 148.09 17.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.545 -0.722 . . . . 0.0 110.396 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.04 -41.66 2.79 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' OE2' ' CZ ' ' A' ' 61' ' ' ARG . 95.2 mt-10 -78.09 158.43 29.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.909 -1.348 . . . . 0.0 110.067 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -158.21 154.56 27.51 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.815 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.687 HE21 ' ND2' ' A' ' 8' ' ' ASN . 61.2 tt0 -99.16 130.21 45.46 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.837 . . . . 0.0 110.123 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.9 168.86 16.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.338 -0.851 . . . . 0.0 110.472 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -69.04 -25.59 64.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.467 -0.771 . . . . 0.0 109.15 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -87.11 -12.76 46.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.91 -31.1 8.27 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -58.88 143.7 46.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.313 . . . . 0.0 108.777 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -78.88 165.67 23.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.37 -0.831 . . . . 0.0 109.854 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.433 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 2.5 tm? -149.35 121.23 8.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 89.3 t80 -130.3 161.05 32.1 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 46.8 tttt -120.27 131.87 55.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.759 -0.588 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -135.73 152.15 50.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.581 -0.699 . . . . 0.0 109.25 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.4 mp -98.69 133.75 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 33' ' ' PHE . 44.9 p30 -82.64 173.12 12.22 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.011 0.91 . . . . 0.0 110.795 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 m -60.73 3.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.831 -0.543 . . . . 0.0 111.381 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.46 ' H ' ' C ' ' A' ' 31' ' ' ASP . 30.1 m-85 -107.12 -22.82 12.51 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.895 -1.128 . . . . 0.0 109.312 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.76 34.36 Favored Glycine 0 N--CA 1.505 3.251 0 O-C-N 121.211 -0.931 . . . . 0.0 111.137 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.526 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.2 pt-20 -88.49 152.44 49.62 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.941 -1.329 . . . . 0.0 109.263 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.41 147.6 25.76 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.413 2.075 . . . . 0.0 113.305 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -144.53 166.59 24.72 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -135.4 153.85 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.243 -0.911 . . . . 0.0 109.561 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.51 157.36 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.718 . . . . 0.0 109.231 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -135.21 144.78 47.13 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 t -169.45 155.01 5.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.035 . . . . 0.0 109.743 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CZ2' ' NZ ' ' A' ' 54' ' ' LYS . 96.1 m95 -93.98 5.54 51.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.137 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 56' ' ' ASP . 43.9 mtmt -123.92 140.43 52.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.547 0.689 . . . . 0.0 110.158 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.38 -44.83 7.04 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.41 ' CG1' ' H ' ' A' ' 46' ' ' ALA . 9.0 t -122.38 178.91 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' H ' ' CG1' ' A' ' 45' ' ' VAL . . . -78.56 -12.94 60.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.122 -0.986 . . . . 0.0 110.995 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.28 -10.69 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 109.944 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -74.42 168.13 20.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.034 -1.041 . . . . 0.0 109.815 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.448 HH11 ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -144.73 136.06 25.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 108.904 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.12 148.56 71.61 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.807 . . . . 0.0 110.514 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.95 149.4 77.53 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.183 1.922 . . . . 0.0 111.845 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.54 146.17 1.11 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.71 0.766 . . . . 0.0 110.124 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.7 4.61 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' NZ ' ' CZ2' ' A' ' 42' ' ' TRP . 28.4 mmtp -95.56 135.22 37.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -73.09 152.62 41.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.759 . . . . 0.0 109.472 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 43' ' ' LYS . 43.7 t0 -61.73 166.27 4.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 48.9 t -159.15 160.85 36.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -0.812 . . . . 0.0 109.108 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 85.5 mt -80.87 137.78 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.351 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.421 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 97.4 p -63.57 156.13 27.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.811 0.815 . . . . 0.0 111.224 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.44 -55.45 33.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.585 -0.697 . . . . 0.0 109.838 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 15.7 mmt180 -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.243 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' H ' ' HG ' ' A' ' 59' ' ' SER . 86.5 mt-10 -72.07 -39.53 68.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.927 . . . . 0.0 110.273 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.12 -37.02 80.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.032 -1.042 . . . . 0.0 110.102 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.1 -50.66 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.099 -1.001 . . . . 0.0 110.729 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.95 -45.85 82.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.819 -1.176 . . . . 0.0 110.422 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.52 -41.73 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 0.0 111.676 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.38 -21.51 66.65 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.884 -1.76 . . . . 0.0 110.987 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 120.79 -1.194 . . . . 0.0 111.32 -179.221 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.853 0.835 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -79.7 -179.79 7.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.676 HD21 ' NE2' ' A' ' 19' ' ' GLN . 12.5 p30 -66.96 -14.52 62.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.919 . . . . 0.0 111.259 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -98.75 14.93 26.96 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.049 . . . . 0.0 109.941 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.21 20.95 75.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -90.76 126.27 35.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -1.065 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.8 mt -77.52 95.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 13' ' ' LEU . 1.6 pt? -87.37 156.11 19.74 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -92.0 -176.02 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.691 1.234 . . . . 0.0 110.773 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.1 m -57.91 144.08 40.45 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.14 -54.39 3.6 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.3 149.27 24.88 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.203 -1.175 . . . . 0.0 108.801 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -160.96 159.73 29.88 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 108.848 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.676 ' NE2' HD21 ' A' ' 8' ' ' ASN . 17.3 pt20 -97.14 140.86 31.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 109.652 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.416 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.75 -174.14 4.62 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.09 -29.86 55.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.309 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -89.94 -11.88 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 111.538 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.44 -28.08 7.69 Favored Glycine 0 N--CA 1.504 3.199 0 O-C-N 121.012 -1.055 . . . . 0.0 110.908 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.4 140.88 56.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.352 -1.675 . . . . 0.0 109.341 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -80.03 170.56 16.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.434 -0.791 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.4 tp -151.68 127.25 10.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.537 -0.727 . . . . 0.0 109.328 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -129.58 157.15 42.86 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tttm -127.06 143.7 51.22 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.381 -0.825 . . . . 0.0 110.289 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -151.88 -178.99 7.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.46 144.99 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.488 -0.758 . . . . 0.0 109.006 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 33' ' ' PHE . 90.6 m-20 -84.05 165.85 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.469 -0.769 . . . . 0.0 109.856 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -59.28 -0.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.584 -0.697 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.53 ' H ' ' C ' ' A' ' 31' ' ' ASP . 18.8 m-85 -108.76 -13.95 14.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.473 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.51 -8.67 52.16 Favored Glycine 0 N--CA 1.502 3.068 0 O-C-N 121.045 -1.035 . . . . 0.0 110.871 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.8 pt-20 -81.68 149.94 65.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.825 -1.397 . . . . 0.0 109.129 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.534 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 59.0 Cg_endo -83.67 143.55 10.81 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.361 2.041 . . . . 0.0 112.67 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.534 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.4 mp0 -140.68 173.51 11.43 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.256 -0.903 . . . . 0.0 108.682 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -137.89 154.32 49.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.442 -0.786 . . . . 0.0 109.801 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -128.57 143.72 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.525 -0.735 . . . . 0.0 109.232 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -122.35 147.61 46.06 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -171.52 150.86 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.899 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -94.26 10.42 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -127.02 138.84 53.31 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.5 tp -93.02 -44.41 8.42 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.39 166.48 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -14.24 62.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.65 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.4 p -90.04 -6.01 56.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.725 -1.234 . . . . 0.0 111.305 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -70.96 160.56 32.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.68 -1.262 . . . . 0.0 109.417 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.82 126.22 39.39 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.303 -0.873 . . . . 0.0 108.91 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.68 150.1 75.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 110.032 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.4 151.16 80.71 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.834 1.689 . . . . 0.0 110.619 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.33 159.55 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -0.928 . . . . 0.0 109.859 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.04 -36.59 3.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -95.08 137.0 34.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.342 . . . . 0.0 109.64 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -79.87 150.38 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -0.982 . . . . 0.0 109.701 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -52.1 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.447 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 42.6 t -168.41 169.71 10.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.33 -0.856 . . . . 0.0 108.9 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.447 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 6.5 mm -84.55 122.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.4 p -58.88 158.84 7.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.71 -49.88 69.66 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.732 -0.605 . . . . 0.0 109.484 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -51.45 -47.65 63.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.926 -1.109 . . . . 0.0 110.178 -179.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.85 -43.68 67.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 0.0 110.892 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -65.85 -41.4 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.613 -1.305 . . . . 0.0 109.693 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.58 -36.58 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -51.51 69.15 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.018 -1.051 . . . . 0.0 110.087 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.4 -41.26 63.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.866 -1.146 . . . . 0.0 112.462 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -68.05 -44.29 76.72 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.286 -1.509 . . . . 0.0 111.752 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 . . . . . 0 N--CA 1.497 1.889 0 O-C-N 120.893 -1.129 . . . . 0.0 111.569 -177.919 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.685 ' HE ' ' C ' ' A' ' 10' ' ' GLY . 33.4 mtp180 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.412 ' HB2' HH12 ' A' ' 11' ' ' ARG . 3.8 m-20 -130.98 -159.59 0.98 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.648 -0.658 . . . . 0.0 109.823 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.481 ' ND2' ' NE2' ' A' ' 19' ' ' GLN . 77.6 m-20 -63.29 -33.06 74.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.121 -0.987 . . . . 0.0 111.659 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HB2' ' NH1' ' A' ' 11' ' ' ARG . 15.1 mmt180 -96.03 8.28 44.13 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.017 -1.052 . . . . 0.0 112.09 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.685 ' C ' ' HE ' ' A' ' 6' ' ' ARG . . . 76.88 19.99 76.79 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.422 -1.424 . . . . 0.0 111.704 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.586 HH11 ' HG3' ' A' ' 11' ' ' ARG . 2.3 mtm-85 -94.19 144.95 25.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.495 . . . . 0.0 108.374 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.4 mt -85.56 117.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 108.879 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -84.99 144.69 28.14 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.423 -0.798 . . . . 0.0 109.46 -179.098 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -89.26 -171.66 3.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.18 0.991 . . . . 0.0 110.502 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.4 m -56.42 143.53 34.44 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.691 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.99 -51.46 3.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.256 -0.903 . . . . 0.0 111.479 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.1 140.67 58.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.401 . . . . 0.0 110.093 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -160.01 -174.51 4.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.273 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.481 ' NE2' ' ND2' ' A' ' 8' ' ' ASN . 4.1 tt0 -110.11 147.41 33.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HG2' HH11 ' A' ' 20' ' ' ARG . 10.3 ttt-85 -88.87 164.1 15.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 8.4 mptt -63.71 -19.41 64.92 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.94 -8.17 50.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.608 -0.683 . . . . 0.0 110.714 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.68 6.32 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -61.41 145.79 50.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.969 -1.312 . . . . 0.0 108.041 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 11' ' ' ARG . 72.2 m-85 -78.75 167.93 20.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.103 -0.998 . . . . 0.0 110.659 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 tp -152.01 132.56 13.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 50.9 t80 -132.92 162.76 30.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 25.0 tttt -137.34 137.1 38.55 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.034 -1.041 . . . . 0.0 110.873 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.513 ' CD2' ' OE1' ' A' ' 37' ' ' GLN . 13.8 p90 -149.95 -175.55 5.09 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.414 ' HA ' HE22 ' A' ' 37' ' ' GLN . 39.9 mm -109.17 131.88 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.257 -0.902 . . . . 0.0 109.287 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 33' ' ' PHE . 46.0 p30 -88.92 178.38 6.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 0.0 110.047 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 t -63.01 0.36 0.58 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.054 -1.029 . . . . 0.0 110.881 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 6.6 m-85 -102.69 -10.47 19.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.4 59.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.0 pt-20 -80.17 150.7 71.73 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 108.395 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.76 135.61 21.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.632 1.555 . . . . 0.0 111.459 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.679 ' NE2' ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -132.74 165.68 23.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -137.11 155.79 49.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -0.839 . . . . 0.0 109.304 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.7 m -126.05 150.09 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.01 156.89 33.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.8 t -171.46 152.07 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.096 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -95.61 9.32 40.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 109.654 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.479 ' HZ3' ' H ' ' A' ' 57' ' ' CYS . 0.3 OUTLIER -141.47 156.01 45.79 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.224 -0.923 . . . . 0.0 109.507 179.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.461 ' CB ' ' HE ' ' A' ' 11' ' ' ARG . 59.6 tp -98.66 -38.63 9.04 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.418 HG11 ' H ' ' A' ' 46' ' ' ALA . 1.1 t -120.26 173.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.418 ' H ' HG11 ' A' ' 45' ' ' VAL . . . -78.69 -20.53 49.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 0.0 110.452 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.0 p -86.04 -7.17 58.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -71.94 167.62 19.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.84 136.85 51.03 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.6 149.52 78.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 110.616 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.26 140.79 25.45 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.677 1.585 . . . . 0.0 111.377 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.57 5.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 109.561 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.09 -19.97 48.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.62 142.86 27.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.827 -1.396 . . . . 0.0 109.205 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -78.08 151.21 33.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 109.829 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 p30 -62.08 175.08 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.79 . . . . 0.0 109.764 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.479 ' H ' ' HZ3' ' A' ' 43' ' ' LYS . 15.3 t -172.46 -174.99 1.27 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 58' ' ' ILE . 49.8 mm -98.97 127.44 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.013 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.454 ' OG ' ' C ' ' A' ' 44' ' ' LEU . 22.7 t -56.91 157.23 5.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.382 -0.824 . . . . 0.0 109.392 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.5 -51.69 66.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.987 -1.07 . . . . 0.0 109.986 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -47.79 -41.76 24.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.77 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.06 -39.69 65.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.923 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -65.36 -55.47 17.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.868 -1.145 . . . . 0.0 109.611 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mp -48.05 -58.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.6 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.08 -42.36 69.25 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.684 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.18 -42.43 62.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.822 . . . . 0.0 111.598 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.56 -44.42 67.46 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.779 -1.2 . . . . 0.0 111.817 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 120.614 -1.304 . . . . 0.0 110.524 -178.194 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' HG3' HH11 ' A' ' 6' ' ' ARG . 14.9 mtm-85 . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.801 0.81 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' CD2' ' A' ' 13' ' ' LEU . 93.6 m-20 -87.21 170.92 11.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -63.84 -3.55 2.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.881 -1.137 . . . . 0.0 109.063 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -102.91 -11.23 18.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.52 4.77 59.26 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.55 ' HG2' HH11 ' A' ' 11' ' ' ARG . 8.6 mtt-85 -85.91 130.29 34.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -1.113 . . . . 0.0 109.545 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.0 110.48 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' CD2' ' OD1' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -86.29 150.36 24.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -89.29 -179.33 5.84 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.687 -1.258 . . . . 0.0 110.789 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -53.46 154.51 3.44 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -39.46 2.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -76.46 167.8 21.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.275 . . . . 0.0 109.518 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 19' ' ' GLN . 38.4 t -158.82 161.96 36.97 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.863 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.521 ' N ' ' HG ' ' A' ' 18' ' ' SER . 47.8 tt0 -104.51 138.13 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.3 156.37 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.942 -1.099 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CG ' ' N ' ' A' ' 22' ' ' ASP . 10.2 ptmm? -53.52 -39.24 64.48 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.107 -0.995 . . . . 0.0 109.491 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 51.1 p30 -83.89 -30.82 26.08 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.184 -0.948 . . . . 0.0 110.41 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 135.05 -24.72 3.4 Favored Glycine 0 N--CA 1.505 3.272 0 O-C-N 120.81 -1.181 . . . . 0.0 112.576 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -57.46 147.25 27.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 120.15 1.975 . . . . 0.0 107.714 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -85.32 169.55 13.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.44 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -152.96 129.01 10.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.146 -0.971 . . . . 0.0 109.75 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 87.1 t80 -131.02 162.35 29.99 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.549 -0.719 . . . . 0.0 109.216 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 36.0 tttt -122.66 135.22 54.53 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.531 -0.73 . . . . 0.0 110.048 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.532 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 6.0 p90 -141.61 162.93 34.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.53 130.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 3.8 m-20 -88.5 179.74 6.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 t -57.08 -3.94 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 111.372 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 46.3 m-85 -96.26 -4.79 41.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.075 . . . . 0.0 110.473 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 10.33 81.71 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -88.25 164.36 33.35 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 122.034 -0.686 . . . . 0.0 110.092 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.28 122.6 0.75 Allowed 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 121.823 1.682 . . . . 0.0 110.144 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.571 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -123.07 166.11 15.68 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.222 -0.924 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -135.85 146.55 47.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.505 -0.747 . . . . 0.0 110.486 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -124.34 148.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -132.35 155.02 49.15 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.134 -0.979 . . . . 0.0 109.956 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -171.83 157.74 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.963 -1.085 . . . . 0.0 109.728 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -91.85 12.47 21.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.148 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 8.6 mtmp? -135.31 138.09 43.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.432 -0.792 . . . . 0.0 109.7 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.7 tp -88.46 -43.27 11.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.69 173.92 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.17 62.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.266 -0.896 . . . . 0.0 111.541 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 t -86.6 -10.59 53.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.72 -1.237 . . . . 0.0 111.466 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.87 176.37 3.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.662 -1.274 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.35 140.38 30.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.8 m -84.79 146.35 46.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 109.385 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.95 150.98 78.37 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.992 1.794 . . . . 0.0 111.698 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.42 143.67 2.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.567 -0.708 . . . . 0.0 110.393 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.97 -26.65 22.54 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -96.99 131.93 43.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.368 -1.078 . . . . 0.0 108.527 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -75.91 145.89 40.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.36 -0.837 . . . . 0.0 109.7 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 60.8 t0 -50.27 153.73 1.41 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.664 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 81.1 m -148.59 167.3 25.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.217 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.5 mt -87.97 133.1 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.199 -0.938 . . . . 0.0 110.354 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.6 p -62.81 157.7 20.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.819 . . . . 0.0 110.623 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.42 -52.46 65.52 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.841 0.829 . . . . 0.0 109.588 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -51.2 -45.32 61.8 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.461 -0.774 . . . . 0.0 110.154 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.31 -40.99 70.47 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 109.704 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 ttmp? -66.32 -41.83 89.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.942 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.4 -53.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.776 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.31 71.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.917 -1.115 . . . . 0.0 109.958 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -73.87 -42.57 60.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.972 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -68.0 -43.39 78.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.616 -1.302 . . . . 0.0 110.594 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 . . . . . 0 C--N 1.294 -1.837 0 O-C-N 120.245 -1.535 . . . . 0.0 110.49 -178.822 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.514 0.673 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -83.44 166.85 18.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.287 -0.883 . . . . 0.0 109.832 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 23.2 p30 -69.17 1.64 3.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.192 -0.943 . . . . 0.0 109.902 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 92.2 mtt180 -100.11 -52.68 3.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.84 -3.34 1.11 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.627 HH11 ' CG ' ' A' ' 11' ' ' ARG . 1.6 mtt-85 -89.29 130.06 35.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.459 -1.612 . . . . 0.0 110.171 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 mm -72.73 110.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.249 -0.907 . . . . 0.0 108.561 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 152.53 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 109.484 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 35.9 mmtt -89.0 -173.27 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.978 -1.077 . . . . 0.0 110.78 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 p -57.14 165.6 1.31 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.454 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.1 -44.07 1.04 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.366 -0.834 . . . . 0.0 111.56 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 12.2 mp0 -65.23 152.39 43.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.019 -1.283 . . . . 0.0 110.823 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -158.58 139.62 13.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.2 tt0 -100.0 129.31 46.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.192 -0.942 . . . . 0.0 109.891 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.686 ' NH1' HH21 ' A' ' 24' ' ' ARG . 49.2 mtp180 -89.27 166.19 13.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.431 -0.793 . . . . 0.0 110.656 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -20.27 63.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 109.729 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -85.78 -17.38 35.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.993 . . . . 0.0 109.463 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.09 -22.69 32.61 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.686 HH21 ' NH1' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -63.83 146.81 53.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.742 -1.446 . . . . 0.0 109.413 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.401 ' OH ' ' NH1' ' A' ' 9' ' ' ARG . 71.8 m-85 -88.63 166.47 14.09 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.802 0.81 . . . . 0.0 109.845 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -148.74 119.87 7.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 90.4 t80 -131.67 168.63 17.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.645 -0.659 . . . . 0.0 109.437 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 71.1 tttt -130.91 135.17 47.43 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.541 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 18.9 p90 -133.18 165.03 25.72 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.461 -0.774 . . . . 0.0 108.912 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.01 134.78 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.077 -1.014 . . . . 0.0 109.302 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 16.7 m-20 -83.27 156.67 22.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.7 m -53.66 -8.59 0.16 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.893 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' ASP . 23.0 m-85 -97.3 -13.9 21.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.881 -1.137 . . . . 0.0 108.807 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.34 0.73 59.5 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 20.6 pt-20 -83.38 148.52 55.85 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.892 -1.358 . . . . 0.0 108.329 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 96.0 Cg_endo -82.64 141.63 11.11 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.354 2.036 . . . . 0.0 113.198 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.1 mp0 -139.67 161.68 36.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.186 -0.946 . . . . 0.0 108.753 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -132.09 142.54 49.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -122.2 151.58 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.561 0.695 . . . . 0.0 109.904 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -123.72 150.47 44.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -166.05 148.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.391 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -90.94 10.38 26.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 109.573 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -140.18 144.02 36.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.99 -42.79 10.35 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.35 167.57 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.05 -6.24 44.27 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.982 -1.073 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.8 p -88.7 -18.53 27.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.433 -1.417 . . . . 0.0 110.011 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.28 175.11 7.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.409 HH12 ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -138.83 145.73 40.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 5.9 m -79.91 128.53 73.72 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.713 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.32 141.17 10.5 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.028 1.152 . . . . 0.0 110.327 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.409 ' N ' HH12 ' A' ' 49' ' ' ARG . . . -44.81 143.44 1.43 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.07 -32.26 7.69 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -91.88 140.66 29.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 108.546 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -76.16 155.62 34.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.455 ' O ' ' SG ' ' A' ' 57' ' ' CYS . 44.1 p30 -52.66 155.55 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.254 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 56' ' ' ASP . 64.9 m -154.54 157.99 39.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -85.05 135.08 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.8 p -58.82 153.65 16.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.09 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -60.47 -52.03 66.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.951 -1.093 . . . . 0.0 109.928 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -46.95 -50.0 19.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.824 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -69.13 -34.09 74.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.248 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -69.84 -41.26 75.16 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.428 -0.795 . . . . 0.0 110.02 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.18 -50.04 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.243 -0.91 . . . . 0.0 109.358 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.33 79.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.986 -1.071 . . . . 0.0 109.819 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -71.62 -44.02 65.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.466 -0.771 . . . . 0.0 111.308 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.74 -32.9 74.5 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.524 -1.36 . . . . 0.0 111.701 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 . . . . . 0 C--N 1.295 -1.783 0 O-C-N 120.215 -1.553 . . . . 0.0 110.308 -178.936 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 121.215 0.531 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.2 p30 -75.46 -179.66 4.71 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.753 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.464 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 61.8 m-80 -67.99 -8.6 38.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -101.79 -22.97 14.26 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.779 -1.201 . . . . 0.0 111.029 -178.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 123.06 7.93 6.89 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 121.199 -0.938 . . . . 0.0 110.78 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.527 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 9.2 mtm180 -85.09 126.25 33.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.884 -1.362 . . . . 0.0 109.596 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 12' ' ' ILE . 17.2 mm -71.56 105.53 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pp -87.78 149.02 24.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -91.09 -175.14 4.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.04 0.924 . . . . 0.0 110.903 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.435 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 7.5 p -55.19 146.24 19.24 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.665 0.745 . . . . 0.0 111.481 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.3 -54.12 4.85 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.422 -0.799 . . . . 0.0 111.37 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 36.8 mp0 -60.69 145.87 47.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 109.644 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -160.83 149.28 16.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.071 . . . . 0.0 109.649 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.464 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.8 tt0 -99.3 130.87 45.62 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.081 -1.012 . . . . 0.0 108.568 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -84.54 -171.24 3.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 0.0 109.605 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -75.32 -23.04 57.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.176 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -86.2 -15.02 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.19 -19.2 49.63 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -62.4 141.88 58.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.491 -1.594 . . . . 0.0 108.66 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -87.83 165.58 15.2 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.427 -0.796 . . . . 0.0 108.915 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' CD2' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -154.71 130.91 10.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -178.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.459 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 71.6 t80 -131.23 168.6 17.22 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 53.1 tttt -136.83 140.01 42.13 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.58 173.35 11.73 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.34 -0.85 . . . . 0.0 109.513 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.1 mm -103.35 126.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.412 -0.805 . . . . 0.0 109.615 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.14 176.41 9.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.005 -1.06 . . . . 0.0 109.058 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.8 p -64.09 0.59 0.89 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.042 -1.036 . . . . 0.0 111.203 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 14.4 m-85 -103.65 -15.89 15.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.107 -0.996 . . . . 0.0 109.463 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.65 -0.62 74.12 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -82.81 148.39 57.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.248 . . . . 0.0 109.299 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.06 124.44 9.09 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.489 1.459 . . . . 0.0 111.019 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.468 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -122.81 163.55 20.03 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -136.29 153.55 51.14 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.192 -0.943 . . . . 0.0 110.124 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.54 146.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -131.23 149.11 52.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.179 -0.951 . . . . 0.0 109.682 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.3 t -171.53 154.6 3.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.38 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -92.67 14.77 16.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.005 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.64 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 24.4 mtmm -130.91 138.51 49.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -93.38 -45.06 7.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.494 ' O ' ' OG ' ' A' ' 59' ' ' SER . 1.2 t -119.73 167.54 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.63 -17.57 64.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 110.664 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 p -86.89 -12.0 49.06 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.901 -1.124 . . . . 0.0 110.886 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -70.7 169.26 14.8 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.871 -1.143 . . . . 0.0 110.458 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -139.49 137.29 35.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.12 150.97 72.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 109.657 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.45 150.16 63.58 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.786 1.657 . . . . 0.0 111.049 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.86 146.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.3 -32.4 7.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -98.04 132.84 43.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -1.211 . . . . 0.0 109.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -74.95 147.91 40.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 109.182 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 60.0 p30 -51.82 152.06 3.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.114 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.64 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 35.6 m -146.78 164.07 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 58' ' ' ILE . 84.1 mt -81.47 133.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 110.823 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 56.3 m -58.19 166.95 1.43 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.412 0.625 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.68 -65.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.888 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -47.47 -34.45 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.502 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.94 -40.11 72.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.659 -1.275 . . . . 0.0 108.837 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -66.24 -44.02 84.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 110.245 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.5 mp -59.92 -45.12 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.134 -0.979 . . . . 0.0 110.677 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.62 81.65 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.745 -1.222 . . . . 0.0 110.981 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -77.85 -36.71 49.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.846 -1.159 . . . . 0.0 112.477 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.6 mt -67.53 -44.41 78.43 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.364 -1.46 . . . . 0.0 111.523 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 110.985 -178.619 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 121.267 0.556 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.0 p-10 -88.96 -176.9 5.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.083 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -64.78 -6.31 7.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 110.006 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 9' ' ' ARG . 52.9 mtt-85 -105.39 -16.88 14.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.172 -0.955 . . . . 0.0 110.318 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 101.65 19.01 16.7 Favored Glycine 0 N--CA 1.501 2.989 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.49 HH11 ' CG ' ' A' ' 11' ' ' ARG . 6.6 mtt-85 -86.03 140.18 30.5 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.77 -1.43 . . . . 0.0 109.168 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.78 103.24 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.525 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.4 149.97 22.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.388 -0.82 . . . . 0.0 109.065 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -89.02 -173.86 4.23 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.423 1.106 . . . . 0.0 111.785 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 m -59.4 140.0 56.55 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.229 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 -39.12 2.93 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.312 -0.867 . . . . 0.0 111.338 177.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -72.56 153.38 41.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.745 -1.444 . . . . 0.0 109.862 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -160.55 155.68 24.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -96.42 139.94 31.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -83.75 148.33 27.11 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -57.56 -18.9 21.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.61 -21.04 23.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.782 -0.573 . . . . 0.0 109.924 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.86 -35.59 4.01 Favored Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -59.54 140.98 55.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.877 -1.366 . . . . 0.0 109.23 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -75.85 170.73 15.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.316 -0.865 . . . . 0.0 110.338 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.9 tp -154.83 130.98 10.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.73 -0.606 . . . . 0.0 109.551 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -134.51 161.93 33.69 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -126.3 134.88 51.01 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.8 p90 -137.98 167.72 21.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.76 131.92 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 109.259 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 41.5 m-20 -82.09 -174.13 4.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.218 -0.926 . . . . 0.0 109.61 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -72.32 -4.64 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.42 -0.8 . . . . 0.0 110.239 -179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 18.3 m-85 -99.59 -10.73 21.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.15 -0.968 . . . . 0.0 109.913 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.41 86.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.39 147.33 52.8 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.392 -1.063 . . . . 0.0 108.733 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.98 128.51 15.93 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.846 1.697 . . . . 0.0 110.522 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.486 ' CA ' HE21 ' A' ' 37' ' ' GLN . 0.0 OUTLIER -127.87 164.69 21.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 109.011 -179.106 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.38 155.32 50.48 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.356 -0.84 . . . . 0.0 110.786 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.86 152.72 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -128.3 150.89 49.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.208 -0.933 . . . . 0.0 110.049 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 t -169.08 146.4 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.469 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -88.31 3.55 49.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 109.289 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 57' ' ' CYS . 24.4 mtmm -128.56 141.99 51.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.88 -49.59 6.35 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.53 174.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.95 -11.92 59.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.62 -0.675 . . . . 0.0 110.669 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -87.25 -14.35 41.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.763 -1.211 . . . . 0.0 110.105 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.2 174.89 5.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 1.9 tmt_? -146.49 135.94 22.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.409 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 19.3 m -75.23 147.95 83.4 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.772 -1.205 . . . . 0.0 109.954 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.33 155.73 66.51 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.04 1.827 . . . . 0.0 111.764 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.18 146.98 2.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.55 -0.719 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.4 6.91 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -95.97 139.64 31.88 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.005 -1.291 . . . . 0.0 109.073 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.507 HH11 ' CG ' ' A' ' 55' ' ' ARG . 1.4 ttt-85 -75.41 151.26 38.15 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.68 159.06 22.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.365 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.535 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -156.34 175.03 14.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.032 -179.848 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.81 135.38 25.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.524 -0.735 . . . . 0.0 110.68 -178.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.9 p -61.35 163.67 6.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 108.695 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.1 -51.98 40.19 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 111.149 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' HG2' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -44.27 -45.49 8.64 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.143 -0.973 . . . . 0.0 110.003 -178.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -68.58 -40.58 80.45 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 109.672 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -66.62 -44.14 82.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.986 -1.072 . . . . 0.0 110.516 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -56.93 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.91 -1.119 . . . . 0.0 110.318 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.07 70.29 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.74 -53.79 7.49 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -69.28 -41.28 77.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.996 -1.065 . . . . 0.0 110.144 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.296 -1.75 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -177.731 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.562 HH11 ' CG ' ' A' ' 6' ' ' ARG . 2.9 mtt-85 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 51.3 p-10 -74.4 -167.36 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.761 -1.212 . . . . 0.0 108.91 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.489 ' N ' ' OE1' ' A' ' 19' ' ' GLN . 95.6 m-20 -68.61 -16.35 63.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.781 -1.2 . . . . 0.0 108.599 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.45 ' CD ' ' N ' ' A' ' 9' ' ' ARG . 9.2 mpt_? -101.3 -87.13 0.4 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -169.5 19.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.455 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 81.3 mtm180 -89.84 138.59 31.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.303 . . . . 0.0 109.704 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.9 mm -77.68 130.26 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.888 . . . . 0.0 109.98 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -93.6 150.64 20.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -87.88 170.87 10.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.957 -1.09 . . . . 0.0 109.513 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.0 m -58.11 137.17 57.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.455 -0.778 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.98 -24.81 24.88 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.943 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 44.1 mp0 -82.04 157.2 24.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.677 -1.484 . . . . 0.0 110.12 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 t -158.93 147.56 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 109.389 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 8' ' ' ASN . 41.7 tt0 -106.45 133.04 51.75 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -83.03 166.0 19.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 109.862 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -16.49 48.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 108.643 179.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -86.9 -10.23 53.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.482 -0.761 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.31 -29.2 13.03 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.248 -0.907 . . . . 0.0 111.379 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -57.86 157.0 8.1 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.548 -1.56 . . . . 0.0 109.382 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.455 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 71.2 m-85 -100.41 166.91 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 109.42 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.79 141.29 20.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -135.26 149.23 49.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -114.88 135.42 54.22 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.253 -0.905 . . . . 0.0 110.792 -178.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -142.46 164.78 29.19 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.2 mt -107.96 139.62 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 33' ' ' PHE . 23.8 m-20 -81.79 159.93 23.68 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.935 -1.103 . . . . 0.0 109.222 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.7 m -58.2 -2.18 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 110.031 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.498 ' H ' ' C ' ' A' ' 31' ' ' ASP . 88.1 m-85 -95.29 -15.43 23.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.044 -1.035 . . . . 0.0 108.59 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.07 -5.26 49.71 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 23.5 pt-20 -84.73 144.02 41.7 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.872 -1.369 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.69 139.83 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.534 2.156 . . . . 0.0 111.969 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.4 mp0 -136.8 172.75 12.54 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.108 -0.995 . . . . 0.0 109.402 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -137.01 139.51 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.51 154.27 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -126.12 151.36 47.35 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.449 0.643 . . . . 0.0 109.273 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.8 t -168.22 136.57 2.29 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.013 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -87.58 12.9 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.189 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 53.0 mtmt -130.98 133.22 45.59 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.659 0.742 . . . . 0.0 109.574 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 66.9 tp -89.26 -43.44 10.97 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.47 HG21 HH12 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -111.63 175.39 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.48 -18.28 49.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.953 -1.092 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.2 p -93.58 7.29 45.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.679 -1.263 . . . . 0.0 110.955 -179.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.4 -179.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.611 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -142.1 116.79 9.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.13 -0.981 . . . . 0.0 109.196 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.47 149.45 51.88 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.204 -0.935 . . . . 0.0 110.839 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' LYS . 56.8 Cg_exo -49.58 134.42 33.12 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.208 1.272 . . . . 0.0 110.739 177.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.55 -23.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.848 -1.158 . . . . 0.0 109.791 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -25.4 73.65 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' PRO . 47.8 mmtt -103.93 133.93 48.06 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -78.99 152.65 30.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.087 . . . . 0.0 110.546 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -43.78 154.81 0.09 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.448 0.642 . . . . 0.0 109.826 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.498 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 61.4 m -149.73 167.59 26.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -86.96 128.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.141 -0.975 . . . . 0.0 108.779 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.6 p -58.64 167.64 1.43 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 110.443 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.78 -51.89 43.61 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.369 -0.832 . . . . 0.0 110.206 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.635 HH11 ' CG ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -47.07 -46.4 22.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 109.218 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -70.21 -39.65 75.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.512 -0.742 . . . . 0.0 110.19 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.0 -47.51 74.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.687 -1.258 . . . . 0.0 109.465 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.48 -56.69 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.21 76.97 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -77.29 -36.0 54.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.85 . . . . 0.0 111.945 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.82 -41.41 83.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.542 -1.349 . . . . 0.0 110.178 -179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 . . . . . 0 C--N 1.297 -1.705 0 O-C-N 120.239 -1.538 . . . . 0.0 109.813 -179.624 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.493 ' CG ' HH11 ' A' ' 6' ' ' ARG . 4.9 mtt-85 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -104.09 -167.66 1.39 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.755 . . . . 0.0 109.503 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 3.1 p30 -66.89 -16.86 64.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.28 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.543 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -97.6 -3.66 39.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.965 -1.084 . . . . 0.0 110.061 -179.422 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.85 90.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.525 HH11 ' CG ' ' A' ' 11' ' ' ARG . 2.6 mtt-85 -88.71 130.79 35.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.016 -1.285 . . . . 0.0 109.641 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 12' ' ' ILE . 55.4 mt -72.75 121.64 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 109.233 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.566 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -97.23 155.94 16.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -0.78 . . . . 0.0 108.948 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.07 179.42 6.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.871 -1.143 . . . . 0.0 110.111 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -56.81 152.47 12.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.729 -0.607 . . . . 0.0 110.295 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.44 -43.32 3.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' CD1' ' A' ' 44' ' ' LEU . 2.1 mt-10 -66.39 155.12 38.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.229 -1.16 . . . . 0.0 108.464 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.483 ' HG ' ' N ' ' A' ' 19' ' ' GLN . 25.5 t -159.03 164.27 35.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.126 -179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.483 ' N ' ' HG ' ' A' ' 18' ' ' SER . 39.4 tt0 -103.61 126.53 50.81 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 108.9 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -85.17 147.17 26.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.046 . . . . 0.0 108.947 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 1.3 mptt -49.26 -22.6 1.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -89.77 -26.74 20.44 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.799 -1.188 . . . . 0.0 110.821 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.62 -34.33 2.79 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 24' ' ' ARG . 0.1 OUTLIER -60.45 148.19 38.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.779 -1.424 . . . . 0.0 108.778 -179.753 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -86.47 168.71 13.5 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' C ' ' CD2' ' A' ' 26' ' ' LEU . 4.3 tt -145.12 122.95 11.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.349 -0.844 . . . . 0.0 109.536 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.424 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 74.0 t80 -128.04 161.54 28.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.424 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 17.4 tttt -129.42 138.63 51.57 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.426 -0.796 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -140.42 162.82 34.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.1 mt -110.96 136.27 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -85.27 170.47 12.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.357 -0.84 . . . . 0.0 109.479 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.0 p -60.35 5.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 110.546 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 31' ' ' ASP . 37.3 m-85 -99.45 -17.68 17.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.039 -1.038 . . . . 0.0 109.43 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 -2.91 82.31 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -83.92 142.07 41.5 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.282 -1.128 . . . . 0.0 108.172 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.5 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 50.4 Cg_endo -69.9 145.54 56.64 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.685 1.59 . . . . 0.0 111.124 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -140.07 153.97 46.92 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -129.56 148.69 51.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.044 -1.035 . . . . 0.0 109.892 -179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.14 142.92 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -117.22 160.91 20.32 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.1 t -168.74 152.46 5.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -93.78 7.55 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -143.65 149.09 36.77 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 51.1 tp -94.09 -42.99 8.71 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.443 ' CG2' ' HG1' ' A' ' 47' ' ' THR . 19.5 m -121.65 158.01 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.683 -0.636 . . . . 0.0 109.452 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.36 -11.4 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.191 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.443 ' HG1' ' CG2' ' A' ' 45' ' ' VAL . 72.0 p -90.3 -6.91 54.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.039 -1.038 . . . . 0.0 110.129 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -70.71 179.36 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.97 -1.081 . . . . 0.0 110.009 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.401 ' NH1' ' HG2' ' A' ' 49' ' ' ARG . 6.5 tpt180 -142.44 120.76 12.32 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 109.116 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.31 142.35 50.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.252 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -49.34 146.29 14.02 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.879 1.053 . . . . 0.0 110.503 178.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.56 -47.55 39.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.994 -1.067 . . . . 0.0 110.166 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.97 -21.02 4.85 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -102.51 139.71 37.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -1.17 . . . . 0.0 109.934 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.551 ' H ' ' CD ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.54 159.29 30.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 179.839 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 25.6 p-10 -66.39 164.25 16.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.16 171.68 15.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.62 133.05 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 110.17 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.7 p -58.82 152.58 18.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.066 179.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.27 -47.21 87.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.219 -0.925 . . . . 0.0 109.867 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -42.95 -45.07 4.88 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.08 -1.012 . . . . 0.0 109.819 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 97.5 mt-10 -72.29 -37.5 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -66.32 -42.51 88.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.693 -1.255 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.04 -53.5 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.668 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.87 93.03 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.15 -0.969 . . . . 0.0 110.116 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -72.33 -38.73 68.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.893 -1.129 . . . . 0.0 111.436 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.62 -46.4 72.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.576 -1.327 . . . . 0.0 110.094 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 . . . . . 0 C--N 1.298 -1.63 0 O-C-N 120.794 -1.191 . . . . 0.0 109.838 179.874 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.499 0.666 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -64.83 165.51 10.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.391 -0.818 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.441 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 26.0 p30 -63.17 -6.97 4.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.368 -0.832 . . . . 0.0 109.823 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -96.41 -75.79 0.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.95 -1.32 0.03 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.924 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' A' ' 11' ' ' ARG . 5.3 mtt-85 -85.59 133.18 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.469 . . . . 0.0 108.895 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.96 117.0 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.958 . . . . 0.0 109.385 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.8 151.42 22.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -88.89 173.78 8.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.337 -0.852 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 m -56.82 139.34 51.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.397 -0.815 . . . . 0.0 110.636 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.18 -42.35 2.27 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.24 150.6 43.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.807 -1.408 . . . . 0.0 109.539 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -157.03 140.0 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.441 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 53.9 tt0 -101.86 140.72 35.77 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -91.19 173.13 8.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 110.425 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -64.16 -19.66 65.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -84.81 -9.81 57.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.1 -25.53 25.08 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 121.096 -1.002 . . . . 0.0 110.96 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -62.21 137.95 58.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.739 -1.447 . . . . 0.0 109.302 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.81 166.76 19.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 110.496 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tt -153.51 138.76 17.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.696 . . . . 0.0 110.043 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -133.16 148.39 52.09 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -115.05 139.31 49.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.386 -0.821 . . . . 0.0 109.663 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.91 166.07 27.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 0.0 109.098 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -103.81 134.0 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.259 -0.901 . . . . 0.0 109.695 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -84.01 171.59 12.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.894 -1.128 . . . . 0.0 109.236 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -62.33 -0.13 0.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.568 -0.708 . . . . 0.0 111.367 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 39.2 m-85 -103.77 -21.59 13.66 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.901 -1.124 . . . . 0.0 110.255 -178.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.82 -1.91 38.8 Favored Glycine 0 N--CA 1.503 3.109 0 O-C-N 121.059 -1.026 . . . . 0.0 111.199 178.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -86.97 153.91 54.87 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.69 -1.476 . . . . 0.0 108.709 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -82.5 133.99 7.46 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.301 2.001 . . . . 0.0 112.796 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 3.7 mp0 -127.95 164.68 21.78 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.422 -0.798 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -137.49 147.35 45.18 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 156.22 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.34 154.9 44.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.458 -0.776 . . . . 0.0 110.065 -178.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -172.34 137.74 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.605 -0.684 . . . . 0.0 109.276 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -88.38 11.56 16.51 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -126.27 147.67 49.65 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.42 0.628 . . . . 0.0 109.78 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.1 tp -95.67 -47.22 6.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.15 -176.87 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.56 -15.87 58.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 111.109 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -88.1 -10.03 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.711 -1.243 . . . . 0.0 110.234 -178.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -75.85 166.78 23.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.978 . . . . 0.0 110.467 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.49 139.91 40.84 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -81.06 149.58 66.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.801 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.39 154.46 50.85 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.488 2.125 . . . . 0.0 111.338 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.13 144.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.63 -38.54 3.07 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.562 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 9.6 mptt -93.2 126.03 38.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -1.165 . . . . 0.0 108.175 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.473 ' HB3' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.5 155.67 33.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 110.109 -179.137 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -50.98 164.67 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.939 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 52.2 t -162.15 165.75 26.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.439 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 97.6 mt -83.93 126.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.59 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.5 p -54.37 157.62 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 108.925 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.54 -59.97 3.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 110.677 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -46.69 -39.93 12.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.115 . . . . 0.0 110.392 -178.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -71.5 -40.22 70.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.929 -1.107 . . . . 0.0 109.394 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -70.84 -41.81 70.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.78 -49.65 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.94 -1.1 . . . . 0.0 109.137 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.66 80.19 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.179 -0.95 . . . . 0.0 109.859 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.71 -53.5 13.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 111.07 -178.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.68 -49.19 41.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.631 -1.293 . . . . 0.0 110.442 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 C--N 1.295 -1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 -176.499 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.538 ' CG ' HH11 ' A' ' 6' ' ' ARG . 2.6 mtt-85 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 58.3 p30 -101.26 178.15 4.73 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -62.05 -6.77 3.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.718 -1.239 . . . . 0.0 109.462 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' NH2' ' NH2' ' A' ' 11' ' ' ARG . 17.7 mmm180 -96.95 -12.12 23.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 86.73 10.05 73.57 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.313 178.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 11' ' ' ARG . 2.9 mtt-85 -85.67 152.02 23.42 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.668 -1.489 . . . . 0.0 109.544 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -84.48 104.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 pp -92.77 146.43 23.65 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.936 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -88.78 -174.54 4.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.049 -1.032 . . . . 0.0 111.466 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 m -57.63 147.33 27.67 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.4 -44.82 3.41 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.51 149.06 50.66 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.995 -1.297 . . . . 0.0 109.555 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -157.21 155.1 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.491 ' OE1' ' CD1' ' A' ' 25' ' ' TYR . 5.2 tp60 -110.81 132.39 54.24 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.542 -0.724 . . . . 0.0 110.007 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.789 HH11 HH21 ' A' ' 24' ' ' ARG . 36.0 mtp180 -90.46 -177.41 5.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -24.1 65.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.209 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.51 -13.1 41.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.004 -1.06 . . . . 0.0 109.702 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.65 -14.46 59.09 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.345 -0.847 . . . . 0.0 111.393 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.789 HH21 HH11 ' A' ' 20' ' ' ARG . 2.1 ptt180 -64.46 141.03 58.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.444 -1.621 . . . . 0.0 109.348 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.491 ' CD1' ' OE1' ' A' ' 19' ' ' GLN . 71.5 m-85 -81.45 165.95 20.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.418 -0.802 . . . . 0.0 110.066 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 tp -153.85 125.81 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.473 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 69.0 t80 -130.72 170.15 14.72 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 33.1 tttm -139.76 142.24 36.77 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.931 -1.106 . . . . 0.0 111.173 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.58 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 43.5 p90 -149.17 -172.91 4.24 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.352 -0.843 . . . . 0.0 108.966 176.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -114.22 134.54 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.952 -1.092 . . . . 0.0 110.147 -178.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 5.0 m-20 -83.98 174.87 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 t -66.6 -6.53 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.9 . . . . 0.0 108.808 178.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 12.0 m-85 -98.18 -4.76 34.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.773 . . . . 0.0 109.069 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.08 -1.11 86.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 pp20? -85.5 144.44 40.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 0.0 108.959 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.62 131.08 11.14 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.978 1.785 . . . . 0.0 112.146 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.627 ' NE2' ' H ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -129.4 172.1 11.85 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.964 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 19.0 m-85 -141.08 163.47 32.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 0.0 110.512 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.54 135.46 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -122.49 143.54 49.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.531 -0.731 . . . . 0.0 110.01 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.6 t -171.7 157.64 4.72 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 178.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -91.19 10.18 28.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HZ2' ' H ' ' A' ' 57' ' ' CYS . 34.1 mtmm -131.81 141.19 49.38 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.717 0.77 . . . . 0.0 110.152 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -94.58 -40.45 9.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.59 168.1 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.04 60.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.421 -0.799 . . . . 0.0 109.729 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.8 p -90.06 -5.52 56.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.165 -0.959 . . . . 0.0 110.314 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.95 172.15 9.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.924 -1.11 . . . . 0.0 109.366 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -142.15 133.65 26.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.135 -0.978 . . . . 0.0 109.255 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.4 150.0 62.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.301 -179.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 151.8 62.84 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.161 1.907 . . . . 0.0 111.213 178.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.84 153.32 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 0.0 110.481 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.21 5.77 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -95.43 139.38 31.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.059 -1.26 . . . . 0.0 109.572 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.509 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.84 164.62 25.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 109.349 -179.48 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -74.45 161.94 29.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.355 -0.841 . . . . 0.0 109.608 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.666 ' H ' ' HZ2' ' A' ' 43' ' ' LYS . 27.8 t -161.73 161.22 29.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.479 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 81.6 mt -82.42 136.34 23.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.021 -1.049 . . . . 0.0 109.227 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -59.19 176.04 0.26 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.53 -0.732 . . . . 0.0 110.123 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 6.9 mp -77.2 -52.68 8.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.474 ' H ' ' CD ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -42.63 -44.41 4.22 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.182 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -71.84 -40.0 69.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -65.04 -40.38 94.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.709 -1.245 . . . . 0.0 109.884 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.19 -55.61 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.958 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.16 95.75 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.5 -1.375 . . . . 0.0 109.89 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.43 -45.28 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 110.652 -179.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.73 -43.5 68.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.815 -1.178 . . . . 0.0 110.255 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 . . . . . 0 C--N 1.298 -1.665 0 O-C-N 121.725 -0.609 . . . . 0.0 110.329 -177.702 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.372 0.606 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 mtpt -152.67 90.15 1.46 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.407 ' CA ' ' HE ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -88.82 151.3 22.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 -179.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -133.95 167.54 20.41 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.539 -0.726 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 42.4 p-10 -91.35 -177.08 4.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 109.772 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -63.09 -9.47 10.72 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.506 -0.746 . . . . 0.0 109.698 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -101.3 -71.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.994 -1.066 . . . . 0.0 110.02 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 169.09 7.08 0.03 OUTLIER Glycine 0 N--CA 1.497 2.703 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.949 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.566 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 67.0 mtm180 -87.98 136.49 32.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.644 -1.503 . . . . 0.0 109.066 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.3 mt -82.61 111.72 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.42 149.85 22.78 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -86.04 -179.71 6.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.803 -1.186 . . . . 0.0 110.97 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t -58.63 145.62 39.03 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.691 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.02 -40.1 2.81 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.328 -0.857 . . . . 0.0 111.189 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 27' ' ' TYR . 46.5 mp0 -72.07 152.18 42.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.709 -1.465 . . . . 0.0 109.997 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -154.67 142.38 19.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -110.27 132.43 54.18 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -89.5 169.87 11.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.313 -0.867 . . . . 0.0 109.347 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -12.6 41.79 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.534 -0.729 . . . . 0.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -87.65 -18.41 29.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.272 -0.893 . . . . 0.0 109.831 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.54 -23.85 25.46 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -64.86 137.89 58.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.424 . . . . 0.0 109.569 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.566 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -82.8 171.41 13.97 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.643 -0.661 . . . . 0.0 110.115 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tt -154.56 127.23 8.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.511 ' CE1' ' OE2' ' A' ' 17' ' ' GLU . 75.9 t80 -132.78 163.19 29.6 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.249 -0.907 . . . . 0.0 109.058 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -131.52 137.05 48.35 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.323 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.72 133.13 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 33' ' ' PHE . 34.6 p30 -88.31 174.61 8.08 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.667 -0.646 . . . . 0.0 110.319 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 t -62.11 6.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 0.0 110.555 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.512 ' H ' ' C ' ' A' ' 31' ' ' ASP . 19.9 m-85 -100.69 -16.31 17.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.98 -1.075 . . . . 0.0 108.432 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.61 -4.86 85.11 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.26 149.88 59.46 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.072 -1.252 . . . . 0.0 108.717 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.96 137.41 24.21 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.405 1.403 . . . . 0.0 109.786 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -135.21 137.63 42.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.915 -1.116 . . . . 0.0 109.274 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.61 145.23 40.74 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.518 -0.739 . . . . 0.0 110.172 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.0 157.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.527 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 55.6 m-85 -127.53 155.73 43.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -170.78 136.5 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.85 -1.156 . . . . 0.0 110.868 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -86.62 5.99 33.14 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -131.76 131.73 43.22 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.615 0.722 . . . . 0.0 110.098 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 tp -86.18 -42.78 13.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.6 OUTLIER -118.75 174.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.93 -16.74 59.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.086 -1.008 . . . . 0.0 110.6 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.5 p -88.39 -4.91 58.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.849 -1.157 . . . . 0.0 110.596 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.546 ' CG ' HH12 ' A' ' 11' ' ' ARG . 73.2 m-20 -70.01 177.31 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.595 -1.316 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -139.6 138.08 35.88 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.08 144.07 50.32 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.49 -0.756 . . . . 0.0 111.044 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.0 143.92 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.449 2.099 . . . . 0.0 112.912 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.79 130.6 17.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -0.775 . . . . 0.0 110.072 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.84 59.71 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -92.22 135.24 34.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.013 -1.286 . . . . 0.0 109.061 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -75.24 161.27 29.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.314 -0.867 . . . . 0.0 110.189 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.55 158.86 3.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.57 -0.706 . . . . 0.0 110.23 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 9.3 t -147.31 158.0 43.8 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 87.1 mt -83.09 124.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.872 -1.143 . . . . 0.0 109.306 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 19.8 m -58.41 153.9 14.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.206 -0.934 . . . . 0.0 109.543 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.86 -53.45 57.8 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.611 -0.835 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -48.88 -44.65 40.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.885 -1.135 . . . . 0.0 109.043 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -72.33 -39.06 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 40' ' ' TYR . 11.0 ttmt -67.32 -49.86 62.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.977 -1.077 . . . . 0.0 109.444 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -50.34 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.27 -49.26 74.73 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 110.42 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -68.87 -39.75 79.66 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 111.701 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.31 -48.59 49.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.699 -1.251 . . . . 0.0 111.305 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -71.35 -37.74 71.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.123 -0.985 . . . . 0.0 110.44 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -74.08 -23.03 59.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.646 -1.284 . . . . 0.0 110.29 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -98.8 -51.41 3.9 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.172 -0.955 . . . . 0.0 110.827 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -81.37 13.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.079 -1.013 . . . . 0.0 109.373 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -151.65 37.14 0.58 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.585 -1.322 . . . . 0.0 109.011 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.42 -0.8 . . . . 0.0 109.638 179.793 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.667 ' N ' ' HZ1' ' A' ' 4' ' ' LYS . 77.7 mm-40 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.667 ' HZ1' ' N ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -152.61 -113.92 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.238 -0.913 . . . . 0.0 109.577 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.531 ' CG ' HH11 ' A' ' 5' ' ' ARG . 0.2 OUTLIER -83.82 147.75 27.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.804 -1.185 . . . . 0.0 108.802 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -135.16 172.97 12.26 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.36 -0.837 . . . . 0.0 109.27 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 37.6 p-10 -95.24 -170.81 2.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.371 -0.831 . . . . 0.0 109.59 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 70.1 m-80 -68.18 -11.57 59.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.849 . . . . 0.0 110.789 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -103.47 -23.27 13.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.028 -1.045 . . . . 0.0 109.907 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 109.41 19.27 8.48 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 24.3 mtt180 -84.71 124.59 31.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.131 -1.217 . . . . 0.0 109.47 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mm -75.45 101.73 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.835 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.24 150.62 20.04 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -87.48 -171.81 3.63 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.0 111.45 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.431 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 66.2 p -54.06 149.95 8.68 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.0 -45.25 2.48 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 1.4 mp0 -69.22 131.84 45.55 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.563 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.3 m -152.7 152.35 31.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.287 -0.883 . . . . 0.0 108.775 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.444 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.1 tt0 -95.92 141.59 29.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.042 -1.037 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -88.11 163.03 16.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.718 -0.613 . . . . 0.0 109.376 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -62.71 -19.82 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.018 -1.051 . . . . 0.0 108.571 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.91 -13.59 44.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.913 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.31 -26.83 19.02 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 121.258 -0.901 . . . . 0.0 111.075 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -61.99 135.92 57.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.694 -1.474 . . . . 0.0 110.237 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH1' ' A' ' 11' ' ' ARG . 74.1 m-85 -80.57 168.28 19.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -161.04 147.38 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.0 -1.062 . . . . 0.0 109.298 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.537 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 84.6 t80 -139.16 168.05 20.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 65.5 tttt -127.06 138.99 53.32 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.433 -0.792 . . . . 0.0 109.437 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -138.39 170.7 15.55 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mm -108.47 136.57 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.405 -0.809 . . . . 0.0 110.123 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.4 m-20 -78.47 161.82 26.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.22 -0.925 . . . . 0.0 108.649 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 t -59.79 -2.82 0.42 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 109.317 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.4 m-85 -101.53 -18.46 15.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.335 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 2.4 51.5 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 121.227 -0.921 . . . . 0.0 111.237 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -86.26 148.15 46.57 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.78 -1.424 . . . . 0.0 110.191 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 87.2 Cg_endo -76.99 128.32 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 122.94 2.427 . . . . 0.0 113.213 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.524 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -131.29 163.45 27.79 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -131.73 156.2 46.35 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.282 -0.886 . . . . 0.0 109.892 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.41 147.04 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -125.79 151.57 46.58 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.783 0.801 . . . . 0.0 109.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -172.27 145.47 1.72 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -87.79 23.79 1.92 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.951 -1.093 . . . . 0.0 108.281 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -137.37 137.56 38.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.593 -0.692 . . . . 0.0 110.539 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.0 tp -95.18 -42.33 8.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 47' ' ' THR . 18.2 m -126.86 147.49 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.15 -7.04 0.17 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 45' ' ' VAL . 30.8 p -89.82 -4.74 57.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.998 -1.064 . . . . 0.0 110.184 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.21 164.18 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.142 -0.974 . . . . 0.0 110.801 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -134.86 121.03 20.04 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.3 150.69 64.61 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.75 150.52 44.84 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.491 2.128 . . . . 0.0 111.69 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.83 147.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.83 -38.36 3.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -95.17 131.21 41.45 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.307 -1.114 . . . . 0.0 108.485 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -77.76 153.4 32.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.839 -1.163 . . . . 0.0 109.689 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.02 163.31 22.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.45 -0.781 . . . . 0.0 110.128 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 29.6 t -157.16 169.71 24.17 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.589 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.7 mt -82.42 136.82 22.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 94.5 p -55.85 154.31 7.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.149 -0.969 . . . . 0.0 109.311 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 61' ' ' ARG . 78.6 mt -62.01 -49.61 75.37 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.308 -0.87 . . . . 0.0 110.272 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 60' ' ' LEU . 30.5 mtt180 -46.65 -47.53 20.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.786 -1.196 . . . . 0.0 109.787 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -72.18 -34.83 68.72 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -68.71 -41.57 78.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 108.913 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.26 -52.54 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.45 -34.45 72.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -70.85 -35.33 72.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.424 -0.798 . . . . 0.0 111.535 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.61 -39.93 95.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.821 -1.174 . . . . 0.0 110.658 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -70.96 -44.59 65.73 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 120.538 -1.351 . . . . 0.0 111.352 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.94 -14.86 58.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.577 -1.327 . . . . 0.0 111.369 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -89.04 -23.55 22.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.868 -1.145 . . . . 0.0 110.658 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 mm -88.67 -4.59 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.001 -1.062 . . . . 0.0 109.402 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -150.33 149.82 30.62 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.04 -1.037 . . . . 0.0 110.047 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.561 -0.712 . . . . 0.0 110.095 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -85.32 -172.7 4.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.077 -1.015 . . . . 0.0 110.597 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.518 ' CG ' HH11 ' A' ' 5' ' ' ARG . 5.3 mtt-85 -87.66 162.0 17.35 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.474 0.654 . . . . 0.0 110.299 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 6' ' ' ARG . 35.9 mtm-85 -137.89 -179.31 5.69 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -95.69 -163.88 1.1 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.082 -1.012 . . . . 0.0 109.85 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 13.4 p30 -67.07 -23.54 65.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -100.03 5.02 45.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 110.637 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.43 49.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -87.19 134.86 33.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.137 -1.214 . . . . 0.0 110.205 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.4 mm -84.44 97.1 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 108.773 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.78 146.02 24.47 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.039 -1.038 . . . . 0.0 109.708 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.79 178.59 6.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.122 -0.986 . . . . 0.0 109.732 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -57.26 147.02 26.61 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.532 0.682 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.55 -45.23 1.76 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 24.3 mp0 -72.41 156.62 38.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.106 -1.232 . . . . 0.0 109.802 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.8 m -157.75 140.91 15.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.534 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.4 tt0 -94.85 142.18 27.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -92.25 169.08 10.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.631 0.729 . . . . 0.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -63.48 -23.1 67.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.701 -0.624 . . . . 0.0 110.553 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -88.1 -17.49 30.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 0.0 110.133 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.39 -32.21 6.02 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -60.4 135.15 57.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.736 -1.449 . . . . 0.0 109.558 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.68 170.18 16.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 111.192 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.3 tp -152.03 121.66 6.93 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 82.3 t80 -125.14 174.66 7.91 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.236 -0.915 . . . . 0.0 108.57 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.576 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 75.1 tttt -128.06 121.77 30.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 109.779 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -124.3 158.47 32.49 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.96 150.02 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.467 ' CG ' ' NE2' ' A' ' 37' ' ' GLN . 69.1 m-20 -80.9 170.44 16.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 108.937 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.7 m -68.07 -2.64 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -96.96 -17.51 20.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.132 -0.98 . . . . 0.0 109.389 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.59 -4.41 32.71 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 20.9 pt-20 -85.34 145.67 43.08 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.882 -1.363 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 86.2 Cg_endo -78.57 146.97 21.94 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.645 2.23 . . . . 0.0 113.44 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.469 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.8 mp0 -142.3 178.35 7.63 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -133.95 152.9 52.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 0.0 109.531 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.92 158.58 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.451 -0.781 . . . . 0.0 109.33 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -128.95 149.96 50.58 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.277 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -168.37 142.28 3.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 0.0 109.949 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -90.37 11.63 20.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -139.87 153.48 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 0.0 110.442 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 59' ' ' SER . 42.9 tp -99.25 -43.61 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.95 170.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.15 -15.58 59.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 0.0 110.886 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.2 p -86.57 -13.76 44.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.588 -1.32 . . . . 0.0 110.069 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -71.17 178.94 3.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.389 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.8 147.73 46.78 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.92 149.66 74.09 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.976 -1.077 . . . . 0.0 109.553 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -51.7 147.64 23.72 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.337 1.358 . . . . 0.0 111.432 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.24 141.18 11.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 -24.64 29.14 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -96.81 140.74 30.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.313 . . . . 0.0 109.356 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -74.45 153.28 39.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.807 -1.183 . . . . 0.0 109.148 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.31 163.32 0.41 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.181 -0.949 . . . . 0.0 110.09 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -148.38 160.12 43.33 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 99.0 mt -84.84 134.26 27.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 44.3 t -58.47 153.87 15.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.661 -0.65 . . . . 0.0 110.052 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -60.82 -53.13 61.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -49.87 -45.74 50.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.935 -1.103 . . . . 0.0 109.845 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.9 -29.9 66.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 108.675 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -72.39 -45.54 59.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.459 -0.775 . . . . 0.0 109.204 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.35 -55.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 0.0 110.252 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.06 93.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 0.0 110.647 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -68.74 -35.16 76.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 111.803 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.03 -41.78 86.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.569 -1.332 . . . . 0.0 111.755 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -67.06 -44.71 79.44 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 120.239 -1.538 . . . . 0.0 111.335 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -78.97 -3.11 43.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.777 -1.202 . . . . 0.0 111.514 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -109.14 -52.65 2.74 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.839 -1.163 . . . . 0.0 112.446 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 71' ' ' ILE . 2.0 pp -82.6 102.19 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.786 -1.196 . . . . 0.0 110.342 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 9.7 p-80 -156.52 15.84 0.31 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.648 -1.283 . . . . 0.0 109.66 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 109.526 -179.654 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.2 pm0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -83.7 114.51 21.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.174 -0.954 . . . . 0.0 108.727 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -91.96 125.58 36.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.219 -0.926 . . . . 0.0 109.355 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -139.46 -178.38 5.36 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -70.34 175.24 4.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 0.0 110.264 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.5 HD21 ' CD ' ' A' ' 19' ' ' GLN . 79.9 m-20 -66.81 -12.4 58.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.476 -0.765 . . . . 0.0 109.931 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' NH1' ' HG3' ' A' ' 9' ' ' ARG . 7.7 mmm-85 -95.57 -77.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 0.0 109.349 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.96 3.7 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.216 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 55.9 mtm180 -88.14 125.27 34.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.732 -1.452 . . . . 0.0 108.869 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.3 mt -77.79 110.95 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.07 -1.019 . . . . 0.0 109.832 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.2 156.71 18.12 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -88.79 -176.84 5.36 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.816 -1.178 . . . . 0.0 110.775 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 17' ' ' GLU . 73.2 p -54.63 161.65 1.42 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.801 0.81 . . . . 0.0 112.068 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.34 -19.26 1.89 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 40.4 mt-10 -86.92 150.03 24.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.266 . . . . 0.0 110.295 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.0 p -157.5 134.05 9.83 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.5 ' CD ' HD21 ' A' ' 8' ' ' ASN . 47.9 tt0 -99.2 125.8 44.86 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' CG ' HH11 ' A' ' 20' ' ' ARG . 1.0 OUTLIER -85.57 -174.13 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.816 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -72.48 -22.9 60.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 109.937 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.67 -10.97 57.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.89 -21.94 43.42 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -61.33 138.05 58.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.847 -1.384 . . . . 0.0 109.294 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 67.3 m-85 -80.54 166.72 20.9 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.252 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.3 tp -150.24 119.07 6.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 109.623 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -125.44 162.27 25.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -131.44 138.13 48.92 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.25 -0.906 . . . . 0.0 110.736 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.2 p90 -142.82 164.51 29.9 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.62 138.85 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.94 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 52.8 m-20 -87.37 -178.35 6.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.949 . . . . 0.0 110.4 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 p -66.91 -1.37 3.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.321 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 47.9 m-85 -98.58 -10.63 23.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.951 . . . . 0.0 108.713 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.45 -8.52 76.88 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -81.37 145.2 54.99 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.5 148.22 42.27 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.94 1.76 . . . . 0.0 112.717 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.1 mp0 -135.67 170.71 15.54 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.28 145.89 39.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.346 -0.846 . . . . 0.0 110.383 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.85 146.49 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -128.91 151.11 50.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.597 -0.69 . . . . 0.0 109.596 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -171.66 146.19 2.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -88.83 11.42 17.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 108.51 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -123.57 140.99 52.44 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.555 -0.716 . . . . 0.0 110.226 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.79 -44.95 6.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.38 172.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -19.41 62.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.2 p -86.7 -1.98 58.15 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.703 -1.248 . . . . 0.0 110.788 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' OD1' ' NH1' ' A' ' 11' ' ' ARG . 76.0 m-20 -70.6 -174.22 0.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.585 -1.322 . . . . 0.0 109.334 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -148.75 130.53 15.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.043 -1.035 . . . . 0.0 109.454 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 15.0 m -80.97 130.07 64.91 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.83 -1.169 . . . . 0.0 109.272 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -48.87 148.05 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.188 1.259 . . . . 0.0 111.711 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.14 135.46 13.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.112 -0.992 . . . . 0.0 109.817 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.13 -32.66 6.68 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -92.33 136.47 33.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -1.165 . . . . 0.0 108.553 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -74.59 151.78 39.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.377 -0.827 . . . . 0.0 110.439 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -55.62 169.48 0.32 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 43.6 t -165.15 166.46 19.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.131 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 71.5 mt -83.6 125.48 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.015 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -56.69 156.0 6.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.337 -0.852 . . . . 0.0 109.638 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 mp -56.13 -47.85 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 17' ' ' GLU . 5.0 mmp_? -53.25 -50.6 64.47 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.013 -1.054 . . . . 0.0 110.291 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.29 -36.68 61.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.753 -1.217 . . . . 0.0 110.806 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -65.97 -44.34 85.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.747 -1.22 . . . . 0.0 110.105 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.68 -48.78 87.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.48 -42.71 74.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.93 -1.106 . . . . 0.0 109.974 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.27 -51.86 27.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 110.807 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.7 mt -68.27 -26.32 65.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 111.752 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.98 -68.68 0.58 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 120.804 -1.185 . . . . 0.0 112.745 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 73' ' ' ASP . 16.1 ptmt -75.06 -39.1 61.13 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.611 -1.306 . . . . 0.0 112.844 -177.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -60.85 -33.49 73.15 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.458 -1.401 . . . . 0.0 109.369 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.2 mm -85.76 -3.11 8.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.549 -0.719 . . . . 0.0 110.743 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -144.76 -59.98 0.36 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.934 -1.104 . . . . 0.0 109.673 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' LYS . 58.1 t0 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.129 -0.982 . . . . 0.0 109.317 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -82.64 168.55 17.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.059 -1.026 . . . . 0.0 109.439 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -80.95 151.81 28.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.671 -0.643 . . . . 0.0 110.446 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -134.92 166.63 22.56 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.527 -0.733 . . . . 0.0 109.93 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -100.82 -176.47 3.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.732 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -66.29 -15.17 63.01 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.042 -1.036 . . . . 0.0 110.034 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.512 HH11 ' CG ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -95.39 -0.51 52.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 -178.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 0.45 86.45 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -84.57 137.04 33.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.107 -1.231 . . . . 0.0 109.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.6 mt -80.47 120.06 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.916 -1.115 . . . . 0.0 109.743 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -90.32 150.59 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 18.8 mtpp -87.09 -178.03 6.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.926 -1.109 . . . . 0.0 110.608 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 29.7 p -57.1 149.05 20.21 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 111.571 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.16 -30.37 2.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 15' ' ' THR . 43.1 mp0 -76.15 154.17 35.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.845 -1.385 . . . . 0.0 109.296 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -157.43 138.24 13.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.066 -1.022 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -99.37 134.34 42.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.464 HH11 ' HG3' ' A' ' 20' ' ' ARG . 5.2 mmm-85 -87.54 176.02 7.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -21.33 63.56 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -83.52 -7.27 59.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.618 -0.676 . . . . 0.0 110.527 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.11 -28.46 13.84 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 120.97 -1.081 . . . . 0.0 111.068 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -57.13 154.33 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.853 -1.381 . . . . 0.0 109.616 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.63 169.85 9.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 109.731 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 tt -154.83 133.3 11.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.456 -0.777 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.96 146.41 49.08 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -118.92 136.38 54.09 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.653 -0.654 . . . . 0.0 110.606 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.513 ' CD2' ' OE1' ' A' ' 37' ' ' GLN . 7.3 p90 -148.12 -171.9 3.94 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.365 -0.834 . . . . 0.0 110.287 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.7 mp -106.64 129.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.9 p30 -86.47 -171.66 3.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.189 -0.944 . . . . 0.0 109.6 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.76 19.89 0.19 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.881 -1.137 . . . . 0.0 109.291 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 10.7 m-85 -118.29 -15.05 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.337 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.21 64.56 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.6 147.94 50.6 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.183 -1.186 . . . . 0.0 109.583 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.8 140.07 34.73 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.014 1.81 . . . . 0.0 112.36 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.677 ' N ' ' NE2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.0 164.65 26.51 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 23.2 m-85 -128.65 141.41 51.35 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.17 -0.957 . . . . 0.0 109.271 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.85 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -122.52 154.89 37.26 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.702 0.763 . . . . 0.0 110.113 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -171.26 143.6 1.9 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.999 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -97.17 18.25 15.38 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.81 144.72 31.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.324 -0.86 . . . . 0.0 110.202 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 59' ' ' SER . 45.1 tp -94.25 -43.92 8.21 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.24 167.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -12.55 61.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.488 -0.757 . . . . 0.0 111.261 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.0 m -86.79 -9.6 55.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.903 -1.123 . . . . 0.0 110.098 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.28 167.19 16.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -140.2 118.85 12.34 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.92 148.24 86.88 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.38 157.1 62.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.183 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.96 150.5 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.311 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.64 -41.62 2.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -98.13 132.04 44.0 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.493 -1.004 . . . . 0.0 108.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.86 157.66 31.3 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.086 -1.009 . . . . 0.0 109.896 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -53.78 159.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.4 m -148.6 176.19 10.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 109.192 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.61 126.66 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 31.5 t -55.63 148.53 15.83 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.16 -0.963 . . . . 0.0 108.481 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 mt -58.52 -52.43 65.68 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.461 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -49.36 -37.24 24.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.704 -1.247 . . . . 0.0 108.989 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.35 -43.5 60.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.279 -0.888 . . . . 0.0 109.364 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -65.06 -44.36 89.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.494 -0.754 . . . . 0.0 109.613 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.09 -47.06 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.67 -46.58 88.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.099 -1.0 . . . . 0.0 109.851 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.47 -40.05 70.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.234 -0.916 . . . . 0.0 110.843 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.4 -45.24 80.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 112.082 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.42 -24.74 57.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.27 -1.519 . . . . 0.0 110.263 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -77.43 -39.75 45.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.08 -1.012 . . . . 0.0 110.725 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.86 -18.83 38.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.087 -1.008 . . . . 0.0 109.933 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.477 ' N ' HD11 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -78.99 -36.65 18.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.702 -0.623 . . . . 0.0 109.751 -178.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -147.62 129.24 15.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.09 -1.006 . . . . 0.0 108.941 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.698 -0.627 . . . . 0.0 110.088 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.4 mtpp -82.54 168.87 16.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.4 -0.812 . . . . 0.0 110.003 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.2 ptt-85 -82.17 164.14 21.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.227 -0.92 . . . . 0.0 110.362 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.6 mtm-85 -138.76 160.22 40.2 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 43.6 p-10 -76.83 -175.08 3.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.042 . . . . 0.0 109.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.58 -6.16 3.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.65 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -104.77 -81.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 0.0 109.404 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 177.72 2.81 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 17.5 ptt180 -86.96 132.03 33.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.082 -1.246 . . . . 0.0 108.584 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 12' ' ' ILE . 96.0 mt -70.08 131.86 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.46 163.01 16.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 175.98 7.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.098 -1.001 . . . . 0.0 109.783 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -60.96 130.32 45.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.859 -0.526 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.58 -37.29 3.42 Favored Glycine 0 N--CA 1.501 2.973 0 O-C-N 121.218 -0.926 . . . . 0.0 111.892 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 59.1 mp0 -72.62 150.58 42.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.638 -1.507 . . . . 0.0 110.265 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -155.8 148.39 23.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.316 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -104.8 132.93 50.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.963 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -85.42 170.9 12.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 109.632 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -68.68 -18.49 64.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.15 -21.31 36.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 110.359 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.53 3.86 Favored Glycine 0 N--CA 1.502 3.082 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -61.06 139.64 58.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.124 -1.221 . . . . 0.0 109.191 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 86.6 m-85 -85.73 170.3 12.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.835 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.4 tp -151.46 128.15 10.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -129.88 142.95 50.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.57 142.08 47.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.569 -0.707 . . . . 0.0 110.247 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -149.09 -171.41 3.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.0 109.53 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.11 134.85 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.261 -0.899 . . . . 0.0 110.221 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' OD2' ' OE1' ' A' ' 37' ' ' GLN . 12.5 m-20 -87.05 175.25 8.2 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.862 -1.149 . . . . 0.0 110.392 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.594 ' HG ' ' H ' ' A' ' 73' ' ' ASP . 47.4 m -70.76 -2.71 15.58 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 11.0 m-85 -98.67 -11.59 21.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.589 -0.694 . . . . 0.0 109.357 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.79 -5.88 79.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.547 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.9 pt-20 -86.75 152.08 53.54 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.159 -1.201 . . . . 0.0 109.328 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' C ' HE21 ' A' ' 37' ' ' GLN . 95.3 Cg_endo -78.25 155.1 28.92 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.137 1.891 . . . . 0.0 112.441 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -148.86 160.14 43.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.217 -0.927 . . . . 0.0 109.235 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -136.66 148.97 47.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 m -122.24 145.37 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -116.03 151.51 35.36 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 t -169.64 145.54 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.28 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.72 9.07 36.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -132.32 133.64 44.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.1 tp -88.99 -42.96 11.47 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.67 151.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.42 -7.08 3.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.109 -0.995 . . . . 0.0 111.156 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.1 p -90.34 -11.8 39.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.749 -1.22 . . . . 0.0 109.774 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.62 172.49 11.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.181 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.33 135.03 33.34 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.24 147.39 60.53 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.745 -1.222 . . . . 0.0 110.451 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.61 145.7 71.02 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.13 1.887 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.72 144.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 110.573 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.12 -32.62 7.3 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -97.07 139.11 33.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.159 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.62 151.8 34.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -0.966 . . . . 0.0 109.771 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.7 150.53 15.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.141 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.7 p -147.32 161.98 39.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.046 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.69 126.81 40.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.0 m -56.33 160.94 2.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.157 -0.964 . . . . 0.0 108.801 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.04 -47.6 73.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.748 -1.22 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -41.54 -53.01 3.58 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.401 -0.812 . . . . 0.0 110.28 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -69.01 -34.43 75.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.088 -1.008 . . . . 0.0 108.662 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -68.77 -41.87 78.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -50.15 -51.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.138 -0.976 . . . . 0.0 109.266 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.7 70.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.852 -1.155 . . . . 0.0 109.525 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.93 -44.87 60.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.91 . . . . 0.0 111.481 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.414 ' O ' ' CG1' ' A' ' 71' ' ' ILE . 4.5 mm? -69.54 -44.06 71.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.23 -1.544 . . . . 0.0 110.899 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -73.26 -18.01 61.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.762 -1.836 . . . . 0.0 110.886 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -79.46 -63.65 1.37 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.572 -1.33 . . . . 0.0 110.905 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.85 -27.78 31.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.505 -1.372 . . . . 0.0 107.824 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.469 HD11 ' H ' ' A' ' 32' ' ' SER . 36.7 mm -81.55 113.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.402 ' CD2' ' C ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -133.09 15.5 4.2 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.296 -177.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.594 ' H ' ' HG ' ' A' ' 32' ' ' SER . 57.3 t0 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 120.913 -1.117 . . . . 0.0 109.423 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -155.28 -141.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -83.34 150.42 26.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.943 -1.098 . . . . 0.0 109.536 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -136.35 177.84 7.53 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.327 -0.858 . . . . 0.0 109.849 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.57 -159.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.407 -0.808 . . . . 0.0 109.743 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.112 -0.992 . . . . 0.0 110.261 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -92.18 -86.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.041 . . . . 0.0 109.496 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.1 22.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.551 ' NH1' ' OD2' ' A' ' 48' ' ' ASP . 67.6 mtm180 -88.72 135.73 33.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.795 -1.415 . . . . 0.0 110.578 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.8 mm -76.37 114.46 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 140.45 33.14 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -86.39 179.01 6.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.963 -1.085 . . . . 0.0 111.028 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -52.13 155.12 2.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.418 0.628 . . . . 0.0 109.84 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.68 -44.75 2.06 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -70.28 147.17 50.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -1.231 . . . . 0.0 109.272 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -155.24 157.5 37.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.649 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.0 tp-100 -107.28 123.12 47.85 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.388 -0.82 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.539 ' NH2' ' OH ' ' A' ' 40' ' ' TYR . 18.3 mtt180 -83.62 169.49 15.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.201 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.877 . . . . 0.0 109.622 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' A' ' 24' ' ' ARG . 1.4 p30 -91.43 -26.58 18.78 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.97 -1.081 . . . . 0.0 109.98 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.42 -36.25 2.96 Favored Glycine 0 N--CA 1.505 3.295 0 O-C-N 121.268 -0.895 . . . . 0.0 111.443 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.531 ' NH2' ' OD2' ' A' ' 22' ' ' ASP . 3.3 ptt-85 -60.57 132.92 55.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.604 -1.527 . . . . 0.0 109.438 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 86.2 m-85 -87.04 168.93 12.86 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pp -147.4 138.22 23.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -125.31 156.97 37.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.662 -0.649 . . . . 0.0 109.452 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -117.68 138.97 51.64 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 16.7 p90 -148.83 -165.89 2.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.984 -1.072 . . . . 0.0 109.961 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.439 ' O ' ' CD2' ' A' ' 29' ' ' TYR . 1.4 mp -107.48 136.37 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 O-C-N 121.315 -0.866 . . . . 0.0 110.461 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.59 ' CG ' HE21 ' A' ' 37' ' ' GLN . 17.0 m-20 -80.56 173.01 13.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.006 -1.059 . . . . 0.0 109.494 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -9.59 10.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 11.5 m-85 -104.21 -6.76 20.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.471 -0.768 . . . . 0.0 110.824 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.26 -4.6 64.87 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.028 -1.045 . . . . 0.0 110.539 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.02 150.54 47.8 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.832 -1.393 . . . . 0.0 110.102 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.55 152.65 23.12 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.268 1.979 . . . . 0.0 113.554 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.59 HE21 ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -157.83 179.89 8.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.75 149.58 50.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.857 -1.152 . . . . 0.0 110.179 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.02 162.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.539 ' OH ' ' NH2' ' A' ' 20' ' ' ARG . 84.1 m-85 -137.0 153.83 50.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.256 -0.902 . . . . 0.0 110.767 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -168.23 149.75 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -86.97 3.68 44.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.337 -0.852 . . . . 0.0 109.302 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.579 ' CB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -131.95 153.13 50.61 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.392 -0.818 . . . . 0.0 109.459 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 59' ' ' SER . 19.5 tp -93.36 -51.14 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.348 0.594 . . . . 0.0 109.975 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.51 175.62 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.42 0.628 . . . . 0.0 110.5 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.86 63.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 111.095 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -85.16 -8.08 58.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.817 -1.177 . . . . 0.0 110.309 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 59.8 m-20 -74.46 174.38 9.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 109.819 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -139.68 149.51 43.76 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -80.85 138.81 49.99 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.269 -0.894 . . . . 0.0 109.934 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -46.18 140.82 10.47 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.923 1.749 . . . . 0.0 111.706 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.6 132.13 17.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.14 -30.75 6.6 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -94.54 145.5 24.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -1.083 . . . . 0.0 108.706 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.6 150.66 34.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 108.726 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -49.53 162.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.01 -1.056 . . . . 0.0 109.845 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 38.2 t -154.78 173.64 16.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.155 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.473 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 5.9 mm -92.1 132.16 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.467 -0.77 . . . . 0.0 109.317 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 45.9 t -55.78 164.11 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.283 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 mp -71.32 -57.48 4.43 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.521 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -45.82 -41.92 11.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -69.06 -41.88 77.02 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.34 -0.944 . . . . 0.0 108.877 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -67.16 -42.03 84.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.938 . . . . 0.0 109.954 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.76 -49.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.76 -1.213 . . . . 0.0 108.635 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.61 83.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.0 110.292 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -70.97 -43.12 68.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.89 . . . . 0.0 111.171 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.66 -44.06 78.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 111.545 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.438 ' O ' ' O ' ' A' ' 72' ' ' HIS . 32.6 mt-30 -71.99 -38.74 69.63 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.815 -1.178 . . . . 0.0 110.539 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -74.88 -42.0 58.7 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.407 -0.808 . . . . 0.0 110.59 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.05 -36.4 81.51 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.193 -0.942 . . . . 0.0 111.307 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.504 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 8.4 pt -82.44 -42.13 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.0 110.258 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 71' ' ' ILE . 77.9 m-70 -157.83 154.0 27.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.085 -1.01 . . . . 0.0 109.704 179.795 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -87.42 74.88 9.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -94.7 -148.03 0.27 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 110.02 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 6' ' ' ARG . 1.7 mtt-85 -132.61 163.65 28.42 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -84.66 -171.66 3.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -66.96 -14.87 63.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.882 . . . . 0.0 109.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -95.04 -5.07 45.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -0.894 . . . . 0.0 108.911 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.82 58.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' CG ' ' A' ' 48' ' ' ASP . 17.9 mmt180 -90.67 142.12 28.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -1.183 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mm -82.55 119.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 108.004 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp -90.75 145.06 25.11 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -87.6 179.28 6.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.052 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -57.52 136.74 56.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.256 -0.902 . . . . 0.0 110.036 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.27 -56.48 1.23 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -49.3 148.69 2.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 110.021 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -157.13 156.84 33.39 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -99.74 145.17 27.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.027 -1.046 . . . . 0.0 110.493 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -89.59 149.72 22.72 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.594 ' CD ' ' H ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -58.36 -20.57 44.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -89.15 -11.23 44.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 110.43 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.28 -35.0 5.24 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.525 HH21 ' HE1' ' A' ' 42' ' ' TRP . 2.4 ptp180 -59.12 143.96 47.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.412 . . . . 0.0 108.738 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -90.73 162.68 14.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.915 . . . . 0.0 110.183 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.33 140.42 25.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.666 0.746 . . . . 0.0 109.509 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -134.47 151.98 51.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -120.04 142.11 49.13 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.549 -0.719 . . . . 0.0 109.286 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -140.86 163.1 33.86 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.92 138.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.153 -0.967 . . . . 0.0 109.969 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' CG ' ' NE2' ' A' ' 37' ' ' GLN . 45.3 m-20 -84.12 161.68 20.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.6 p -63.24 -3.25 1.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' ASP . 3.4 m-85 -99.75 -15.96 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.379 -0.826 . . . . 0.0 109.085 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.32 56.89 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -80.59 156.29 73.22 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.499 -1.589 . . . . 0.0 107.125 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -93.53 141.08 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.563 1.508 . . . . 0.0 111.101 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.493 ' NE2' ' CG ' ' A' ' 31' ' ' ASP . 2.8 mp0 -130.02 154.64 47.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.539 -0.726 . . . . 0.0 109.126 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.2 147.89 52.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -123.11 156.05 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.442 -0.786 . . . . 0.0 109.037 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.9 156.12 44.93 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.427 -0.795 . . . . 0.0 109.696 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -174.31 146.31 1.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.592 -0.693 . . . . 0.0 109.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.64 ' H ' ' HG ' ' A' ' 57' ' ' CYS . 54.7 m95 -90.46 3.49 53.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -123.77 142.5 51.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -92.42 -44.49 8.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.543 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 46' ' ' ALA . 2.1 t -121.7 174.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' H ' HG13 ' A' ' 45' ' ' VAL . . . -72.74 -15.14 61.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -92.47 -8.52 44.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.049 -1.032 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.474 ' CG ' ' NH2' ' A' ' 11' ' ' ARG . 1.1 m-20 -72.54 168.84 17.75 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.278 -0.888 . . . . 0.0 109.805 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -134.73 144.64 47.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.21 122.62 81.57 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.0 110.495 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.88 151.79 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.509 1.473 . . . . 0.0 112.025 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.85 139.58 7.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.56 -30.88 9.31 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 13.0 mptt -93.46 127.26 39.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -1.15 . . . . 0.0 108.242 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -78.01 149.74 33.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.579 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 53.1 t0 -40.06 147.03 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.789 -0.569 . . . . 0.0 109.902 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.64 ' HG ' ' H ' ' A' ' 42' ' ' TRP . 21.5 p -153.66 164.86 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG2' ' CD ' ' A' ' 62' ' ' GLU . 20.3 mt -83.29 129.3 37.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.634 0.731 . . . . 0.0 110.032 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 92.4 p -60.84 173.14 0.8 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 63' ' ' LYS . 96.6 mt -83.92 -59.71 2.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.867 -1.146 . . . . 0.0 110.071 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' LEU . 37.6 mtt180 -40.01 -35.0 0.33 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' CD ' ' CG2' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -72.9 -40.89 65.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.736 -1.227 . . . . 0.0 108.582 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 60' ' ' LEU . 46.2 mttm -63.91 -46.46 84.72 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.505 -0.747 . . . . 0.0 109.719 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.2 mp -53.44 -49.41 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.66 94.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -78.73 -44.18 24.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.06 -1.025 . . . . 0.0 112.501 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -66.71 -38.82 87.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.127 -1.608 . . . . 0.0 111.432 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -70.67 -50.07 40.5 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 120.477 -1.389 . . . . 0.0 110.612 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.31 -14.64 58.87 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.762 -1.211 . . . . 0.0 112.13 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -84.27 -13.12 53.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.282 -1.511 . . . . 0.0 110.505 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 mm -85.63 -37.75 12.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.106 -0.996 . . . . 0.0 109.399 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.5 m170 -85.41 -175.69 5.79 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.115 -0.991 . . . . 0.0 109.554 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -84.66 149.48 25.79 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -82.68 140.61 33.03 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.905 -1.122 . . . . 0.0 109.436 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -140.29 173.96 10.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.284 -0.885 . . . . 0.0 109.216 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 39.4 p-10 -80.57 -169.23 2.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.726 HD22 ' NE2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -70.24 -21.11 63.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 108.831 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.5 mmm-85 -95.81 1.89 53.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.457 -0.777 . . . . 0.0 110.42 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 82.51 20.64 61.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.543 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -86.97 149.29 24.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.344 . . . . 0.0 108.567 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 mm -90.6 119.37 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.422 -0.799 . . . . 0.0 109.174 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 1.7 mm? -89.45 136.68 32.89 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 14' ' ' LYS . 8.9 mtmp? -86.38 -174.15 4.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.876 -1.14 . . . . 0.0 110.447 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 17' ' ' GLU . 8.8 m -51.55 138.99 21.29 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.753 -0.592 . . . . 0.0 110.206 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.04 -42.18 0.76 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 15' ' ' THR . 85.7 mt-10 -66.02 140.18 58.26 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.043 -1.269 . . . . 0.0 109.845 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 92.4 p -158.22 164.47 36.47 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.726 ' NE2' HD22 ' A' ' 8' ' ' ASN . 1.5 tm0? -92.8 150.44 20.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.888 -1.132 . . . . 0.0 109.393 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' NH1' ' CZ ' ' A' ' 24' ' ' ARG . 2.2 ttt180 -89.79 161.77 15.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.336 -0.852 . . . . 0.0 109.429 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -57.36 -30.06 64.55 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.906 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -84.92 -44.22 13.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 0.0 110.16 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.53 -31.81 1.02 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' CZ ' ' NH1' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -61.26 144.61 53.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.897 -1.355 . . . . 0.0 108.985 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -85.7 164.73 17.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.32 150.94 28.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 109.708 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.502 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 63.4 t80 -134.96 169.2 17.77 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 26.8 tttm -128.09 138.74 52.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.298 -0.876 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.498 ' HH ' ' CD1' ' A' ' 67' ' ' LEU . 8.3 p90 -144.82 159.8 42.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.4 mp -100.34 136.31 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.34 -0.85 . . . . 0.0 109.165 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 33' ' ' PHE . 54.8 m-20 -81.5 166.76 20.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.164 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -60.55 1.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -1.0 . . . . 0.0 111.068 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 9.6 m-85 -101.47 -21.17 14.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.924 -1.11 . . . . 0.0 108.557 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.52 39.12 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.565 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.1 pt-20 -84.82 150.13 55.26 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.912 -1.346 . . . . 0.0 109.961 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 85.3 Cg_endo -78.7 139.66 16.0 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.78 2.32 . . . . 0.0 113.527 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.565 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -137.88 161.33 36.9 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.28 -0.888 . . . . 0.0 108.827 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -132.11 150.1 52.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.25 151.05 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -126.45 155.03 42.88 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.333 -0.854 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.1 t -170.06 152.66 4.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.657 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -93.99 16.54 14.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' CB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.14 144.24 32.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' ' OG ' ' A' ' 59' ' ' SER . 21.5 tp -96.53 -44.49 7.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.79 153.93 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 121.547 0.689 . . . . 0.0 109.261 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.45 -11.75 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.72 . . . . 0.0 110.904 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 -8.28 39.17 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.73 -1.231 . . . . 0.0 111.222 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.0 166.36 21.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.903 -1.123 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 49' ' ' ARG . 4.0 tpt180 -128.24 124.01 35.61 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.469 -0.77 . . . . 0.0 109.093 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.41 142.22 40.21 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.847 . . . . 0.0 109.971 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -48.59 147.87 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.284 1.323 . . . . 0.0 110.823 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.23 -37.3 46.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.853 -1.154 . . . . 0.0 109.595 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.25 -31.24 56.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -98.35 135.16 40.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -1.161 . . . . 0.0 108.587 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -79.04 166.55 22.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 109.74 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -65.51 159.27 24.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.193 -0.942 . . . . 0.0 110.021 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.8 p -161.54 178.34 9.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.6 mt -87.48 134.12 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 21.9 t -61.62 161.39 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 109.883 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.8 -48.72 73.4 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.948 -1.095 . . . . 0.0 109.644 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 61' ' ' ARG . 0.6 OUTLIER -48.09 -51.39 24.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.793 -1.192 . . . . 0.0 109.133 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -70.01 -38.12 75.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.59 -45.62 86.18 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.712 -1.243 . . . . 0.0 109.149 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.49 -54.29 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -30.2 69.74 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.171 -0.956 . . . . 0.0 109.687 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.91 -42.91 76.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.148 -0.97 . . . . 0.0 111.542 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.498 ' CD1' ' HH ' ' A' ' 29' ' ' TYR . 4.4 mm? -69.21 -51.24 39.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.846 -1.159 . . . . 0.0 111.418 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -71.37 -35.25 71.05 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 112.075 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -76.42 -21.44 55.96 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.328 -1.483 . . . . 0.0 111.29 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -82.17 -47.02 13.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.727 -1.233 . . . . 0.0 111.597 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 pt -86.53 -42.43 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.016 . . . . 0.0 111.05 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.37 -39.51 12.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.241 -0.912 . . . . 0.0 109.212 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.553 -0.717 . . . . 0.0 110.4 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 11.2 mp0 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.84 152.89 22.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.098 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -84.45 138.56 32.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.062 -1.024 . . . . 0.0 109.164 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -143.79 173.14 11.94 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 53.6 p-10 -87.13 -165.5 1.31 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.884 -1.135 . . . . 0.0 109.996 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -66.67 -17.92 65.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.699 -0.625 . . . . 0.0 109.403 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.495 ' CG ' HH11 ' A' ' 9' ' ' ARG . 4.4 mtt-85 -103.98 -80.13 0.53 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.382 -0.824 . . . . 0.0 109.162 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -178.92 34.7 0.07 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -90.56 130.95 36.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -1.055 . . . . 0.0 110.178 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.6 mm -79.91 107.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.29 157.49 18.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.93 -1.106 . . . . 0.0 110.481 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -87.82 170.48 11.15 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 m -52.75 138.63 28.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.141 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.73 -57.75 1.87 Allowed Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.111 -0.993 . . . . 0.0 110.74 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -51.56 141.88 15.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 110.081 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.2 m -152.21 149.81 29.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.617 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.4 tp-100 -95.26 137.99 33.56 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.256 -0.903 . . . . 0.0 109.727 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.632 ' NH1' ' NH2' ' A' ' 24' ' ' ARG . 4.7 mtp180 -81.84 -177.04 6.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -76.71 -24.97 53.09 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.825 -0.547 . . . . 0.0 110.042 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' OD2' ' NE ' ' A' ' 24' ' ' ARG . 38.6 p-10 -89.98 -28.53 19.06 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.753 -1.217 . . . . 0.0 111.407 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 19' ' ' GLN . . . 136.05 -26.24 3.13 Favored Glycine 0 N--CA 1.503 3.157 0 O-C-N 120.757 -1.214 . . . . 0.0 111.382 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.632 ' NH2' ' NH1' ' A' ' 20' ' ' ARG . 8.0 ptt180 -65.59 135.99 55.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.364 -1.668 . . . . 0.0 108.714 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.617 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 72.0 m-85 -72.67 173.55 8.84 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -152.4 126.89 9.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.5 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -129.4 151.87 49.57 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.407 ' HZ1' ' CA ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -124.55 135.03 52.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.33 -0.856 . . . . 0.0 110.055 -178.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.407 ' CA ' ' HZ1' ' A' ' 28' ' ' LYS . 17.4 p90 -139.17 164.88 28.64 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.316 -0.865 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 30' ' ' ILE . 87.1 mt -105.41 137.71 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.357 -0.84 . . . . 0.0 109.0 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 33' ' ' PHE . 5.0 p30 -83.39 175.39 9.88 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.143 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -66.2 6.06 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.936 -1.103 . . . . 0.0 110.882 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 31' ' ' ASP . 12.3 m-85 -102.36 -18.93 15.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.933 -1.105 . . . . 0.0 110.118 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.24 -9.4 45.96 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 121.11 -0.994 . . . . 0.0 110.651 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HG3' HE22 ' A' ' 37' ' ' GLN . 17.4 pt-20 -87.9 146.15 38.13 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.953 -1.322 . . . . 0.0 109.137 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.592 ' C ' HE21 ' A' ' 37' ' ' GLN . 95.2 Cg_endo -77.87 136.65 15.16 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.481 2.121 . . . . 0.0 112.679 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.639 ' N ' HE21 ' A' ' 37' ' ' GLN . 0.0 OUTLIER -122.19 174.93 6.66 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.268 -0.895 . . . . 0.0 109.073 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.95 146.32 39.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.561 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.99 143.56 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.646 -0.659 . . . . 0.0 109.273 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -124.15 160.0 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.518 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 153.8 5.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -98.09 14.81 26.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.8 146.94 38.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.089 -1.007 . . . . 0.0 109.136 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.7 tp -89.74 -49.3 6.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 109.123 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 m -118.97 171.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.95 -17.54 62.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.359 -0.838 . . . . 0.0 111.893 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.4 t -87.92 -4.86 58.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.626 -1.296 . . . . 0.0 110.629 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.7 -175.08 1.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 0.0 110.55 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -142.03 133.76 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.9 m -73.53 150.59 89.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.073 -1.017 . . . . 0.0 108.426 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.64 148.07 92.45 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.903 1.735 . . . . 0.0 111.723 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.95 143.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.411 -0.805 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.43 -29.03 10.17 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -94.87 143.08 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.317 . . . . 0.0 109.819 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 55' ' ' ARG . 8.1 ptt-85 -78.67 154.92 29.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.5 155.52 15.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.061 -1.024 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.1 m -149.11 177.85 9.24 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.0 mt -93.55 135.68 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.99 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 p -57.97 174.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 108.874 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.417 HD11 ' H ' ' A' ' 60' ' ' LEU . 4.3 mp -77.93 -54.25 6.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.868 -1.145 . . . . 0.0 110.234 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -47.01 -40.8 15.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.447 -0.783 . . . . 0.0 110.282 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -70.49 -38.46 74.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 66' ' ' GLU . 41.9 mttt -67.26 -50.52 60.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 108.767 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 63' ' ' LYS . 1.5 mp -40.0 -54.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.618 -0.676 . . . . 0.0 109.437 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.46 73.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 109.691 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 63' ' ' LYS . 11.0 tp10 -76.42 -41.66 46.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.396 -0.815 . . . . 0.0 111.738 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.419 ' O ' ' CG1' ' A' ' 71' ' ' ILE . 4.6 mm? -62.79 -48.44 79.13 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.585 -1.322 . . . . 0.0 111.284 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -73.01 -35.38 66.8 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.009 -1.057 . . . . 0.0 111.045 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -79.0 -27.77 43.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.949 -1.094 . . . . 0.0 112.608 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -96.2 -27.42 15.03 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.667 -1.27 . . . . 0.0 111.127 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 67' ' ' LEU . 4.4 mm -85.06 73.47 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.965 -1.084 . . . . 0.0 109.779 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -156.45 -42.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 108.93 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.549 -0.72 . . . . 0.0 109.318 -179.538 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.303 0.573 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.11 44.24 1.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.129 -0.982 . . . . 0.0 108.885 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -85.58 155.95 20.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.971 -1.08 . . . . 0.0 109.309 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 70.1 mtt180 -138.01 160.51 39.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.299 -0.875 . . . . 0.0 109.327 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 6' ' ' ARG . 67.7 m-20 -137.56 -103.72 0.19 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.363 -0.836 . . . . 0.0 112.378 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' A' ' 19' ' ' GLN . 72.9 m-20 -66.46 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -94.68 27.8 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.078 -1.014 . . . . 0.0 112.097 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.69 29.5 51.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -81.21 141.04 34.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.401 -1.058 . . . . 0.0 108.606 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.8 mm -86.21 98.36 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 109.681 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 151.5 20.7 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -89.56 -178.84 5.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.005 -1.059 . . . . 0.0 110.941 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 t -55.6 156.44 4.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.8 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.88 -36.62 3.26 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -79.65 159.76 26.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.886 -1.361 . . . . 0.0 110.174 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.585 ' HG ' ' H ' ' A' ' 19' ' ' GLN . 40.0 t -160.41 166.33 29.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.892 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.585 ' H ' ' HG ' ' A' ' 18' ' ' SER . 42.8 tt0 -104.22 148.01 26.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.517 HH21 HH11 ' A' ' 24' ' ' ARG . 9.3 mmm180 -90.76 168.59 11.63 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.713 0.768 . . . . 0.0 110.522 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -67.89 -27.51 66.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.393 -0.817 . . . . 0.0 109.606 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.5 p30 -94.99 -28.61 15.05 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.957 . . . . 0.0 110.949 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 136.5 -26.28 3.06 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.648 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.517 HH11 HH21 ' A' ' 20' ' ' ARG . 0.4 OUTLIER -60.0 145.87 44.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.375 -1.662 . . . . 0.0 109.256 -179.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -79.62 167.96 20.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.093 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.02 129.92 10.98 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.873 0.844 . . . . 0.0 110.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -136.42 154.19 50.87 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -127.3 143.62 51.2 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.007 -1.058 . . . . 0.0 110.05 -178.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.412 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 12.2 p90 -137.06 170.63 15.78 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.6 mm -99.88 135.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.15 -0.969 . . . . 0.0 109.799 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 33' ' ' PHE . 88.2 m-20 -81.71 162.98 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.187 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.1 p -64.1 0.74 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.2 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 31' ' ' ASP . 3.6 m-85 -100.66 -20.43 15.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.7 36.42 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.8 pt-20 -86.12 148.62 48.14 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.847 -1.384 . . . . 0.0 109.663 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.487 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 97.2 Cg_endo -83.65 142.45 10.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.947 1.765 . . . . 0.0 112.414 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.0 mp0 -130.2 167.78 17.88 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -134.57 143.45 47.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.394 -0.816 . . . . 0.0 110.267 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.06 156.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -133.31 147.27 51.87 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 t -172.11 148.61 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.951 . . . . 0.0 109.615 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -91.54 16.25 10.81 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.342 -0.849 . . . . 0.0 108.856 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 47.6 mtmt -134.41 143.67 47.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.351 -0.843 . . . . 0.0 110.153 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -94.2 -44.08 8.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.41 176.7 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-O 121.379 0.609 . . . . 0.0 109.438 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.53 -15.06 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 110.886 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.5 p -92.91 -14.34 27.73 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.791 -1.193 . . . . 0.0 111.453 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.17 169.73 11.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.713 -1.242 . . . . 0.0 110.481 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -123.58 147.92 46.86 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.517 0.675 . . . . 0.0 109.209 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.14 147.15 60.25 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.424 -0.797 . . . . 0.0 110.063 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.15 140.12 51.55 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.297 1.331 . . . . 0.0 110.834 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.94 149.0 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.886 -1.134 . . . . 0.0 109.588 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.17 -20.27 26.66 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.31 137.89 36.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -1.088 . . . . 0.0 108.991 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -76.22 167.8 21.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' O ' ' SG ' ' A' ' 57' ' ' CYS . 35.6 t0 -60.15 161.91 6.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.423 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 77.0 m -151.19 151.58 32.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.1 mt -81.29 134.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.87 -1.144 . . . . 0.0 109.519 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 150.73 28.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 110.655 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.59 -64.72 0.73 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -41.58 -48.35 3.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.587 . . . . 0.0 111.73 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.45 -33.12 73.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.53 -1.356 . . . . 0.0 109.9 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -68.5 -42.19 78.93 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 109.745 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.81 -56.64 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.383 -0.823 . . . . 0.0 110.51 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.76 87.49 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.318 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -75.01 -28.75 60.62 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 111.477 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -70.25 -53.13 18.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.56 -1.338 . . . . 0.0 111.585 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -69.01 -27.26 65.53 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.256 -1.528 . . . . 0.0 109.589 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -78.96 -23.31 44.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.189 -0.944 . . . . 0.0 110.298 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -99.15 -18.44 17.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.893 -1.129 . . . . 0.0 111.135 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.7 mm -87.96 69.48 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.038 -1.039 . . . . 0.0 110.642 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -158.18 13.52 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.021 . . . . 0.0 109.009 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.601 179.704 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -149.08 161.16 42.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.414 HH11 ' HG3' ' A' ' 5' ' ' ARG . 27.2 mtm-85 -82.09 140.38 33.88 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -138.57 169.61 17.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.896 0.855 . . . . 0.0 110.756 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 40.7 p-10 -93.8 -168.2 1.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.627 0.727 . . . . 0.0 110.378 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -66.27 -14.91 62.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.476 -0.765 . . . . 0.0 110.481 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -99.86 -13.58 19.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.352 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.26 14.98 39.89 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 48' ' ' ASP . 30.0 mtt180 -84.07 135.3 34.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.157 . . . . 0.0 109.323 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.8 mt -84.27 111.4 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 109.192 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.94 157.33 15.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -92.26 179.04 5.67 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.018 -1.051 . . . . 0.0 109.968 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.4 m -54.01 146.23 14.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.439 -0.788 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.08 -52.67 4.75 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -52.56 149.84 5.55 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.134 -1.215 . . . . 0.0 109.28 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 t -157.1 161.72 39.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.596 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.3 tp-100 -105.17 131.41 52.69 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -89.53 162.5 15.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.373 -0.829 . . . . 0.0 109.362 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -22.3 66.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -84.75 -7.99 59.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.4 -0.813 . . . . 0.0 109.329 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.31 8.83 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -62.11 137.7 58.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.946 -1.326 . . . . 0.0 109.466 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.596 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 67.0 m-85 -80.41 173.15 12.88 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.512 -0.743 . . . . 0.0 109.548 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.43 ' CD2' ' C ' ' A' ' 26' ' ' LEU . 1.2 tt -156.07 139.24 15.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.326 -0.858 . . . . 0.0 109.874 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -136.57 155.25 50.19 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.23 -0.919 . . . . 0.0 109.275 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -119.97 138.97 53.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.474 -0.766 . . . . 0.0 110.513 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -143.14 165.0 28.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.03 134.84 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 0.0 109.378 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 33' ' ' PHE . 72.1 m-20 -80.11 164.64 23.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 108.401 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.418 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 17.8 t -58.9 0.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.942 -1.099 . . . . 0.0 110.536 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.7 m-85 -101.73 -19.35 15.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.052 -1.03 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.08 46.02 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.528 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 22.9 pt-20 -83.68 147.55 52.44 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.012 -1.287 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 55.7 Cg_endo -81.4 139.2 11.4 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.473 2.115 . . . . 0.0 113.249 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.7 mp0 -137.5 159.86 40.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -132.14 145.02 51.1 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 149.1 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -121.18 152.38 38.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.7 t -168.29 145.03 3.94 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 109.314 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.93 11.74 21.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.967 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -135.99 141.22 44.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.548 -0.72 . . . . 0.0 109.809 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.9 tp -89.65 -42.63 11.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.59 173.81 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.97 -14.35 59.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.047 -1.033 . . . . 0.0 110.598 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 p -91.27 -2.78 57.35 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 11' ' ' ARG . 80.5 m-20 -69.51 -174.43 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.661 -1.274 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -149.62 124.97 10.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.506 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 m -82.21 152.96 68.74 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.85 137.86 42.68 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 120.968 1.112 . . . . 0.0 109.978 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.86 -34.92 5.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.106 -0.996 . . . . 0.0 110.478 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.95 -22.27 62.23 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -99.48 140.83 33.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -1.122 . . . . 0.0 110.957 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 55' ' ' ARG . 2.0 ptt-85 -76.22 153.78 35.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.511 -0.743 . . . . 0.0 109.886 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.4 161.14 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 0.0 109.462 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.5 p -152.03 162.86 40.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.34 -0.85 . . . . 0.0 108.745 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.24 127.91 40.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.056 -1.027 . . . . 0.0 109.771 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.9 p -59.52 169.27 1.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.36 -0.837 . . . . 0.0 109.907 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -79.59 -58.53 3.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -41.45 -43.67 2.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 110.905 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -69.89 -41.38 74.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 0.0 109.433 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -67.99 -44.84 75.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 110.162 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.11 -60.69 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.914 -1.116 . . . . 0.0 109.203 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.01 63.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.942 . . . . 0.0 110.26 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -71.81 -39.04 70.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.06 -54.54 20.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.867 -1.145 . . . . 0.0 111.889 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -68.52 -35.16 77.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.347 -1.471 . . . . 0.0 109.478 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -74.54 -27.96 60.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.033 -1.042 . . . . 0.0 110.932 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -99.66 -29.55 12.61 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.701 -1.25 . . . . 0.0 110.807 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.418 ' CG2' ' H ' ' A' ' 32' ' ' SER . 5.6 mm -82.38 -60.88 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.925 -1.109 . . . . 0.0 108.076 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 68' ' ' GLN . 21.0 t-80 -96.35 125.71 41.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.073 -1.017 . . . . 0.0 109.224 -178.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 3.5 pm0 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.516 0.674 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -151.51 -167.02 2.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.235 -0.916 . . . . 0.0 108.913 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 5' ' ' ARG . 0.1 OUTLIER -93.6 137.17 33.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.513 -0.742 . . . . 0.0 109.481 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -138.58 159.8 41.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.457 -0.777 . . . . 0.0 109.84 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 11' ' ' ARG . 8.3 p-10 -88.6 -168.33 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.783 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -67.15 -11.88 58.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.533 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.599 ' CB ' HH12 ' A' ' 11' ' ' ARG . 0.3 OUTLIER -100.2 -73.39 0.64 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.908 -1.12 . . . . 0.0 110.047 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.18 0.86 0.05 OUTLIER Glycine 0 N--CA 1.501 3.012 0 C-N-CA 118.41 -1.852 . . . . 0.0 113.03 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.599 HH12 ' CB ' ' A' ' 9' ' ' ARG . 2.4 mtm-85 -84.46 114.64 22.07 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 119.95 -1.912 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.95 113.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.444 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.91 169.47 10.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.42 -0.8 . . . . 0.0 109.716 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -89.16 -177.16 5.35 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.27 1.033 . . . . 0.0 111.054 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 t -56.75 153.62 10.37 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.39 -41.43 1.15 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.792 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.86 136.52 56.96 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.938 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -159.24 154.24 25.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.254 -0.904 . . . . 0.0 108.621 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -109.02 140.93 41.88 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.022 -1.048 . . . . 0.0 110.217 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -84.71 177.21 8.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.571 -0.706 . . . . 0.0 110.022 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -14.48 62.11 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -87.83 -20.14 26.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 109.837 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.24 -30.19 8.5 Favored Glycine 0 N--CA 1.501 3.019 0 O-C-N 121.227 -0.92 . . . . 0.0 111.204 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -63.38 140.68 58.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.546 -1.561 . . . . 0.0 109.679 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.47 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 90.8 m-85 -85.07 168.49 14.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.778 . . . . 0.0 109.87 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -150.89 127.48 10.81 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.448 0.642 . . . . 0.0 109.576 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -131.79 156.33 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -127.16 144.11 51.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -0.773 . . . . 0.0 109.861 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 12.1 p90 -144.86 161.66 38.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.201 -0.937 . . . . 0.0 108.776 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.4 mp -102.86 135.96 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.371 -0.83 . . . . 0.0 108.883 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 60.2 m-20 -81.74 174.26 11.52 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.288 -0.883 . . . . 0.0 109.186 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.431 ' H ' HG23 ' A' ' 71' ' ' ILE . 44.4 t -65.58 -3.47 4.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 109.361 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -96.55 -11.32 25.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 108.91 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.6 -6.17 77.36 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -84.69 149.47 54.16 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.179 -1.189 . . . . 0.0 109.249 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 40.1 Cg_endo -82.89 136.51 8.22 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.589 2.193 . . . . 0.0 113.668 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.1 mp0 -125.67 164.9 19.61 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.4 149.09 51.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 109.698 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.8 142.68 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -127.43 156.99 41.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.557 -0.714 . . . . 0.0 109.795 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.5 t -170.91 150.75 3.21 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.488 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -89.38 11.07 20.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 51.7 mtmt -135.64 139.87 44.1 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.501 0.667 . . . . 0.0 110.567 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -92.51 -39.28 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.27 155.36 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.23 -7.67 10.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.181 -0.95 . . . . 0.0 110.972 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.3 p -93.76 -10.47 34.12 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.7 -1.25 . . . . 0.0 111.887 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -71.15 -171.56 0.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.488 -1.382 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -141.99 151.8 42.84 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -79.35 149.69 72.69 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.963 -1.086 . . . . 0.0 109.307 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' ALA . 32.6 Cg_endo -82.09 -112.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.56 2.174 . . . . 0.0 114.498 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.59 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -55.0 -149.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.257 -0.902 . . . . 0.0 112.954 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.97 36.1 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 52' ' ' ALA . 11.9 mptt -89.26 130.99 35.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.112 -1.228 . . . . 0.0 108.818 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.06 159.07 28.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 109.978 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 23.1 p-10 -53.71 162.19 0.93 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.677 -0.639 . . . . 0.0 109.851 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 19.8 t -162.97 161.22 25.49 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.494 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 89.3 mt -82.83 137.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.9 p -61.13 159.06 12.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.32 -0.863 . . . . 0.0 109.854 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HA ' ' HZ1' ' A' ' 63' ' ' LYS . 97.2 mt -63.53 -49.1 74.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -45.82 -46.34 15.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.115 -0.99 . . . . 0.0 110.352 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -37.43 75.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.883 -1.136 . . . . 0.0 109.781 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HZ1' ' HA ' ' A' ' 60' ' ' LEU . 2.8 mtmp? -67.61 -44.68 77.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.856 -1.153 . . . . 0.0 110.202 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.5 -53.56 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.956 -1.09 . . . . 0.0 110.145 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.62 79.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.112 . . . . 0.0 110.133 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.19 -45.47 56.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.89 -1.131 . . . . 0.0 110.177 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.29 -44.12 65.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.025 -1.047 . . . . 0.0 110.008 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -68.12 -36.94 80.54 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 120.609 -1.307 . . . . 0.0 109.646 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -85.79 -26.73 25.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.128 -0.982 . . . . 0.0 111.363 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -93.77 -26.11 17.12 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.628 -1.295 . . . . 0.0 111.325 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 32' ' ' SER . 44.1 mm -83.33 -29.96 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.665 -1.272 . . . . 0.0 109.013 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -85.28 -127.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 109.761 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -150.8 123.85 8.76 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.2 ttm-85 -83.68 148.51 27.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.262 -0.898 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -133.17 166.05 23.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.586 -0.697 . . . . 0.0 110.11 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -98.5 -164.39 1.13 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.61 -0.681 . . . . 0.0 109.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.556 HD21 ' NE2' ' A' ' 19' ' ' GLN . 22.3 p30 -68.65 -12.74 61.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.115 -0.99 . . . . 0.0 110.599 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -96.07 -5.71 40.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.0 -1.063 . . . . 0.0 109.29 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.19 -1.67 69.04 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.281 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.521 HH22 ' CG ' ' A' ' 48' ' ' ASP . 6.8 ptm180 -82.78 136.46 34.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.734 -1.451 . . . . 0.0 109.316 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.8 mt -83.97 110.6 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.149 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.79 161.72 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 77.5 mttt -88.93 -174.3 4.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.842 -1.161 . . . . 0.0 110.831 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t -55.79 162.23 1.86 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.67 -36.94 1.41 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 14' ' ' LYS . 9.5 mp0 -73.72 156.42 37.91 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.919 -1.342 . . . . 0.0 109.303 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -156.96 158.65 37.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 109.423 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.556 ' NE2' HD21 ' A' ' 8' ' ' ASN . 56.5 tt0 -97.05 134.74 40.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 108.735 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -86.47 160.99 18.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.891 -1.13 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.87 -36.49 62.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.584 -0.697 . . . . 0.0 109.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -82.14 -25.29 34.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.171 -0.955 . . . . 0.0 110.515 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.64 -26.9 5.06 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.17 -0.956 . . . . 0.0 110.744 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.666 HH21 ' HE1' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -59.74 148.5 34.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.356 -1.673 . . . . 0.0 108.307 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -87.44 164.42 16.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.232 -0.918 . . . . 0.0 109.187 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.74 137.75 22.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -131.6 161.48 32.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 29' ' ' TYR . 4.7 tmtm? -125.13 136.19 53.39 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.251 -0.906 . . . . 0.0 110.79 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 13.6 p90 -139.7 170.08 16.55 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.474 ' CD1' ' HZ3' ' A' ' 28' ' ' LYS . 5.9 mm -101.87 133.84 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.123 -0.986 . . . . 0.0 110.503 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 33' ' ' PHE . 59.5 m-20 -84.23 162.43 20.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -59.87 -3.98 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 21.8 m-85 -101.07 -15.27 17.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.03 -1.044 . . . . 0.0 109.622 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.31 0.32 58.32 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.984 -1.072 . . . . 0.0 111.064 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -83.9 150.56 59.08 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.837 -1.39 . . . . 0.0 109.682 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 88.8 Cg_endo -81.61 118.94 3.24 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.107 1.872 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.6 ' N ' HE21 ' A' ' 37' ' ' GLN . 0.0 OUTLIER -115.05 163.02 16.21 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.72 142.03 44.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.24 150.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -122.77 151.61 41.45 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.7 t -171.77 148.62 2.41 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.666 ' HE1' HH21 ' A' ' 24' ' ' ARG . 98.7 m95 -91.91 10.6 28.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 57' ' ' CYS . 29.8 mtmt -135.64 146.74 48.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.675 0.75 . . . . 0.0 110.179 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -96.3 -40.07 9.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.15 161.23 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.61 -14.05 62.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.922 -1.111 . . . . 0.0 111.423 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -87.37 0.23 55.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.796 -1.19 . . . . 0.0 110.985 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.521 ' CG ' HH22 ' A' ' 11' ' ' ARG . 84.7 m-20 -72.49 -178.61 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.896 -1.127 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.42 121.18 13.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -75.79 146.29 79.5 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.492 -1.38 . . . . 0.0 109.957 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.82 155.58 62.16 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.031 . . . . 0.0 111.296 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.36 151.6 0.36 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 110.359 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.81 3.76 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -92.49 146.17 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -1.227 . . . . 0.0 108.913 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.493 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -78.08 -99.1 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 66.3 t0 -168.46 140.24 2.76 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.532 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 15.0 p -148.6 169.25 20.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.976 -1.077 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -82.69 139.0 18.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.497 -0.752 . . . . 0.0 110.326 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -60.72 169.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.33 -52.84 28.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -47.16 -47.76 23.7 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.724 -1.235 . . . . 0.0 110.114 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 68.3 mt-10 -71.49 -38.89 71.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.445 -1.409 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -65.75 -39.78 91.44 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 0.0 110.188 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.05 -44.41 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.377 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.19 90.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.955 -1.091 . . . . 0.0 110.782 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -71.34 -34.31 70.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.868 -1.145 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.88 -44.61 80.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.557 -1.339 . . . . 0.0 110.865 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -75.66 -29.28 59.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.853 -1.154 . . . . 0.0 110.617 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -77.57 -27.14 51.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.654 -1.279 . . . . 0.0 110.17 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -80.09 -38.92 30.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.175 -0.953 . . . . 0.0 110.912 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' A' ' 72' ' ' HIS . 6.5 pt -91.5 -44.28 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.134 -0.979 . . . . 0.0 111.03 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.435 ' N ' ' CG1' ' A' ' 71' ' ' ILE . 0.3 OUTLIER -91.57 105.08 17.48 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.075 -1.016 . . . . 0.0 108.457 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.235 -0.916 . . . . 0.0 109.33 -179.856 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -82.42 149.3 27.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.504 ' CG ' HH11 ' A' ' 5' ' ' ARG . 0.0 OUTLIER -85.45 142.2 29.4 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.116 -0.99 . . . . 0.0 110.878 -178.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -146.13 161.63 39.76 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 29.3 p-10 -123.58 -169.57 1.97 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.208 -0.932 . . . . 0.0 109.936 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.687 ' ND2' HE21 ' A' ' 19' ' ' GLN . 68.9 m-80 -67.73 -21.37 65.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 110.077 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.57 -4.69 40.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.73 17.33 61.97 Favored Glycine 0 N--CA 1.497 2.738 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.07 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' A' ' 11' ' ' ARG . 3.6 mtt-85 -86.04 138.58 31.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -1.112 . . . . 0.0 108.913 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.8 mm -82.57 116.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -88.9 147.09 24.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.092 -1.005 . . . . 0.0 108.574 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -90.53 -179.73 5.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.802 -1.187 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 m -55.68 148.09 17.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.545 -0.722 . . . . 0.0 110.396 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.04 -41.66 2.79 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' OE2' ' CZ ' ' A' ' 61' ' ' ARG . 95.2 mt-10 -78.09 158.43 29.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.909 -1.348 . . . . 0.0 110.067 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -158.21 154.56 27.51 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.815 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.687 HE21 ' ND2' ' A' ' 8' ' ' ASN . 61.2 tt0 -99.16 130.21 45.46 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.837 . . . . 0.0 110.123 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.9 168.86 16.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.338 -0.851 . . . . 0.0 110.472 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -69.04 -25.59 64.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.467 -0.771 . . . . 0.0 109.15 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -87.11 -12.76 46.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.91 -31.1 8.27 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -58.88 143.7 46.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.313 . . . . 0.0 108.777 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -78.88 165.67 23.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.37 -0.831 . . . . 0.0 109.854 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 2.5 tm? -149.35 121.23 8.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 89.3 t80 -130.3 161.05 32.1 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 46.8 tttt -120.27 131.87 55.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.759 -0.588 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -135.73 152.15 50.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.581 -0.699 . . . . 0.0 109.25 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.4 mp -98.69 133.75 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 33' ' ' PHE . 44.9 p30 -82.64 173.12 12.22 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.011 0.91 . . . . 0.0 110.795 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 m -60.73 3.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.831 -0.543 . . . . 0.0 111.381 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.46 ' H ' ' C ' ' A' ' 31' ' ' ASP . 30.1 m-85 -107.12 -22.82 12.51 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.895 -1.128 . . . . 0.0 109.312 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.76 34.36 Favored Glycine 0 N--CA 1.505 3.251 0 O-C-N 121.211 -0.931 . . . . 0.0 111.137 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.526 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.2 pt-20 -88.49 152.44 49.62 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.941 -1.329 . . . . 0.0 109.263 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.41 147.6 25.76 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.413 2.075 . . . . 0.0 113.305 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -144.53 166.59 24.72 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -135.4 153.85 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.243 -0.911 . . . . 0.0 109.561 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.51 157.36 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.718 . . . . 0.0 109.231 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -135.21 144.78 47.13 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 t -169.45 155.01 5.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.035 . . . . 0.0 109.743 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CZ2' ' NZ ' ' A' ' 54' ' ' LYS . 96.1 m95 -93.98 5.54 51.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.137 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 56' ' ' ASP . 43.9 mtmt -123.92 140.43 52.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.547 0.689 . . . . 0.0 110.158 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.38 -44.83 7.04 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.41 ' CG1' ' H ' ' A' ' 46' ' ' ALA . 9.0 t -122.38 178.91 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' H ' ' CG1' ' A' ' 45' ' ' VAL . . . -78.56 -12.94 60.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.122 -0.986 . . . . 0.0 110.995 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.28 -10.69 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 109.944 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -74.42 168.13 20.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.034 -1.041 . . . . 0.0 109.815 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.448 HH11 ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -144.73 136.06 25.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 108.904 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.12 148.56 71.61 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.807 . . . . 0.0 110.514 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.95 149.4 77.53 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.183 1.922 . . . . 0.0 111.845 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.54 146.17 1.11 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.71 0.766 . . . . 0.0 110.124 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.7 4.61 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' NZ ' ' CZ2' ' A' ' 42' ' ' TRP . 28.4 mmtp -95.56 135.22 37.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -73.09 152.62 41.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.759 . . . . 0.0 109.472 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 43' ' ' LYS . 43.7 t0 -61.73 166.27 4.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 48.9 t -159.15 160.85 36.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -0.812 . . . . 0.0 109.108 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 85.5 mt -80.87 137.78 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.351 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.421 ' HG ' ' H ' ' A' ' 62' ' ' GLU . 97.4 p -63.57 156.13 27.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.811 0.815 . . . . 0.0 111.224 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.44 -55.45 33.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.585 -0.697 . . . . 0.0 109.838 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 15.7 mmt180 -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.243 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' H ' ' HG ' ' A' ' 59' ' ' SER . 86.5 mt-10 -72.07 -39.53 68.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.927 . . . . 0.0 110.273 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.12 -37.02 80.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.032 -1.042 . . . . 0.0 110.102 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.1 -50.66 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.099 -1.001 . . . . 0.0 110.729 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.95 -45.85 82.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.819 -1.176 . . . . 0.0 110.422 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 36.4 mt-10 -71.52 -41.73 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 0.0 111.676 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.38 -21.51 66.65 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.884 -1.76 . . . . 0.0 110.987 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -78.82 -72.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.79 -1.194 . . . . 0.0 111.32 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -76.8 -4.2 42.31 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.155 -0.966 . . . . 0.0 113.31 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 66' ' ' GLU . 43.5 t0 -93.71 -48.83 6.14 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.195 -1.566 . . . . 0.0 112.56 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.485 ' O ' ' CG1' ' A' ' 71' ' ' ILE . 1.4 pt -80.81 103.99 8.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 122.859 1.314 . . . . 0.0 110.204 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.22 135.5 9.05 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.113 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.1 t0 . . . . . 0 N--CA 1.497 1.913 0 O-C-N 120.886 -1.134 . . . . 0.0 109.635 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -84.89 146.24 27.39 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -83.47 129.05 34.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.07 -1.018 . . . . 0.0 108.977 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 -141.29 157.34 45.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.405 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -79.7 -179.79 7.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.676 HD21 ' NE2' ' A' ' 19' ' ' GLN . 12.5 p30 -66.96 -14.52 62.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.919 . . . . 0.0 111.259 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -98.75 14.93 26.96 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.049 . . . . 0.0 109.941 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.21 20.95 75.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -90.76 126.27 35.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -1.065 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.8 mt -77.52 95.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 13' ' ' LEU . 1.6 pt? -87.37 156.11 19.74 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -92.0 -176.02 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.691 1.234 . . . . 0.0 110.773 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.1 m -57.91 144.08 40.45 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.14 -54.39 3.6 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.3 149.27 24.88 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.203 -1.175 . . . . 0.0 108.801 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -160.96 159.73 29.88 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 108.848 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.676 ' NE2' HD21 ' A' ' 8' ' ' ASN . 17.3 pt20 -97.14 140.86 31.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 109.652 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.416 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.75 -174.14 4.62 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.09 -29.86 55.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.309 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -89.94 -11.88 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 111.538 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.44 -28.08 7.69 Favored Glycine 0 N--CA 1.504 3.199 0 O-C-N 121.012 -1.055 . . . . 0.0 110.908 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.4 140.88 56.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.352 -1.675 . . . . 0.0 109.341 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -80.03 170.56 16.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.434 -0.791 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.4 tp -151.68 127.25 10.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.537 -0.727 . . . . 0.0 109.328 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -129.58 157.15 42.86 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tttm -127.06 143.7 51.22 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.381 -0.825 . . . . 0.0 110.289 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -151.88 -178.99 7.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.46 144.99 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.488 -0.758 . . . . 0.0 109.006 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 33' ' ' PHE . 90.6 m-20 -84.05 165.85 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.469 -0.769 . . . . 0.0 109.856 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 70' ' ' ASP . 15.9 m -59.28 -0.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.584 -0.697 . . . . 0.0 109.902 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.53 ' H ' ' C ' ' A' ' 31' ' ' ASP . 18.8 m-85 -108.76 -13.95 14.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.473 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.51 -8.67 52.16 Favored Glycine 0 N--CA 1.502 3.068 0 O-C-N 121.045 -1.035 . . . . 0.0 110.871 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.8 pt-20 -81.68 149.94 65.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.825 -1.397 . . . . 0.0 109.129 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.534 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 59.0 Cg_endo -83.67 143.55 10.81 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.361 2.041 . . . . 0.0 112.67 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.534 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.4 mp0 -140.68 173.51 11.43 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.256 -0.903 . . . . 0.0 108.682 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -137.89 154.32 49.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.442 -0.786 . . . . 0.0 109.801 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 m -128.57 143.72 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.525 -0.735 . . . . 0.0 109.232 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -122.35 147.61 46.06 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -171.52 150.86 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.899 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -94.26 10.42 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -127.02 138.84 53.31 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.5 tp -93.02 -44.41 8.42 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.39 166.48 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -14.24 62.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.65 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.4 p -90.04 -6.01 56.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.725 -1.234 . . . . 0.0 111.305 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -70.96 160.56 32.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.68 -1.262 . . . . 0.0 109.417 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.82 126.22 39.39 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.303 -0.873 . . . . 0.0 108.91 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.68 150.1 75.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 110.032 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.4 151.16 80.71 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.834 1.689 . . . . 0.0 110.619 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.33 159.55 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -0.928 . . . . 0.0 109.859 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.04 -36.59 3.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -95.08 137.0 34.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.342 . . . . 0.0 109.64 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -79.87 150.38 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -0.982 . . . . 0.0 109.701 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -52.1 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.447 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 42.6 t -168.41 169.71 10.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.33 -0.856 . . . . 0.0 108.9 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.447 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 6.5 mm -84.55 122.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.4 p -58.88 158.84 7.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.71 -49.88 69.66 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.732 -0.605 . . . . 0.0 109.484 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -51.45 -47.65 63.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.926 -1.109 . . . . 0.0 110.178 -179.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.85 -43.68 67.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 0.0 110.892 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -65.85 -41.4 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.613 -1.305 . . . . 0.0 109.693 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.58 -36.58 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -51.51 69.15 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.018 -1.051 . . . . 0.0 110.087 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.4 -41.26 63.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.866 -1.146 . . . . 0.0 112.462 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -68.05 -44.29 76.72 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.286 -1.509 . . . . 0.0 111.752 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.38 -30.15 68.07 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.893 -1.129 . . . . 0.0 111.569 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 71' ' ' ILE . 49.6 mtmt -76.84 -39.37 51.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.278 -1.514 . . . . 0.0 108.801 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' O ' ' OG ' ' A' ' 32' ' ' SER . 92.6 m-20 -55.11 -11.26 0.66 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 69' ' ' LYS . 15.7 mm -79.91 106.3 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.91 168.26 26.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.434 -0.791 . . . . 0.0 109.908 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.451 -0.78 . . . . 0.0 109.318 -179.131 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -147.09 124.46 11.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.286 -0.884 . . . . 0.0 108.907 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 133.98 34.02 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.685 ' HE ' ' C ' ' A' ' 10' ' ' GLY . 33.4 mtp180 -141.13 -169.25 2.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.222 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' HB2' HH12 ' A' ' 11' ' ' ARG . 3.8 m-20 -130.98 -159.59 0.98 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.648 -0.658 . . . . 0.0 109.823 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.481 ' ND2' ' NE2' ' A' ' 19' ' ' GLN . 77.6 m-20 -63.29 -33.06 74.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.121 -0.987 . . . . 0.0 111.659 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HB2' ' NH1' ' A' ' 11' ' ' ARG . 15.1 mmt180 -96.03 8.28 44.13 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.017 -1.052 . . . . 0.0 112.09 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.685 ' C ' ' HE ' ' A' ' 6' ' ' ARG . . . 76.88 19.99 76.79 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.422 -1.424 . . . . 0.0 111.704 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.586 HH11 ' HG3' ' A' ' 11' ' ' ARG . 2.3 mtm-85 -94.19 144.95 25.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.495 . . . . 0.0 108.374 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.4 mt -85.56 117.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 108.879 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -84.99 144.69 28.14 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.423 -0.798 . . . . 0.0 109.46 -179.098 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -89.26 -171.66 3.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.18 0.991 . . . . 0.0 110.502 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.4 m -56.42 143.53 34.44 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.691 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.99 -51.46 3.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.256 -0.903 . . . . 0.0 111.479 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.1 140.67 58.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.401 . . . . 0.0 110.093 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -160.01 -174.51 4.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.273 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.481 ' NE2' ' ND2' ' A' ' 8' ' ' ASN . 4.1 tt0 -110.11 147.41 33.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HG2' HH11 ' A' ' 20' ' ' ARG . 10.3 ttt-85 -88.87 164.1 15.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 8.4 mptt -63.71 -19.41 64.92 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.94 -8.17 50.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.608 -0.683 . . . . 0.0 110.714 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.68 6.32 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -61.41 145.79 50.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.969 -1.312 . . . . 0.0 108.041 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 11' ' ' ARG . 72.2 m-85 -78.75 167.93 20.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.103 -0.998 . . . . 0.0 110.659 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 tp -152.01 132.56 13.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 50.9 t80 -132.92 162.76 30.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 25.0 tttt -137.34 137.1 38.55 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.034 -1.041 . . . . 0.0 110.873 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.513 ' CD2' ' OE1' ' A' ' 37' ' ' GLN . 13.8 p90 -149.95 -175.55 5.09 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.414 ' HA ' HE22 ' A' ' 37' ' ' GLN . 39.9 mm -109.17 131.88 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.257 -0.902 . . . . 0.0 109.287 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 33' ' ' PHE . 46.0 p30 -88.92 178.38 6.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 0.0 110.047 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.463 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 14.8 t -63.01 0.36 0.58 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.054 -1.029 . . . . 0.0 110.881 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 6.6 m-85 -102.69 -10.47 19.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.4 59.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.0 pt-20 -80.17 150.7 71.73 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 108.395 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.76 135.61 21.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.632 1.555 . . . . 0.0 111.459 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.679 ' NE2' ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -132.74 165.68 23.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -137.11 155.79 49.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -0.839 . . . . 0.0 109.304 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.7 m -126.05 150.09 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -123.01 156.89 33.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.8 t -171.46 152.07 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.096 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -95.61 9.32 40.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 109.654 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' HZ3' ' H ' ' A' ' 57' ' ' CYS . 0.3 OUTLIER -141.47 156.01 45.79 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.224 -0.923 . . . . 0.0 109.507 179.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 ' CB ' ' HE ' ' A' ' 11' ' ' ARG . 59.6 tp -98.66 -38.63 9.04 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.418 HG11 ' H ' ' A' ' 46' ' ' ALA . 1.1 t -120.26 173.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.418 ' H ' HG11 ' A' ' 45' ' ' VAL . . . -78.69 -20.53 49.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 0.0 110.452 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.0 p -86.04 -7.17 58.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -71.94 167.62 19.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.84 136.85 51.03 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.6 149.52 78.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 110.616 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.26 140.79 25.45 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.677 1.585 . . . . 0.0 111.377 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.57 5.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 109.561 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.09 -19.97 48.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.62 142.86 27.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.827 -1.396 . . . . 0.0 109.205 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -78.08 151.21 33.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 109.829 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 p30 -62.08 175.08 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.79 . . . . 0.0 109.764 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.479 ' H ' ' HZ3' ' A' ' 43' ' ' LYS . 15.3 t -172.46 -174.99 1.27 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 58' ' ' ILE . 49.8 mm -98.97 127.44 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.013 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.454 ' OG ' ' C ' ' A' ' 44' ' ' LEU . 22.7 t -56.91 157.23 5.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.382 -0.824 . . . . 0.0 109.392 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.5 -51.69 66.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.987 -1.07 . . . . 0.0 109.986 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -47.79 -41.76 24.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.77 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.06 -39.69 65.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.923 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -65.36 -55.47 17.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.868 -1.145 . . . . 0.0 109.611 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mp -48.05 -58.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.6 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.08 -42.36 69.25 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.684 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.18 -42.43 62.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.822 . . . . 0.0 111.598 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.56 -44.42 67.46 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.779 -1.2 . . . . 0.0 111.817 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -72.49 -33.65 67.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.614 -1.304 . . . . 0.0 110.524 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -77.15 -21.53 53.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.862 -1.149 . . . . 0.0 109.468 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -97.23 -43.26 7.43 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.289 -0.882 . . . . 0.0 110.256 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.465 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 76.6 mt -80.06 -7.29 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.513 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 71' ' ' ILE . 9.0 m80 -145.33 -173.06 4.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.203 -0.936 . . . . 0.0 108.832 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.787 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 45.7 mp0 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -81.66 163.79 22.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.065 -1.022 . . . . 0.0 109.671 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.588 ' NE ' ' N ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -83.45 155.39 23.44 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' HG3' HH11 ' A' ' 6' ' ' ARG . 14.9 mtm-85 -141.22 160.51 39.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.158 -0.964 . . . . 0.0 110.575 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' CD2' ' A' ' 13' ' ' LEU . 93.6 m-20 -87.21 170.92 11.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -63.84 -3.55 2.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.881 -1.137 . . . . 0.0 109.063 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -102.91 -11.23 18.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.52 4.77 59.26 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.55 ' HG2' HH11 ' A' ' 11' ' ' ARG . 8.6 mtt-85 -85.91 130.29 34.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -1.113 . . . . 0.0 109.545 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.0 110.48 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' CD2' ' OD1' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -86.29 150.36 24.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -89.29 -179.33 5.84 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.687 -1.258 . . . . 0.0 110.789 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -53.46 154.51 3.44 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -39.46 2.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -76.46 167.8 21.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.275 . . . . 0.0 109.518 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 19' ' ' GLN . 38.4 t -158.82 161.96 36.97 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.863 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.521 ' N ' ' HG ' ' A' ' 18' ' ' SER . 47.8 tt0 -104.51 138.13 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.3 156.37 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.942 -1.099 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CG ' ' N ' ' A' ' 22' ' ' ASP . 10.2 ptmm? -53.52 -39.24 64.48 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.107 -0.995 . . . . 0.0 109.491 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 51.1 p30 -83.89 -30.82 26.08 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.184 -0.948 . . . . 0.0 110.41 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 135.05 -24.72 3.4 Favored Glycine 0 N--CA 1.505 3.272 0 O-C-N 120.81 -1.181 . . . . 0.0 112.576 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -57.46 147.25 27.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 120.15 1.975 . . . . 0.0 107.714 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -85.32 169.55 13.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.44 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -152.96 129.01 10.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.146 -0.971 . . . . 0.0 109.75 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 87.1 t80 -131.02 162.35 29.99 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.549 -0.719 . . . . 0.0 109.216 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 36.0 tttt -122.66 135.22 54.53 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.531 -0.73 . . . . 0.0 110.048 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.532 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 6.0 p90 -141.61 162.93 34.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' O ' ' NE2' ' A' ' 72' ' ' HIS . 24.7 mm -103.53 130.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -178.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 3.8 m-20 -88.5 179.74 6.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.491 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 47.1 t -57.08 -3.94 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 111.372 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 46.3 m-85 -96.26 -4.79 41.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.075 . . . . 0.0 110.473 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 10.33 81.71 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -88.25 164.36 33.35 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 122.034 -0.686 . . . . 0.0 110.092 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.28 122.6 0.75 Allowed 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 121.823 1.682 . . . . 0.0 110.144 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.571 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -123.07 166.11 15.68 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.222 -0.924 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -135.85 146.55 47.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.505 -0.747 . . . . 0.0 110.486 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -124.34 148.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -132.35 155.02 49.15 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.134 -0.979 . . . . 0.0 109.956 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -171.83 157.74 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.963 -1.085 . . . . 0.0 109.728 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -91.85 12.47 21.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.148 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 8.6 mtmp? -135.31 138.09 43.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.432 -0.792 . . . . 0.0 109.7 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.7 tp -88.46 -43.27 11.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.69 173.92 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.17 62.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.266 -0.896 . . . . 0.0 111.541 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 t -86.6 -10.59 53.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.72 -1.237 . . . . 0.0 111.466 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.87 176.37 3.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.662 -1.274 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.35 140.38 30.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.8 m -84.79 146.35 46.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 109.385 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.95 150.98 78.37 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.992 1.794 . . . . 0.0 111.698 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.42 143.67 2.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.567 -0.708 . . . . 0.0 110.393 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.97 -26.65 22.54 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -96.99 131.93 43.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.368 -1.078 . . . . 0.0 108.527 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -75.91 145.89 40.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.36 -0.837 . . . . 0.0 109.7 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 60.8 t0 -50.27 153.73 1.41 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.664 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 81.1 m -148.59 167.3 25.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.217 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.5 mt -87.97 133.1 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.199 -0.938 . . . . 0.0 110.354 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.6 p -62.81 157.7 20.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.819 . . . . 0.0 110.623 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.42 -52.46 65.52 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.841 0.829 . . . . 0.0 109.588 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -51.2 -45.32 61.8 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.461 -0.774 . . . . 0.0 110.154 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.31 -40.99 70.47 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 109.704 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 ttmp? -66.32 -41.83 89.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.942 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.4 -53.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.776 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.31 71.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.917 -1.115 . . . . 0.0 109.958 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -73.87 -42.57 60.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.972 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -68.0 -43.39 78.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.616 -1.302 . . . . 0.0 110.594 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -69.11 -39.68 78.79 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.245 -1.535 . . . . 0.0 110.49 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -82.88 -38.74 22.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.875 -1.14 . . . . 0.0 111.304 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.83 -29.07 60.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.085 . . . . 0.0 111.202 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.491 ' CG2' ' H ' ' A' ' 32' ' ' SER . 42.8 mm -86.2 -44.12 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.0 -1.062 . . . . 0.0 110.325 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.471 ' NE2' ' O ' ' A' ' 30' ' ' ILE . 13.8 m170 -87.92 159.73 18.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.95 -1.094 . . . . 0.0 109.307 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.6 t0 . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.165 -179.375 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.438 ' HZ1' ' C ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -83.18 144.32 29.89 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.229 1.014 . . . . 0.0 110.958 -178.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -97.52 156.18 16.61 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -137.97 150.05 46.67 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.016 -1.052 . . . . 0.0 109.767 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -83.44 166.85 18.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.287 -0.883 . . . . 0.0 109.832 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 23.2 p30 -69.17 1.64 3.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.192 -0.943 . . . . 0.0 109.902 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 92.2 mtt180 -100.11 -52.68 3.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.84 -3.34 1.11 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.627 HH11 ' CG ' ' A' ' 11' ' ' ARG . 1.6 mtt-85 -89.29 130.06 35.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.459 -1.612 . . . . 0.0 110.171 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 mm -72.73 110.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.249 -0.907 . . . . 0.0 108.561 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.26 152.53 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 109.484 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 35.9 mmtt -89.0 -173.27 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.978 -1.077 . . . . 0.0 110.78 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 p -57.14 165.6 1.31 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.454 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.1 -44.07 1.04 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.366 -0.834 . . . . 0.0 111.56 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 12.2 mp0 -65.23 152.39 43.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.019 -1.283 . . . . 0.0 110.823 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -158.58 139.62 13.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.2 tt0 -100.0 129.31 46.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.192 -0.942 . . . . 0.0 109.891 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.686 ' NH1' HH21 ' A' ' 24' ' ' ARG . 49.2 mtp180 -89.27 166.19 13.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.431 -0.793 . . . . 0.0 110.656 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -20.27 63.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 109.729 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -85.78 -17.38 35.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.993 . . . . 0.0 109.463 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.09 -22.69 32.61 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.686 HH21 ' NH1' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -63.83 146.81 53.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.742 -1.446 . . . . 0.0 109.413 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.401 ' OH ' ' NH1' ' A' ' 9' ' ' ARG . 71.8 m-85 -88.63 166.47 14.09 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.802 0.81 . . . . 0.0 109.845 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -148.74 119.87 7.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 90.4 t80 -131.67 168.63 17.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.645 -0.659 . . . . 0.0 109.437 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 71.1 tttt -130.91 135.17 47.43 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.541 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 18.9 p90 -133.18 165.03 25.72 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.461 -0.774 . . . . 0.0 108.912 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.01 134.78 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.077 -1.014 . . . . 0.0 109.302 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 16.7 m-20 -83.27 156.67 22.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 71' ' ' ILE . 42.7 m -53.66 -8.59 0.16 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.893 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' ASP . 23.0 m-85 -97.3 -13.9 21.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.881 -1.137 . . . . 0.0 108.807 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.34 0.73 59.5 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 20.6 pt-20 -83.38 148.52 55.85 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.892 -1.358 . . . . 0.0 108.329 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 96.0 Cg_endo -82.64 141.63 11.11 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.354 2.036 . . . . 0.0 113.198 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.1 mp0 -139.67 161.68 36.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.186 -0.946 . . . . 0.0 108.753 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -132.09 142.54 49.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -122.2 151.58 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.561 0.695 . . . . 0.0 109.904 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -123.72 150.47 44.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -166.05 148.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.391 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -90.94 10.38 26.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 109.573 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -140.18 144.02 36.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.99 -42.79 10.35 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.35 167.57 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.05 -6.24 44.27 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.982 -1.073 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.8 p -88.7 -18.53 27.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.433 -1.417 . . . . 0.0 110.011 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.28 175.11 7.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.409 HH12 ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -138.83 145.73 40.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 5.9 m -79.91 128.53 73.72 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.713 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.32 141.17 10.5 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.028 1.152 . . . . 0.0 110.327 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.409 ' N ' HH12 ' A' ' 49' ' ' ARG . . . -44.81 143.44 1.43 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.07 -32.26 7.69 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -91.88 140.66 29.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 108.546 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -76.16 155.62 34.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.455 ' O ' ' SG ' ' A' ' 57' ' ' CYS . 44.1 p30 -52.66 155.55 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.254 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 56' ' ' ASP . 64.9 m -154.54 157.99 39.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -85.05 135.08 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.8 p -58.82 153.65 16.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.09 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -60.47 -52.03 66.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.951 -1.093 . . . . 0.0 109.928 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -46.95 -50.0 19.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.824 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -69.13 -34.09 74.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.248 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -69.84 -41.26 75.16 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.428 -0.795 . . . . 0.0 110.02 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.18 -50.04 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.243 -0.91 . . . . 0.0 109.358 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.33 79.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.986 -1.071 . . . . 0.0 109.819 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -71.62 -44.02 65.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.466 -0.771 . . . . 0.0 111.308 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.74 -32.9 74.5 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.524 -1.36 . . . . 0.0 111.701 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -70.41 -45.53 65.74 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.215 -1.553 . . . . 0.0 110.308 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -82.93 -13.49 55.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.524 -1.36 . . . . 0.0 112.035 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -95.03 -29.1 14.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.484 -1.385 . . . . 0.0 110.357 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' A' ' 32' ' ' SER . 6.2 mm -79.73 91.71 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-O 121.914 0.864 . . . . 0.0 109.015 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -151.43 -56.28 0.15 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.76 179.557 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 21.6 mp0 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -84.83 -170.81 3.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.046 -1.034 . . . . 0.0 109.492 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 139.75 37.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 0.0 108.534 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -144.22 171.51 14.19 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.609 -0.682 . . . . 0.0 109.872 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.2 p30 -75.46 -179.66 4.71 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.753 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 61.8 m-80 -67.99 -8.6 38.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -101.79 -22.97 14.26 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.779 -1.201 . . . . 0.0 111.029 -178.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 123.06 7.93 6.89 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 121.199 -0.938 . . . . 0.0 110.78 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.527 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 9.2 mtm180 -85.09 126.25 33.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.884 -1.362 . . . . 0.0 109.596 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 12' ' ' ILE . 17.2 mm -71.56 105.53 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pp -87.78 149.02 24.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -91.09 -175.14 4.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.04 0.924 . . . . 0.0 110.903 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.435 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 7.5 p -55.19 146.24 19.24 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.665 0.745 . . . . 0.0 111.481 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.3 -54.12 4.85 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.422 -0.799 . . . . 0.0 111.37 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 36.8 mp0 -60.69 145.87 47.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 109.644 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -160.83 149.28 16.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.071 . . . . 0.0 109.649 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.464 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.8 tt0 -99.3 130.87 45.62 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.081 -1.012 . . . . 0.0 108.568 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -84.54 -171.24 3.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 0.0 109.605 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -75.32 -23.04 57.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.176 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -86.2 -15.02 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.19 -19.2 49.63 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -62.4 141.88 58.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.491 -1.594 . . . . 0.0 108.66 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -87.83 165.58 15.2 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.427 -0.796 . . . . 0.0 108.915 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' CD2' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -154.71 130.91 10.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -178.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.459 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 71.6 t80 -131.23 168.6 17.22 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 53.1 tttt -136.83 140.01 42.13 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.58 173.35 11.73 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.34 -0.85 . . . . 0.0 109.513 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.1 mm -103.35 126.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.412 -0.805 . . . . 0.0 109.615 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.14 176.41 9.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.005 -1.06 . . . . 0.0 109.058 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.8 p -64.09 0.59 0.89 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.042 -1.036 . . . . 0.0 111.203 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 14.4 m-85 -103.65 -15.89 15.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.107 -0.996 . . . . 0.0 109.463 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.65 -0.62 74.12 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -82.81 148.39 57.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.248 . . . . 0.0 109.299 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.06 124.44 9.09 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.489 1.459 . . . . 0.0 111.019 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.468 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -122.81 163.55 20.03 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -136.29 153.55 51.14 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.192 -0.943 . . . . 0.0 110.124 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.54 146.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -131.23 149.11 52.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.179 -0.951 . . . . 0.0 109.682 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.3 t -171.53 154.6 3.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.38 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -92.67 14.77 16.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.005 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.64 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 24.4 mtmm -130.91 138.51 49.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -93.38 -45.06 7.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.494 ' O ' ' OG ' ' A' ' 59' ' ' SER . 1.2 t -119.73 167.54 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.63 -17.57 64.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 110.664 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 p -86.89 -12.0 49.06 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.901 -1.124 . . . . 0.0 110.886 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -70.7 169.26 14.8 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.871 -1.143 . . . . 0.0 110.458 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -139.49 137.29 35.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.12 150.97 72.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 109.657 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.45 150.16 63.58 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.786 1.657 . . . . 0.0 111.049 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.86 146.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.3 -32.4 7.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -98.04 132.84 43.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -1.211 . . . . 0.0 109.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -74.95 147.91 40.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 109.182 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 60.0 p30 -51.82 152.06 3.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.114 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.64 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 35.6 m -146.78 164.07 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 58' ' ' ILE . 84.1 mt -81.47 133.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 110.823 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 56.3 m -58.19 166.95 1.43 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.412 0.625 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.68 -65.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.888 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -47.47 -34.45 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.502 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.94 -40.11 72.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.659 -1.275 . . . . 0.0 108.837 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -66.24 -44.02 84.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 110.245 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.5 mp -59.92 -45.12 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.134 -0.979 . . . . 0.0 110.677 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.62 81.65 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.745 -1.222 . . . . 0.0 110.981 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -77.85 -36.71 49.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.846 -1.159 . . . . 0.0 112.477 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.6 mt -67.53 -44.41 78.43 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.364 -1.46 . . . . 0.0 111.523 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -77.09 -36.22 55.9 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 110.985 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -73.26 -20.67 60.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.92 -1.112 . . . . 0.0 110.309 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -107.99 -52.9 2.7 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.253 -0.905 . . . . 0.0 111.239 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.9 mt -84.97 44.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.197 -0.939 . . . . 0.0 110.456 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -156.9 41.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.928 -1.108 . . . . 0.0 109.467 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.105 -0.997 . . . . 0.0 109.442 179.984 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -84.48 171.82 12.22 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.4 121.27 27.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.901 -1.124 . . . . 0.0 110.156 -178.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -139.7 173.4 11.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.522 -0.736 . . . . 0.0 109.612 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.0 p-10 -88.96 -176.9 5.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.083 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -64.78 -6.31 7.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 110.006 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 9' ' ' ARG . 52.9 mtt-85 -105.39 -16.88 14.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.172 -0.955 . . . . 0.0 110.318 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 101.65 19.01 16.7 Favored Glycine 0 N--CA 1.501 2.989 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.49 HH11 ' CG ' ' A' ' 11' ' ' ARG . 6.6 mtt-85 -86.03 140.18 30.5 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.77 -1.43 . . . . 0.0 109.168 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.78 103.24 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.525 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.4 149.97 22.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.388 -0.82 . . . . 0.0 109.065 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -89.02 -173.86 4.23 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.423 1.106 . . . . 0.0 111.785 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 m -59.4 140.0 56.55 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.229 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 -39.12 2.93 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.312 -0.867 . . . . 0.0 111.338 177.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -72.56 153.38 41.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.745 -1.444 . . . . 0.0 109.862 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -160.55 155.68 24.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -96.42 139.94 31.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -83.75 148.33 27.11 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -57.56 -18.9 21.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.61 -21.04 23.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.782 -0.573 . . . . 0.0 109.924 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.86 -35.59 4.01 Favored Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -59.54 140.98 55.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.877 -1.366 . . . . 0.0 109.23 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -75.85 170.73 15.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.316 -0.865 . . . . 0.0 110.338 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.9 tp -154.83 130.98 10.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.73 -0.606 . . . . 0.0 109.551 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -134.51 161.93 33.69 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -126.3 134.88 51.01 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.8 p90 -137.98 167.72 21.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.76 131.92 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 109.259 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 41.5 m-20 -82.09 -174.13 4.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.218 -0.926 . . . . 0.0 109.61 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.415 ' H ' HG23 ' A' ' 71' ' ' ILE . 70.1 m -72.32 -4.64 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.42 -0.8 . . . . 0.0 110.239 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 18.3 m-85 -99.59 -10.73 21.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.15 -0.968 . . . . 0.0 109.913 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.41 86.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.39 147.33 52.8 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.392 -1.063 . . . . 0.0 108.733 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.98 128.51 15.93 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.846 1.697 . . . . 0.0 110.522 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' CA ' HE21 ' A' ' 37' ' ' GLN . 0.0 OUTLIER -127.87 164.69 21.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 109.011 -179.106 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.38 155.32 50.48 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.356 -0.84 . . . . 0.0 110.786 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.86 152.72 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -128.3 150.89 49.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.208 -0.933 . . . . 0.0 110.049 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 t -169.08 146.4 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.469 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -88.31 3.55 49.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 109.289 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' A' ' 57' ' ' CYS . 24.4 mtmm -128.56 141.99 51.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.88 -49.59 6.35 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.53 174.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.95 -11.92 59.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.62 -0.675 . . . . 0.0 110.669 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -87.25 -14.35 41.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.763 -1.211 . . . . 0.0 110.105 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.2 174.89 5.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 1.9 tmt_? -146.49 135.94 22.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.409 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 19.3 m -75.23 147.95 83.4 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.772 -1.205 . . . . 0.0 109.954 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.33 155.73 66.51 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.04 1.827 . . . . 0.0 111.764 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.18 146.98 2.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.55 -0.719 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.4 6.91 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -95.97 139.64 31.88 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.005 -1.291 . . . . 0.0 109.073 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.507 HH11 ' CG ' ' A' ' 55' ' ' ARG . 1.4 ttt-85 -75.41 151.26 38.15 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.68 159.06 22.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.365 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.535 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -156.34 175.03 14.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.032 -179.848 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.81 135.38 25.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.524 -0.735 . . . . 0.0 110.68 -178.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.9 p -61.35 163.67 6.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 108.695 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.1 -51.98 40.19 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 111.149 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' HG2' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -44.27 -45.49 8.64 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.143 -0.973 . . . . 0.0 110.003 -178.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -68.58 -40.58 80.45 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 109.672 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -66.62 -44.14 82.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.986 -1.072 . . . . 0.0 110.516 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -56.93 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.91 -1.119 . . . . 0.0 110.318 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.07 70.29 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.74 -53.79 7.49 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -69.28 -41.28 77.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.996 -1.065 . . . . 0.0 110.144 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -69.63 -39.81 76.94 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -78.17 -24.57 47.2 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.907 -1.121 . . . . 0.0 111.068 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -100.03 -36.1 9.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.911 -1.118 . . . . 0.0 111.679 -178.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.415 HG23 ' H ' ' A' ' 32' ' ' SER . 3.9 mm -89.88 44.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.841 -1.162 . . . . 0.0 110.415 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -153.59 37.41 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.342 -1.474 . . . . 0.0 109.465 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.309 179.969 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 5.6 mp0 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -156.09 143.47 19.25 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -84.2 152.7 24.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 110.197 -179.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 6' ' ' ARG . 2.9 mtt-85 -134.94 -179.88 5.89 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 51.3 p-10 -74.4 -167.36 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.761 -1.212 . . . . 0.0 108.91 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.489 ' N ' ' OE1' ' A' ' 19' ' ' GLN . 95.6 m-20 -68.61 -16.35 63.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.781 -1.2 . . . . 0.0 108.599 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' N ' ' CD ' ' A' ' 9' ' ' ARG . 9.2 mpt_? -101.3 -87.13 0.4 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -169.5 19.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.455 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 81.3 mtm180 -89.84 138.59 31.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.303 . . . . 0.0 109.704 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.9 mm -77.68 130.26 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.888 . . . . 0.0 109.98 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -93.6 150.64 20.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -87.88 170.87 10.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.957 -1.09 . . . . 0.0 109.513 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.0 m -58.11 137.17 57.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.455 -0.778 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.98 -24.81 24.88 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.943 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 44.1 mp0 -82.04 157.2 24.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.677 -1.484 . . . . 0.0 110.12 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 t -158.93 147.56 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 109.389 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 8' ' ' ASN . 41.7 tt0 -106.45 133.04 51.75 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -83.03 166.0 19.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 109.862 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -16.49 48.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 108.643 179.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -86.9 -10.23 53.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.482 -0.761 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.31 -29.2 13.03 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.248 -0.907 . . . . 0.0 111.379 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -57.86 157.0 8.1 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.548 -1.56 . . . . 0.0 109.382 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.455 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 71.2 m-85 -100.41 166.91 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 109.42 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.79 141.29 20.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -135.26 149.23 49.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -114.88 135.42 54.22 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.253 -0.905 . . . . 0.0 110.792 -178.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -142.46 164.78 29.19 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.2 mt -107.96 139.62 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 33' ' ' PHE . 23.8 m-20 -81.79 159.93 23.68 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.935 -1.103 . . . . 0.0 109.222 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.7 m -58.2 -2.18 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 110.031 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.498 ' H ' ' C ' ' A' ' 31' ' ' ASP . 88.1 m-85 -95.29 -15.43 23.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.044 -1.035 . . . . 0.0 108.59 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.07 -5.26 49.71 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 23.5 pt-20 -84.73 144.02 41.7 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.872 -1.369 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.69 139.83 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.534 2.156 . . . . 0.0 111.969 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.4 mp0 -136.8 172.75 12.54 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.108 -0.995 . . . . 0.0 109.402 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -137.01 139.51 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.51 154.27 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -126.12 151.36 47.35 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.449 0.643 . . . . 0.0 109.273 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.8 t -168.22 136.57 2.29 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.013 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -87.58 12.9 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.189 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 53.0 mtmt -130.98 133.22 45.59 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.659 0.742 . . . . 0.0 109.574 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 66.9 tp -89.26 -43.44 10.97 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.47 HG21 HH12 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -111.63 175.39 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.48 -18.28 49.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.953 -1.092 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.2 p -93.58 7.29 45.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.679 -1.263 . . . . 0.0 110.955 -179.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.4 -179.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.611 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -142.1 116.79 9.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.13 -0.981 . . . . 0.0 109.196 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.47 149.45 51.88 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.204 -0.935 . . . . 0.0 110.839 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' LYS . 56.8 Cg_exo -49.58 134.42 33.12 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.208 1.272 . . . . 0.0 110.739 177.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.55 -23.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.848 -1.158 . . . . 0.0 109.791 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -25.4 73.65 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' PRO . 47.8 mmtt -103.93 133.93 48.06 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -78.99 152.65 30.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.087 . . . . 0.0 110.546 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -43.78 154.81 0.09 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.448 0.642 . . . . 0.0 109.826 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.498 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 61.4 m -149.73 167.59 26.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -86.96 128.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.141 -0.975 . . . . 0.0 108.779 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.6 p -58.64 167.64 1.43 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 110.443 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.78 -51.89 43.61 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.369 -0.832 . . . . 0.0 110.206 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.635 HH11 ' CG ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -47.07 -46.4 22.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 109.218 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -70.21 -39.65 75.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.512 -0.742 . . . . 0.0 110.19 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.0 -47.51 74.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.687 -1.258 . . . . 0.0 109.465 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.48 -56.69 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.21 76.97 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -77.29 -36.0 54.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.85 . . . . 0.0 111.945 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.82 -41.41 83.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.542 -1.349 . . . . 0.0 110.178 -179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -76.98 -32.99 57.64 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.239 -1.538 . . . . 0.0 109.813 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 73' ' ' ASP . 37.4 ttpt -87.04 -39.81 15.29 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.165 -0.96 . . . . 0.0 112.654 -178.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.19 -17.2 60.93 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.777 -1.202 . . . . 0.0 111.548 -177.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mm -86.49 -7.7 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.784 -1.197 . . . . 0.0 110.67 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.61 -33.34 0.23 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.605 -1.309 . . . . 0.0 109.182 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 69' ' ' LYS . 38.9 t70 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.907 . . . . 0.0 109.728 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.634 ' N ' HH22 ' A' ' 6' ' ' ARG . 7.3 tp10 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -83.14 -160.07 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -80.29 154.6 27.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.06 -1.025 . . . . 0.0 110.961 -177.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.634 HH22 ' N ' ' A' ' 3' ' ' GLU . 4.9 mtt-85 -138.98 -178.82 5.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.67 -0.644 . . . . 0.0 109.475 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -104.09 -167.66 1.39 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.755 . . . . 0.0 109.503 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 3.1 p30 -66.89 -16.86 64.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.28 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.543 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -97.6 -3.66 39.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.965 -1.084 . . . . 0.0 110.061 -179.422 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.85 90.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.525 HH11 ' CG ' ' A' ' 11' ' ' ARG . 2.6 mtt-85 -88.71 130.79 35.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.016 -1.285 . . . . 0.0 109.641 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 12' ' ' ILE . 55.4 mt -72.75 121.64 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 109.233 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.566 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -97.23 155.94 16.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -0.78 . . . . 0.0 108.948 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.07 179.42 6.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.871 -1.143 . . . . 0.0 110.111 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -56.81 152.47 12.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.729 -0.607 . . . . 0.0 110.295 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.44 -43.32 3.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' CD1' ' A' ' 44' ' ' LEU . 2.1 mt-10 -66.39 155.12 38.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.229 -1.16 . . . . 0.0 108.464 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.483 ' HG ' ' N ' ' A' ' 19' ' ' GLN . 25.5 t -159.03 164.27 35.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.126 -179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.483 ' N ' ' HG ' ' A' ' 18' ' ' SER . 39.4 tt0 -103.61 126.53 50.81 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 108.9 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -85.17 147.17 26.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.046 . . . . 0.0 108.947 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 1.3 mptt -49.26 -22.6 1.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -89.77 -26.74 20.44 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.799 -1.188 . . . . 0.0 110.821 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.62 -34.33 2.79 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 24' ' ' ARG . 0.1 OUTLIER -60.45 148.19 38.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.779 -1.424 . . . . 0.0 108.778 -179.753 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -86.47 168.71 13.5 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' C ' ' CD2' ' A' ' 26' ' ' LEU . 4.3 tt -145.12 122.95 11.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.349 -0.844 . . . . 0.0 109.536 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.424 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 74.0 t80 -128.04 161.54 28.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 17.4 tttt -129.42 138.63 51.57 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.426 -0.796 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -140.42 162.82 34.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.1 mt -110.96 136.27 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -85.27 170.47 12.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.357 -0.84 . . . . 0.0 109.479 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.0 p -60.35 5.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 110.546 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 31' ' ' ASP . 37.3 m-85 -99.45 -17.68 17.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.039 -1.038 . . . . 0.0 109.43 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 -2.91 82.31 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -83.92 142.07 41.5 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.282 -1.128 . . . . 0.0 108.172 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.5 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 50.4 Cg_endo -69.9 145.54 56.64 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.685 1.59 . . . . 0.0 111.124 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -140.07 153.97 46.92 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -129.56 148.69 51.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.044 -1.035 . . . . 0.0 109.892 -179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.14 142.92 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -117.22 160.91 20.32 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.1 t -168.74 152.46 5.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -93.78 7.55 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -143.65 149.09 36.77 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 51.1 tp -94.09 -42.99 8.71 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.443 ' CG2' ' HG1' ' A' ' 47' ' ' THR . 19.5 m -121.65 158.01 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.683 -0.636 . . . . 0.0 109.452 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.36 -11.4 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.191 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.443 ' HG1' ' CG2' ' A' ' 45' ' ' VAL . 72.0 p -90.3 -6.91 54.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.039 -1.038 . . . . 0.0 110.129 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -70.71 179.36 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.97 -1.081 . . . . 0.0 110.009 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' NH1' ' HG2' ' A' ' 49' ' ' ARG . 6.5 tpt180 -142.44 120.76 12.32 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 109.116 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.31 142.35 50.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.252 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -49.34 146.29 14.02 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.879 1.053 . . . . 0.0 110.503 178.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.56 -47.55 39.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.994 -1.067 . . . . 0.0 110.166 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.97 -21.02 4.85 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -102.51 139.71 37.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -1.17 . . . . 0.0 109.934 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.551 ' H ' ' CD ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.54 159.29 30.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 179.839 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 25.6 p-10 -66.39 164.25 16.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.16 171.68 15.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.62 133.05 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 110.17 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.7 p -58.82 152.58 18.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.066 179.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.27 -47.21 87.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.219 -0.925 . . . . 0.0 109.867 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -42.95 -45.07 4.88 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.08 -1.012 . . . . 0.0 109.819 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 97.5 mt-10 -72.29 -37.5 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -66.32 -42.51 88.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.693 -1.255 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.04 -53.5 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.668 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.87 93.03 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.15 -0.969 . . . . 0.0 110.116 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -72.33 -38.73 68.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.893 -1.129 . . . . 0.0 111.436 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.62 -46.4 72.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.576 -1.327 . . . . 0.0 110.094 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -74.45 -38.06 63.09 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 120.794 -1.191 . . . . 0.0 109.838 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 73' ' ' ASP . 29.0 ttmt -73.09 -30.1 63.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.839 -1.163 . . . . 0.0 110.114 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.35 -32.81 20.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.186 -0.946 . . . . 0.0 110.48 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 86.8 mt -86.74 -49.95 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.099 -1.001 . . . . 0.0 110.257 -179.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -88.44 64.23 7.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.931 -1.106 . . . . 0.0 109.399 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' O ' ' O ' ' A' ' 69' ' ' LYS . 89.3 m-20 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.924 -1.11 . . . . 0.0 109.476 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.497 0.665 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -88.3 -168.31 2.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.417 -0.802 . . . . 0.0 109.533 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.438 HH11 ' HG2' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -81.27 127.13 32.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.855 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 -129.81 135.47 48.46 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.544 -0.723 . . . . 0.0 109.526 -179.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -64.83 165.51 10.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.391 -0.818 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.441 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 26.0 p30 -63.17 -6.97 4.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.368 -0.832 . . . . 0.0 109.823 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -96.41 -75.79 0.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.95 -1.32 0.03 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.924 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' A' ' 11' ' ' ARG . 5.3 mtt-85 -85.59 133.18 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.469 . . . . 0.0 108.895 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.96 117.0 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.958 . . . . 0.0 109.385 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.8 151.42 22.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -88.89 173.78 8.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.337 -0.852 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 m -56.82 139.34 51.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.397 -0.815 . . . . 0.0 110.636 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.18 -42.35 2.27 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.24 150.6 43.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.807 -1.408 . . . . 0.0 109.539 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -157.03 140.0 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.441 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 53.9 tt0 -101.86 140.72 35.77 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -91.19 173.13 8.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 110.425 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -64.16 -19.66 65.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -84.81 -9.81 57.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.1 -25.53 25.08 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 121.096 -1.002 . . . . 0.0 110.96 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -62.21 137.95 58.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.739 -1.447 . . . . 0.0 109.302 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.81 166.76 19.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 110.496 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tt -153.51 138.76 17.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.696 . . . . 0.0 110.043 -179.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -133.16 148.39 52.09 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -115.05 139.31 49.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.386 -0.821 . . . . 0.0 109.663 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.91 166.07 27.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 0.0 109.098 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -103.81 134.0 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.259 -0.901 . . . . 0.0 109.695 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -84.01 171.59 12.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.894 -1.128 . . . . 0.0 109.236 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -62.33 -0.13 0.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.568 -0.708 . . . . 0.0 111.367 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 39.2 m-85 -103.77 -21.59 13.66 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.901 -1.124 . . . . 0.0 110.255 -178.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.82 -1.91 38.8 Favored Glycine 0 N--CA 1.503 3.109 0 O-C-N 121.059 -1.026 . . . . 0.0 111.199 178.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -86.97 153.91 54.87 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.69 -1.476 . . . . 0.0 108.709 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -82.5 133.99 7.46 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.301 2.001 . . . . 0.0 112.796 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 3.7 mp0 -127.95 164.68 21.78 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.422 -0.798 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -137.49 147.35 45.18 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 156.22 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.34 154.9 44.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.458 -0.776 . . . . 0.0 110.065 -178.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -172.34 137.74 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.605 -0.684 . . . . 0.0 109.276 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -88.38 11.56 16.51 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -126.27 147.67 49.65 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.42 0.628 . . . . 0.0 109.78 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.1 tp -95.67 -47.22 6.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.15 -176.87 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.56 -15.87 58.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 111.109 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -88.1 -10.03 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.711 -1.243 . . . . 0.0 110.234 -178.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -75.85 166.78 23.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.978 . . . . 0.0 110.467 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.49 139.91 40.84 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -81.06 149.58 66.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.801 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.39 154.46 50.85 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.488 2.125 . . . . 0.0 111.338 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.13 144.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.63 -38.54 3.07 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.562 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 9.6 mptt -93.2 126.03 38.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -1.165 . . . . 0.0 108.175 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.473 ' HB3' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.5 155.67 33.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 110.109 -179.137 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -50.98 164.67 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.939 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 52.2 t -162.15 165.75 26.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.439 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 97.6 mt -83.93 126.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.59 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.5 p -54.37 157.62 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 108.925 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.54 -59.97 3.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 110.677 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -46.69 -39.93 12.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.115 . . . . 0.0 110.392 -178.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -71.5 -40.22 70.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.929 -1.107 . . . . 0.0 109.394 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -70.84 -41.81 70.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.78 -49.65 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.94 -1.1 . . . . 0.0 109.137 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.66 80.19 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.179 -0.95 . . . . 0.0 109.859 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.71 -53.5 13.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 111.07 -178.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.68 -49.19 41.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.631 -1.293 . . . . 0.0 110.442 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 72' ' ' HIS . 19.9 tt0 -68.1 -44.01 77.18 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 -176.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -75.59 -30.05 59.48 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.392 -1.442 . . . . 0.0 111.17 -178.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -75.0 -45.77 39.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.147 -0.971 . . . . 0.0 112.121 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 pt -87.18 -17.54 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.001 -1.062 . . . . 0.0 111.182 -177.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 68' ' ' GLN . 3.0 m-70 -153.22 154.43 34.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.027 -1.046 . . . . 0.0 109.526 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 C--N 1.303 -1.455 0 O-C-N 121.56 -0.712 . . . . 0.0 109.999 179.019 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.564 0.697 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -81.48 167.64 19.13 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.309 -0.869 . . . . 0.0 108.718 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -81.56 152.2 27.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.908 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.538 ' CG ' HH11 ' A' ' 6' ' ' ARG . 2.6 mtt-85 -141.72 161.56 37.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.325 -0.86 . . . . 0.0 108.969 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 58.3 p30 -101.26 178.15 4.73 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -62.05 -6.77 3.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.718 -1.239 . . . . 0.0 109.462 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' NH2' ' NH2' ' A' ' 11' ' ' ARG . 17.7 mmm180 -96.95 -12.12 23.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 86.73 10.05 73.57 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.313 178.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 11' ' ' ARG . 2.9 mtt-85 -85.67 152.02 23.42 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.668 -1.489 . . . . 0.0 109.544 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -84.48 104.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 pp -92.77 146.43 23.65 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.936 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -88.78 -174.54 4.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.049 -1.032 . . . . 0.0 111.466 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 m -57.63 147.33 27.67 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.4 -44.82 3.41 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.51 149.06 50.66 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.995 -1.297 . . . . 0.0 109.555 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -157.21 155.1 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.491 ' OE1' ' CD1' ' A' ' 25' ' ' TYR . 5.2 tp60 -110.81 132.39 54.24 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.542 -0.724 . . . . 0.0 110.007 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.789 HH11 HH21 ' A' ' 24' ' ' ARG . 36.0 mtp180 -90.46 -177.41 5.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -24.1 65.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.209 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.51 -13.1 41.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.004 -1.06 . . . . 0.0 109.702 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.65 -14.46 59.09 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.345 -0.847 . . . . 0.0 111.393 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.789 HH21 HH11 ' A' ' 20' ' ' ARG . 2.1 ptt180 -64.46 141.03 58.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.444 -1.621 . . . . 0.0 109.348 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.491 ' CD1' ' OE1' ' A' ' 19' ' ' GLN . 71.5 m-85 -81.45 165.95 20.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.418 -0.802 . . . . 0.0 110.066 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 tp -153.85 125.81 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.473 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 69.0 t80 -130.72 170.15 14.72 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 33.1 tttm -139.76 142.24 36.77 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.931 -1.106 . . . . 0.0 111.173 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.58 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 43.5 p90 -149.17 -172.91 4.24 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.352 -0.843 . . . . 0.0 108.966 176.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -114.22 134.54 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.952 -1.092 . . . . 0.0 110.147 -178.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 5.0 m-20 -83.98 174.87 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 t -66.6 -6.53 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.9 . . . . 0.0 108.808 178.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 12.0 m-85 -98.18 -4.76 34.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.773 . . . . 0.0 109.069 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.08 -1.11 86.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 pp20? -85.5 144.44 40.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 0.0 108.959 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.62 131.08 11.14 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.978 1.785 . . . . 0.0 112.146 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.627 ' NE2' ' H ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -129.4 172.1 11.85 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.964 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 19.0 m-85 -141.08 163.47 32.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 0.0 110.512 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.54 135.46 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -122.49 143.54 49.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.531 -0.731 . . . . 0.0 110.01 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.6 t -171.7 157.64 4.72 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 178.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -91.19 10.18 28.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HZ2' ' H ' ' A' ' 57' ' ' CYS . 34.1 mtmm -131.81 141.19 49.38 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.717 0.77 . . . . 0.0 110.152 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -94.58 -40.45 9.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.59 168.1 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.04 60.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.421 -0.799 . . . . 0.0 109.729 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.8 p -90.06 -5.52 56.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.165 -0.959 . . . . 0.0 110.314 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.95 172.15 9.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.924 -1.11 . . . . 0.0 109.366 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -142.15 133.65 26.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.135 -0.978 . . . . 0.0 109.255 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.4 150.0 62.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.301 -179.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 151.8 62.84 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.161 1.907 . . . . 0.0 111.213 178.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.84 153.32 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 0.0 110.481 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.21 5.77 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -95.43 139.38 31.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.059 -1.26 . . . . 0.0 109.572 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.509 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.84 164.62 25.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 109.349 -179.48 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -74.45 161.94 29.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.355 -0.841 . . . . 0.0 109.608 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.666 ' H ' ' HZ2' ' A' ' 43' ' ' LYS . 27.8 t -161.73 161.22 29.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.479 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 81.6 mt -82.42 136.34 23.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.021 -1.049 . . . . 0.0 109.227 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -59.19 176.04 0.26 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.53 -0.732 . . . . 0.0 110.123 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 6.9 mp -77.2 -52.68 8.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.474 ' H ' ' CD ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -42.63 -44.41 4.22 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.182 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -71.84 -40.0 69.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -65.04 -40.38 94.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.709 -1.245 . . . . 0.0 109.884 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.19 -55.61 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.958 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.16 95.75 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.5 -1.375 . . . . 0.0 109.89 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.43 -45.28 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 110.652 -179.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.73 -43.5 68.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.815 -1.178 . . . . 0.0 110.255 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -72.1 -42.02 66.59 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.725 -0.609 . . . . 0.0 110.329 -177.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -77.34 -26.44 52.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.107 -0.996 . . . . 0.0 110.524 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -89.32 -46.58 8.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.917 -1.114 . . . . 0.0 110.924 -178.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.0 mt -83.89 60.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 109.641 -178.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.46 -171.16 3.48 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 t0 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.069 -1.02 . . . . 0.0 109.532 -179.763 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 42.4 p-10 -91.35 -177.08 4.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 109.772 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -63.09 -9.47 10.72 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.506 -0.746 . . . . 0.0 109.698 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.409 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 4.0 mmp_? -101.3 -71.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.994 -1.066 . . . . 0.0 110.02 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 169.09 7.08 0.03 OUTLIER Glycine 0 N--CA 1.497 2.703 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.949 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.566 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 67.0 mtm180 -87.98 136.49 32.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.644 -1.503 . . . . 0.0 109.066 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.3 mt -82.61 111.72 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -89.42 149.85 22.78 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -86.04 -179.71 6.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.803 -1.186 . . . . 0.0 110.97 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t -58.63 145.62 39.03 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.691 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.02 -40.1 2.81 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.328 -0.857 . . . . 0.0 111.189 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 27' ' ' TYR . 46.5 mp0 -72.07 152.18 42.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.709 -1.465 . . . . 0.0 109.997 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -154.67 142.38 19.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -110.27 132.43 54.18 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -89.5 169.87 11.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.313 -0.867 . . . . 0.0 109.347 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -12.6 41.79 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.534 -0.729 . . . . 0.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -87.65 -18.41 29.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.272 -0.893 . . . . 0.0 109.831 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.54 -23.85 25.46 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -64.86 137.89 58.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.424 . . . . 0.0 109.569 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.566 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -82.8 171.41 13.97 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.643 -0.661 . . . . 0.0 110.115 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 27' ' ' TYR . 2.1 tt -154.56 127.23 8.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.557 ' N ' HD23 ' A' ' 26' ' ' LEU . 75.9 t80 -132.78 163.19 29.6 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.249 -0.907 . . . . 0.0 109.058 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -131.52 137.05 48.35 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.323 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.72 133.13 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 33' ' ' PHE . 34.6 p30 -88.31 174.61 8.08 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.667 -0.646 . . . . 0.0 110.319 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 t -62.11 6.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 0.0 110.555 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 31' ' ' ASP . 19.9 m-85 -100.69 -16.31 17.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.98 -1.075 . . . . 0.0 108.432 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.61 -4.86 85.11 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.26 149.88 59.46 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.072 -1.252 . . . . 0.0 108.717 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.96 137.41 24.21 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.405 1.403 . . . . 0.0 109.786 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -135.21 137.63 42.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.915 -1.116 . . . . 0.0 109.274 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.61 145.23 40.74 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.518 -0.739 . . . . 0.0 110.172 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.0 157.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.527 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 55.6 m-85 -127.53 155.73 43.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -170.78 136.5 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.85 -1.156 . . . . 0.0 110.868 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -86.62 5.99 33.14 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -131.76 131.73 43.22 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.615 0.722 . . . . 0.0 110.098 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 tp -86.18 -42.78 13.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.75 174.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.93 -16.74 59.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.086 -1.008 . . . . 0.0 110.6 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.5 p -88.39 -4.91 58.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.849 -1.157 . . . . 0.0 110.596 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.565 ' CG ' HH12 ' A' ' 11' ' ' ARG . 73.2 m-20 -70.01 177.31 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.595 -1.316 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -139.6 138.08 35.88 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.08 144.07 50.32 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.49 -0.756 . . . . 0.0 111.044 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.0 143.92 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.449 2.099 . . . . 0.0 112.912 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.79 130.6 17.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -0.775 . . . . 0.0 110.072 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.84 59.71 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -92.22 135.24 34.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.013 -1.286 . . . . 0.0 109.061 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -75.24 161.27 29.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.314 -0.867 . . . . 0.0 110.189 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.55 158.86 3.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.57 -0.706 . . . . 0.0 110.23 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 9.3 t -147.31 158.0 43.8 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 87.1 mt -83.09 124.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.872 -1.143 . . . . 0.0 109.306 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.41 153.9 14.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.206 -0.934 . . . . 0.0 109.543 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.86 -53.45 57.8 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.611 -0.835 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -48.88 -44.65 40.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.885 -1.135 . . . . 0.0 109.043 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -72.33 -39.06 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 40' ' ' TYR . 11.0 ttmt -67.32 -49.86 62.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.977 -1.077 . . . . 0.0 109.444 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -50.34 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.27 -49.26 74.73 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 110.42 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -68.87 -39.75 79.66 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 111.701 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.31 -48.59 49.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.699 -1.251 . . . . 0.0 111.305 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.123 -0.985 . . . . 0.0 110.44 -178.61 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 37.6 p-10 -95.24 -170.81 2.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.371 -0.831 . . . . 0.0 109.59 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.444 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 70.1 m-80 -68.18 -11.57 59.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.849 . . . . 0.0 110.789 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -103.47 -23.27 13.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.028 -1.045 . . . . 0.0 109.907 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 109.41 19.27 8.48 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 24.3 mtt180 -84.71 124.59 31.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.131 -1.217 . . . . 0.0 109.47 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.7 mm -75.45 101.73 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.835 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -95.24 150.62 20.04 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -87.48 -171.81 3.63 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.0 111.45 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.431 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 66.2 p -54.06 149.95 8.68 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.0 -45.25 2.48 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 1.4 mp0 -69.22 131.84 45.55 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.563 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.3 m -152.7 152.35 31.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.287 -0.883 . . . . 0.0 108.775 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.444 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.1 tt0 -95.92 141.59 29.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.042 -1.037 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -88.11 163.03 16.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.718 -0.613 . . . . 0.0 109.376 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -62.71 -19.82 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.018 -1.051 . . . . 0.0 108.571 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.91 -13.59 44.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.913 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.31 -26.83 19.02 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 121.258 -0.901 . . . . 0.0 111.075 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -61.99 135.92 57.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.694 -1.474 . . . . 0.0 110.237 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH1' ' A' ' 11' ' ' ARG . 74.1 m-85 -80.57 168.28 19.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -161.04 147.38 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.0 -1.062 . . . . 0.0 109.298 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.978 ' N ' HD22 ' A' ' 26' ' ' LEU . 84.6 t80 -139.16 168.05 20.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 65.5 tttt -127.06 138.99 53.32 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.433 -0.792 . . . . 0.0 109.437 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.603 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 19.4 p90 -138.39 170.7 15.55 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mm -108.47 136.57 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.405 -0.809 . . . . 0.0 110.123 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.4 m-20 -78.47 161.82 26.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.22 -0.925 . . . . 0.0 108.649 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 t -59.79 -2.82 0.42 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 109.317 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.4 m-85 -101.53 -18.46 15.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.335 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 2.4 51.5 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 121.227 -0.921 . . . . 0.0 111.237 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -86.26 148.15 46.57 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.78 -1.424 . . . . 0.0 110.191 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 87.2 Cg_endo -76.99 128.32 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 122.94 2.427 . . . . 0.0 113.213 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 36' ' ' PRO . 2.7 mp0 -131.29 163.45 27.79 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -131.73 156.2 46.35 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.282 -0.886 . . . . 0.0 109.892 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.41 147.04 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -125.79 151.57 46.58 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.783 0.801 . . . . 0.0 109.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -172.27 145.47 1.72 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -87.79 23.79 1.92 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.951 -1.093 . . . . 0.0 108.281 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -137.37 137.56 38.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.593 -0.692 . . . . 0.0 110.539 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.0 tp -95.18 -42.33 8.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 47' ' ' THR . 18.2 m -126.86 147.49 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.15 -7.04 0.17 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 45' ' ' VAL . 30.8 p -89.82 -4.74 57.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.998 -1.064 . . . . 0.0 110.184 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.21 164.18 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.142 -0.974 . . . . 0.0 110.801 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.539 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -134.86 121.03 20.04 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.3 150.69 64.61 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.75 150.52 44.84 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.491 2.128 . . . . 0.0 111.69 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.83 147.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.83 -38.36 3.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -95.17 131.21 41.45 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.307 -1.114 . . . . 0.0 108.485 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -77.76 153.4 32.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.839 -1.163 . . . . 0.0 109.689 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.02 163.31 22.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.45 -0.781 . . . . 0.0 110.128 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 29.6 t -157.16 169.71 24.17 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.589 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.7 mt -82.42 136.82 22.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 94.5 p -55.85 154.31 7.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.149 -0.969 . . . . 0.0 109.311 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 61' ' ' ARG . 78.6 mt -62.01 -49.61 75.37 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.308 -0.87 . . . . 0.0 110.272 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 60' ' ' LEU . 30.5 mtt180 -46.65 -47.53 20.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.786 -1.196 . . . . 0.0 109.787 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -72.18 -34.83 68.72 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -68.71 -41.57 78.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 108.913 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.26 -52.54 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.45 -34.45 72.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -70.85 -35.33 72.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.424 -0.798 . . . . 0.0 111.535 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.603 HD12 ' CZ ' ' A' ' 29' ' ' TYR . 4.0 mm? -63.61 -39.93 95.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.821 -1.174 . . . . 0.0 110.658 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 . . . . . 0 C--N 1.293 -1.88 0 O-C-N 120.538 -1.351 . . . . 0.0 111.352 -177.881 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.447 HH11 ' HG3' ' A' ' 6' ' ' ARG . 35.9 mtm-85 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -95.69 -163.88 1.1 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.082 -1.012 . . . . 0.0 109.85 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 13.4 p30 -67.07 -23.54 65.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -100.03 5.02 45.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 110.637 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.43 49.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -87.19 134.86 33.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.137 -1.214 . . . . 0.0 110.205 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.4 mm -84.44 97.1 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 108.773 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.78 146.02 24.47 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.039 -1.038 . . . . 0.0 109.708 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.79 178.59 6.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.122 -0.986 . . . . 0.0 109.732 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -57.26 147.02 26.61 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.532 0.682 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.55 -45.23 1.76 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 24.3 mp0 -72.41 156.62 38.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.106 -1.232 . . . . 0.0 109.802 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.8 m -157.75 140.91 15.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.534 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.4 tt0 -94.85 142.18 27.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -92.25 169.08 10.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.631 0.729 . . . . 0.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -63.48 -23.1 67.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.701 -0.624 . . . . 0.0 110.553 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -88.1 -17.49 30.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 0.0 110.133 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.39 -32.21 6.02 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -60.4 135.15 57.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.736 -1.449 . . . . 0.0 109.558 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.68 170.18 16.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 111.192 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.3 tp -152.03 121.66 6.93 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 82.3 t80 -125.14 174.66 7.91 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.236 -0.915 . . . . 0.0 108.57 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.576 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 75.1 tttt -128.06 121.77 30.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 109.779 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -124.3 158.47 32.49 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.96 150.02 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.9 170.44 16.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 108.937 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.7 m -68.07 -2.64 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -96.96 -17.51 20.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.132 -0.98 . . . . 0.0 109.389 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.59 -4.41 32.71 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 20.9 pt-20 -85.34 145.67 43.08 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.882 -1.363 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.57 146.97 21.94 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.645 2.23 . . . . 0.0 113.44 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.406 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 16.3 mp0 -142.3 178.35 7.63 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -133.95 152.9 52.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 0.0 109.531 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.578 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -129.92 158.58 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.451 -0.781 . . . . 0.0 109.33 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 36.6 m-85 -128.95 149.96 50.58 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.277 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -168.37 142.28 3.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 0.0 109.949 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -90.37 11.63 20.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -139.87 153.48 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 0.0 110.442 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 59' ' ' SER . 42.9 tp -99.25 -43.61 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.95 170.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.15 -15.58 59.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 0.0 110.886 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.2 p -86.57 -13.76 44.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.588 -1.32 . . . . 0.0 110.069 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -71.17 178.94 3.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.389 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.8 147.73 46.78 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.92 149.66 74.09 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.976 -1.077 . . . . 0.0 109.553 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -51.7 147.64 23.72 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.337 1.358 . . . . 0.0 111.432 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.24 141.18 11.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 -24.64 29.14 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -96.81 140.74 30.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.313 . . . . 0.0 109.356 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -74.45 153.28 39.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.807 -1.183 . . . . 0.0 109.148 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.31 163.32 0.41 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.181 -0.949 . . . . 0.0 110.09 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -148.38 160.12 43.33 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 99.0 mt -84.84 134.26 27.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 44.3 t -58.47 153.87 15.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.661 -0.65 . . . . 0.0 110.052 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -60.82 -53.13 61.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -49.87 -45.74 50.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.935 -1.103 . . . . 0.0 109.845 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.9 -29.9 66.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 108.675 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -72.39 -45.54 59.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.459 -0.775 . . . . 0.0 109.204 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.35 -55.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 0.0 110.252 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.06 93.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 0.0 110.647 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -68.74 -35.16 76.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 111.803 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.03 -41.78 86.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.569 -1.332 . . . . 0.0 111.755 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 . . . . . 0 C--N 1.293 -1.874 0 O-C-N 120.239 -1.538 . . . . 0.0 111.335 -177.383 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -70.34 175.24 4.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 0.0 110.264 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -66.81 -12.4 58.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.476 -0.765 . . . . 0.0 109.931 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.435 ' NH1' ' HG3' ' A' ' 9' ' ' ARG . 7.7 mmm-85 -95.57 -77.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 0.0 109.349 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.96 3.7 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.216 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 55.9 mtm180 -88.14 125.27 34.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.732 -1.452 . . . . 0.0 108.869 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.3 mt -77.79 110.95 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.07 -1.019 . . . . 0.0 109.832 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.2 156.71 18.12 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -88.79 -176.84 5.36 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.816 -1.178 . . . . 0.0 110.775 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -54.63 161.65 1.42 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.801 0.81 . . . . 0.0 112.068 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.34 -19.26 1.89 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 40.4 mt-10 -86.92 150.03 24.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.266 . . . . 0.0 110.295 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.0 p -157.5 134.05 9.83 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -99.2 125.8 44.86 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' CG ' HH11 ' A' ' 20' ' ' ARG . 1.0 OUTLIER -85.57 -174.13 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.816 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -72.48 -22.9 60.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 109.937 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.67 -10.97 57.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.89 -21.94 43.42 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -61.33 138.05 58.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.847 -1.384 . . . . 0.0 109.294 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 67.3 m-85 -80.54 166.72 20.9 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.252 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 24.3 tp -150.24 119.07 6.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 109.623 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -125.44 162.27 25.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -131.44 138.13 48.92 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.25 -0.906 . . . . 0.0 110.736 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.2 p90 -142.82 164.51 29.9 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.62 138.85 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.94 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.456 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 52.8 m-20 -87.37 -178.35 6.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.949 . . . . 0.0 110.4 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 p -66.91 -1.37 3.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.321 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 47.9 m-85 -98.58 -10.63 23.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.951 . . . . 0.0 108.713 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.45 -8.52 76.88 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -81.37 145.2 54.99 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.5 148.22 42.27 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.94 1.76 . . . . 0.0 112.717 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.1 mp0 -135.67 170.71 15.54 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.28 145.89 39.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.346 -0.846 . . . . 0.0 110.383 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.85 146.49 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.704 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 62.2 m-85 -128.91 151.11 50.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.597 -0.69 . . . . 0.0 109.596 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -171.66 146.19 2.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -88.83 11.42 17.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 108.51 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -123.57 140.99 52.44 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.555 -0.716 . . . . 0.0 110.226 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.79 -44.95 6.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.38 172.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -19.41 62.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.2 p -86.7 -1.98 58.15 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.703 -1.248 . . . . 0.0 110.788 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' OD1' ' NH1' ' A' ' 11' ' ' ARG . 76.0 m-20 -70.6 -174.22 0.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.585 -1.322 . . . . 0.0 109.334 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -148.75 130.53 15.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.043 -1.035 . . . . 0.0 109.454 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 15.0 m -80.97 130.07 64.91 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.83 -1.169 . . . . 0.0 109.272 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -48.87 148.05 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.188 1.259 . . . . 0.0 111.711 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.14 135.46 13.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.112 -0.992 . . . . 0.0 109.817 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.13 -32.66 6.68 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -92.33 136.47 33.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -1.165 . . . . 0.0 108.553 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.3 mmp_? -74.59 151.78 39.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.377 -0.827 . . . . 0.0 110.439 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -55.62 169.48 0.32 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 43.6 t -165.15 166.46 19.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.131 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 71.5 mt -83.6 125.48 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.015 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -56.69 156.0 6.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.337 -0.852 . . . . 0.0 109.638 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.456 ' O ' HD13 ' A' ' 64' ' ' ILE . 8.2 mp -56.13 -47.85 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 17' ' ' GLU . 5.0 mmp_? -53.25 -50.6 64.47 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.013 -1.054 . . . . 0.0 110.291 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.29 -36.68 61.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.753 -1.217 . . . . 0.0 110.806 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -65.97 -44.34 85.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.747 -1.22 . . . . 0.0 110.105 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.3 mp -60.68 -48.78 87.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.48 -42.71 74.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.93 -1.106 . . . . 0.0 109.974 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.27 -51.86 27.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 110.807 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.417 HD22 ' OH ' ' A' ' 29' ' ' TYR . 30.7 mt -68.27 -26.32 65.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 111.752 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 C--N 1.292 -1.912 0 O-C-N 120.804 -1.185 . . . . 0.0 112.745 -177.003 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 121.456 0.646 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -100.82 -176.47 3.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.732 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -66.29 -15.17 63.01 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.042 -1.036 . . . . 0.0 110.034 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.3 OUTLIER -95.39 -0.51 52.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 -178.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 0.45 86.45 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -84.57 137.04 33.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.107 -1.231 . . . . 0.0 109.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.6 mt -80.47 120.06 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.916 -1.115 . . . . 0.0 109.743 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -90.32 150.59 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 18.8 mtpp -87.09 -178.03 6.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.926 -1.109 . . . . 0.0 110.608 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 29.7 p -57.1 149.05 20.21 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 111.571 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.16 -30.37 2.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 15' ' ' THR . 43.1 mp0 -76.15 154.17 35.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.845 -1.385 . . . . 0.0 109.296 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -157.43 138.24 13.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.066 -1.022 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -99.37 134.34 42.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 20' ' ' ARG . 5.2 mmm-85 -87.54 176.02 7.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -21.33 63.56 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -83.52 -7.27 59.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.618 -0.676 . . . . 0.0 110.527 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.11 -28.46 13.84 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 120.97 -1.081 . . . . 0.0 111.068 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -57.13 154.33 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.853 -1.381 . . . . 0.0 109.616 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.63 169.85 9.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 109.731 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 tt -154.83 133.3 11.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.456 -0.777 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.96 146.41 49.08 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -118.92 136.38 54.09 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.653 -0.654 . . . . 0.0 110.606 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.551 ' C ' HD12 ' A' ' 30' ' ' ILE . 7.3 p90 -148.12 -171.9 3.94 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.365 -0.834 . . . . 0.0 110.287 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.551 HD12 ' C ' ' A' ' 29' ' ' TYR . 1.7 mp -106.64 129.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.9 p30 -86.47 -171.66 3.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.189 -0.944 . . . . 0.0 109.6 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.76 19.89 0.19 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.881 -1.137 . . . . 0.0 109.291 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 10.7 m-85 -118.29 -15.05 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.337 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.21 64.56 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.6 147.94 50.6 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.183 -1.186 . . . . 0.0 109.583 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.8 140.07 34.73 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.014 1.81 . . . . 0.0 112.36 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.682 ' N ' HE21 ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.0 164.65 26.51 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 23.2 m-85 -128.65 141.41 51.35 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.17 -0.957 . . . . 0.0 109.271 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.85 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -122.52 154.89 37.26 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.702 0.763 . . . . 0.0 110.113 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -171.26 143.6 1.9 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.999 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -97.17 18.25 15.38 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.81 144.72 31.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.324 -0.86 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 59' ' ' SER . 45.1 tp -94.25 -43.92 8.21 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.24 167.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -12.55 61.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.488 -0.757 . . . . 0.0 111.261 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.0 m -86.79 -9.6 55.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.903 -1.123 . . . . 0.0 110.098 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.28 167.19 16.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -140.2 118.85 12.34 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.92 148.24 86.88 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.38 157.1 62.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.183 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.96 150.5 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.311 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.64 -41.62 2.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -98.13 132.04 44.0 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.493 -1.004 . . . . 0.0 108.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.469 ' H ' ' CD ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.86 157.66 31.3 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.086 -1.009 . . . . 0.0 109.896 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -53.78 159.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.4 m -148.6 176.19 10.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 109.192 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.61 126.66 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 31.5 t -55.63 148.53 15.83 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.16 -0.963 . . . . 0.0 108.481 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 mt -58.52 -52.43 65.68 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.461 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 16.1 mmt180 -49.36 -37.24 24.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.704 -1.247 . . . . 0.0 108.989 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.35 -43.5 60.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.279 -0.888 . . . . 0.0 109.364 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -65.06 -44.36 89.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.494 -0.754 . . . . 0.0 109.613 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.09 -47.06 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.67 -46.58 88.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.099 -1.0 . . . . 0.0 109.851 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.47 -40.05 70.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.234 -0.916 . . . . 0.0 110.843 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.4 -45.24 80.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 112.082 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.27 -1.519 . . . . 0.0 110.263 -178.517 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.6 mtm-85 . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 43.6 p-10 -76.83 -175.08 3.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.042 . . . . 0.0 109.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.58 -6.16 3.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.65 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -104.77 -81.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 0.0 109.404 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 177.72 2.81 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 17.5 ptt180 -86.96 132.03 33.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.082 -1.246 . . . . 0.0 108.584 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 131.86 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.46 163.01 16.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 175.98 7.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.098 -1.001 . . . . 0.0 109.783 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -60.96 130.32 45.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.859 -0.526 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.58 -37.29 3.42 Favored Glycine 0 N--CA 1.501 2.973 0 O-C-N 121.218 -0.926 . . . . 0.0 111.892 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 59.1 mp0 -72.62 150.58 42.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.638 -1.507 . . . . 0.0 110.265 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -155.8 148.39 23.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.316 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -104.8 132.93 50.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.963 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -85.42 170.9 12.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 109.632 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -68.68 -18.49 64.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.15 -21.31 36.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 110.359 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.53 3.86 Favored Glycine 0 N--CA 1.502 3.082 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -61.06 139.64 58.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.124 -1.221 . . . . 0.0 109.191 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 86.6 m-85 -85.73 170.3 12.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.835 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.604 HD13 ' CE2' ' A' ' 40' ' ' TYR . 41.4 tp -151.46 128.15 10.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -129.88 142.95 50.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.57 142.08 47.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.569 -0.707 . . . . 0.0 110.247 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.625 ' OH ' HD12 ' A' ' 67' ' ' LEU . 9.8 p90 -149.09 -171.41 3.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.0 109.53 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.11 134.85 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.261 -0.899 . . . . 0.0 110.221 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.595 ' OD2' ' NE2' ' A' ' 37' ' ' GLN . 12.5 m-20 -87.05 175.25 8.2 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.862 -1.149 . . . . 0.0 110.392 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 m -70.76 -2.71 15.58 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 11.0 m-85 -98.67 -11.59 21.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.589 -0.694 . . . . 0.0 109.357 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.79 -5.88 79.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.407 ' HG3' ' NE2' ' A' ' 37' ' ' GLN . 12.9 pt-20 -86.75 152.08 53.54 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.159 -1.201 . . . . 0.0 109.328 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.25 155.1 28.92 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.137 1.891 . . . . 0.0 112.441 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.595 ' NE2' ' OD2' ' A' ' 31' ' ' ASP . 6.0 mp0 -148.86 160.14 43.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.217 -0.927 . . . . 0.0 109.235 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HB3' HD11 ' A' ' 26' ' ' LEU . 51.8 m-85 -136.66 148.97 47.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 26' ' ' LEU . 11.2 m -122.24 145.37 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.604 ' CE2' HD13 ' A' ' 26' ' ' LEU . 55.6 m-85 -116.03 151.51 35.36 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 t -169.64 145.54 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.28 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.72 9.07 36.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -132.32 133.64 44.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD11 ' NH2' ' A' ' 61' ' ' ARG . 35.1 tp -88.99 -42.96 11.47 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.67 151.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.42 -7.08 3.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.109 -0.995 . . . . 0.0 111.156 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.1 p -90.34 -11.8 39.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.749 -1.22 . . . . 0.0 109.774 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.62 172.49 11.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.181 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.33 135.03 33.34 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.24 147.39 60.53 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.745 -1.222 . . . . 0.0 110.451 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.61 145.7 71.02 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.13 1.887 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.72 144.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 110.573 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.12 -32.62 7.3 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -97.07 139.11 33.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.159 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.62 151.8 34.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -0.966 . . . . 0.0 109.771 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.7 150.53 15.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.141 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.7 p -147.32 161.98 39.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.046 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.69 126.81 40.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.0 m -56.33 160.94 2.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.157 -0.964 . . . . 0.0 108.801 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.04 -47.6 73.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.748 -1.22 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.596 ' NH2' HD11 ' A' ' 44' ' ' LEU . 5.1 mmt-85 -41.54 -53.01 3.58 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.401 -0.812 . . . . 0.0 110.28 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -69.01 -34.43 75.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.088 -1.008 . . . . 0.0 108.662 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -68.77 -41.87 78.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -50.15 -51.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.138 -0.976 . . . . 0.0 109.266 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.7 70.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.852 -1.155 . . . . 0.0 109.525 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.93 -44.87 60.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.91 . . . . 0.0 111.481 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.625 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.5 mm? -69.54 -44.06 71.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.23 -1.544 . . . . 0.0 110.899 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 . . . . . 0 N--CA 1.496 1.863 0 O-C-N 119.762 -1.836 . . . . 0.0 110.886 -178.513 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 121.444 0.64 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.57 -159.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.407 -0.808 . . . . 0.0 109.743 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.112 -0.992 . . . . 0.0 110.261 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -92.18 -86.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.041 . . . . 0.0 109.496 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.1 22.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.551 ' NH1' ' OD2' ' A' ' 48' ' ' ASP . 67.6 mtm180 -88.72 135.73 33.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.795 -1.415 . . . . 0.0 110.578 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.8 mm -76.37 114.46 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 140.45 33.14 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -86.39 179.01 6.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.963 -1.085 . . . . 0.0 111.028 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -52.13 155.12 2.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.418 0.628 . . . . 0.0 109.84 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.68 -44.75 2.06 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -70.28 147.17 50.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -1.231 . . . . 0.0 109.272 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -155.24 157.5 37.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.649 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.0 tp-100 -107.28 123.12 47.85 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.388 -0.82 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.539 ' NH2' ' OH ' ' A' ' 40' ' ' TYR . 18.3 mtt180 -83.62 169.49 15.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.201 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.877 . . . . 0.0 109.622 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' A' ' 24' ' ' ARG . 1.4 p30 -91.43 -26.58 18.78 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.97 -1.081 . . . . 0.0 109.98 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.42 -36.25 2.96 Favored Glycine 0 N--CA 1.505 3.295 0 O-C-N 121.268 -0.895 . . . . 0.0 111.443 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.531 ' NH2' ' OD2' ' A' ' 22' ' ' ASP . 3.3 ptt-85 -60.57 132.92 55.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.604 -1.527 . . . . 0.0 109.438 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 86.2 m-85 -87.04 168.93 12.86 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pp -147.4 138.22 23.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -125.31 156.97 37.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.662 -0.649 . . . . 0.0 109.452 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -117.68 138.97 51.64 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 16.7 p90 -148.83 -165.89 2.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.984 -1.072 . . . . 0.0 109.961 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.439 ' O ' ' CD2' ' A' ' 29' ' ' TYR . 1.4 mp -107.48 136.37 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 O-C-N 121.315 -0.866 . . . . 0.0 110.461 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.64 ' CG ' HE21 ' A' ' 37' ' ' GLN . 17.0 m-20 -80.56 173.01 13.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.006 -1.059 . . . . 0.0 109.494 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -9.59 10.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 11.5 m-85 -104.21 -6.76 20.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.471 -0.768 . . . . 0.0 110.824 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.26 -4.6 64.87 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.028 -1.045 . . . . 0.0 110.539 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.02 150.54 47.8 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.832 -1.393 . . . . 0.0 110.102 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.55 152.65 23.12 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.268 1.979 . . . . 0.0 113.554 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.64 HE21 ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -157.83 179.89 8.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.75 149.58 50.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.857 -1.152 . . . . 0.0 110.179 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.02 162.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.539 ' OH ' ' NH2' ' A' ' 20' ' ' ARG . 84.1 m-85 -137.0 153.83 50.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.256 -0.902 . . . . 0.0 110.767 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -168.23 149.75 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -86.97 3.68 44.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.337 -0.852 . . . . 0.0 109.302 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -131.95 153.13 50.61 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.392 -0.818 . . . . 0.0 109.459 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 59' ' ' SER . 19.5 tp -93.36 -51.14 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.348 0.594 . . . . 0.0 109.975 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.51 175.62 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.42 0.628 . . . . 0.0 110.5 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.86 63.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 111.095 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -85.16 -8.08 58.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.817 -1.177 . . . . 0.0 110.309 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 59.8 m-20 -74.46 174.38 9.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 109.819 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -139.68 149.51 43.76 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -80.85 138.81 49.99 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.269 -0.894 . . . . 0.0 109.934 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -46.18 140.82 10.47 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.923 1.749 . . . . 0.0 111.706 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.6 132.13 17.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.14 -30.75 6.6 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -94.54 145.5 24.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -1.083 . . . . 0.0 108.706 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HD3' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.6 150.66 34.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 108.726 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -49.53 162.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.01 -1.056 . . . . 0.0 109.845 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 38.2 t -154.78 173.64 16.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.155 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.473 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 5.9 mm -92.1 132.16 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.467 -0.77 . . . . 0.0 109.317 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 45.9 t -55.78 164.11 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.283 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 43' ' ' LYS . 4.5 mp -71.32 -57.48 4.43 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.521 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -45.82 -41.92 11.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -69.06 -41.88 77.02 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.34 -0.944 . . . . 0.0 108.877 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -67.16 -42.03 84.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.938 . . . . 0.0 109.954 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.76 -49.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.76 -1.213 . . . . 0.0 108.635 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.61 83.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.0 110.292 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -70.97 -43.12 68.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.89 . . . . 0.0 111.171 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.453 HD22 ' OH ' ' A' ' 29' ' ' TYR . 11.0 mt -67.66 -44.06 78.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 111.545 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--N 1.296 -1.744 0 O-C-N 120.815 -1.178 . . . . 0.0 110.539 -178.328 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.551 ' CG ' HH11 ' A' ' 6' ' ' ARG . 1.7 mtt-85 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -84.66 -171.66 3.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -66.96 -14.87 63.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.882 . . . . 0.0 109.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -95.04 -5.07 45.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -0.894 . . . . 0.0 108.911 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.82 58.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' CG ' ' A' ' 48' ' ' ASP . 17.9 mmt180 -90.67 142.12 28.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -1.183 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mm -82.55 119.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 108.004 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 13' ' ' LEU . 4.0 mp -90.75 145.06 25.11 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -87.6 179.28 6.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.052 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -57.52 136.74 56.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.256 -0.902 . . . . 0.0 110.036 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.27 -56.48 1.23 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -49.3 148.69 2.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 110.021 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -157.13 156.84 33.39 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -99.74 145.17 27.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.027 -1.046 . . . . 0.0 110.493 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -89.59 149.72 22.72 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.676 ' H ' ' CD ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -58.36 -20.57 44.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -89.15 -11.23 44.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 110.43 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.28 -35.0 5.24 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.56 HH21 ' HE1' ' A' ' 42' ' ' TRP . 2.4 ptp180 -59.12 143.96 47.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.412 . . . . 0.0 108.738 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -90.73 162.68 14.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.915 . . . . 0.0 110.183 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.501 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -147.33 140.42 25.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.666 0.746 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 39' ' ' VAL . 86.4 t80 -134.47 151.98 51.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -120.04 142.11 49.13 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.549 -0.719 . . . . 0.0 109.286 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -140.86 163.1 33.86 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.92 138.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.153 -0.967 . . . . 0.0 109.969 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' CG ' ' NE2' ' A' ' 37' ' ' GLN . 45.3 m-20 -84.12 161.68 20.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.6 p -63.24 -3.25 1.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -99.75 -15.96 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.379 -0.826 . . . . 0.0 109.085 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.32 56.89 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -80.59 156.29 73.22 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.499 -1.589 . . . . 0.0 107.125 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -93.53 141.08 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.563 1.508 . . . . 0.0 111.101 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.493 ' NE2' ' CG ' ' A' ' 31' ' ' ASP . 2.8 mp0 -130.02 154.64 47.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.539 -0.726 . . . . 0.0 109.126 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.2 147.89 52.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 27' ' ' TYR . 2.0 m -123.11 156.05 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.442 -0.786 . . . . 0.0 109.037 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 64.4 m-85 -129.9 156.12 44.93 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.427 -0.795 . . . . 0.0 109.696 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -174.31 146.31 1.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.592 -0.693 . . . . 0.0 109.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.56 ' HE1' HH21 ' A' ' 24' ' ' ARG . 54.7 m95 -90.46 3.49 53.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -123.77 142.5 51.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -92.42 -44.49 8.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.543 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 46' ' ' ALA . 2.1 t -121.7 174.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -72.74 -15.14 61.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -92.47 -8.52 44.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.049 -1.032 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.474 ' CG ' ' NH2' ' A' ' 11' ' ' ARG . 1.1 m-20 -72.54 168.84 17.75 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.278 -0.888 . . . . 0.0 109.805 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -134.73 144.64 47.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 50' ' ' VAL . 32.9 m -81.21 122.62 81.57 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.88 151.79 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.509 1.473 . . . . 0.0 112.025 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.85 139.58 7.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.56 -30.88 9.31 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 13.0 mptt -93.46 127.26 39.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -1.15 . . . . 0.0 108.242 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -78.01 149.74 33.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.579 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 53.1 t0 -40.06 147.03 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.789 -0.569 . . . . 0.0 109.902 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.5 p -153.66 164.86 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG2' ' CD ' ' A' ' 62' ' ' GLU . 20.3 mt -83.29 129.3 37.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.634 0.731 . . . . 0.0 110.032 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 92.4 p -60.84 173.14 0.8 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 63' ' ' LYS . 96.6 mt -83.92 -59.71 2.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.867 -1.146 . . . . 0.0 110.071 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' LEU . 37.6 mtt180 -40.01 -35.0 0.33 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' CD ' ' CG2' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -72.9 -40.89 65.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.736 -1.227 . . . . 0.0 108.582 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 60' ' ' LEU . 46.2 mttm -63.91 -46.46 84.72 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.505 -0.747 . . . . 0.0 109.719 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -53.44 -49.41 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.66 94.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -78.73 -44.18 24.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.06 -1.025 . . . . 0.0 112.501 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -66.71 -38.82 87.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.127 -1.608 . . . . 0.0 111.432 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--N 1.292 -1.892 0 O-C-N 120.477 -1.389 . . . . 0.0 110.612 -178.843 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.478 ' HG2' HD13 ' A' ' 12' ' ' ILE . 65.8 mtm180 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 39.4 p-10 -80.57 -169.23 2.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.54 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -70.24 -21.11 63.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 108.831 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 9' ' ' ARG . 22.5 mmm-85 -95.81 1.89 53.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.457 -0.777 . . . . 0.0 110.42 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 82.51 20.64 61.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.543 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -86.97 149.29 24.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.344 . . . . 0.0 108.567 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.478 HD13 ' HG2' ' A' ' 6' ' ' ARG . 6.5 mm -90.6 119.37 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.422 -0.799 . . . . 0.0 109.174 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.794 HD22 ' N ' ' A' ' 13' ' ' LEU . 1.7 mm? -89.45 136.68 32.89 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 14' ' ' LYS . 8.9 mtmp? -86.38 -174.15 4.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.876 -1.14 . . . . 0.0 110.447 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 17' ' ' GLU . 8.8 m -51.55 138.99 21.29 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.753 -0.592 . . . . 0.0 110.206 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.04 -42.18 0.76 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 15' ' ' THR . 85.7 mt-10 -66.02 140.18 58.26 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.043 -1.269 . . . . 0.0 109.845 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 92.4 p -158.22 164.47 36.47 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.606 ' NE2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -92.8 150.44 20.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.888 -1.132 . . . . 0.0 109.393 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.606 ' O ' ' NE2' ' A' ' 19' ' ' GLN . 2.2 ttt180 -89.79 161.77 15.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.336 -0.852 . . . . 0.0 109.429 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -57.36 -30.06 64.55 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.906 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -84.92 -44.22 13.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 0.0 110.16 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.53 -31.81 1.02 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.485 ' CZ ' ' NH1' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -61.26 144.61 53.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.897 -1.355 . . . . 0.0 108.985 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -85.7 164.73 17.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.32 150.94 28.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 109.708 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.502 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 63.4 t80 -134.96 169.2 17.77 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 26.8 tttm -128.09 138.74 52.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.298 -0.876 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.434 ' C ' HD12 ' A' ' 30' ' ' ILE . 8.3 p90 -144.82 159.8 42.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.481 HD11 ' NZ ' ' A' ' 28' ' ' LYS . 1.4 mp -100.34 136.31 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.34 -0.85 . . . . 0.0 109.165 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 33' ' ' PHE . 54.8 m-20 -81.5 166.76 20.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.164 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -60.55 1.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -1.0 . . . . 0.0 111.068 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 9.6 m-85 -101.47 -21.17 14.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.924 -1.11 . . . . 0.0 108.557 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.52 39.12 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 15.1 pt-20 -84.82 150.13 55.26 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.912 -1.346 . . . . 0.0 109.961 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.7 139.66 16.0 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.78 2.32 . . . . 0.0 113.527 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.415 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 11.9 mp0 -137.88 161.33 36.9 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.28 -0.888 . . . . 0.0 108.827 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -132.11 150.1 52.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.25 151.05 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -126.45 155.03 42.88 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.333 -0.854 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.1 t -170.06 152.66 4.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.657 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -93.99 16.54 14.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 144.24 32.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' ' OG ' ' A' ' 59' ' ' SER . 21.5 tp -96.53 -44.49 7.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.41 HG12 ' NH1' ' A' ' 61' ' ' ARG . 15.7 m -119.79 153.93 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 121.547 0.689 . . . . 0.0 109.261 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.45 -11.75 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.72 . . . . 0.0 110.904 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 -8.28 39.17 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.73 -1.231 . . . . 0.0 111.222 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.0 166.36 21.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.903 -1.123 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 49' ' ' ARG . 4.0 tpt180 -128.24 124.01 35.61 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.469 -0.77 . . . . 0.0 109.093 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.41 142.22 40.21 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.847 . . . . 0.0 109.971 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -48.59 147.87 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.284 1.323 . . . . 0.0 110.823 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.23 -37.3 46.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.853 -1.154 . . . . 0.0 109.595 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.25 -31.24 56.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -98.35 135.16 40.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -1.161 . . . . 0.0 108.587 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -79.04 166.55 22.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 109.74 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -65.51 159.27 24.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.193 -0.942 . . . . 0.0 110.021 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.8 p -161.54 178.34 9.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.6 mt -87.48 134.12 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 21.9 t -61.62 161.39 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 109.883 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 64' ' ' ILE . 84.1 mt -64.8 -48.72 73.4 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.948 -1.095 . . . . 0.0 109.644 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -48.09 -51.39 24.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.793 -1.192 . . . . 0.0 109.133 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -70.01 -38.12 75.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.59 -45.62 86.18 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.712 -1.243 . . . . 0.0 109.149 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -48.49 -54.29 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -30.2 69.74 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.171 -0.956 . . . . 0.0 109.687 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.91 -42.91 76.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.148 -0.97 . . . . 0.0 111.542 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.4 mm? -69.21 -51.24 39.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.846 -1.159 . . . . 0.0 111.418 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 . . . . . 0 C--N 1.298 -1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 112.075 -177.134 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 53.6 p-10 -87.13 -165.5 1.31 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.884 -1.135 . . . . 0.0 109.996 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -66.67 -17.92 65.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.699 -0.625 . . . . 0.0 109.403 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' CG ' HH11 ' A' ' 9' ' ' ARG . 4.4 mtt-85 -103.98 -80.13 0.53 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.382 -0.824 . . . . 0.0 109.162 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -178.92 34.7 0.07 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -90.56 130.95 36.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -1.055 . . . . 0.0 110.178 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.6 mm -79.91 107.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.3 mp -88.29 157.49 18.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.93 -1.106 . . . . 0.0 110.481 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -87.82 170.48 11.15 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 m -52.75 138.63 28.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.141 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.73 -57.75 1.87 Allowed Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.111 -0.993 . . . . 0.0 110.74 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -51.56 141.88 15.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 110.081 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.2 m -152.21 149.81 29.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.617 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.4 tp-100 -95.26 137.99 33.56 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.256 -0.903 . . . . 0.0 109.727 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.632 ' NH1' ' NH2' ' A' ' 24' ' ' ARG . 4.7 mtp180 -81.84 -177.04 6.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -76.71 -24.97 53.09 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.825 -0.547 . . . . 0.0 110.042 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' OD2' ' NE ' ' A' ' 24' ' ' ARG . 38.6 p-10 -89.98 -28.53 19.06 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.753 -1.217 . . . . 0.0 111.407 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 19' ' ' GLN . . . 136.05 -26.24 3.13 Favored Glycine 0 N--CA 1.503 3.157 0 O-C-N 120.757 -1.214 . . . . 0.0 111.382 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.632 ' NH2' ' NH1' ' A' ' 20' ' ' ARG . 8.0 ptt180 -65.59 135.99 55.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.364 -1.668 . . . . 0.0 108.714 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.617 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 72.0 m-85 -72.67 173.55 8.84 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 40' ' ' TYR . 25.5 tp -152.4 126.89 9.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.5 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -129.4 151.87 49.57 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HZ3' ' C ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -124.55 135.03 52.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.33 -0.856 . . . . 0.0 110.055 -178.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.635 ' OH ' HD12 ' A' ' 67' ' ' LEU . 17.4 p90 -139.17 164.88 28.64 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.316 -0.865 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.428 HG13 ' NZ ' ' A' ' 28' ' ' LYS . 87.1 mt -105.41 137.71 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.357 -0.84 . . . . 0.0 109.0 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' CG ' ' A' ' 35' ' ' GLU . 5.0 p30 -83.39 175.39 9.88 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.143 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -66.2 6.06 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.936 -1.103 . . . . 0.0 110.882 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -102.36 -18.93 15.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.933 -1.105 . . . . 0.0 110.118 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.24 -9.4 45.96 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 121.11 -0.994 . . . . 0.0 110.651 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' CG ' ' OD2' ' A' ' 31' ' ' ASP . 17.4 pt-20 -87.9 146.15 38.13 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.953 -1.322 . . . . 0.0 109.137 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.87 136.65 15.16 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.481 2.121 . . . . 0.0 112.679 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.19 174.93 6.66 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.268 -0.895 . . . . 0.0 109.073 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.95 146.32 39.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.561 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -131.99 143.56 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.646 -0.659 . . . . 0.0 109.273 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' A' ' 26' ' ' LEU . 61.2 m-85 -124.15 160.0 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.518 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 153.8 5.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -98.09 14.81 26.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -140.8 146.94 38.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.089 -1.007 . . . . 0.0 109.136 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.7 tp -89.74 -49.3 6.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 109.123 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 m -118.97 171.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.95 -17.54 62.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.359 -0.838 . . . . 0.0 111.893 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.4 t -87.92 -4.86 58.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.626 -1.296 . . . . 0.0 110.629 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.7 -175.08 1.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 0.0 110.55 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -142.03 133.76 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.9 m -73.53 150.59 89.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.073 -1.017 . . . . 0.0 108.426 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.64 148.07 92.45 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.903 1.735 . . . . 0.0 111.723 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.95 143.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.411 -0.805 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.43 -29.03 10.17 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -94.87 143.08 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.317 . . . . 0.0 109.819 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.444 ' HG2' HH11 ' A' ' 55' ' ' ARG . 8.1 ptt-85 -78.67 154.92 29.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.5 155.52 15.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.061 -1.024 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.1 m -149.11 177.85 9.24 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.0 mt -93.55 135.68 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.99 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 p -57.97 174.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 108.874 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 60' ' ' LEU . 4.3 mp -77.93 -54.25 6.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.868 -1.145 . . . . 0.0 110.234 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -47.01 -40.8 15.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.447 -0.783 . . . . 0.0 110.282 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -70.49 -38.46 74.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 66' ' ' GLU . 41.9 mttt -67.26 -50.52 60.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 108.767 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 63' ' ' LYS . 1.5 mp -40.0 -54.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.618 -0.676 . . . . 0.0 109.437 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.46 73.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 109.691 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 63' ' ' LYS . 11.0 tp10 -76.42 -41.66 46.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.396 -0.815 . . . . 0.0 111.738 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.6 mm? -62.79 -48.44 79.13 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.585 -1.322 . . . . 0.0 111.284 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 . . . . . 0 C--N 1.294 -1.81 0 O-C-N 121.009 -1.057 . . . . 0.0 111.045 -177.659 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 70.1 mtt180 . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 6' ' ' ARG . 67.7 m-20 -137.56 -103.72 0.19 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.363 -0.836 . . . . 0.0 112.378 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -66.46 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -94.68 27.8 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.078 -1.014 . . . . 0.0 112.097 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.69 29.5 51.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -81.21 141.04 34.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.401 -1.058 . . . . 0.0 108.606 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.8 mm -86.21 98.36 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 109.681 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -91.57 151.5 20.7 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -89.56 -178.84 5.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.005 -1.059 . . . . 0.0 110.941 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 t -55.6 156.44 4.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.8 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.88 -36.62 3.26 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -79.65 159.76 26.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.886 -1.361 . . . . 0.0 110.174 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -160.41 166.33 29.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.892 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -104.22 148.01 26.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.552 HH21 HH11 ' A' ' 24' ' ' ARG . 9.3 mmm180 -90.76 168.59 11.63 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.713 0.768 . . . . 0.0 110.522 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -67.89 -27.51 66.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.393 -0.817 . . . . 0.0 109.606 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.5 p30 -94.99 -28.61 15.05 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.957 . . . . 0.0 110.949 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 136.5 -26.28 3.06 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.648 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.552 HH11 HH21 ' A' ' 20' ' ' ARG . 0.4 OUTLIER -60.0 145.87 44.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.375 -1.662 . . . . 0.0 109.256 -179.164 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -79.62 167.96 20.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.093 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.455 HD12 ' CE2' ' A' ' 40' ' ' TYR . 1.2 tt -153.02 129.92 10.98 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.873 0.844 . . . . 0.0 110.028 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 39' ' ' VAL . 92.1 t80 -136.42 154.19 50.87 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -127.3 143.62 51.2 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.007 -1.058 . . . . 0.0 110.05 -178.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.426 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 12.2 p90 -137.06 170.63 15.78 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.6 mm -99.88 135.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.15 -0.969 . . . . 0.0 109.799 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 33' ' ' PHE . 88.2 m-20 -81.71 162.98 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.187 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.1 p -64.1 0.74 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.2 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' ASP . 3.6 m-85 -100.66 -20.43 15.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.7 36.42 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -86.12 148.62 48.14 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.847 -1.384 . . . . 0.0 109.663 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.65 142.45 10.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.947 1.765 . . . . 0.0 112.414 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -130.2 167.78 17.88 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -134.57 143.45 47.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.394 -0.816 . . . . 0.0 110.267 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -113.06 156.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.455 ' CE2' HD12 ' A' ' 26' ' ' LEU . 95.0 m-85 -133.31 147.27 51.87 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 t -172.11 148.61 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.951 . . . . 0.0 109.615 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -91.54 16.25 10.81 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.342 -0.849 . . . . 0.0 108.856 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 47.6 mtmt -134.41 143.67 47.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.351 -0.843 . . . . 0.0 110.153 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -94.2 -44.08 8.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 46' ' ' ALA . 1.7 t -116.41 176.7 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-O 121.379 0.609 . . . . 0.0 109.438 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -79.53 -15.06 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 110.886 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.5 p -92.91 -14.34 27.73 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.791 -1.193 . . . . 0.0 111.453 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.17 169.73 11.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.713 -1.242 . . . . 0.0 110.481 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -123.58 147.92 46.86 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.517 0.675 . . . . 0.0 109.209 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.14 147.15 60.25 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.424 -0.797 . . . . 0.0 110.063 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.15 140.12 51.55 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.297 1.331 . . . . 0.0 110.834 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.94 149.0 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.886 -1.134 . . . . 0.0 109.588 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.17 -20.27 26.66 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HZ2' ' HB3' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -98.31 137.89 36.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -1.088 . . . . 0.0 108.991 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -76.22 167.8 21.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -60.15 161.91 6.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.423 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 77.0 m -151.19 151.58 32.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.1 mt -81.29 134.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.87 -1.144 . . . . 0.0 109.519 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 150.73 28.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 110.655 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.59 -64.72 0.73 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -41.58 -48.35 3.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.587 . . . . 0.0 111.73 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.45 -33.12 73.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.53 -1.356 . . . . 0.0 109.9 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -68.5 -42.19 78.93 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 109.745 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.81 -56.64 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.383 -0.823 . . . . 0.0 110.51 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.76 87.49 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.318 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -75.01 -28.75 60.62 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 111.477 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -70.25 -53.13 18.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.56 -1.338 . . . . 0.0 111.585 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 C--N 1.3 -1.582 0 O-C-N 120.256 -1.528 . . . . 0.0 109.589 -178.479 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.896 0.855 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 40.7 p-10 -93.8 -168.2 1.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.627 0.727 . . . . 0.0 110.378 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -66.27 -14.91 62.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.476 -0.765 . . . . 0.0 110.481 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -99.86 -13.58 19.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.352 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.26 14.98 39.89 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 48' ' ' ASP . 30.0 mtt180 -84.07 135.3 34.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.157 . . . . 0.0 109.323 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.8 mt -84.27 111.4 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 109.192 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 11' ' ' ARG . 4.8 mp -94.94 157.33 15.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -92.26 179.04 5.67 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.018 -1.051 . . . . 0.0 109.968 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.4 m -54.01 146.23 14.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.439 -0.788 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.08 -52.67 4.75 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -52.56 149.84 5.55 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.134 -1.215 . . . . 0.0 109.28 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 t -157.1 161.72 39.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.596 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.3 tp-100 -105.17 131.41 52.69 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 22' ' ' ASP . 21.3 ttt180 -89.53 162.5 15.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.373 -0.829 . . . . 0.0 109.362 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -66.07 -22.3 66.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 95.8 m-20 -84.75 -7.99 59.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.4 -0.813 . . . . 0.0 109.329 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.31 8.83 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -62.11 137.7 58.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.946 -1.326 . . . . 0.0 109.466 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.596 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 67.0 m-85 -80.41 173.15 12.88 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.512 -0.743 . . . . 0.0 109.548 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 26' ' ' LEU . 1.2 tt -156.07 139.24 15.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.326 -0.858 . . . . 0.0 109.874 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -136.57 155.25 50.19 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.23 -0.919 . . . . 0.0 109.275 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -119.97 138.97 53.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.474 -0.766 . . . . 0.0 110.513 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.436 ' CE1' HD13 ' A' ' 67' ' ' LEU . 9.7 p90 -143.14 165.0 28.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.03 134.84 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 0.0 109.378 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 33' ' ' PHE . 72.1 m-20 -80.11 164.64 23.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 108.401 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.8 t -58.9 0.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.942 -1.099 . . . . 0.0 110.536 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.7 m-85 -101.73 -19.35 15.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.052 -1.03 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.08 46.02 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.41 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 22.9 pt-20 -83.68 147.55 52.44 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.012 -1.287 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -81.4 139.2 11.4 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.473 2.115 . . . . 0.0 113.249 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.41 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 15.0 mp0 -137.5 159.86 40.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -132.14 145.02 51.1 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 149.1 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.443 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 78.5 m-85 -121.18 152.38 38.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.7 t -168.29 145.03 3.94 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 109.314 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.93 11.74 21.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.967 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -135.99 141.22 44.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.548 -0.72 . . . . 0.0 109.809 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.9 tp -89.65 -42.63 11.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.59 173.81 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.97 -14.35 59.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.047 -1.033 . . . . 0.0 110.598 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 p -91.27 -2.78 57.35 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 11' ' ' ARG . 80.5 m-20 -69.51 -174.43 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.661 -1.274 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -149.62 124.97 10.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.506 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 m -82.21 152.96 68.74 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.85 137.86 42.68 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 120.968 1.112 . . . . 0.0 109.978 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.86 -34.92 5.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.106 -0.996 . . . . 0.0 110.478 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.95 -22.27 62.23 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -99.48 140.83 33.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -1.122 . . . . 0.0 110.957 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 55' ' ' ARG . 2.0 ptt-85 -76.22 153.78 35.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.511 -0.743 . . . . 0.0 109.886 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.4 161.14 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 0.0 109.462 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.5 p -152.03 162.86 40.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.34 -0.85 . . . . 0.0 108.745 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.24 127.91 40.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.056 -1.027 . . . . 0.0 109.771 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.9 p -59.52 169.27 1.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.36 -0.837 . . . . 0.0 109.907 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -79.59 -58.53 3.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -41.45 -43.67 2.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 110.905 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -69.89 -41.38 74.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 0.0 109.433 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -67.99 -44.84 75.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 110.162 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.11 -60.69 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.914 -1.116 . . . . 0.0 109.203 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.01 63.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.942 . . . . 0.0 110.26 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -71.81 -39.04 70.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD13 ' CE1' ' A' ' 29' ' ' TYR . 64.7 mt -67.06 -54.54 20.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.867 -1.145 . . . . 0.0 111.889 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.347 -1.471 . . . . 0.0 109.478 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.381 0.61 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 11' ' ' ARG . 8.3 p-10 -88.6 -168.33 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.783 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -67.15 -11.88 58.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.533 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.638 ' CB ' HH12 ' A' ' 11' ' ' ARG . 0.3 OUTLIER -100.2 -73.39 0.64 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.908 -1.12 . . . . 0.0 110.047 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.18 0.86 0.05 OUTLIER Glycine 0 N--CA 1.501 3.012 0 C-N-CA 118.41 -1.852 . . . . 0.0 113.03 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.638 HH12 ' CB ' ' A' ' 9' ' ' ARG . 2.4 mtm-85 -84.46 114.64 22.07 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 119.95 -1.912 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.95 113.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.444 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -91.91 169.47 10.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.42 -0.8 . . . . 0.0 109.716 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -89.16 -177.16 5.35 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.27 1.033 . . . . 0.0 111.054 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 t -56.75 153.62 10.37 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.39 -41.43 1.15 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.792 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.86 136.52 56.96 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.938 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -159.24 154.24 25.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.254 -0.904 . . . . 0.0 108.621 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -109.02 140.93 41.88 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.022 -1.048 . . . . 0.0 110.217 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -84.71 177.21 8.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.571 -0.706 . . . . 0.0 110.022 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -71.54 -14.48 62.11 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -87.83 -20.14 26.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 109.837 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.24 -30.19 8.5 Favored Glycine 0 N--CA 1.501 3.019 0 O-C-N 121.227 -0.92 . . . . 0.0 111.204 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -63.38 140.68 58.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.546 -1.561 . . . . 0.0 109.679 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.47 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 90.8 m-85 -85.07 168.49 14.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.778 . . . . 0.0 109.87 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.765 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 11.9 tp -150.89 127.48 10.81 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.448 0.642 . . . . 0.0 109.576 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.421 ' N ' HD12 ' A' ' 26' ' ' LEU . 79.6 t80 -131.79 156.33 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -127.16 144.11 51.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -0.773 . . . . 0.0 109.861 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.484 ' C ' HD12 ' A' ' 30' ' ' ILE . 12.1 p90 -144.86 161.66 38.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.201 -0.937 . . . . 0.0 108.776 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' C ' ' A' ' 29' ' ' TYR . 1.4 mp -102.86 135.96 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.371 -0.83 . . . . 0.0 108.883 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 60.2 m-20 -81.74 174.26 11.52 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.288 -0.883 . . . . 0.0 109.186 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.4 t -65.58 -3.47 4.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 109.361 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -96.55 -11.32 25.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 108.91 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.6 -6.17 77.36 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.627 ' HG3' HE22 ' A' ' 37' ' ' GLN . 14.4 pt-20 -84.69 149.47 54.16 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.179 -1.189 . . . . 0.0 109.249 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -82.89 136.51 8.22 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.589 2.193 . . . . 0.0 113.668 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.627 HE22 ' HG3' ' A' ' 35' ' ' GLU . 8.5 mp0 -125.67 164.9 19.61 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.4 149.09 51.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 109.698 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.8 142.68 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.765 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 49.1 m-85 -127.43 156.99 41.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.557 -0.714 . . . . 0.0 109.795 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.5 t -170.91 150.75 3.21 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.488 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -89.38 11.07 20.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 51.7 mtmt -135.64 139.87 44.1 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.501 0.667 . . . . 0.0 110.567 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -92.51 -39.28 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.27 155.36 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.23 -7.67 10.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.181 -0.95 . . . . 0.0 110.972 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.3 p -93.76 -10.47 34.12 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.7 -1.25 . . . . 0.0 111.887 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -71.15 -171.56 0.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.488 -1.382 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -141.99 151.8 42.84 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -79.35 149.69 72.69 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.963 -1.086 . . . . 0.0 109.307 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' ALA . 32.6 Cg_endo -82.09 -112.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.56 2.174 . . . . 0.0 114.498 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -55.0 -149.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.257 -0.902 . . . . 0.0 112.954 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.97 36.1 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 52' ' ' ALA . 11.9 mptt -89.26 130.99 35.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.112 -1.228 . . . . 0.0 108.818 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.06 159.07 28.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 109.978 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 23.1 p-10 -53.71 162.19 0.93 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.677 -0.639 . . . . 0.0 109.851 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 19.8 t -162.97 161.22 25.49 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.494 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 89.3 mt -82.83 137.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.9 p -61.13 159.06 12.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.32 -0.863 . . . . 0.0 109.854 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HA ' ' HZ3' ' A' ' 63' ' ' LYS . 97.2 mt -63.53 -49.1 74.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -45.82 -46.34 15.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.115 -0.99 . . . . 0.0 110.352 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -37.43 75.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.883 -1.136 . . . . 0.0 109.781 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HZ3' ' HA ' ' A' ' 60' ' ' LEU . 2.8 mtmp? -67.61 -44.68 77.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.856 -1.153 . . . . 0.0 110.202 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.5 -53.56 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.956 -1.09 . . . . 0.0 110.145 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.62 79.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.112 . . . . 0.0 110.133 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.19 -45.47 56.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.89 -1.131 . . . . 0.0 110.177 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.29 -44.12 65.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.025 -1.047 . . . . 0.0 110.008 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--N 1.289 -2.034 0 O-C-N 120.609 -1.307 . . . . 0.0 109.646 -178.338 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 121.388 0.613 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -98.5 -164.39 1.13 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.61 -0.681 . . . . 0.0 109.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -68.65 -12.74 61.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.115 -0.99 . . . . 0.0 110.599 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -96.07 -5.71 40.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.0 -1.063 . . . . 0.0 109.29 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.19 -1.67 69.04 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.281 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.541 HH22 ' CG ' ' A' ' 48' ' ' ASP . 6.8 ptm180 -82.78 136.46 34.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.734 -1.451 . . . . 0.0 109.316 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.8 mt -83.97 110.6 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.149 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.79 161.72 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 77.5 mttt -88.93 -174.3 4.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.842 -1.161 . . . . 0.0 110.831 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 15' ' ' THR . 1.2 t -55.79 162.23 1.86 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.67 -36.94 1.41 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 14' ' ' LYS . 9.5 mp0 -73.72 156.42 37.91 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.919 -1.342 . . . . 0.0 109.303 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -156.96 158.65 37.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 109.423 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -97.05 134.74 40.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 108.735 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -86.47 160.99 18.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.891 -1.13 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.87 -36.49 62.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.584 -0.697 . . . . 0.0 109.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -82.14 -25.29 34.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.171 -0.955 . . . . 0.0 110.515 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.64 -26.9 5.06 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.17 -0.956 . . . . 0.0 110.744 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.699 HH21 ' HE1' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -59.74 148.5 34.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.356 -1.673 . . . . 0.0 108.307 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -87.44 164.42 16.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.232 -0.918 . . . . 0.0 109.187 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -147.74 137.75 22.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -131.6 161.48 32.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 29' ' ' TYR . 4.7 tmtm? -125.13 136.19 53.39 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.251 -0.906 . . . . 0.0 110.79 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 13.6 p90 -139.7 170.08 16.55 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.512 HD13 ' HZ1' ' A' ' 28' ' ' LYS . 5.9 mm -101.87 133.84 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.123 -0.986 . . . . 0.0 110.503 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -84.23 162.43 20.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -59.87 -3.98 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 21.8 m-85 -101.07 -15.27 17.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.03 -1.044 . . . . 0.0 109.622 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.31 0.32 58.32 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.984 -1.072 . . . . 0.0 111.064 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -83.9 150.56 59.08 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.837 -1.39 . . . . 0.0 109.682 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.61 118.94 3.24 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.107 1.872 . . . . 0.0 110.905 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.05 163.02 16.21 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.72 142.03 44.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.24 150.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 85.4 m-85 -122.77 151.61 41.45 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.7 t -171.77 148.62 2.41 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.699 ' HE1' HH21 ' A' ' 24' ' ' ARG . 98.7 m95 -91.91 10.6 28.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 57' ' ' CYS . 29.8 mtmt -135.64 146.74 48.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.675 0.75 . . . . 0.0 110.179 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.412 HD23 ' HE ' ' A' ' 11' ' ' ARG . 60.8 tp -96.3 -40.07 9.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.15 161.23 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.61 -14.05 62.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.922 -1.111 . . . . 0.0 111.423 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -87.37 0.23 55.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.796 -1.19 . . . . 0.0 110.985 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.541 ' CG ' HH22 ' A' ' 11' ' ' ARG . 84.7 m-20 -72.49 -178.61 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.896 -1.127 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.42 121.18 13.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -75.79 146.29 79.5 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.492 -1.38 . . . . 0.0 109.957 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.82 155.58 62.16 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.031 . . . . 0.0 111.296 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.36 151.6 0.36 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 110.359 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.81 3.76 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -92.49 146.17 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -1.227 . . . . 0.0 108.913 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -78.08 -99.1 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 66.3 t0 -168.46 140.24 2.76 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.532 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 15.0 p -148.6 169.25 20.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.976 -1.077 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -82.69 139.0 18.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.497 -0.752 . . . . 0.0 110.326 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -60.72 169.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.33 -52.84 28.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -47.16 -47.76 23.7 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.724 -1.235 . . . . 0.0 110.114 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 68.3 mt-10 -71.49 -38.89 71.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.445 -1.409 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -65.75 -39.78 91.44 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 0.0 110.188 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.05 -44.41 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.377 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.19 90.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.955 -1.091 . . . . 0.0 110.782 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -71.34 -34.31 70.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.868 -1.145 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.88 -44.61 80.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.557 -1.339 . . . . 0.0 110.865 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.853 -1.154 . . . . 0.0 110.617 -178.721 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 29.3 p-10 -123.58 -169.57 1.97 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.208 -0.932 . . . . 0.0 109.936 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -67.73 -21.37 65.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 110.077 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.57 -4.69 40.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.73 17.33 61.97 Favored Glycine 0 N--CA 1.497 2.738 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.07 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 11' ' ' ARG . 3.6 mtt-85 -86.04 138.58 31.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -1.112 . . . . 0.0 108.913 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.8 mm -82.57 116.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -88.9 147.09 24.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.092 -1.005 . . . . 0.0 108.574 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -90.53 -179.73 5.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.802 -1.187 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 m -55.68 148.09 17.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.545 -0.722 . . . . 0.0 110.396 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.04 -41.66 2.79 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' OE2' ' CZ ' ' A' ' 61' ' ' ARG . 95.2 mt-10 -78.09 158.43 29.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.909 -1.348 . . . . 0.0 110.067 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -158.21 154.56 27.51 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.815 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -99.16 130.21 45.46 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.837 . . . . 0.0 110.123 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.9 168.86 16.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.338 -0.851 . . . . 0.0 110.472 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -69.04 -25.59 64.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.467 -0.771 . . . . 0.0 109.15 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -87.11 -12.76 46.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.91 -31.1 8.27 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -58.88 143.7 46.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.313 . . . . 0.0 108.777 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -78.88 165.67 23.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.37 -0.831 . . . . 0.0 109.854 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.5 tm? -149.35 121.23 8.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 89.3 t80 -130.3 161.05 32.1 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 46.8 tttt -120.27 131.87 55.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.759 -0.588 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -135.73 152.15 50.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.581 -0.699 . . . . 0.0 109.25 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.4 mp -98.69 133.75 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' OD2' ' CG ' ' A' ' 35' ' ' GLU . 44.9 p30 -82.64 173.12 12.22 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.011 0.91 . . . . 0.0 110.795 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 m -60.73 3.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.831 -0.543 . . . . 0.0 111.381 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 31' ' ' ASP . 30.1 m-85 -107.12 -22.82 12.51 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.895 -1.128 . . . . 0.0 109.312 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.76 34.36 Favored Glycine 0 N--CA 1.505 3.251 0 O-C-N 121.211 -0.931 . . . . 0.0 111.137 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.578 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.2 pt-20 -88.49 152.44 49.62 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.941 -1.329 . . . . 0.0 109.263 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.41 147.6 25.76 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.413 2.075 . . . . 0.0 113.305 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -144.53 166.59 24.72 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -135.4 153.85 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.243 -0.911 . . . . 0.0 109.561 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -130.51 157.36 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.718 . . . . 0.0 109.231 -179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 48.0 m-85 -135.21 144.78 47.13 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 t -169.45 155.01 5.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.035 . . . . 0.0 109.743 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CZ2' ' NZ ' ' A' ' 54' ' ' LYS . 96.1 m95 -93.98 5.54 51.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.137 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 43.9 mtmt -123.92 140.43 52.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.547 0.689 . . . . 0.0 110.158 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.38 -44.83 7.04 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 46' ' ' ALA . 9.0 t -122.38 178.91 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -78.56 -12.94 60.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.122 -0.986 . . . . 0.0 110.995 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.28 -10.69 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 109.944 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -74.42 168.13 20.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.034 -1.041 . . . . 0.0 109.815 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.486 HH11 ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -144.73 136.06 25.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 108.904 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.12 148.56 71.61 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.807 . . . . 0.0 110.514 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.95 149.4 77.53 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.183 1.922 . . . . 0.0 111.845 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.54 146.17 1.11 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.71 0.766 . . . . 0.0 110.124 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.7 4.61 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' NZ ' ' CZ2' ' A' ' 42' ' ' TRP . 28.4 mmtp -95.56 135.22 37.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -73.09 152.62 41.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.759 . . . . 0.0 109.472 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -61.73 166.27 4.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 48.9 t -159.15 160.85 36.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -0.812 . . . . 0.0 109.108 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 85.5 mt -80.87 137.78 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.351 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.4 p -63.57 156.13 27.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.811 0.815 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.44 -55.45 33.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.585 -0.697 . . . . 0.0 109.838 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 15.7 mmt180 -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.243 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -72.07 -39.53 68.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.927 . . . . 0.0 110.273 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.12 -37.02 80.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.032 -1.042 . . . . 0.0 110.102 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.1 -50.66 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.099 -1.001 . . . . 0.0 110.729 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.95 -45.85 82.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.819 -1.176 . . . . 0.0 110.422 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.52 -41.73 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 0.0 111.676 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.38 -21.51 66.65 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.884 -1.76 . . . . 0.0 110.987 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 120.79 -1.194 . . . . 0.0 111.32 -179.221 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.853 0.835 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.76 ' CG ' HD22 ' A' ' 13' ' ' LEU . 30.8 m-20 -79.7 -179.79 7.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -66.96 -14.52 62.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.919 . . . . 0.0 111.259 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -98.75 14.93 26.96 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.049 . . . . 0.0 109.941 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.21 20.95 75.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -90.76 126.27 35.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -1.065 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.8 mt -77.52 95.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.015 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.6 pt? -87.37 156.11 19.74 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -92.0 -176.02 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.691 1.234 . . . . 0.0 110.773 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.1 m -57.91 144.08 40.45 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.14 -54.39 3.6 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.3 149.27 24.88 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.203 -1.175 . . . . 0.0 108.801 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -160.96 159.73 29.88 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 108.848 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -97.14 140.86 31.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 109.652 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.75 -174.14 4.62 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.515 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.09 -29.86 55.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.309 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -89.94 -11.88 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 111.538 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.44 -28.08 7.69 Favored Glycine 0 N--CA 1.504 3.199 0 O-C-N 121.012 -1.055 . . . . 0.0 110.908 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.4 140.88 56.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.352 -1.675 . . . . 0.0 109.341 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -80.03 170.56 16.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.434 -0.791 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.598 HD13 ' CE2' ' A' ' 40' ' ' TYR . 64.4 tp -151.68 127.25 10.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.537 -0.727 . . . . 0.0 109.328 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -129.58 157.15 42.86 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tttm -127.06 143.7 51.22 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.381 -0.825 . . . . 0.0 110.289 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.627 ' OH ' HD22 ' A' ' 67' ' ' LEU . 4.1 p90 -151.88 -178.99 7.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.46 144.99 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.488 -0.758 . . . . 0.0 109.006 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 33' ' ' PHE . 90.6 m-20 -84.05 165.85 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.469 -0.769 . . . . 0.0 109.856 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -59.28 -0.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.584 -0.697 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 31' ' ' ASP . 18.8 m-85 -108.76 -13.95 14.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.473 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.51 -8.67 52.16 Favored Glycine 0 N--CA 1.502 3.068 0 O-C-N 121.045 -1.035 . . . . 0.0 110.871 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.8 pt-20 -81.68 149.94 65.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.825 -1.397 . . . . 0.0 109.129 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.534 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 59.0 Cg_endo -83.67 143.55 10.81 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.361 2.041 . . . . 0.0 112.67 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.534 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.4 mp0 -140.68 173.51 11.43 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.256 -0.903 . . . . 0.0 108.682 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HB3' HD11 ' A' ' 26' ' ' LEU . 89.8 m-85 -137.89 154.32 49.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.442 -0.786 . . . . 0.0 109.801 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.546 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.1 m -128.57 143.72 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.525 -0.735 . . . . 0.0 109.232 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CE2' HD13 ' A' ' 26' ' ' LEU . 43.5 m-85 -122.35 147.61 46.06 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -171.52 150.86 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.899 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -94.26 10.42 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -127.02 138.84 53.31 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.5 tp -93.02 -44.41 8.42 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.39 166.48 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -14.24 62.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.65 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.4 p -90.04 -6.01 56.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.725 -1.234 . . . . 0.0 111.305 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -70.96 160.56 32.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.68 -1.262 . . . . 0.0 109.417 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.82 126.22 39.39 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.303 -0.873 . . . . 0.0 108.91 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.68 150.1 75.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 110.032 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.4 151.16 80.71 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.834 1.689 . . . . 0.0 110.619 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.33 159.55 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -0.928 . . . . 0.0 109.859 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.04 -36.59 3.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -95.08 137.0 34.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.342 . . . . 0.0 109.64 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.2 mmp_? -79.87 150.38 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -0.982 . . . . 0.0 109.701 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -52.1 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.447 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 42.6 t -168.41 169.71 10.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.33 -0.856 . . . . 0.0 108.9 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.447 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 6.5 mm -84.55 122.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.4 p -58.88 158.84 7.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 64' ' ' ILE . 3.2 mm? -54.71 -49.88 69.66 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.732 -0.605 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -51.45 -47.65 63.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.926 -1.109 . . . . 0.0 110.178 -179.13 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.85 -43.68 67.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 0.0 110.892 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -65.85 -41.4 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.613 -1.305 . . . . 0.0 109.693 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -60.58 -36.58 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -51.51 69.15 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.018 -1.051 . . . . 0.0 110.087 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.4 -41.26 63.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.866 -1.146 . . . . 0.0 112.462 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.627 HD22 ' OH ' ' A' ' 29' ' ' TYR . 22.7 mt -68.05 -44.29 76.72 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.286 -1.509 . . . . 0.0 111.752 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 . . . . . 0 N--CA 1.497 1.889 0 O-C-N 120.893 -1.129 . . . . 0.0 111.569 -177.919 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.731 ' HE ' ' C ' ' A' ' 10' ' ' GLY . 33.4 mtp180 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' HB2' HH12 ' A' ' 11' ' ' ARG . 3.8 m-20 -130.98 -159.59 0.98 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.648 -0.658 . . . . 0.0 109.823 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -63.29 -33.06 74.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.121 -0.987 . . . . 0.0 111.659 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HB2' ' NH1' ' A' ' 11' ' ' ARG . 15.1 mmt180 -96.03 8.28 44.13 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.017 -1.052 . . . . 0.0 112.09 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.731 ' C ' ' HE ' ' A' ' 6' ' ' ARG . . . 76.88 19.99 76.79 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.422 -1.424 . . . . 0.0 111.704 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.627 HH11 ' HG3' ' A' ' 11' ' ' ARG . 2.3 mtm-85 -94.19 144.95 25.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.495 . . . . 0.0 108.374 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.4 mt -85.56 117.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 108.879 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -84.99 144.69 28.14 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.423 -0.798 . . . . 0.0 109.46 -179.098 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -89.26 -171.66 3.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.18 0.991 . . . . 0.0 110.502 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.4 m -56.42 143.53 34.44 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.691 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.99 -51.46 3.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.256 -0.903 . . . . 0.0 111.479 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.1 140.67 58.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.401 . . . . 0.0 110.093 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -160.01 -174.51 4.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.273 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -110.11 147.41 33.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' A' ' 20' ' ' ARG . 10.3 ttt-85 -88.87 164.1 15.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.553 ' H ' ' CD ' ' A' ' 21' ' ' LYS . 8.4 mptt -63.71 -19.41 64.92 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.94 -8.17 50.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.608 -0.683 . . . . 0.0 110.714 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.68 6.32 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -61.41 145.79 50.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.969 -1.312 . . . . 0.0 108.041 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 11' ' ' ARG . 72.2 m-85 -78.75 167.93 20.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.103 -0.998 . . . . 0.0 110.659 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.645 HD13 ' CE2' ' A' ' 40' ' ' TYR . 67.8 tp -152.01 132.56 13.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 50.9 t80 -132.92 162.76 30.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 25.0 tttt -137.34 137.1 38.55 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.034 -1.041 . . . . 0.0 110.873 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.513 ' CD2' ' OE1' ' A' ' 37' ' ' GLN . 13.8 p90 -149.95 -175.55 5.09 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.45 ' HA ' HE22 ' A' ' 37' ' ' GLN . 39.9 mm -109.17 131.88 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.257 -0.902 . . . . 0.0 109.287 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.92 178.38 6.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 0.0 110.047 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 t -63.01 0.36 0.58 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.054 -1.029 . . . . 0.0 110.881 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 6.6 m-85 -102.69 -10.47 19.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.4 59.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.0 pt-20 -80.17 150.7 71.73 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 108.395 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.76 135.61 21.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.632 1.555 . . . . 0.0 111.459 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.679 ' NE2' ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -132.74 165.68 23.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.508 ' HB3' HD11 ' A' ' 26' ' ' LEU . 48.5 m-85 -137.11 155.79 49.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -0.839 . . . . 0.0 109.304 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.56 ' O ' HD12 ' A' ' 26' ' ' LEU . 10.7 m -126.05 150.09 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.645 ' CE2' HD13 ' A' ' 26' ' ' LEU . 71.6 m-85 -123.01 156.89 33.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.8 t -171.46 152.07 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.096 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -95.61 9.32 40.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 109.654 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.47 156.01 45.79 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.224 -0.923 . . . . 0.0 109.507 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.507 ' CB ' ' HE ' ' A' ' 11' ' ' ARG . 59.6 tp -98.66 -38.63 9.04 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -120.26 173.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.53 49.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 0.0 110.452 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.0 p -86.04 -7.17 58.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -71.94 167.62 19.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.84 136.85 51.03 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.6 149.52 78.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 110.616 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.26 140.79 25.45 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.677 1.585 . . . . 0.0 111.377 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.57 5.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 109.561 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.09 -19.97 48.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.62 142.86 27.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.827 -1.396 . . . . 0.0 109.205 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -78.08 151.21 33.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 109.829 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 p30 -62.08 175.08 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.79 . . . . 0.0 109.764 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 15.3 t -172.46 -174.99 1.27 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.411 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 49.8 mm -98.97 127.44 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.013 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.454 ' OG ' ' C ' ' A' ' 44' ' ' LEU . 22.7 t -56.91 157.23 5.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.382 -0.824 . . . . 0.0 109.392 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.5 -51.69 66.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.987 -1.07 . . . . 0.0 109.986 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -47.79 -41.76 24.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.77 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.06 -39.69 65.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.923 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -65.36 -55.47 17.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.868 -1.145 . . . . 0.0 109.611 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 64' ' ' ILE . 1.6 mp -48.05 -58.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.6 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.08 -42.36 69.25 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.684 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.18 -42.43 62.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.822 . . . . 0.0 111.598 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.487 HD23 ' OH ' ' A' ' 29' ' ' TYR . 6.3 mp -70.56 -44.42 67.46 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.779 -1.2 . . . . 0.0 111.817 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 120.614 -1.304 . . . . 0.0 110.524 -178.194 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 6' ' ' ARG . 14.9 mtm-85 . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.801 0.81 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' CD2' ' A' ' 13' ' ' LEU . 93.6 m-20 -87.21 170.92 11.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -63.84 -3.55 2.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.881 -1.137 . . . . 0.0 109.063 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 -11.23 18.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.52 4.77 59.26 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.598 ' HG2' HH11 ' A' ' 11' ' ' ARG . 8.6 mtt-85 -85.91 130.29 34.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -1.113 . . . . 0.0 109.545 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.0 110.48 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -86.29 150.36 24.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -89.29 -179.33 5.84 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.687 -1.258 . . . . 0.0 110.789 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -53.46 154.51 3.44 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -39.46 2.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -76.46 167.8 21.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.275 . . . . 0.0 109.518 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 t -158.82 161.96 36.97 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.863 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -104.51 138.13 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.3 156.37 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.942 -1.099 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CG ' ' N ' ' A' ' 22' ' ' ASP . 10.2 ptmm? -53.52 -39.24 64.48 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.107 -0.995 . . . . 0.0 109.491 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 51.1 p30 -83.89 -30.82 26.08 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.184 -0.948 . . . . 0.0 110.41 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 135.05 -24.72 3.4 Favored Glycine 0 N--CA 1.505 3.272 0 O-C-N 120.81 -1.181 . . . . 0.0 112.576 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -57.46 147.25 27.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 120.15 1.975 . . . . 0.0 107.714 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -85.32 169.55 13.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -152.96 129.01 10.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.146 -0.971 . . . . 0.0 109.75 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.859 ' N ' HD12 ' A' ' 26' ' ' LEU . 87.1 t80 -131.02 162.35 29.99 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.549 -0.719 . . . . 0.0 109.216 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 36.0 tttt -122.66 135.22 54.53 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.531 -0.73 . . . . 0.0 110.048 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.532 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 6.0 p90 -141.61 162.93 34.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.53 130.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 3.8 m-20 -88.5 179.74 6.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 t -57.08 -3.94 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 111.372 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 46.3 m-85 -96.26 -4.79 41.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.075 . . . . 0.0 110.473 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 10.33 81.71 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -88.25 164.36 33.35 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 122.034 -0.686 . . . . 0.0 110.092 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.28 122.6 0.75 Allowed 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 121.823 1.682 . . . . 0.0 110.144 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -123.07 166.11 15.68 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.222 -0.924 . . . . 0.0 109.724 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -135.85 146.55 47.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.505 -0.747 . . . . 0.0 110.486 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -124.34 148.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -132.35 155.02 49.15 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.134 -0.979 . . . . 0.0 109.956 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -171.83 157.74 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.963 -1.085 . . . . 0.0 109.728 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -91.85 12.47 21.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.148 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 8.6 mtmp? -135.31 138.09 43.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.432 -0.792 . . . . 0.0 109.7 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.7 tp -88.46 -43.27 11.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.69 173.92 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.17 62.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.266 -0.896 . . . . 0.0 111.541 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 t -86.6 -10.59 53.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.72 -1.237 . . . . 0.0 111.466 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.87 176.37 3.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.662 -1.274 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.35 140.38 30.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.8 m -84.79 146.35 46.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 109.385 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.95 150.98 78.37 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.992 1.794 . . . . 0.0 111.698 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.42 143.67 2.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.567 -0.708 . . . . 0.0 110.393 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.97 -26.65 22.54 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -96.99 131.93 43.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.368 -1.078 . . . . 0.0 108.527 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -75.91 145.89 40.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.36 -0.837 . . . . 0.0 109.7 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 60.8 t0 -50.27 153.73 1.41 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.664 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 81.1 m -148.59 167.3 25.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.217 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.5 mt -87.97 133.1 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.199 -0.938 . . . . 0.0 110.354 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.6 p -62.81 157.7 20.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.819 . . . . 0.0 110.623 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 64' ' ' ILE . 7.7 mp -58.42 -52.46 65.52 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.841 0.829 . . . . 0.0 109.588 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -51.2 -45.32 61.8 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.461 -0.774 . . . . 0.0 110.154 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.31 -40.99 70.47 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 109.704 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 ttmp? -66.32 -41.83 89.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.942 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.49 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -59.4 -53.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.776 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.31 71.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.917 -1.115 . . . . 0.0 109.958 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -73.87 -42.57 60.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.972 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -68.0 -43.39 78.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.616 -1.302 . . . . 0.0 110.594 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 . . . . . 0 C--N 1.294 -1.837 0 O-C-N 120.245 -1.535 . . . . 0.0 110.49 -178.822 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.514 0.673 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -83.44 166.85 18.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.287 -0.883 . . . . 0.0 109.832 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 23.2 p30 -69.17 1.64 3.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.192 -0.943 . . . . 0.0 109.902 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 92.2 mtt180 -100.11 -52.68 3.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.84 -3.34 1.11 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.639 HH11 ' CG ' ' A' ' 11' ' ' ARG . 1.6 mtt-85 -89.29 130.06 35.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.459 -1.612 . . . . 0.0 110.171 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 mm -72.73 110.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.249 -0.907 . . . . 0.0 108.561 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -94.26 152.53 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 109.484 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 35.9 mmtt -89.0 -173.27 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.978 -1.077 . . . . 0.0 110.78 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 p -57.14 165.6 1.31 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.454 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.1 -44.07 1.04 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.366 -0.834 . . . . 0.0 111.56 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 12.2 mp0 -65.23 152.39 43.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.019 -1.283 . . . . 0.0 110.823 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -158.58 139.62 13.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.2 tt0 -100.0 129.31 46.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.192 -0.942 . . . . 0.0 109.891 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.708 ' NH1' HH21 ' A' ' 24' ' ' ARG . 49.2 mtp180 -89.27 166.19 13.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.431 -0.793 . . . . 0.0 110.656 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.88 -20.27 63.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 109.729 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -85.78 -17.38 35.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.993 . . . . 0.0 109.463 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.09 -22.69 32.61 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.708 HH21 ' NH1' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -63.83 146.81 53.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.742 -1.446 . . . . 0.0 109.413 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.401 ' OH ' ' NH1' ' A' ' 9' ' ' ARG . 71.8 m-85 -88.63 166.47 14.09 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.802 0.81 . . . . 0.0 109.845 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.617 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 20.8 tp -148.74 119.87 7.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 90.4 t80 -131.67 168.63 17.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.645 -0.659 . . . . 0.0 109.437 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 71.1 tttt -130.91 135.17 47.43 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.541 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 18.9 p90 -133.18 165.03 25.72 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.461 -0.774 . . . . 0.0 108.912 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.01 134.78 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.077 -1.014 . . . . 0.0 109.302 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 16.7 m-20 -83.27 156.67 22.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.7 m -53.66 -8.59 0.16 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.893 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.3 -13.9 21.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.881 -1.137 . . . . 0.0 108.807 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.34 0.73 59.5 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 20.6 pt-20 -83.38 148.52 55.85 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.892 -1.358 . . . . 0.0 108.329 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -82.64 141.63 11.11 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.354 2.036 . . . . 0.0 113.198 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 18.3 mp0 -139.67 161.68 36.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.186 -0.946 . . . . 0.0 108.753 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -132.09 142.54 49.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -122.2 151.58 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.561 0.695 . . . . 0.0 109.904 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.617 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 46.9 m-85 -123.72 150.47 44.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -166.05 148.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.391 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -90.94 10.38 26.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 109.573 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -140.18 144.02 36.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.99 -42.79 10.35 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.35 167.57 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.05 -6.24 44.27 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.982 -1.073 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.8 p -88.7 -18.53 27.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.433 -1.417 . . . . 0.0 110.011 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.28 175.11 7.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.42 HH12 ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -138.83 145.73 40.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 50' ' ' VAL . 5.9 m -79.91 128.53 73.72 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.713 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.32 141.17 10.5 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.028 1.152 . . . . 0.0 110.327 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' N ' HH12 ' A' ' 49' ' ' ARG . . . -44.81 143.44 1.43 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.07 -32.26 7.69 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -91.88 140.66 29.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 108.546 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -76.16 155.62 34.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 44.1 p30 -52.66 155.55 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.254 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 56' ' ' ASP . 64.9 m -154.54 157.99 39.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -85.05 135.08 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.8 p -58.82 153.65 16.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.09 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -60.47 -52.03 66.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.951 -1.093 . . . . 0.0 109.928 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -46.95 -50.0 19.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.824 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -69.13 -34.09 74.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.248 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -69.84 -41.26 75.16 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.428 -0.795 . . . . 0.0 110.02 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.18 -50.04 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.243 -0.91 . . . . 0.0 109.358 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.33 79.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.986 -1.071 . . . . 0.0 109.819 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -71.62 -44.02 65.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.466 -0.771 . . . . 0.0 111.308 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.74 -32.9 74.5 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.524 -1.36 . . . . 0.0 111.701 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 C--N 1.295 -1.783 0 O-C-N 120.215 -1.553 . . . . 0.0 110.308 -178.936 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 121.215 0.531 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.2 p30 -75.46 -179.66 4.71 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.753 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -67.99 -8.6 38.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.829 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -101.79 -22.97 14.26 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.779 -1.201 . . . . 0.0 111.029 -178.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 123.06 7.93 6.89 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 121.199 -0.938 . . . . 0.0 110.78 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.527 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 9.2 mtm180 -85.09 126.25 33.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.884 -1.362 . . . . 0.0 109.596 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.2 mm -71.56 105.53 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' H ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 pp -87.78 149.02 24.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -91.09 -175.14 4.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.04 0.924 . . . . 0.0 110.903 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.466 ' H ' HG23 ' A' ' 15' ' ' THR . 7.5 p -55.19 146.24 19.24 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.665 0.745 . . . . 0.0 111.481 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.3 -54.12 4.85 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.422 -0.799 . . . . 0.0 111.37 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 36.8 mp0 -60.69 145.87 47.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 109.644 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -160.83 149.28 16.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.071 . . . . 0.0 109.649 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -99.3 130.87 45.62 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.081 -1.012 . . . . 0.0 108.568 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -84.54 -171.24 3.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 0.0 109.605 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -75.32 -23.04 57.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.176 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -86.2 -15.02 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.19 -19.2 49.63 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -62.4 141.88 58.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.491 -1.594 . . . . 0.0 108.66 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -87.83 165.58 15.2 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.427 -0.796 . . . . 0.0 108.915 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.941 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -154.71 130.91 10.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -178.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.941 ' N ' HD22 ' A' ' 26' ' ' LEU . 71.6 t80 -131.23 168.6 17.22 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 53.1 tttt -136.83 140.01 42.13 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.58 173.35 11.73 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.34 -0.85 . . . . 0.0 109.513 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.1 mm -103.35 126.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.412 -0.805 . . . . 0.0 109.615 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.14 176.41 9.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.005 -1.06 . . . . 0.0 109.058 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.8 p -64.09 0.59 0.89 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.042 -1.036 . . . . 0.0 111.203 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 14.4 m-85 -103.65 -15.89 15.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.107 -0.996 . . . . 0.0 109.463 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.65 -0.62 74.12 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -82.81 148.39 57.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.248 . . . . 0.0 109.299 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.06 124.44 9.09 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.489 1.459 . . . . 0.0 111.019 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -122.81 163.55 20.03 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -136.29 153.55 51.14 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.192 -0.943 . . . . 0.0 110.124 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.54 146.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -131.23 149.11 52.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.179 -0.951 . . . . 0.0 109.682 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.3 t -171.53 154.6 3.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.38 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -92.67 14.77 16.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.005 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.693 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 24.4 mtmm -130.91 138.51 49.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -93.38 -45.06 7.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.482 ' O ' ' OG ' ' A' ' 59' ' ' SER . 1.2 t -119.73 167.54 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.63 -17.57 64.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 110.664 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 p -86.89 -12.0 49.06 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.901 -1.124 . . . . 0.0 110.886 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -70.7 169.26 14.8 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.871 -1.143 . . . . 0.0 110.458 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -139.49 137.29 35.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.12 150.97 72.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 109.657 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.45 150.16 63.58 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.786 1.657 . . . . 0.0 111.049 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.86 146.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.3 -32.4 7.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -98.04 132.84 43.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -1.211 . . . . 0.0 109.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -74.95 147.91 40.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 109.182 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 60.0 p30 -51.82 152.06 3.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.114 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.693 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 35.6 m -146.78 164.07 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.47 133.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 110.823 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 56.3 m -58.19 166.95 1.43 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.412 0.625 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.467 HD12 ' CB ' ' A' ' 27' ' ' TYR . 4.4 mm? -63.68 -65.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.888 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -47.47 -34.45 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.502 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.94 -40.11 72.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.659 -1.275 . . . . 0.0 108.837 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -66.24 -44.02 84.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 110.245 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.5 mp -59.92 -45.12 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.134 -0.979 . . . . 0.0 110.677 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.62 81.65 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.745 -1.222 . . . . 0.0 110.981 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -77.85 -36.71 49.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.846 -1.159 . . . . 0.0 112.477 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.6 mt -67.53 -44.41 78.43 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.364 -1.46 . . . . 0.0 111.523 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 110.985 -178.619 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 121.267 0.556 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.0 p-10 -88.96 -176.9 5.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.083 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -64.78 -6.31 7.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 110.006 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 9' ' ' ARG . 52.9 mtt-85 -105.39 -16.88 14.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.172 -0.955 . . . . 0.0 110.318 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 101.65 19.01 16.7 Favored Glycine 0 N--CA 1.501 2.989 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.521 ' HG2' HH11 ' A' ' 11' ' ' ARG . 6.6 mtt-85 -86.03 140.18 30.5 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.77 -1.43 . . . . 0.0 109.168 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.78 103.24 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.525 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -99.4 149.97 22.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.388 -0.82 . . . . 0.0 109.065 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -89.02 -173.86 4.23 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.423 1.106 . . . . 0.0 111.785 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 m -59.4 140.0 56.55 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.229 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 -39.12 2.93 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.312 -0.867 . . . . 0.0 111.338 177.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -72.56 153.38 41.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.745 -1.444 . . . . 0.0 109.862 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -160.55 155.68 24.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -96.42 139.94 31.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -83.75 148.33 27.11 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.568 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -57.56 -18.9 21.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.61 -21.04 23.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.782 -0.573 . . . . 0.0 109.924 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.86 -35.59 4.01 Favored Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 24' ' ' ARG . 2.9 ptp180 -59.54 140.98 55.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.877 -1.366 . . . . 0.0 109.23 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -75.85 170.73 15.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.316 -0.865 . . . . 0.0 110.338 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 39' ' ' VAL . 62.9 tp -154.83 130.98 10.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.73 -0.606 . . . . 0.0 109.551 -179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -134.51 161.93 33.69 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -126.3 134.88 51.01 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.8 p90 -137.98 167.72 21.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.76 131.92 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 109.259 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 41.5 m-20 -82.09 -174.13 4.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.218 -0.926 . . . . 0.0 109.61 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -72.32 -4.64 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.42 -0.8 . . . . 0.0 110.239 -179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 18.3 m-85 -99.59 -10.73 21.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.15 -0.968 . . . . 0.0 109.913 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.41 86.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.39 147.33 52.8 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.392 -1.063 . . . . 0.0 108.733 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.98 128.51 15.93 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.846 1.697 . . . . 0.0 110.522 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -127.87 164.69 21.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 109.011 -179.106 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.38 155.32 50.48 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.356 -0.84 . . . . 0.0 110.786 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.673 ' O ' HD12 ' A' ' 26' ' ' LEU . 2.9 m -128.86 152.72 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.652 ' CE2' HD13 ' A' ' 26' ' ' LEU . 78.5 m-85 -128.3 150.89 49.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.208 -0.933 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 t -169.08 146.4 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.469 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -88.31 3.55 49.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 109.289 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.66 ' HZ1' ' C ' ' A' ' 57' ' ' CYS . 24.4 mtmm -128.56 141.99 51.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.88 -49.59 6.35 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 46' ' ' ALA . 3.2 t -112.53 174.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -77.95 -11.92 59.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.62 -0.675 . . . . 0.0 110.669 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -87.25 -14.35 41.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.763 -1.211 . . . . 0.0 110.105 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.2 174.89 5.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 1.9 tmt_? -146.49 135.94 22.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.409 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 19.3 m -75.23 147.95 83.4 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.772 -1.205 . . . . 0.0 109.954 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.33 155.73 66.51 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.04 1.827 . . . . 0.0 111.764 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.18 146.98 2.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.55 -0.719 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.4 6.91 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -95.97 139.64 31.88 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.005 -1.291 . . . . 0.0 109.073 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 55' ' ' ARG . 1.4 ttt-85 -75.41 151.26 38.15 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.68 159.06 22.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.365 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.66 ' C ' ' HZ1' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -156.34 175.03 14.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.032 -179.848 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.81 135.38 25.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.524 -0.735 . . . . 0.0 110.68 -178.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.9 p -61.35 163.67 6.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 108.695 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.1 -51.98 40.19 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 111.149 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' NH1' ' HG2' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -44.27 -45.49 8.64 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.143 -0.973 . . . . 0.0 110.003 -178.853 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -68.58 -40.58 80.45 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 109.672 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -66.62 -44.14 82.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.986 -1.072 . . . . 0.0 110.516 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -56.93 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.91 -1.119 . . . . 0.0 110.318 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.07 70.29 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.74 -53.79 7.49 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -69.28 -41.28 77.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.996 -1.065 . . . . 0.0 110.144 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.296 -1.75 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -177.731 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 6' ' ' ARG . 2.9 mtt-85 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 51.3 p-10 -74.4 -167.36 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.761 -1.212 . . . . 0.0 108.91 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.489 ' N ' ' OE1' ' A' ' 19' ' ' GLN . 11.7 m120 -68.61 -16.35 63.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.781 -1.2 . . . . 0.0 108.599 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.45 ' N ' ' CD ' ' A' ' 9' ' ' ARG . 9.2 mpt_? -101.3 -87.13 0.4 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -169.5 19.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.455 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 81.3 mtm180 -89.84 138.59 31.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.303 . . . . 0.0 109.704 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.9 mm -77.68 130.26 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.888 . . . . 0.0 109.98 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -93.6 150.64 20.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -87.88 170.87 10.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.957 -1.09 . . . . 0.0 109.513 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.0 m -58.11 137.17 57.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.455 -0.778 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.98 -24.81 24.88 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.943 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 44.1 mp0 -82.04 157.2 24.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.677 -1.484 . . . . 0.0 110.12 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 t -158.93 147.56 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 109.389 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 8' ' ' ASN . 41.7 tt0 -106.45 133.04 51.75 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -83.03 166.0 19.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 109.862 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HD3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.59 -16.49 48.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 108.643 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -86.9 -10.23 53.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.482 -0.761 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.31 -29.2 13.03 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.248 -0.907 . . . . 0.0 111.379 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -57.86 157.0 8.1 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.548 -1.56 . . . . 0.0 109.382 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.455 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 71.2 m-85 -100.41 166.91 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 109.42 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.484 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -152.79 141.29 20.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -135.26 149.23 49.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -114.88 135.42 54.22 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.253 -0.905 . . . . 0.0 110.792 -178.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.693 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.2 p90 -142.46 164.78 29.19 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.2 mt -107.96 139.62 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 33' ' ' PHE . 23.8 m-20 -81.79 159.93 23.68 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.935 -1.103 . . . . 0.0 109.222 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.7 m -58.2 -2.18 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 110.031 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 31' ' ' ASP . 88.1 m-85 -95.29 -15.43 23.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.044 -1.035 . . . . 0.0 108.59 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.07 -5.26 49.71 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.413 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 23.5 pt-20 -84.73 144.02 41.7 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.872 -1.369 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.69 139.83 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.534 2.156 . . . . 0.0 111.969 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.413 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 17.6 mp0 -136.8 172.75 12.54 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.108 -0.995 . . . . 0.0 109.402 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -137.01 139.51 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.51 154.27 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 66.9 m-85 -126.12 151.36 47.35 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.449 0.643 . . . . 0.0 109.273 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.8 t -168.22 136.57 2.29 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.013 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -87.58 12.9 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.189 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 53.0 mtmt -130.98 133.22 45.59 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.659 0.742 . . . . 0.0 109.574 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 66.9 tp -89.26 -43.44 10.97 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.528 HG22 HH12 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -111.63 175.39 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.48 -18.28 49.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.953 -1.092 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.2 p -93.58 7.29 45.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.679 -1.263 . . . . 0.0 110.955 -179.036 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.4 -179.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.611 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -142.1 116.79 9.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.13 -0.981 . . . . 0.0 109.196 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.47 149.45 51.88 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.204 -0.935 . . . . 0.0 110.839 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' LYS . 56.8 Cg_exo -49.58 134.42 33.12 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.208 1.272 . . . . 0.0 110.739 177.325 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.55 -23.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.848 -1.158 . . . . 0.0 109.791 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -25.4 73.65 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' PRO . 47.8 mmtt -103.93 133.93 48.06 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -78.99 152.65 30.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.087 . . . . 0.0 110.546 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -43.78 154.81 0.09 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.448 0.642 . . . . 0.0 109.826 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.498 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 61.4 m -149.73 167.59 26.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -86.96 128.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.141 -0.975 . . . . 0.0 108.779 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.6 p -58.64 167.64 1.43 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 110.443 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.78 -51.89 43.61 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.369 -0.832 . . . . 0.0 110.206 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.652 HH11 ' CG ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -47.07 -46.4 22.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 109.218 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -70.21 -39.65 75.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.512 -0.742 . . . . 0.0 110.19 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.0 -47.51 74.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.687 -1.258 . . . . 0.0 109.465 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.48 -56.69 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.21 76.97 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -77.29 -36.0 54.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.85 . . . . 0.0 111.945 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.693 HD12 ' CZ ' ' A' ' 29' ' ' TYR . 4.2 mm? -67.82 -41.41 83.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.542 -1.349 . . . . 0.0 110.178 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 . . . . . 0 C--N 1.297 -1.705 0 O-C-N 120.239 -1.538 . . . . 0.0 109.813 -179.624 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.501 ' CG ' HH11 ' A' ' 6' ' ' ARG . 4.9 mtt-85 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -104.09 -167.66 1.39 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.755 . . . . 0.0 109.503 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 3.1 p30 -66.89 -16.86 64.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.28 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.593 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -97.6 -3.66 39.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.965 -1.084 . . . . 0.0 110.061 -179.422 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.85 90.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.533 HH11 ' CG ' ' A' ' 11' ' ' ARG . 2.6 mtt-85 -88.71 130.79 35.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.016 -1.285 . . . . 0.0 109.641 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.75 121.64 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 109.233 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.953 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -97.23 155.94 16.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -0.78 . . . . 0.0 108.948 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.07 179.42 6.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.871 -1.143 . . . . 0.0 110.111 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -56.81 152.47 12.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.729 -0.607 . . . . 0.0 110.295 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.44 -43.32 3.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.015 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' CD1' ' A' ' 44' ' ' LEU . 2.1 mt-10 -66.39 155.12 38.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.229 -1.16 . . . . 0.0 108.464 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 t -159.03 164.27 35.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.126 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -103.61 126.53 50.81 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 108.9 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -85.17 147.17 26.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.046 . . . . 0.0 108.947 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 1.3 mptt -49.26 -22.6 1.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -89.77 -26.74 20.44 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.799 -1.188 . . . . 0.0 110.821 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.62 -34.33 2.79 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 24' ' ' ARG . 0.1 OUTLIER -60.45 148.19 38.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.779 -1.424 . . . . 0.0 108.778 -179.753 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -86.47 168.71 13.5 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 27' ' ' TYR . 4.3 tt -145.12 122.95 11.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.349 -0.844 . . . . 0.0 109.536 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.655 ' N ' HD23 ' A' ' 26' ' ' LEU . 74.0 t80 -128.04 161.54 28.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.424 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 17.4 tttt -129.42 138.63 51.57 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.426 -0.796 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -140.42 162.82 34.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.1 mt -110.96 136.27 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -85.27 170.47 12.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.357 -0.84 . . . . 0.0 109.479 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.0 p -60.35 5.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 110.546 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 31' ' ' ASP . 37.3 m-85 -99.45 -17.68 17.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.039 -1.038 . . . . 0.0 109.43 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 -2.91 82.31 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -83.92 142.07 41.5 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.282 -1.128 . . . . 0.0 108.172 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.9 145.54 56.64 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.685 1.59 . . . . 0.0 111.124 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -140.07 153.97 46.92 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -129.56 148.69 51.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.044 -1.035 . . . . 0.0 109.892 -179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.14 142.92 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -117.22 160.91 20.32 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.1 t -168.74 152.46 5.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -93.78 7.55 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -143.65 149.09 36.77 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 51.1 tp -94.09 -42.99 8.71 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.65 158.01 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.683 -0.636 . . . . 0.0 109.452 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.36 -11.4 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.191 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.0 p -90.3 -6.91 54.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.039 -1.038 . . . . 0.0 110.129 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -70.71 179.36 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.97 -1.081 . . . . 0.0 110.009 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 49' ' ' ARG . 6.5 tpt180 -142.44 120.76 12.32 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 109.116 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.31 142.35 50.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.252 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -49.34 146.29 14.02 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.879 1.053 . . . . 0.0 110.503 178.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.56 -47.55 39.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.994 -1.067 . . . . 0.0 110.166 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.97 -21.02 4.85 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -102.51 139.71 37.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -1.17 . . . . 0.0 109.934 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.638 ' H ' ' CD ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.54 159.29 30.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 179.839 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 25.6 p-10 -66.39 164.25 16.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.16 171.68 15.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.62 133.05 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 110.17 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.7 p -58.82 152.58 18.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.066 179.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.27 -47.21 87.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.219 -0.925 . . . . 0.0 109.867 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -42.95 -45.07 4.88 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.08 -1.012 . . . . 0.0 109.819 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 97.5 mt-10 -72.29 -37.5 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -66.32 -42.51 88.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.693 -1.255 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.04 -53.5 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.668 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.87 93.03 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.15 -0.969 . . . . 0.0 110.116 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -72.33 -38.73 68.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.893 -1.129 . . . . 0.0 111.436 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.62 -46.4 72.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.576 -1.327 . . . . 0.0 110.094 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 . . . . . 0 C--N 1.298 -1.63 0 O-C-N 120.794 -1.191 . . . . 0.0 109.838 179.874 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.499 0.666 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -64.83 165.51 10.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.391 -0.818 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.441 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 26.0 p30 -63.17 -6.97 4.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.368 -0.832 . . . . 0.0 109.823 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -96.41 -75.79 0.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.205 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.95 -1.32 0.03 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.924 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.554 HH11 ' CG ' ' A' ' 11' ' ' ARG . 5.3 mtt-85 -85.59 133.18 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.469 . . . . 0.0 108.895 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.96 117.0 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.958 . . . . 0.0 109.385 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.8 151.42 22.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -88.89 173.78 8.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.337 -0.852 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 m -56.82 139.34 51.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.397 -0.815 . . . . 0.0 110.636 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.18 -42.35 2.27 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.24 150.6 43.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.807 -1.408 . . . . 0.0 109.539 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -157.03 140.0 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.441 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 53.9 tt0 -101.86 140.72 35.77 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.454 HH21 HD13 ' A' ' 26' ' ' LEU . 37.1 mtt-85 -91.19 173.13 8.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 110.425 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 1.5 mptt -64.16 -19.66 65.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -84.81 -9.81 57.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.1 -25.53 25.08 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 121.096 -1.002 . . . . 0.0 110.96 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -62.21 137.95 58.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.739 -1.447 . . . . 0.0 109.302 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.81 166.76 19.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 110.496 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 HH21 ' A' ' 20' ' ' ARG . 3.0 tt -153.51 138.76 17.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.696 . . . . 0.0 110.043 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -133.16 148.39 52.09 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -115.05 139.31 49.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.386 -0.821 . . . . 0.0 109.663 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.91 166.07 27.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 0.0 109.098 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -103.81 134.0 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.259 -0.901 . . . . 0.0 109.695 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -84.01 171.59 12.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.894 -1.128 . . . . 0.0 109.236 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -62.33 -0.13 0.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.568 -0.708 . . . . 0.0 111.367 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 39.2 m-85 -103.77 -21.59 13.66 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.901 -1.124 . . . . 0.0 110.255 -178.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.82 -1.91 38.8 Favored Glycine 0 N--CA 1.503 3.109 0 O-C-N 121.059 -1.026 . . . . 0.0 111.199 178.385 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -86.97 153.91 54.87 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.69 -1.476 . . . . 0.0 108.709 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -82.5 133.99 7.46 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.301 2.001 . . . . 0.0 112.796 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 3.7 mp0 -127.95 164.68 21.78 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.422 -0.798 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -137.49 147.35 45.18 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 156.22 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.34 154.9 44.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.458 -0.776 . . . . 0.0 110.065 -178.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -172.34 137.74 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.605 -0.684 . . . . 0.0 109.276 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -88.38 11.56 16.51 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -126.27 147.67 49.65 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.42 0.628 . . . . 0.0 109.78 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.1 tp -95.67 -47.22 6.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 47' ' ' THR . 35.5 m -122.15 -176.87 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.56 -15.87 58.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 111.109 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.424 ' H ' HG23 ' A' ' 45' ' ' VAL . 24.0 p -88.1 -10.03 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.711 -1.243 . . . . 0.0 110.234 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -75.85 166.78 23.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.978 . . . . 0.0 110.467 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.49 139.91 40.84 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -81.06 149.58 66.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.801 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.39 154.46 50.85 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.488 2.125 . . . . 0.0 111.338 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.13 144.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.63 -38.54 3.07 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.562 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 9.6 mptt -93.2 126.03 38.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -1.165 . . . . 0.0 108.175 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' HB3' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.5 155.67 33.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 110.109 -179.137 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -50.98 164.67 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.939 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 52.2 t -162.15 165.75 26.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.439 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 97.6 mt -83.93 126.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.59 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.5 p -54.37 157.62 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 108.925 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.54 -59.97 3.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 110.677 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -46.69 -39.93 12.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.115 . . . . 0.0 110.392 -178.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -71.5 -40.22 70.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.929 -1.107 . . . . 0.0 109.394 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -70.84 -41.81 70.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.78 -49.65 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.94 -1.1 . . . . 0.0 109.137 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.66 80.19 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.179 -0.95 . . . . 0.0 109.859 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.71 -53.5 13.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 111.07 -178.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.68 -49.19 41.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.631 -1.293 . . . . 0.0 110.442 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 C--N 1.295 -1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 -176.499 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.547 ' CG ' HH11 ' A' ' 6' ' ' ARG . 2.6 mtt-85 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 58.3 p30 -101.26 178.15 4.73 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -62.05 -6.77 3.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.718 -1.239 . . . . 0.0 109.462 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.488 HH21 HH21 ' A' ' 11' ' ' ARG . 17.7 mmm180 -96.95 -12.12 23.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 86.73 10.05 73.57 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.313 178.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.598 HH11 ' CG ' ' A' ' 11' ' ' ARG . 2.9 mtt-85 -85.67 152.02 23.42 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.668 -1.489 . . . . 0.0 109.544 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -84.48 104.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 pp -92.77 146.43 23.65 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.936 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -88.78 -174.54 4.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.049 -1.032 . . . . 0.0 111.466 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 m -57.63 147.33 27.67 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.4 -44.82 3.41 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.51 149.06 50.66 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.995 -1.297 . . . . 0.0 109.555 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -157.21 155.1 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.491 ' OE1' ' CD1' ' A' ' 25' ' ' TYR . 5.2 tp60 -110.81 132.39 54.24 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.542 -0.724 . . . . 0.0 110.007 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.82 HH11 HH21 ' A' ' 24' ' ' ARG . 36.0 mtp180 -90.46 -177.41 5.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -67.67 -24.1 65.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.209 -179.229 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.51 -13.1 41.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.004 -1.06 . . . . 0.0 109.702 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.65 -14.46 59.09 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.345 -0.847 . . . . 0.0 111.393 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.82 HH21 HH11 ' A' ' 20' ' ' ARG . 2.1 ptt180 -64.46 141.03 58.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.444 -1.621 . . . . 0.0 109.348 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.491 ' CD1' ' OE1' ' A' ' 19' ' ' GLN . 71.5 m-85 -81.45 165.95 20.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.418 -0.802 . . . . 0.0 110.066 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.532 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 9.3 tp -153.85 125.81 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.43 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.473 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 69.0 t80 -130.72 170.15 14.72 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 33.1 tttm -139.76 142.24 36.77 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.931 -1.106 . . . . 0.0 111.173 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.58 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 43.5 p90 -149.17 -172.91 4.24 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.352 -0.843 . . . . 0.0 108.966 176.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -114.22 134.54 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.952 -1.092 . . . . 0.0 110.147 -178.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' CG ' HE21 ' A' ' 37' ' ' GLN . 5.0 m-20 -83.98 174.87 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 t -66.6 -6.53 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.9 . . . . 0.0 108.808 178.685 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 12.0 m-85 -98.18 -4.76 34.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.773 . . . . 0.0 109.069 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.08 -1.11 86.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 pp20? -85.5 144.44 40.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 0.0 108.959 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.62 131.08 11.14 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.978 1.785 . . . . 0.0 112.146 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.668 ' NE2' ' H ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -129.4 172.1 11.85 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.964 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 19.0 m-85 -141.08 163.47 32.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 0.0 110.512 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.54 135.46 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.532 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 76.7 m-85 -122.49 143.54 49.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.531 -0.731 . . . . 0.0 110.01 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.6 t -171.7 157.64 4.72 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 178.461 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -91.19 10.18 28.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.544 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 34.1 mtmm -131.81 141.19 49.38 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.717 0.77 . . . . 0.0 110.152 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -94.58 -40.45 9.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.59 168.1 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.04 60.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.421 -0.799 . . . . 0.0 109.729 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.8 p -90.06 -5.52 56.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.165 -0.959 . . . . 0.0 110.314 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.95 172.15 9.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.924 -1.11 . . . . 0.0 109.366 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -142.15 133.65 26.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.135 -0.978 . . . . 0.0 109.255 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.4 150.0 62.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.301 -179.198 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 151.8 62.84 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.161 1.907 . . . . 0.0 111.213 178.506 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.84 153.32 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 0.0 110.481 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.21 5.77 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -95.43 139.38 31.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.059 -1.26 . . . . 0.0 109.572 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.521 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.84 164.62 25.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 109.349 -179.48 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -74.45 161.94 29.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.355 -0.841 . . . . 0.0 109.608 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.544 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 27.8 t -161.73 161.22 29.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.479 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 81.6 mt -82.42 136.34 23.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.021 -1.049 . . . . 0.0 109.227 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -59.19 176.04 0.26 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.53 -0.732 . . . . 0.0 110.123 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 60' ' ' LEU . 6.9 mp -77.2 -52.68 8.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.546 ' H ' ' CD ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -42.63 -44.41 4.22 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.182 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -71.84 -40.0 69.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -65.04 -40.38 94.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.709 -1.245 . . . . 0.0 109.884 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.19 -55.61 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.958 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.16 95.75 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.5 -1.375 . . . . 0.0 109.89 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.43 -45.28 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 110.652 -179.101 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.73 -43.5 68.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.815 -1.178 . . . . 0.0 110.255 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 . . . . . 0 C--N 1.298 -1.665 0 O-C-N 121.725 -0.609 . . . . 0.0 110.329 -177.702 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.372 0.606 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 mtpt -152.67 90.15 1.46 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.441 ' HE ' ' CA ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -88.82 151.3 22.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 -179.285 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -133.95 167.54 20.41 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.539 -0.726 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 42.4 p-10 -91.35 -177.08 4.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 109.772 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -63.09 -9.47 10.72 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.506 -0.746 . . . . 0.0 109.698 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.409 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 4.0 mmp_? -101.3 -71.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.994 -1.066 . . . . 0.0 110.02 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 169.09 7.08 0.03 OUTLIER Glycine 0 N--CA 1.497 2.703 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.949 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.566 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 67.0 mtm180 -87.98 136.49 32.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.644 -1.503 . . . . 0.0 109.066 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.3 mt -82.61 111.72 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -89.42 149.85 22.78 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -86.04 -179.71 6.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.803 -1.186 . . . . 0.0 110.97 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t -58.63 145.62 39.03 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.691 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.02 -40.1 2.81 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.328 -0.857 . . . . 0.0 111.189 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 27' ' ' TYR . 46.5 mp0 -72.07 152.18 42.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.709 -1.465 . . . . 0.0 109.997 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -154.67 142.38 19.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -110.27 132.43 54.18 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -89.5 169.87 11.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.313 -0.867 . . . . 0.0 109.347 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -12.6 41.79 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.534 -0.729 . . . . 0.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -87.65 -18.41 29.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.272 -0.893 . . . . 0.0 109.831 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.54 -23.85 25.46 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -64.86 137.89 58.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.424 . . . . 0.0 109.569 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.566 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -82.8 171.41 13.97 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.643 -0.661 . . . . 0.0 110.115 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 27' ' ' TYR . 2.1 tt -154.56 127.23 8.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.557 ' N ' HD23 ' A' ' 26' ' ' LEU . 75.9 t80 -132.78 163.19 29.6 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.249 -0.907 . . . . 0.0 109.058 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -131.52 137.05 48.35 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.323 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.72 133.13 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 33' ' ' PHE . 34.6 p30 -88.31 174.61 8.08 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.667 -0.646 . . . . 0.0 110.319 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 t -62.11 6.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 0.0 110.555 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 31' ' ' ASP . 19.9 m-85 -100.69 -16.31 17.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.98 -1.075 . . . . 0.0 108.432 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.61 -4.86 85.11 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.26 149.88 59.46 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.072 -1.252 . . . . 0.0 108.717 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.96 137.41 24.21 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.405 1.403 . . . . 0.0 109.786 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -135.21 137.63 42.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.915 -1.116 . . . . 0.0 109.274 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.61 145.23 40.74 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.518 -0.739 . . . . 0.0 110.172 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.0 157.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.527 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 55.6 m-85 -127.53 155.73 43.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -170.78 136.5 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.85 -1.156 . . . . 0.0 110.868 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -86.62 5.99 33.14 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -131.76 131.73 43.22 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.615 0.722 . . . . 0.0 110.098 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 tp -86.18 -42.78 13.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.75 174.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.93 -16.74 59.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.086 -1.008 . . . . 0.0 110.6 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.5 p -88.39 -4.91 58.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.849 -1.157 . . . . 0.0 110.596 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.565 ' CG ' HH12 ' A' ' 11' ' ' ARG . 73.2 m-20 -70.01 177.31 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.595 -1.316 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -139.6 138.08 35.88 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.08 144.07 50.32 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.49 -0.756 . . . . 0.0 111.044 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.0 143.92 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.449 2.099 . . . . 0.0 112.912 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.79 130.6 17.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -0.775 . . . . 0.0 110.072 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.84 59.71 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -92.22 135.24 34.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.013 -1.286 . . . . 0.0 109.061 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -75.24 161.27 29.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.314 -0.867 . . . . 0.0 110.189 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.55 158.86 3.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.57 -0.706 . . . . 0.0 110.23 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 9.3 t -147.31 158.0 43.8 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 87.1 mt -83.09 124.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.872 -1.143 . . . . 0.0 109.306 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.41 153.9 14.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.206 -0.934 . . . . 0.0 109.543 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.86 -53.45 57.8 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.611 -0.835 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -48.88 -44.65 40.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.885 -1.135 . . . . 0.0 109.043 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -72.33 -39.06 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 40' ' ' TYR . 11.0 ttmt -67.32 -49.86 62.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.977 -1.077 . . . . 0.0 109.444 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -50.34 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.27 -49.26 74.73 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 110.42 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -68.87 -39.75 79.66 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 111.701 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.31 -48.59 49.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.699 -1.251 . . . . 0.0 111.305 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -71.35 -37.74 71.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.123 -0.985 . . . . 0.0 110.44 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -74.08 -23.03 59.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.646 -1.284 . . . . 0.0 110.29 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -98.8 -51.41 3.9 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.172 -0.955 . . . . 0.0 110.827 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -81.37 13.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.079 -1.013 . . . . 0.0 109.373 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -151.65 37.14 0.58 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.585 -1.322 . . . . 0.0 109.011 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.42 -0.8 . . . . 0.0 109.638 179.793 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.881 ' N ' ' HZ2' ' A' ' 4' ' ' LYS . 77.7 mm-40 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.881 ' HZ2' ' N ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -152.61 -113.92 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.238 -0.913 . . . . 0.0 109.577 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.546 ' CG ' HH11 ' A' ' 5' ' ' ARG . 0.2 OUTLIER -83.82 147.75 27.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.804 -1.185 . . . . 0.0 108.802 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -135.16 172.97 12.26 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.36 -0.837 . . . . 0.0 109.27 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 37.6 p-10 -95.24 -170.81 2.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.371 -0.831 . . . . 0.0 109.59 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 70.1 m-80 -68.18 -11.57 59.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.849 . . . . 0.0 110.789 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -103.47 -23.27 13.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.028 -1.045 . . . . 0.0 109.907 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 109.41 19.27 8.48 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 24.3 mtt180 -84.71 124.59 31.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.131 -1.217 . . . . 0.0 109.47 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.7 mm -75.45 101.73 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.835 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -95.24 150.62 20.04 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -87.48 -171.81 3.63 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.0 111.45 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.431 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 66.2 p -54.06 149.95 8.68 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.0 -45.25 2.48 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 1.4 mp0 -69.22 131.84 45.55 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.563 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.3 m -152.7 152.35 31.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.287 -0.883 . . . . 0.0 108.775 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.444 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.1 tt0 -95.92 141.59 29.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.042 -1.037 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -88.11 163.03 16.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.718 -0.613 . . . . 0.0 109.376 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -62.71 -19.82 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.018 -1.051 . . . . 0.0 108.571 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.91 -13.59 44.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.913 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.31 -26.83 19.02 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 121.258 -0.901 . . . . 0.0 111.075 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -61.99 135.92 57.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.694 -1.474 . . . . 0.0 110.237 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH1' ' A' ' 11' ' ' ARG . 74.1 m-85 -80.57 168.28 19.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -161.04 147.38 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.0 -1.062 . . . . 0.0 109.298 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.978 ' N ' HD22 ' A' ' 26' ' ' LEU . 84.6 t80 -139.16 168.05 20.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 65.5 tttt -127.06 138.99 53.32 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.433 -0.792 . . . . 0.0 109.437 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.603 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 19.4 p90 -138.39 170.7 15.55 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mm -108.47 136.57 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.405 -0.809 . . . . 0.0 110.123 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.4 m-20 -78.47 161.82 26.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.22 -0.925 . . . . 0.0 108.649 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 t -59.79 -2.82 0.42 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 109.317 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.4 m-85 -101.53 -18.46 15.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.335 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 2.4 51.5 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 121.227 -0.921 . . . . 0.0 111.237 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -86.26 148.15 46.57 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.78 -1.424 . . . . 0.0 110.191 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 87.2 Cg_endo -76.99 128.32 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 122.94 2.427 . . . . 0.0 113.213 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 36' ' ' PRO . 2.7 mp0 -131.29 163.45 27.79 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -131.73 156.2 46.35 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.282 -0.886 . . . . 0.0 109.892 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.41 147.04 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -125.79 151.57 46.58 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.783 0.801 . . . . 0.0 109.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -172.27 145.47 1.72 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -87.79 23.79 1.92 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.951 -1.093 . . . . 0.0 108.281 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -137.37 137.56 38.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.593 -0.692 . . . . 0.0 110.539 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.0 tp -95.18 -42.33 8.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 47' ' ' THR . 18.2 m -126.86 147.49 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.15 -7.04 0.17 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 45' ' ' VAL . 30.8 p -89.82 -4.74 57.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.998 -1.064 . . . . 0.0 110.184 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.21 164.18 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.142 -0.974 . . . . 0.0 110.801 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.539 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -134.86 121.03 20.04 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.3 150.69 64.61 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.75 150.52 44.84 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.491 2.128 . . . . 0.0 111.69 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.83 147.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.83 -38.36 3.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -95.17 131.21 41.45 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.307 -1.114 . . . . 0.0 108.485 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -77.76 153.4 32.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.839 -1.163 . . . . 0.0 109.689 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.02 163.31 22.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.45 -0.781 . . . . 0.0 110.128 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 29.6 t -157.16 169.71 24.17 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.589 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.7 mt -82.42 136.82 22.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 94.5 p -55.85 154.31 7.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.149 -0.969 . . . . 0.0 109.311 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 61' ' ' ARG . 78.6 mt -62.01 -49.61 75.37 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.308 -0.87 . . . . 0.0 110.272 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 60' ' ' LEU . 30.5 mtt180 -46.65 -47.53 20.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.786 -1.196 . . . . 0.0 109.787 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -72.18 -34.83 68.72 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -68.71 -41.57 78.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 108.913 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.26 -52.54 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.45 -34.45 72.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -70.85 -35.33 72.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.424 -0.798 . . . . 0.0 111.535 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.603 HD12 ' CZ ' ' A' ' 29' ' ' TYR . 4.0 mm? -63.61 -39.93 95.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.821 -1.174 . . . . 0.0 110.658 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -70.96 -44.59 65.73 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 120.538 -1.351 . . . . 0.0 111.352 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.94 -14.86 58.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.577 -1.327 . . . . 0.0 111.369 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -89.04 -23.55 22.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.868 -1.145 . . . . 0.0 110.658 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 71' ' ' ILE . 6.2 mm -88.67 -4.59 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.001 -1.062 . . . . 0.0 109.402 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -150.33 149.82 30.62 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.04 -1.037 . . . . 0.0 110.047 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.561 -0.712 . . . . 0.0 110.095 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -85.32 -172.7 4.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.077 -1.015 . . . . 0.0 110.597 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.548 HH11 ' HG2' ' A' ' 5' ' ' ARG . 5.3 mtt-85 -87.66 162.0 17.35 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.474 0.654 . . . . 0.0 110.299 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.447 HH11 ' HG3' ' A' ' 6' ' ' ARG . 35.9 mtm-85 -137.89 -179.31 5.69 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -95.69 -163.88 1.1 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.082 -1.012 . . . . 0.0 109.85 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 13.4 p30 -67.07 -23.54 65.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -100.03 5.02 45.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 110.637 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.43 49.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -87.19 134.86 33.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.137 -1.214 . . . . 0.0 110.205 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.4 mm -84.44 97.1 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 108.773 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.78 146.02 24.47 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.039 -1.038 . . . . 0.0 109.708 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.79 178.59 6.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.122 -0.986 . . . . 0.0 109.732 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -57.26 147.02 26.61 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.532 0.682 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.55 -45.23 1.76 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 24.3 mp0 -72.41 156.62 38.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.106 -1.232 . . . . 0.0 109.802 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.8 m -157.75 140.91 15.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.534 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.4 tt0 -94.85 142.18 27.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -92.25 169.08 10.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.631 0.729 . . . . 0.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -63.48 -23.1 67.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.701 -0.624 . . . . 0.0 110.553 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -88.1 -17.49 30.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 0.0 110.133 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.39 -32.21 6.02 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -60.4 135.15 57.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.736 -1.449 . . . . 0.0 109.558 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.68 170.18 16.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 111.192 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.3 tp -152.03 121.66 6.93 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 82.3 t80 -125.14 174.66 7.91 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.236 -0.915 . . . . 0.0 108.57 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.576 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 75.1 tttt -128.06 121.77 30.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 109.779 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -124.3 158.47 32.49 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.96 150.02 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' HA ' HD11 ' A' ' 71' ' ' ILE . 69.1 m-20 -80.9 170.44 16.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 108.937 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.7 m -68.07 -2.64 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -96.96 -17.51 20.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.132 -0.98 . . . . 0.0 109.389 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.59 -4.41 32.71 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 20.9 pt-20 -85.34 145.67 43.08 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.882 -1.363 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.57 146.97 21.94 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.645 2.23 . . . . 0.0 113.44 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.406 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 16.3 mp0 -142.3 178.35 7.63 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -133.95 152.9 52.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 0.0 109.531 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.578 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -129.92 158.58 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.451 -0.781 . . . . 0.0 109.33 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 36.6 m-85 -128.95 149.96 50.58 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.277 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -168.37 142.28 3.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 0.0 109.949 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -90.37 11.63 20.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -139.87 153.48 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 0.0 110.442 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 59' ' ' SER . 42.9 tp -99.25 -43.61 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.95 170.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.15 -15.58 59.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 0.0 110.886 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.2 p -86.57 -13.76 44.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.588 -1.32 . . . . 0.0 110.069 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -71.17 178.94 3.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.389 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.8 147.73 46.78 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.92 149.66 74.09 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.976 -1.077 . . . . 0.0 109.553 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -51.7 147.64 23.72 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.337 1.358 . . . . 0.0 111.432 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.24 141.18 11.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 -24.64 29.14 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -96.81 140.74 30.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.313 . . . . 0.0 109.356 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -74.45 153.28 39.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.807 -1.183 . . . . 0.0 109.148 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.31 163.32 0.41 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.181 -0.949 . . . . 0.0 110.09 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -148.38 160.12 43.33 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 99.0 mt -84.84 134.26 27.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 44.3 t -58.47 153.87 15.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.661 -0.65 . . . . 0.0 110.052 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -60.82 -53.13 61.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -49.87 -45.74 50.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.935 -1.103 . . . . 0.0 109.845 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.9 -29.9 66.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 108.675 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -72.39 -45.54 59.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.459 -0.775 . . . . 0.0 109.204 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.35 -55.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 0.0 110.252 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.06 93.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 0.0 110.647 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -68.74 -35.16 76.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 111.803 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.03 -41.78 86.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.569 -1.332 . . . . 0.0 111.755 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -67.06 -44.71 79.44 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 120.239 -1.538 . . . . 0.0 111.335 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -78.97 -3.11 43.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.777 -1.202 . . . . 0.0 111.514 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -109.14 -52.65 2.74 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.839 -1.163 . . . . 0.0 112.446 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.733 HD12 ' O ' ' A' ' 71' ' ' ILE . 2.0 pp -82.6 102.19 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.786 -1.196 . . . . 0.0 110.342 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -156.52 15.84 0.31 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.648 -1.283 . . . . 0.0 109.66 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 109.526 -179.654 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 1.2 pm0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -83.7 114.51 21.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.174 -0.954 . . . . 0.0 108.727 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -91.96 125.58 36.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.219 -0.926 . . . . 0.0 109.355 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -139.46 -178.38 5.36 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -70.34 175.24 4.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 0.0 110.264 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -66.81 -12.4 58.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.476 -0.765 . . . . 0.0 109.931 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.435 ' NH1' ' HG3' ' A' ' 9' ' ' ARG . 7.7 mmm-85 -95.57 -77.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 0.0 109.349 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.96 3.7 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.216 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 55.9 mtm180 -88.14 125.27 34.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.732 -1.452 . . . . 0.0 108.869 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.3 mt -77.79 110.95 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.07 -1.019 . . . . 0.0 109.832 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.2 156.71 18.12 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -88.79 -176.84 5.36 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.816 -1.178 . . . . 0.0 110.775 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -54.63 161.65 1.42 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.801 0.81 . . . . 0.0 112.068 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.34 -19.26 1.89 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 40.4 mt-10 -86.92 150.03 24.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.266 . . . . 0.0 110.295 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.0 p -157.5 134.05 9.83 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -99.2 125.8 44.86 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' CG ' HH11 ' A' ' 20' ' ' ARG . 1.0 OUTLIER -85.57 -174.13 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.816 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -72.48 -22.9 60.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 109.937 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.67 -10.97 57.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.89 -21.94 43.42 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -61.33 138.05 58.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.847 -1.384 . . . . 0.0 109.294 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 67.3 m-85 -80.54 166.72 20.9 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.252 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 24.3 tp -150.24 119.07 6.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 109.623 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -125.44 162.27 25.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -131.44 138.13 48.92 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.25 -0.906 . . . . 0.0 110.736 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.2 p90 -142.82 164.51 29.9 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.62 138.85 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.94 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 52.8 m-20 -87.37 -178.35 6.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.949 . . . . 0.0 110.4 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 p -66.91 -1.37 3.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.321 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 47.9 m-85 -98.58 -10.63 23.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.951 . . . . 0.0 108.713 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.45 -8.52 76.88 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -81.37 145.2 54.99 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.5 148.22 42.27 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.94 1.76 . . . . 0.0 112.717 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.1 mp0 -135.67 170.71 15.54 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.28 145.89 39.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.346 -0.846 . . . . 0.0 110.383 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.85 146.49 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.704 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 62.2 m-85 -128.91 151.11 50.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.597 -0.69 . . . . 0.0 109.596 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -171.66 146.19 2.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -88.83 11.42 17.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 108.51 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -123.57 140.99 52.44 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.555 -0.716 . . . . 0.0 110.226 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.79 -44.95 6.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.38 172.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -19.41 62.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.2 p -86.7 -1.98 58.15 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.703 -1.248 . . . . 0.0 110.788 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' OD1' ' NH1' ' A' ' 11' ' ' ARG . 76.0 m-20 -70.6 -174.22 0.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.585 -1.322 . . . . 0.0 109.334 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -148.75 130.53 15.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.043 -1.035 . . . . 0.0 109.454 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 15.0 m -80.97 130.07 64.91 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.83 -1.169 . . . . 0.0 109.272 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -48.87 148.05 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.188 1.259 . . . . 0.0 111.711 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.14 135.46 13.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.112 -0.992 . . . . 0.0 109.817 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.13 -32.66 6.68 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -92.33 136.47 33.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -1.165 . . . . 0.0 108.553 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.3 mmp_? -74.59 151.78 39.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.377 -0.827 . . . . 0.0 110.439 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -55.62 169.48 0.32 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 43.6 t -165.15 166.46 19.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.131 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 71.5 mt -83.6 125.48 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.015 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -56.69 156.0 6.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.337 -0.852 . . . . 0.0 109.638 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' O ' HD13 ' A' ' 64' ' ' ILE . 8.2 mp -56.13 -47.85 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 17' ' ' GLU . 5.0 mmp_? -53.25 -50.6 64.47 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.013 -1.054 . . . . 0.0 110.291 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.29 -36.68 61.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.753 -1.217 . . . . 0.0 110.806 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -65.97 -44.34 85.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.747 -1.22 . . . . 0.0 110.105 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.3 mp -60.68 -48.78 87.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.48 -42.71 74.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.93 -1.106 . . . . 0.0 109.974 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.27 -51.86 27.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 110.807 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.417 HD22 ' OH ' ' A' ' 29' ' ' TYR . 30.7 mt -68.27 -26.32 65.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 111.752 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -76.98 -68.68 0.58 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 120.804 -1.185 . . . . 0.0 112.745 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 73' ' ' ASP . 16.1 ptmt -75.06 -39.1 61.13 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.611 -1.306 . . . . 0.0 112.844 -177.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -60.85 -33.49 73.15 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.458 -1.401 . . . . 0.0 109.369 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 71' ' ' ILE . 42.2 mm -85.76 -3.11 8.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.549 -0.719 . . . . 0.0 110.743 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -144.76 -59.98 0.36 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.934 -1.104 . . . . 0.0 109.673 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' LYS . 58.1 t0 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.129 -0.982 . . . . 0.0 109.317 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -82.64 168.55 17.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.059 -1.026 . . . . 0.0 109.439 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -80.95 151.81 28.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.671 -0.643 . . . . 0.0 110.446 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -134.92 166.63 22.56 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.527 -0.733 . . . . 0.0 109.93 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -100.82 -176.47 3.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.732 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -66.29 -15.17 63.01 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.042 -1.036 . . . . 0.0 110.034 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.3 OUTLIER -95.39 -0.51 52.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 -178.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 0.45 86.45 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -84.57 137.04 33.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.107 -1.231 . . . . 0.0 109.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.6 mt -80.47 120.06 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.916 -1.115 . . . . 0.0 109.743 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -90.32 150.59 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 18.8 mtpp -87.09 -178.03 6.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.926 -1.109 . . . . 0.0 110.608 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 29.7 p -57.1 149.05 20.21 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 111.571 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.16 -30.37 2.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 15' ' ' THR . 43.1 mp0 -76.15 154.17 35.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.845 -1.385 . . . . 0.0 109.296 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -157.43 138.24 13.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.066 -1.022 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -99.37 134.34 42.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 20' ' ' ARG . 5.2 mmm-85 -87.54 176.02 7.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -21.33 63.56 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -83.52 -7.27 59.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.618 -0.676 . . . . 0.0 110.527 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.11 -28.46 13.84 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 120.97 -1.081 . . . . 0.0 111.068 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -57.13 154.33 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.853 -1.381 . . . . 0.0 109.616 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.63 169.85 9.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 109.731 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 tt -154.83 133.3 11.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.456 -0.777 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.96 146.41 49.08 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -118.92 136.38 54.09 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.653 -0.654 . . . . 0.0 110.606 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.551 ' C ' HD12 ' A' ' 30' ' ' ILE . 7.3 p90 -148.12 -171.9 3.94 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.365 -0.834 . . . . 0.0 110.287 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.551 HD12 ' C ' ' A' ' 29' ' ' TYR . 1.7 mp -106.64 129.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.9 p30 -86.47 -171.66 3.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.189 -0.944 . . . . 0.0 109.6 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.76 19.89 0.19 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.881 -1.137 . . . . 0.0 109.291 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 10.7 m-85 -118.29 -15.05 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.337 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.21 64.56 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.6 147.94 50.6 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.183 -1.186 . . . . 0.0 109.583 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.8 140.07 34.73 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.014 1.81 . . . . 0.0 112.36 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.682 ' N ' HE21 ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.0 164.65 26.51 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 23.2 m-85 -128.65 141.41 51.35 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.17 -0.957 . . . . 0.0 109.271 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.85 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -122.52 154.89 37.26 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.702 0.763 . . . . 0.0 110.113 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -171.26 143.6 1.9 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.999 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -97.17 18.25 15.38 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.81 144.72 31.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.324 -0.86 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 59' ' ' SER . 45.1 tp -94.25 -43.92 8.21 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.24 167.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -12.55 61.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.488 -0.757 . . . . 0.0 111.261 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.0 m -86.79 -9.6 55.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.903 -1.123 . . . . 0.0 110.098 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.28 167.19 16.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -140.2 118.85 12.34 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.92 148.24 86.88 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.38 157.1 62.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.183 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.96 150.5 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.311 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.64 -41.62 2.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -98.13 132.04 44.0 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.493 -1.004 . . . . 0.0 108.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.469 ' H ' ' CD ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.86 157.66 31.3 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.086 -1.009 . . . . 0.0 109.896 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -53.78 159.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.4 m -148.6 176.19 10.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 109.192 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.61 126.66 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 31.5 t -55.63 148.53 15.83 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.16 -0.963 . . . . 0.0 108.481 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 mt -58.52 -52.43 65.68 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.461 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 16.1 mmt180 -49.36 -37.24 24.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.704 -1.247 . . . . 0.0 108.989 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.35 -43.5 60.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.279 -0.888 . . . . 0.0 109.364 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -65.06 -44.36 89.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.494 -0.754 . . . . 0.0 109.613 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.09 -47.06 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.67 -46.58 88.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.099 -1.0 . . . . 0.0 109.851 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.47 -40.05 70.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.234 -0.916 . . . . 0.0 110.843 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 71' ' ' ILE . 40.7 mt -66.4 -45.24 80.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 112.082 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.42 -24.74 57.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.27 -1.519 . . . . 0.0 110.263 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -77.43 -39.75 45.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.08 -1.012 . . . . 0.0 110.725 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.86 -18.83 38.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.087 -1.008 . . . . 0.0 109.933 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.514 HD13 ' O ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -78.99 -36.65 18.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.702 -0.623 . . . . 0.0 109.751 -178.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -147.62 129.24 15.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.09 -1.006 . . . . 0.0 108.941 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.698 -0.627 . . . . 0.0 110.088 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.4 mtpp -82.54 168.87 16.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.4 -0.812 . . . . 0.0 110.003 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.4 ' HG2' ' NH1' ' A' ' 5' ' ' ARG . 8.2 ptt-85 -82.17 164.14 21.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.227 -0.92 . . . . 0.0 110.362 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.6 mtm-85 -138.76 160.22 40.2 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 43.6 p-10 -76.83 -175.08 3.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.042 . . . . 0.0 109.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.58 -6.16 3.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.65 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -104.77 -81.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 0.0 109.404 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 177.72 2.81 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 17.5 ptt180 -86.96 132.03 33.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.082 -1.246 . . . . 0.0 108.584 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 131.86 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.46 163.01 16.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 175.98 7.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.098 -1.001 . . . . 0.0 109.783 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -60.96 130.32 45.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.859 -0.526 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.58 -37.29 3.42 Favored Glycine 0 N--CA 1.501 2.973 0 O-C-N 121.218 -0.926 . . . . 0.0 111.892 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 59.1 mp0 -72.62 150.58 42.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.638 -1.507 . . . . 0.0 110.265 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -155.8 148.39 23.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.316 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -104.8 132.93 50.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.963 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -85.42 170.9 12.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 109.632 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -68.68 -18.49 64.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.15 -21.31 36.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 110.359 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.53 3.86 Favored Glycine 0 N--CA 1.502 3.082 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -61.06 139.64 58.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.124 -1.221 . . . . 0.0 109.191 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 86.6 m-85 -85.73 170.3 12.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.835 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.604 HD13 ' CE2' ' A' ' 40' ' ' TYR . 41.4 tp -151.46 128.15 10.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -129.88 142.95 50.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.57 142.08 47.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.569 -0.707 . . . . 0.0 110.247 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.625 ' OH ' HD12 ' A' ' 67' ' ' LEU . 9.8 p90 -149.09 -171.41 3.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.0 109.53 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.11 134.85 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.261 -0.899 . . . . 0.0 110.221 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.595 ' OD2' ' NE2' ' A' ' 37' ' ' GLN . 12.5 m-20 -87.05 175.25 8.2 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.862 -1.149 . . . . 0.0 110.392 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.644 ' H ' HD12 ' A' ' 71' ' ' ILE . 47.4 m -70.76 -2.71 15.58 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 11.0 m-85 -98.67 -11.59 21.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.589 -0.694 . . . . 0.0 109.357 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.79 -5.88 79.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.407 ' HG3' ' NE2' ' A' ' 37' ' ' GLN . 12.9 pt-20 -86.75 152.08 53.54 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.159 -1.201 . . . . 0.0 109.328 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.25 155.1 28.92 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.137 1.891 . . . . 0.0 112.441 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.595 ' NE2' ' OD2' ' A' ' 31' ' ' ASP . 6.0 mp0 -148.86 160.14 43.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.217 -0.927 . . . . 0.0 109.235 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HB3' HD11 ' A' ' 26' ' ' LEU . 51.8 m-85 -136.66 148.97 47.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 26' ' ' LEU . 11.2 m -122.24 145.37 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.604 ' CE2' HD13 ' A' ' 26' ' ' LEU . 55.6 m-85 -116.03 151.51 35.36 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 t -169.64 145.54 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.28 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.72 9.07 36.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -132.32 133.64 44.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD11 ' NH2' ' A' ' 61' ' ' ARG . 35.1 tp -88.99 -42.96 11.47 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.67 151.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.42 -7.08 3.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.109 -0.995 . . . . 0.0 111.156 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.1 p -90.34 -11.8 39.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.749 -1.22 . . . . 0.0 109.774 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.62 172.49 11.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.181 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.33 135.03 33.34 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.24 147.39 60.53 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.745 -1.222 . . . . 0.0 110.451 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.61 145.7 71.02 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.13 1.887 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.72 144.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 110.573 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.12 -32.62 7.3 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -97.07 139.11 33.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.159 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.62 151.8 34.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -0.966 . . . . 0.0 109.771 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.7 150.53 15.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.141 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.7 p -147.32 161.98 39.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.046 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.69 126.81 40.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.0 m -56.33 160.94 2.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.157 -0.964 . . . . 0.0 108.801 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.04 -47.6 73.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.748 -1.22 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' NH2' HD11 ' A' ' 44' ' ' LEU . 5.1 mmt-85 -41.54 -53.01 3.58 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.401 -0.812 . . . . 0.0 110.28 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -69.01 -34.43 75.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.088 -1.008 . . . . 0.0 108.662 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -68.77 -41.87 78.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -50.15 -51.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.138 -0.976 . . . . 0.0 109.266 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.7 70.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.852 -1.155 . . . . 0.0 109.525 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.93 -44.87 60.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.91 . . . . 0.0 111.481 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.625 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.5 mm? -69.54 -44.06 71.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.23 -1.544 . . . . 0.0 110.899 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -73.26 -18.01 61.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.762 -1.836 . . . . 0.0 110.886 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -79.46 -63.65 1.37 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.572 -1.33 . . . . 0.0 110.905 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.85 -27.78 31.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.505 -1.372 . . . . 0.0 107.824 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.644 HD12 ' H ' ' A' ' 32' ' ' SER . 36.7 mm -81.55 113.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.09 15.5 4.2 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.296 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 t0 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 120.913 -1.117 . . . . 0.0 109.423 -179.533 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -155.28 -141.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -83.34 150.42 26.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.943 -1.098 . . . . 0.0 109.536 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -136.35 177.84 7.53 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.327 -0.858 . . . . 0.0 109.849 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.57 -159.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.407 -0.808 . . . . 0.0 109.743 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.112 -0.992 . . . . 0.0 110.261 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -92.18 -86.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.041 . . . . 0.0 109.496 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.1 22.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.551 ' NH1' ' OD2' ' A' ' 48' ' ' ASP . 67.6 mtm180 -88.72 135.73 33.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.795 -1.415 . . . . 0.0 110.578 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.8 mm -76.37 114.46 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 140.45 33.14 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -86.39 179.01 6.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.963 -1.085 . . . . 0.0 111.028 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -52.13 155.12 2.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.418 0.628 . . . . 0.0 109.84 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.68 -44.75 2.06 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -70.28 147.17 50.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -1.231 . . . . 0.0 109.272 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -155.24 157.5 37.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.649 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.0 tp-100 -107.28 123.12 47.85 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.388 -0.82 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.539 ' NH2' ' OH ' ' A' ' 40' ' ' TYR . 18.3 mtt180 -83.62 169.49 15.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.201 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.877 . . . . 0.0 109.622 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' A' ' 24' ' ' ARG . 1.4 p30 -91.43 -26.58 18.78 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.97 -1.081 . . . . 0.0 109.98 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.42 -36.25 2.96 Favored Glycine 0 N--CA 1.505 3.295 0 O-C-N 121.268 -0.895 . . . . 0.0 111.443 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.531 ' NH2' ' OD2' ' A' ' 22' ' ' ASP . 3.3 ptt-85 -60.57 132.92 55.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.604 -1.527 . . . . 0.0 109.438 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 86.2 m-85 -87.04 168.93 12.86 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pp -147.4 138.22 23.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -125.31 156.97 37.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.662 -0.649 . . . . 0.0 109.452 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -117.68 138.97 51.64 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 16.7 p90 -148.83 -165.89 2.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.984 -1.072 . . . . 0.0 109.961 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.439 ' O ' ' CD2' ' A' ' 29' ' ' TYR . 1.4 mp -107.48 136.37 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 O-C-N 121.315 -0.866 . . . . 0.0 110.461 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.64 ' CG ' HE21 ' A' ' 37' ' ' GLN . 17.0 m-20 -80.56 173.01 13.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.006 -1.059 . . . . 0.0 109.494 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -9.59 10.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 11.5 m-85 -104.21 -6.76 20.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.471 -0.768 . . . . 0.0 110.824 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.26 -4.6 64.87 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.028 -1.045 . . . . 0.0 110.539 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.02 150.54 47.8 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.832 -1.393 . . . . 0.0 110.102 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.55 152.65 23.12 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.268 1.979 . . . . 0.0 113.554 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.64 HE21 ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -157.83 179.89 8.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.75 149.58 50.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.857 -1.152 . . . . 0.0 110.179 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.02 162.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.539 ' OH ' ' NH2' ' A' ' 20' ' ' ARG . 84.1 m-85 -137.0 153.83 50.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.256 -0.902 . . . . 0.0 110.767 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -168.23 149.75 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -86.97 3.68 44.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.337 -0.852 . . . . 0.0 109.302 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -131.95 153.13 50.61 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.392 -0.818 . . . . 0.0 109.459 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 59' ' ' SER . 19.5 tp -93.36 -51.14 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.348 0.594 . . . . 0.0 109.975 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.51 175.62 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.42 0.628 . . . . 0.0 110.5 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.86 63.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 111.095 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -85.16 -8.08 58.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.817 -1.177 . . . . 0.0 110.309 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 59.8 m-20 -74.46 174.38 9.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 109.819 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -139.68 149.51 43.76 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -80.85 138.81 49.99 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.269 -0.894 . . . . 0.0 109.934 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -46.18 140.82 10.47 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.923 1.749 . . . . 0.0 111.706 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.6 132.13 17.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.14 -30.75 6.6 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -94.54 145.5 24.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -1.083 . . . . 0.0 108.706 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HD3' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.6 150.66 34.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 108.726 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -49.53 162.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.01 -1.056 . . . . 0.0 109.845 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 38.2 t -154.78 173.64 16.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.155 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.473 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 5.9 mm -92.1 132.16 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.467 -0.77 . . . . 0.0 109.317 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 45.9 t -55.78 164.11 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.283 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 43' ' ' LYS . 4.5 mp -71.32 -57.48 4.43 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.521 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -45.82 -41.92 11.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -69.06 -41.88 77.02 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.34 -0.944 . . . . 0.0 108.877 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -67.16 -42.03 84.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.938 . . . . 0.0 109.954 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.76 -49.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.76 -1.213 . . . . 0.0 108.635 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.61 83.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.0 110.292 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -70.97 -43.12 68.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.89 . . . . 0.0 111.171 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.453 HD22 ' OH ' ' A' ' 29' ' ' TYR . 11.0 mt -67.66 -44.06 78.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 111.545 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.438 ' O ' ' O ' ' A' ' 72' ' ' HIS . 89.5 mt-30 -71.99 -38.74 69.63 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.815 -1.178 . . . . 0.0 110.539 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -74.88 -42.0 58.7 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.407 -0.808 . . . . 0.0 110.59 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.05 -36.4 81.51 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.193 -0.942 . . . . 0.0 111.307 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.448 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 8.4 pt -82.44 -42.13 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.0 110.258 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.448 ' CG ' ' O ' ' A' ' 71' ' ' ILE . 62.1 m80 -157.83 154.0 27.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.085 -1.01 . . . . 0.0 109.704 179.795 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -87.42 74.88 9.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -94.7 -148.03 0.27 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 110.02 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.551 ' CG ' HH11 ' A' ' 6' ' ' ARG . 1.7 mtt-85 -132.61 163.65 28.42 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -84.66 -171.66 3.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -66.96 -14.87 63.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.882 . . . . 0.0 109.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -95.04 -5.07 45.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -0.894 . . . . 0.0 108.911 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.82 58.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' CG ' ' A' ' 48' ' ' ASP . 17.9 mmt180 -90.67 142.12 28.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -1.183 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mm -82.55 119.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 108.004 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 13' ' ' LEU . 4.0 mp -90.75 145.06 25.11 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -87.6 179.28 6.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.052 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -57.52 136.74 56.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.256 -0.902 . . . . 0.0 110.036 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.27 -56.48 1.23 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -49.3 148.69 2.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 110.021 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -157.13 156.84 33.39 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -99.74 145.17 27.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.027 -1.046 . . . . 0.0 110.493 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -89.59 149.72 22.72 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.676 ' H ' ' CD ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -58.36 -20.57 44.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -89.15 -11.23 44.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 110.43 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.28 -35.0 5.24 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.56 HH21 ' HE1' ' A' ' 42' ' ' TRP . 2.4 ptp180 -59.12 143.96 47.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.412 . . . . 0.0 108.738 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -90.73 162.68 14.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.915 . . . . 0.0 110.183 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -147.33 140.42 25.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.666 0.746 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 39' ' ' VAL . 86.4 t80 -134.47 151.98 51.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -120.04 142.11 49.13 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.549 -0.719 . . . . 0.0 109.286 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -140.86 163.1 33.86 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.92 138.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.153 -0.967 . . . . 0.0 109.969 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' CG ' ' NE2' ' A' ' 37' ' ' GLN . 45.3 m-20 -84.12 161.68 20.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.6 p -63.24 -3.25 1.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -99.75 -15.96 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.379 -0.826 . . . . 0.0 109.085 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.32 56.89 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -80.59 156.29 73.22 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.499 -1.589 . . . . 0.0 107.125 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -93.53 141.08 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.563 1.508 . . . . 0.0 111.101 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.493 ' NE2' ' CG ' ' A' ' 31' ' ' ASP . 2.8 mp0 -130.02 154.64 47.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.539 -0.726 . . . . 0.0 109.126 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.2 147.89 52.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 27' ' ' TYR . 2.0 m -123.11 156.05 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.442 -0.786 . . . . 0.0 109.037 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 64.4 m-85 -129.9 156.12 44.93 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.427 -0.795 . . . . 0.0 109.696 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -174.31 146.31 1.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.592 -0.693 . . . . 0.0 109.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.56 ' HE1' HH21 ' A' ' 24' ' ' ARG . 54.7 m95 -90.46 3.49 53.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -123.77 142.5 51.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -92.42 -44.49 8.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.543 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 46' ' ' ALA . 2.1 t -121.7 174.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -72.74 -15.14 61.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -92.47 -8.52 44.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.049 -1.032 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.474 ' CG ' ' NH2' ' A' ' 11' ' ' ARG . 1.1 m-20 -72.54 168.84 17.75 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.278 -0.888 . . . . 0.0 109.805 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -134.73 144.64 47.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 50' ' ' VAL . 32.9 m -81.21 122.62 81.57 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.88 151.79 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.509 1.473 . . . . 0.0 112.025 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.85 139.58 7.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.56 -30.88 9.31 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 13.0 mptt -93.46 127.26 39.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -1.15 . . . . 0.0 108.242 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -78.01 149.74 33.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.579 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 53.1 t0 -40.06 147.03 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.789 -0.569 . . . . 0.0 109.902 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.5 p -153.66 164.86 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG2' ' CD ' ' A' ' 62' ' ' GLU . 20.3 mt -83.29 129.3 37.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.634 0.731 . . . . 0.0 110.032 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 92.4 p -60.84 173.14 0.8 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 63' ' ' LYS . 96.6 mt -83.92 -59.71 2.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.867 -1.146 . . . . 0.0 110.071 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' LEU . 37.6 mtt180 -40.01 -35.0 0.33 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' CD ' ' CG2' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -72.9 -40.89 65.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.736 -1.227 . . . . 0.0 108.582 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 60' ' ' LEU . 46.2 mttm -63.91 -46.46 84.72 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.505 -0.747 . . . . 0.0 109.719 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -53.44 -49.41 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.66 94.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -78.73 -44.18 24.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.06 -1.025 . . . . 0.0 112.501 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -66.71 -38.82 87.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.127 -1.608 . . . . 0.0 111.432 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -70.67 -50.07 40.5 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 120.477 -1.389 . . . . 0.0 110.612 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.31 -14.64 58.87 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.762 -1.211 . . . . 0.0 112.13 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -84.27 -13.12 53.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.282 -1.511 . . . . 0.0 110.505 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 mm -85.63 -37.75 12.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.106 -0.996 . . . . 0.0 109.399 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.5 m170 -85.41 -175.69 5.79 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.115 -0.991 . . . . 0.0 109.554 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -84.66 149.48 25.79 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -82.68 140.61 33.03 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.905 -1.122 . . . . 0.0 109.436 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.478 ' HG2' HD13 ' A' ' 12' ' ' ILE . 65.8 mtm180 -140.29 173.96 10.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.284 -0.885 . . . . 0.0 109.216 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 39.4 p-10 -80.57 -169.23 2.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.54 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -70.24 -21.11 63.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 108.831 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 9' ' ' ARG . 22.5 mmm-85 -95.81 1.89 53.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.457 -0.777 . . . . 0.0 110.42 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 82.51 20.64 61.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.543 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -86.97 149.29 24.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.344 . . . . 0.0 108.567 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.478 HD13 ' HG2' ' A' ' 6' ' ' ARG . 6.5 mm -90.6 119.37 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.422 -0.799 . . . . 0.0 109.174 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.794 HD22 ' N ' ' A' ' 13' ' ' LEU . 1.7 mm? -89.45 136.68 32.89 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 14' ' ' LYS . 8.9 mtmp? -86.38 -174.15 4.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.876 -1.14 . . . . 0.0 110.447 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 17' ' ' GLU . 8.8 m -51.55 138.99 21.29 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.753 -0.592 . . . . 0.0 110.206 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.04 -42.18 0.76 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 15' ' ' THR . 85.7 mt-10 -66.02 140.18 58.26 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.043 -1.269 . . . . 0.0 109.845 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 92.4 p -158.22 164.47 36.47 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.606 ' NE2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -92.8 150.44 20.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.888 -1.132 . . . . 0.0 109.393 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.606 ' O ' ' NE2' ' A' ' 19' ' ' GLN . 2.2 ttt180 -89.79 161.77 15.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.336 -0.852 . . . . 0.0 109.429 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -57.36 -30.06 64.55 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.906 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -84.92 -44.22 13.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 0.0 110.16 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.53 -31.81 1.02 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' CZ ' ' NH1' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -61.26 144.61 53.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.897 -1.355 . . . . 0.0 108.985 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -85.7 164.73 17.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.32 150.94 28.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 109.708 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.502 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 63.4 t80 -134.96 169.2 17.77 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 26.8 tttm -128.09 138.74 52.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.298 -0.876 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.434 ' C ' HD12 ' A' ' 30' ' ' ILE . 8.3 p90 -144.82 159.8 42.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.481 HD11 ' NZ ' ' A' ' 28' ' ' LYS . 1.4 mp -100.34 136.31 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.34 -0.85 . . . . 0.0 109.165 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 33' ' ' PHE . 54.8 m-20 -81.5 166.76 20.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.164 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -60.55 1.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -1.0 . . . . 0.0 111.068 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 9.6 m-85 -101.47 -21.17 14.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.924 -1.11 . . . . 0.0 108.557 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.52 39.12 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 15.1 pt-20 -84.82 150.13 55.26 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.912 -1.346 . . . . 0.0 109.961 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.7 139.66 16.0 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.78 2.32 . . . . 0.0 113.527 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.415 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 11.9 mp0 -137.88 161.33 36.9 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.28 -0.888 . . . . 0.0 108.827 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -132.11 150.1 52.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.25 151.05 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -126.45 155.03 42.88 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.333 -0.854 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.1 t -170.06 152.66 4.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.657 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -93.99 16.54 14.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 144.24 32.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' ' OG ' ' A' ' 59' ' ' SER . 21.5 tp -96.53 -44.49 7.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.41 HG12 ' NH1' ' A' ' 61' ' ' ARG . 15.7 m -119.79 153.93 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 121.547 0.689 . . . . 0.0 109.261 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.45 -11.75 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.72 . . . . 0.0 110.904 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 -8.28 39.17 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.73 -1.231 . . . . 0.0 111.222 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.0 166.36 21.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.903 -1.123 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 49' ' ' ARG . 4.0 tpt180 -128.24 124.01 35.61 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.469 -0.77 . . . . 0.0 109.093 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.41 142.22 40.21 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.847 . . . . 0.0 109.971 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -48.59 147.87 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.284 1.323 . . . . 0.0 110.823 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.23 -37.3 46.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.853 -1.154 . . . . 0.0 109.595 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.25 -31.24 56.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -98.35 135.16 40.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -1.161 . . . . 0.0 108.587 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -79.04 166.55 22.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 109.74 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -65.51 159.27 24.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.193 -0.942 . . . . 0.0 110.021 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.8 p -161.54 178.34 9.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.6 mt -87.48 134.12 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 21.9 t -61.62 161.39 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 109.883 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 64' ' ' ILE . 84.1 mt -64.8 -48.72 73.4 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.948 -1.095 . . . . 0.0 109.644 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -48.09 -51.39 24.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.793 -1.192 . . . . 0.0 109.133 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -70.01 -38.12 75.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.59 -45.62 86.18 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.712 -1.243 . . . . 0.0 109.149 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -48.49 -54.29 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -30.2 69.74 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.171 -0.956 . . . . 0.0 109.687 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.91 -42.91 76.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.148 -0.97 . . . . 0.0 111.542 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.4 mm? -69.21 -51.24 39.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.846 -1.159 . . . . 0.0 111.418 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -71.37 -35.25 71.05 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 112.075 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -76.42 -21.44 55.96 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.328 -1.483 . . . . 0.0 111.29 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -82.17 -47.02 13.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.727 -1.233 . . . . 0.0 111.597 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 pt -86.53 -42.43 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.016 . . . . 0.0 111.05 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.37 -39.51 12.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.241 -0.912 . . . . 0.0 109.212 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.553 -0.717 . . . . 0.0 110.4 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 11.2 mp0 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.84 152.89 22.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.098 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -84.45 138.56 32.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.062 -1.024 . . . . 0.0 109.164 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -143.79 173.14 11.94 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 53.6 p-10 -87.13 -165.5 1.31 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.884 -1.135 . . . . 0.0 109.996 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -66.67 -17.92 65.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.699 -0.625 . . . . 0.0 109.403 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' CG ' HH11 ' A' ' 9' ' ' ARG . 4.4 mtt-85 -103.98 -80.13 0.53 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.382 -0.824 . . . . 0.0 109.162 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -178.92 34.7 0.07 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -90.56 130.95 36.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -1.055 . . . . 0.0 110.178 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.6 mm -79.91 107.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.3 mp -88.29 157.49 18.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.93 -1.106 . . . . 0.0 110.481 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -87.82 170.48 11.15 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 m -52.75 138.63 28.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.141 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.73 -57.75 1.87 Allowed Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.111 -0.993 . . . . 0.0 110.74 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -51.56 141.88 15.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 110.081 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.2 m -152.21 149.81 29.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.617 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.4 tp-100 -95.26 137.99 33.56 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.256 -0.903 . . . . 0.0 109.727 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.632 ' NH1' ' NH2' ' A' ' 24' ' ' ARG . 4.7 mtp180 -81.84 -177.04 6.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -76.71 -24.97 53.09 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.825 -0.547 . . . . 0.0 110.042 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' OD2' ' NE ' ' A' ' 24' ' ' ARG . 38.6 p-10 -89.98 -28.53 19.06 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.753 -1.217 . . . . 0.0 111.407 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 19' ' ' GLN . . . 136.05 -26.24 3.13 Favored Glycine 0 N--CA 1.503 3.157 0 O-C-N 120.757 -1.214 . . . . 0.0 111.382 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.632 ' NH2' ' NH1' ' A' ' 20' ' ' ARG . 8.0 ptt180 -65.59 135.99 55.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.364 -1.668 . . . . 0.0 108.714 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.617 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 72.0 m-85 -72.67 173.55 8.84 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 40' ' ' TYR . 25.5 tp -152.4 126.89 9.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.5 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -129.4 151.87 49.57 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HZ3' ' C ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -124.55 135.03 52.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.33 -0.856 . . . . 0.0 110.055 -178.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.635 ' OH ' HD12 ' A' ' 67' ' ' LEU . 17.4 p90 -139.17 164.88 28.64 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.316 -0.865 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.428 HG13 ' NZ ' ' A' ' 28' ' ' LYS . 87.1 mt -105.41 137.71 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.357 -0.84 . . . . 0.0 109.0 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' CG ' ' A' ' 35' ' ' GLU . 5.0 p30 -83.39 175.39 9.88 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.143 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -66.2 6.06 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.936 -1.103 . . . . 0.0 110.882 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -102.36 -18.93 15.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.933 -1.105 . . . . 0.0 110.118 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.24 -9.4 45.96 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 121.11 -0.994 . . . . 0.0 110.651 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' CG ' ' OD2' ' A' ' 31' ' ' ASP . 17.4 pt-20 -87.9 146.15 38.13 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.953 -1.322 . . . . 0.0 109.137 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.87 136.65 15.16 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.481 2.121 . . . . 0.0 112.679 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.19 174.93 6.66 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.268 -0.895 . . . . 0.0 109.073 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.95 146.32 39.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.561 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -131.99 143.56 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.646 -0.659 . . . . 0.0 109.273 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' A' ' 26' ' ' LEU . 61.2 m-85 -124.15 160.0 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.518 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 153.8 5.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -98.09 14.81 26.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -140.8 146.94 38.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.089 -1.007 . . . . 0.0 109.136 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.7 tp -89.74 -49.3 6.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 109.123 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 m -118.97 171.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.95 -17.54 62.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.359 -0.838 . . . . 0.0 111.893 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.4 t -87.92 -4.86 58.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.626 -1.296 . . . . 0.0 110.629 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.7 -175.08 1.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 0.0 110.55 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -142.03 133.76 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.9 m -73.53 150.59 89.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.073 -1.017 . . . . 0.0 108.426 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.64 148.07 92.45 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.903 1.735 . . . . 0.0 111.723 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.95 143.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.411 -0.805 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.43 -29.03 10.17 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -94.87 143.08 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.317 . . . . 0.0 109.819 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.444 ' HG2' HH11 ' A' ' 55' ' ' ARG . 8.1 ptt-85 -78.67 154.92 29.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.5 155.52 15.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.061 -1.024 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.1 m -149.11 177.85 9.24 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.0 mt -93.55 135.68 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.99 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 p -57.97 174.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 108.874 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 60' ' ' LEU . 4.3 mp -77.93 -54.25 6.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.868 -1.145 . . . . 0.0 110.234 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -47.01 -40.8 15.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.447 -0.783 . . . . 0.0 110.282 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -70.49 -38.46 74.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 66' ' ' GLU . 41.9 mttt -67.26 -50.52 60.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 108.767 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 63' ' ' LYS . 1.5 mp -40.0 -54.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.618 -0.676 . . . . 0.0 109.437 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.46 73.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 109.691 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 63' ' ' LYS . 11.0 tp10 -76.42 -41.66 46.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.396 -0.815 . . . . 0.0 111.738 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.6 mm? -62.79 -48.44 79.13 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.585 -1.322 . . . . 0.0 111.284 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -73.01 -35.38 66.8 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.009 -1.057 . . . . 0.0 111.045 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -79.0 -27.77 43.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.949 -1.094 . . . . 0.0 112.608 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -96.2 -27.42 15.03 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.667 -1.27 . . . . 0.0 111.127 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 67' ' ' LEU . 4.4 mm -85.06 73.47 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.965 -1.084 . . . . 0.0 109.779 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -156.45 -42.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 108.93 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.549 -0.72 . . . . 0.0 109.318 -179.538 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.303 0.573 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.11 44.24 1.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.129 -0.982 . . . . 0.0 108.885 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -85.58 155.95 20.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.971 -1.08 . . . . 0.0 109.309 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 70.1 mtt180 -138.01 160.51 39.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.299 -0.875 . . . . 0.0 109.327 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 6' ' ' ARG . 67.7 m-20 -137.56 -103.72 0.19 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.363 -0.836 . . . . 0.0 112.378 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -66.46 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -94.68 27.8 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.078 -1.014 . . . . 0.0 112.097 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.69 29.5 51.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -81.21 141.04 34.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.401 -1.058 . . . . 0.0 108.606 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.8 mm -86.21 98.36 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 109.681 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -91.57 151.5 20.7 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -89.56 -178.84 5.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.005 -1.059 . . . . 0.0 110.941 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 t -55.6 156.44 4.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.8 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.88 -36.62 3.26 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -79.65 159.76 26.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.886 -1.361 . . . . 0.0 110.174 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -160.41 166.33 29.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.892 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -104.22 148.01 26.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.552 HH21 HH11 ' A' ' 24' ' ' ARG . 9.3 mmm180 -90.76 168.59 11.63 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.713 0.768 . . . . 0.0 110.522 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -67.89 -27.51 66.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.393 -0.817 . . . . 0.0 109.606 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.5 p30 -94.99 -28.61 15.05 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.957 . . . . 0.0 110.949 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 136.5 -26.28 3.06 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.648 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.552 HH11 HH21 ' A' ' 20' ' ' ARG . 0.4 OUTLIER -60.0 145.87 44.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.375 -1.662 . . . . 0.0 109.256 -179.164 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -79.62 167.96 20.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.093 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.455 HD12 ' CE2' ' A' ' 40' ' ' TYR . 1.2 tt -153.02 129.92 10.98 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.873 0.844 . . . . 0.0 110.028 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 39' ' ' VAL . 92.1 t80 -136.42 154.19 50.87 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -127.3 143.62 51.2 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.007 -1.058 . . . . 0.0 110.05 -178.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.426 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 12.2 p90 -137.06 170.63 15.78 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.6 mm -99.88 135.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.15 -0.969 . . . . 0.0 109.799 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 33' ' ' PHE . 88.2 m-20 -81.71 162.98 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.187 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.1 p -64.1 0.74 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.2 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' ASP . 3.6 m-85 -100.66 -20.43 15.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.7 36.42 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -86.12 148.62 48.14 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.847 -1.384 . . . . 0.0 109.663 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.65 142.45 10.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.947 1.765 . . . . 0.0 112.414 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -130.2 167.78 17.88 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -134.57 143.45 47.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.394 -0.816 . . . . 0.0 110.267 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -113.06 156.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.455 ' CE2' HD12 ' A' ' 26' ' ' LEU . 95.0 m-85 -133.31 147.27 51.87 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 t -172.11 148.61 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.951 . . . . 0.0 109.615 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -91.54 16.25 10.81 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.342 -0.849 . . . . 0.0 108.856 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 47.6 mtmt -134.41 143.67 47.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.351 -0.843 . . . . 0.0 110.153 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -94.2 -44.08 8.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 46' ' ' ALA . 1.7 t -116.41 176.7 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-O 121.379 0.609 . . . . 0.0 109.438 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -79.53 -15.06 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 110.886 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.5 p -92.91 -14.34 27.73 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.791 -1.193 . . . . 0.0 111.453 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.17 169.73 11.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.713 -1.242 . . . . 0.0 110.481 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -123.58 147.92 46.86 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.517 0.675 . . . . 0.0 109.209 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.14 147.15 60.25 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.424 -0.797 . . . . 0.0 110.063 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.15 140.12 51.55 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.297 1.331 . . . . 0.0 110.834 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.94 149.0 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.886 -1.134 . . . . 0.0 109.588 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.17 -20.27 26.66 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HZ2' ' HB3' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -98.31 137.89 36.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -1.088 . . . . 0.0 108.991 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -76.22 167.8 21.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -60.15 161.91 6.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.423 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 77.0 m -151.19 151.58 32.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.1 mt -81.29 134.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.87 -1.144 . . . . 0.0 109.519 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 150.73 28.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 110.655 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.59 -64.72 0.73 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -41.58 -48.35 3.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.587 . . . . 0.0 111.73 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.45 -33.12 73.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.53 -1.356 . . . . 0.0 109.9 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -68.5 -42.19 78.93 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 109.745 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.81 -56.64 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.383 -0.823 . . . . 0.0 110.51 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.76 87.49 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.318 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -75.01 -28.75 60.62 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 111.477 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -70.25 -53.13 18.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.56 -1.338 . . . . 0.0 111.585 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -69.01 -27.26 65.53 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.256 -1.528 . . . . 0.0 109.589 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -78.96 -23.31 44.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.189 -0.944 . . . . 0.0 110.298 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -99.15 -18.44 17.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.893 -1.129 . . . . 0.0 111.135 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 71' ' ' ILE . 4.7 mm -87.96 69.48 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.038 -1.039 . . . . 0.0 110.642 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -158.18 13.52 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.021 . . . . 0.0 109.009 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.601 179.704 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -149.08 161.16 42.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 5' ' ' ARG . 27.2 mtm-85 -82.09 140.38 33.88 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -138.57 169.61 17.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.896 0.855 . . . . 0.0 110.756 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 40.7 p-10 -93.8 -168.2 1.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.627 0.727 . . . . 0.0 110.378 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -66.27 -14.91 62.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.476 -0.765 . . . . 0.0 110.481 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -99.86 -13.58 19.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.352 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.26 14.98 39.89 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 48' ' ' ASP . 30.0 mtt180 -84.07 135.3 34.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.157 . . . . 0.0 109.323 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.8 mt -84.27 111.4 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 109.192 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 11' ' ' ARG . 4.8 mp -94.94 157.33 15.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -92.26 179.04 5.67 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.018 -1.051 . . . . 0.0 109.968 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.4 m -54.01 146.23 14.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.439 -0.788 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.08 -52.67 4.75 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -52.56 149.84 5.55 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.134 -1.215 . . . . 0.0 109.28 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 t -157.1 161.72 39.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.596 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.3 tp-100 -105.17 131.41 52.69 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 22' ' ' ASP . 21.3 ttt180 -89.53 162.5 15.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.373 -0.829 . . . . 0.0 109.362 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -66.07 -22.3 66.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 95.8 m-20 -84.75 -7.99 59.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.4 -0.813 . . . . 0.0 109.329 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.31 8.83 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -62.11 137.7 58.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.946 -1.326 . . . . 0.0 109.466 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.596 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 67.0 m-85 -80.41 173.15 12.88 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.512 -0.743 . . . . 0.0 109.548 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 26' ' ' LEU . 1.2 tt -156.07 139.24 15.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.326 -0.858 . . . . 0.0 109.874 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -136.57 155.25 50.19 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.23 -0.919 . . . . 0.0 109.275 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -119.97 138.97 53.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.474 -0.766 . . . . 0.0 110.513 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.436 ' CE1' HD13 ' A' ' 67' ' ' LEU . 9.7 p90 -143.14 165.0 28.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.03 134.84 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 0.0 109.378 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 33' ' ' PHE . 72.1 m-20 -80.11 164.64 23.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 108.401 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.457 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 17.8 t -58.9 0.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.942 -1.099 . . . . 0.0 110.536 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.7 m-85 -101.73 -19.35 15.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.052 -1.03 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.08 46.02 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.41 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 22.9 pt-20 -83.68 147.55 52.44 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.012 -1.287 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -81.4 139.2 11.4 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.473 2.115 . . . . 0.0 113.249 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.41 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 15.0 mp0 -137.5 159.86 40.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -132.14 145.02 51.1 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 149.1 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.443 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 78.5 m-85 -121.18 152.38 38.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.7 t -168.29 145.03 3.94 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 109.314 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.93 11.74 21.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.967 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -135.99 141.22 44.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.548 -0.72 . . . . 0.0 109.809 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.9 tp -89.65 -42.63 11.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.59 173.81 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.97 -14.35 59.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.047 -1.033 . . . . 0.0 110.598 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 p -91.27 -2.78 57.35 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 11' ' ' ARG . 80.5 m-20 -69.51 -174.43 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.661 -1.274 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -149.62 124.97 10.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.506 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 m -82.21 152.96 68.74 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.85 137.86 42.68 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 120.968 1.112 . . . . 0.0 109.978 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.86 -34.92 5.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.106 -0.996 . . . . 0.0 110.478 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.95 -22.27 62.23 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -99.48 140.83 33.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -1.122 . . . . 0.0 110.957 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.496 ' HG2' HH11 ' A' ' 55' ' ' ARG . 2.0 ptt-85 -76.22 153.78 35.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.511 -0.743 . . . . 0.0 109.886 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.4 161.14 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 0.0 109.462 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.5 p -152.03 162.86 40.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.34 -0.85 . . . . 0.0 108.745 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.24 127.91 40.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.056 -1.027 . . . . 0.0 109.771 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.9 p -59.52 169.27 1.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.36 -0.837 . . . . 0.0 109.907 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -79.59 -58.53 3.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -41.45 -43.67 2.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 110.905 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -69.89 -41.38 74.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 0.0 109.433 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -67.99 -44.84 75.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 110.162 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.11 -60.69 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.914 -1.116 . . . . 0.0 109.203 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.01 63.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.942 . . . . 0.0 110.26 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -71.81 -39.04 70.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD13 ' CE1' ' A' ' 29' ' ' TYR . 64.7 mt -67.06 -54.54 20.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.867 -1.145 . . . . 0.0 111.889 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -68.52 -35.16 77.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.347 -1.471 . . . . 0.0 109.478 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -74.54 -27.96 60.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.033 -1.042 . . . . 0.0 110.932 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -99.66 -29.55 12.61 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.701 -1.25 . . . . 0.0 110.807 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.457 ' CG2' ' H ' ' A' ' 32' ' ' SER . 5.6 mm -82.38 -60.88 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.925 -1.109 . . . . 0.0 108.076 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 68' ' ' GLN . 21.0 t-80 -96.35 125.71 41.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.073 -1.017 . . . . 0.0 109.224 -178.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 3.5 pm0 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.516 0.674 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -151.51 -167.02 2.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.235 -0.916 . . . . 0.0 108.913 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 5' ' ' ARG . 0.1 OUTLIER -93.6 137.17 33.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.513 -0.742 . . . . 0.0 109.481 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -138.58 159.8 41.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.457 -0.777 . . . . 0.0 109.84 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 11' ' ' ARG . 8.3 p-10 -88.6 -168.33 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.783 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -67.15 -11.88 58.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.533 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.638 ' CB ' HH12 ' A' ' 11' ' ' ARG . 0.3 OUTLIER -100.2 -73.39 0.64 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.908 -1.12 . . . . 0.0 110.047 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.18 0.86 0.05 OUTLIER Glycine 0 N--CA 1.501 3.012 0 C-N-CA 118.41 -1.852 . . . . 0.0 113.03 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.638 HH12 ' CB ' ' A' ' 9' ' ' ARG . 2.4 mtm-85 -84.46 114.64 22.07 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 119.95 -1.912 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.95 113.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.444 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -91.91 169.47 10.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.42 -0.8 . . . . 0.0 109.716 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -89.16 -177.16 5.35 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.27 1.033 . . . . 0.0 111.054 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 t -56.75 153.62 10.37 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.39 -41.43 1.15 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.792 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.86 136.52 56.96 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.938 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -159.24 154.24 25.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.254 -0.904 . . . . 0.0 108.621 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -109.02 140.93 41.88 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.022 -1.048 . . . . 0.0 110.217 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -84.71 177.21 8.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.571 -0.706 . . . . 0.0 110.022 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -71.54 -14.48 62.11 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -87.83 -20.14 26.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 109.837 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.24 -30.19 8.5 Favored Glycine 0 N--CA 1.501 3.019 0 O-C-N 121.227 -0.92 . . . . 0.0 111.204 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -63.38 140.68 58.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.546 -1.561 . . . . 0.0 109.679 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.47 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 90.8 m-85 -85.07 168.49 14.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.778 . . . . 0.0 109.87 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.765 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 11.9 tp -150.89 127.48 10.81 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.448 0.642 . . . . 0.0 109.576 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.421 ' N ' HD12 ' A' ' 26' ' ' LEU . 79.6 t80 -131.79 156.33 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -127.16 144.11 51.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -0.773 . . . . 0.0 109.861 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.484 ' C ' HD12 ' A' ' 30' ' ' ILE . 12.1 p90 -144.86 161.66 38.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.201 -0.937 . . . . 0.0 108.776 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' C ' ' A' ' 29' ' ' TYR . 1.4 mp -102.86 135.96 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.371 -0.83 . . . . 0.0 108.883 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 60.2 m-20 -81.74 174.26 11.52 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.288 -0.883 . . . . 0.0 109.186 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 71' ' ' ILE . 44.4 t -65.58 -3.47 4.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 109.361 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -96.55 -11.32 25.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 108.91 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.6 -6.17 77.36 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.627 ' HG3' HE22 ' A' ' 37' ' ' GLN . 14.4 pt-20 -84.69 149.47 54.16 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.179 -1.189 . . . . 0.0 109.249 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -82.89 136.51 8.22 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.589 2.193 . . . . 0.0 113.668 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.627 HE22 ' HG3' ' A' ' 35' ' ' GLU . 8.5 mp0 -125.67 164.9 19.61 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.4 149.09 51.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 109.698 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.8 142.68 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.765 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 49.1 m-85 -127.43 156.99 41.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.557 -0.714 . . . . 0.0 109.795 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.5 t -170.91 150.75 3.21 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.488 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -89.38 11.07 20.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 51.7 mtmt -135.64 139.87 44.1 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.501 0.667 . . . . 0.0 110.567 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -92.51 -39.28 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.27 155.36 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.23 -7.67 10.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.181 -0.95 . . . . 0.0 110.972 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.3 p -93.76 -10.47 34.12 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.7 -1.25 . . . . 0.0 111.887 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -71.15 -171.56 0.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.488 -1.382 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -141.99 151.8 42.84 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -79.35 149.69 72.69 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.963 -1.086 . . . . 0.0 109.307 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' ALA . 32.6 Cg_endo -82.09 -112.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.56 2.174 . . . . 0.0 114.498 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -55.0 -149.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.257 -0.902 . . . . 0.0 112.954 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.97 36.1 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 52' ' ' ALA . 11.9 mptt -89.26 130.99 35.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.112 -1.228 . . . . 0.0 108.818 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.06 159.07 28.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 109.978 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 23.1 p-10 -53.71 162.19 0.93 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.677 -0.639 . . . . 0.0 109.851 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 19.8 t -162.97 161.22 25.49 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.494 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 89.3 mt -82.83 137.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.9 p -61.13 159.06 12.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.32 -0.863 . . . . 0.0 109.854 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HA ' ' HZ3' ' A' ' 63' ' ' LYS . 97.2 mt -63.53 -49.1 74.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -45.82 -46.34 15.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.115 -0.99 . . . . 0.0 110.352 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -37.43 75.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.883 -1.136 . . . . 0.0 109.781 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HZ3' ' HA ' ' A' ' 60' ' ' LEU . 2.8 mtmp? -67.61 -44.68 77.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.856 -1.153 . . . . 0.0 110.202 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.5 -53.56 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.956 -1.09 . . . . 0.0 110.145 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.62 79.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.112 . . . . 0.0 110.133 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.19 -45.47 56.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.89 -1.131 . . . . 0.0 110.177 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.29 -44.12 65.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.025 -1.047 . . . . 0.0 110.008 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -68.12 -36.94 80.54 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 120.609 -1.307 . . . . 0.0 109.646 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -85.79 -26.73 25.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.128 -0.982 . . . . 0.0 111.363 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -93.77 -26.11 17.12 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.628 -1.295 . . . . 0.0 111.325 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 32' ' ' SER . 44.1 mm -83.33 -29.96 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.665 -1.272 . . . . 0.0 109.013 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -85.28 -127.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 109.761 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -150.8 123.85 8.76 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.2 ttm-85 -83.68 148.51 27.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.262 -0.898 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -133.17 166.05 23.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.586 -0.697 . . . . 0.0 110.11 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -98.5 -164.39 1.13 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.61 -0.681 . . . . 0.0 109.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -68.65 -12.74 61.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.115 -0.99 . . . . 0.0 110.599 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -96.07 -5.71 40.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.0 -1.063 . . . . 0.0 109.29 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.19 -1.67 69.04 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.281 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.541 HH22 ' CG ' ' A' ' 48' ' ' ASP . 6.8 ptm180 -82.78 136.46 34.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.734 -1.451 . . . . 0.0 109.316 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.8 mt -83.97 110.6 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.149 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.79 161.72 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 77.5 mttt -88.93 -174.3 4.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.842 -1.161 . . . . 0.0 110.831 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 15' ' ' THR . 1.2 t -55.79 162.23 1.86 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.67 -36.94 1.41 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 14' ' ' LYS . 9.5 mp0 -73.72 156.42 37.91 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.919 -1.342 . . . . 0.0 109.303 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -156.96 158.65 37.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 109.423 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -97.05 134.74 40.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 108.735 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -86.47 160.99 18.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.891 -1.13 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.87 -36.49 62.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.584 -0.697 . . . . 0.0 109.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -82.14 -25.29 34.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.171 -0.955 . . . . 0.0 110.515 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.64 -26.9 5.06 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.17 -0.956 . . . . 0.0 110.744 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.699 HH21 ' HE1' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -59.74 148.5 34.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.356 -1.673 . . . . 0.0 108.307 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -87.44 164.42 16.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.232 -0.918 . . . . 0.0 109.187 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -147.74 137.75 22.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -131.6 161.48 32.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 29' ' ' TYR . 4.7 tmtm? -125.13 136.19 53.39 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.251 -0.906 . . . . 0.0 110.79 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 13.6 p90 -139.7 170.08 16.55 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.512 HD13 ' HZ1' ' A' ' 28' ' ' LYS . 5.9 mm -101.87 133.84 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.123 -0.986 . . . . 0.0 110.503 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -84.23 162.43 20.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -59.87 -3.98 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 21.8 m-85 -101.07 -15.27 17.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.03 -1.044 . . . . 0.0 109.622 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.31 0.32 58.32 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.984 -1.072 . . . . 0.0 111.064 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -83.9 150.56 59.08 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.837 -1.39 . . . . 0.0 109.682 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.61 118.94 3.24 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.107 1.872 . . . . 0.0 110.905 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.05 163.02 16.21 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.72 142.03 44.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.24 150.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 85.4 m-85 -122.77 151.61 41.45 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.7 t -171.77 148.62 2.41 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.699 ' HE1' HH21 ' A' ' 24' ' ' ARG . 98.7 m95 -91.91 10.6 28.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 57' ' ' CYS . 29.8 mtmt -135.64 146.74 48.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.675 0.75 . . . . 0.0 110.179 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.412 HD23 ' HE ' ' A' ' 11' ' ' ARG . 60.8 tp -96.3 -40.07 9.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.15 161.23 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.61 -14.05 62.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.922 -1.111 . . . . 0.0 111.423 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -87.37 0.23 55.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.796 -1.19 . . . . 0.0 110.985 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.541 ' CG ' HH22 ' A' ' 11' ' ' ARG . 84.7 m-20 -72.49 -178.61 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.896 -1.127 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.42 121.18 13.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -75.79 146.29 79.5 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.492 -1.38 . . . . 0.0 109.957 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.82 155.58 62.16 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.031 . . . . 0.0 111.296 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.36 151.6 0.36 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 110.359 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.81 3.76 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -92.49 146.17 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -1.227 . . . . 0.0 108.913 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -78.08 -99.1 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 66.3 t0 -168.46 140.24 2.76 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.532 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 15.0 p -148.6 169.25 20.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.976 -1.077 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -82.69 139.0 18.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.497 -0.752 . . . . 0.0 110.326 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -60.72 169.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.33 -52.84 28.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -47.16 -47.76 23.7 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.724 -1.235 . . . . 0.0 110.114 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 68.3 mt-10 -71.49 -38.89 71.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.445 -1.409 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -65.75 -39.78 91.44 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 0.0 110.188 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.05 -44.41 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.377 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.19 90.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.955 -1.091 . . . . 0.0 110.782 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -71.34 -34.31 70.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.868 -1.145 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.88 -44.61 80.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.557 -1.339 . . . . 0.0 110.865 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -75.66 -29.28 59.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.853 -1.154 . . . . 0.0 110.617 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -77.57 -27.14 51.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.654 -1.279 . . . . 0.0 110.17 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -80.09 -38.92 30.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.175 -0.953 . . . . 0.0 110.912 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' A' ' 72' ' ' HIS . 6.5 pt -91.5 -44.28 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.134 -0.979 . . . . 0.0 111.03 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.435 ' N ' ' CG1' ' A' ' 71' ' ' ILE . 0.3 OUTLIER -91.57 105.08 17.48 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.075 -1.016 . . . . 0.0 108.457 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.235 -0.916 . . . . 0.0 109.33 -179.856 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -82.42 149.3 27.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.514 ' CG ' HH11 ' A' ' 5' ' ' ARG . 0.0 OUTLIER -85.45 142.2 29.4 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.116 -0.99 . . . . 0.0 110.878 -178.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -146.13 161.63 39.76 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 29.3 p-10 -123.58 -169.57 1.97 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.208 -0.932 . . . . 0.0 109.936 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -67.73 -21.37 65.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 110.077 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.57 -4.69 40.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.73 17.33 61.97 Favored Glycine 0 N--CA 1.497 2.738 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.07 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 11' ' ' ARG . 3.6 mtt-85 -86.04 138.58 31.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -1.112 . . . . 0.0 108.913 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.8 mm -82.57 116.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -88.9 147.09 24.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.092 -1.005 . . . . 0.0 108.574 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -90.53 -179.73 5.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.802 -1.187 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 m -55.68 148.09 17.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.545 -0.722 . . . . 0.0 110.396 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.04 -41.66 2.79 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' OE2' ' CZ ' ' A' ' 61' ' ' ARG . 95.2 mt-10 -78.09 158.43 29.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.909 -1.348 . . . . 0.0 110.067 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -158.21 154.56 27.51 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.815 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -99.16 130.21 45.46 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.837 . . . . 0.0 110.123 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.9 168.86 16.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.338 -0.851 . . . . 0.0 110.472 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -69.04 -25.59 64.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.467 -0.771 . . . . 0.0 109.15 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -87.11 -12.76 46.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.91 -31.1 8.27 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -58.88 143.7 46.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.313 . . . . 0.0 108.777 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -78.88 165.67 23.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.37 -0.831 . . . . 0.0 109.854 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.5 tm? -149.35 121.23 8.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 89.3 t80 -130.3 161.05 32.1 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 46.8 tttt -120.27 131.87 55.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.759 -0.588 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -135.73 152.15 50.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.581 -0.699 . . . . 0.0 109.25 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.4 mp -98.69 133.75 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' OD2' ' CG ' ' A' ' 35' ' ' GLU . 44.9 p30 -82.64 173.12 12.22 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.011 0.91 . . . . 0.0 110.795 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 m -60.73 3.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.831 -0.543 . . . . 0.0 111.381 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 31' ' ' ASP . 30.1 m-85 -107.12 -22.82 12.51 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.895 -1.128 . . . . 0.0 109.312 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.76 34.36 Favored Glycine 0 N--CA 1.505 3.251 0 O-C-N 121.211 -0.931 . . . . 0.0 111.137 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.578 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.2 pt-20 -88.49 152.44 49.62 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.941 -1.329 . . . . 0.0 109.263 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.41 147.6 25.76 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.413 2.075 . . . . 0.0 113.305 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -144.53 166.59 24.72 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -135.4 153.85 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.243 -0.911 . . . . 0.0 109.561 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -130.51 157.36 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.718 . . . . 0.0 109.231 -179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 48.0 m-85 -135.21 144.78 47.13 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 t -169.45 155.01 5.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.035 . . . . 0.0 109.743 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CZ2' ' NZ ' ' A' ' 54' ' ' LYS . 96.1 m95 -93.98 5.54 51.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.137 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 43.9 mtmt -123.92 140.43 52.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.547 0.689 . . . . 0.0 110.158 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.38 -44.83 7.04 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 46' ' ' ALA . 9.0 t -122.38 178.91 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -78.56 -12.94 60.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.122 -0.986 . . . . 0.0 110.995 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.28 -10.69 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 109.944 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -74.42 168.13 20.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.034 -1.041 . . . . 0.0 109.815 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.486 HH11 ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -144.73 136.06 25.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 108.904 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.12 148.56 71.61 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.807 . . . . 0.0 110.514 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.95 149.4 77.53 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.183 1.922 . . . . 0.0 111.845 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.54 146.17 1.11 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.71 0.766 . . . . 0.0 110.124 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.7 4.61 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' NZ ' ' CZ2' ' A' ' 42' ' ' TRP . 28.4 mmtp -95.56 135.22 37.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -73.09 152.62 41.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.759 . . . . 0.0 109.472 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -61.73 166.27 4.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 48.9 t -159.15 160.85 36.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -0.812 . . . . 0.0 109.108 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 85.5 mt -80.87 137.78 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.351 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.4 p -63.57 156.13 27.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.811 0.815 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.44 -55.45 33.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.585 -0.697 . . . . 0.0 109.838 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 15.7 mmt180 -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.243 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -72.07 -39.53 68.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.927 . . . . 0.0 110.273 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.12 -37.02 80.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.032 -1.042 . . . . 0.0 110.102 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.1 -50.66 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.099 -1.001 . . . . 0.0 110.729 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.95 -45.85 82.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.819 -1.176 . . . . 0.0 110.422 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 36.4 mt-10 -71.52 -41.73 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 0.0 111.676 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.38 -21.51 66.65 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.884 -1.76 . . . . 0.0 110.987 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -78.82 -72.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.79 -1.194 . . . . 0.0 111.32 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -76.8 -4.2 42.31 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.155 -0.966 . . . . 0.0 113.31 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 66' ' ' GLU . 43.5 t0 -93.71 -48.83 6.14 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.195 -1.566 . . . . 0.0 112.56 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.485 ' O ' ' CG1' ' A' ' 71' ' ' ILE . 1.4 pt -80.81 103.99 8.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 122.859 1.314 . . . . 0.0 110.204 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.22 135.5 9.05 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.113 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.1 t0 . . . . . 0 N--CA 1.497 1.913 0 O-C-N 120.886 -1.134 . . . . 0.0 109.635 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -84.89 146.24 27.39 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -83.47 129.05 34.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.07 -1.018 . . . . 0.0 108.977 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 -141.29 157.34 45.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.405 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.76 ' CG ' HD22 ' A' ' 13' ' ' LEU . 30.8 m-20 -79.7 -179.79 7.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -66.96 -14.52 62.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.919 . . . . 0.0 111.259 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -98.75 14.93 26.96 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.049 . . . . 0.0 109.941 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.21 20.95 75.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -90.76 126.27 35.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -1.065 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.8 mt -77.52 95.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.015 HD23 ' H ' ' A' ' 13' ' ' LEU . 1.6 pt? -87.37 156.11 19.74 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -92.0 -176.02 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.691 1.234 . . . . 0.0 110.773 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.1 m -57.91 144.08 40.45 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.14 -54.39 3.6 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.3 149.27 24.88 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.203 -1.175 . . . . 0.0 108.801 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -160.96 159.73 29.88 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 108.848 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -97.14 140.86 31.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 109.652 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.75 -174.14 4.62 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.515 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.09 -29.86 55.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.309 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -89.94 -11.88 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 111.538 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.44 -28.08 7.69 Favored Glycine 0 N--CA 1.504 3.199 0 O-C-N 121.012 -1.055 . . . . 0.0 110.908 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.4 140.88 56.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.352 -1.675 . . . . 0.0 109.341 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -80.03 170.56 16.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.434 -0.791 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.598 HD13 ' CE2' ' A' ' 40' ' ' TYR . 64.4 tp -151.68 127.25 10.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.537 -0.727 . . . . 0.0 109.328 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -129.58 157.15 42.86 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tttm -127.06 143.7 51.22 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.381 -0.825 . . . . 0.0 110.289 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.627 ' OH ' HD22 ' A' ' 67' ' ' LEU . 4.1 p90 -151.88 -178.99 7.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.46 144.99 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.488 -0.758 . . . . 0.0 109.006 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 33' ' ' PHE . 90.6 m-20 -84.05 165.85 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.469 -0.769 . . . . 0.0 109.856 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -59.28 -0.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.584 -0.697 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 31' ' ' ASP . 18.8 m-85 -108.76 -13.95 14.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.473 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.51 -8.67 52.16 Favored Glycine 0 N--CA 1.502 3.068 0 O-C-N 121.045 -1.035 . . . . 0.0 110.871 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.8 pt-20 -81.68 149.94 65.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.825 -1.397 . . . . 0.0 109.129 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.534 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 59.0 Cg_endo -83.67 143.55 10.81 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.361 2.041 . . . . 0.0 112.67 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.534 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.4 mp0 -140.68 173.51 11.43 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.256 -0.903 . . . . 0.0 108.682 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HB3' HD11 ' A' ' 26' ' ' LEU . 89.8 m-85 -137.89 154.32 49.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.442 -0.786 . . . . 0.0 109.801 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.546 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.1 m -128.57 143.72 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.525 -0.735 . . . . 0.0 109.232 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CE2' HD13 ' A' ' 26' ' ' LEU . 43.5 m-85 -122.35 147.61 46.06 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -171.52 150.86 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.899 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -94.26 10.42 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -127.02 138.84 53.31 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.5 tp -93.02 -44.41 8.42 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.39 166.48 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -14.24 62.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.65 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.4 p -90.04 -6.01 56.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.725 -1.234 . . . . 0.0 111.305 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -70.96 160.56 32.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.68 -1.262 . . . . 0.0 109.417 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.82 126.22 39.39 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.303 -0.873 . . . . 0.0 108.91 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.68 150.1 75.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 110.032 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.4 151.16 80.71 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.834 1.689 . . . . 0.0 110.619 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.33 159.55 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -0.928 . . . . 0.0 109.859 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.04 -36.59 3.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -95.08 137.0 34.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.342 . . . . 0.0 109.64 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.2 mmp_? -79.87 150.38 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -0.982 . . . . 0.0 109.701 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -52.1 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.447 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 42.6 t -168.41 169.71 10.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.33 -0.856 . . . . 0.0 108.9 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.447 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 6.5 mm -84.55 122.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.4 p -58.88 158.84 7.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 64' ' ' ILE . 3.2 mm? -54.71 -49.88 69.66 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.732 -0.605 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -51.45 -47.65 63.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.926 -1.109 . . . . 0.0 110.178 -179.13 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.85 -43.68 67.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 0.0 110.892 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -65.85 -41.4 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.613 -1.305 . . . . 0.0 109.693 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -60.58 -36.58 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -51.51 69.15 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.018 -1.051 . . . . 0.0 110.087 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.4 -41.26 63.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.866 -1.146 . . . . 0.0 112.462 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.627 HD22 ' OH ' ' A' ' 29' ' ' TYR . 22.7 mt -68.05 -44.29 76.72 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.286 -1.509 . . . . 0.0 111.752 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -69.38 -30.15 68.07 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.893 -1.129 . . . . 0.0 111.569 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' C ' ' N ' ' A' ' 71' ' ' ILE . 49.6 mtmt -76.84 -39.37 51.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.278 -1.514 . . . . 0.0 108.801 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -55.11 -11.26 0.66 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.427 ' N ' ' C ' ' A' ' 69' ' ' LYS . 15.7 mm -79.91 106.3 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.91 168.26 26.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.434 -0.791 . . . . 0.0 109.908 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.451 -0.78 . . . . 0.0 109.318 -179.131 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -147.09 124.46 11.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.286 -0.884 . . . . 0.0 108.907 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 133.98 34.02 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.731 ' HE ' ' C ' ' A' ' 10' ' ' GLY . 33.4 mtp180 -141.13 -169.25 2.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.222 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' HB2' HH12 ' A' ' 11' ' ' ARG . 3.8 m-20 -130.98 -159.59 0.98 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.648 -0.658 . . . . 0.0 109.823 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -63.29 -33.06 74.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.121 -0.987 . . . . 0.0 111.659 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HB2' ' NH1' ' A' ' 11' ' ' ARG . 15.1 mmt180 -96.03 8.28 44.13 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.017 -1.052 . . . . 0.0 112.09 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.731 ' C ' ' HE ' ' A' ' 6' ' ' ARG . . . 76.88 19.99 76.79 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.422 -1.424 . . . . 0.0 111.704 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.627 HH11 ' HG3' ' A' ' 11' ' ' ARG . 2.3 mtm-85 -94.19 144.95 25.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.495 . . . . 0.0 108.374 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.4 mt -85.56 117.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 108.879 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -84.99 144.69 28.14 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.423 -0.798 . . . . 0.0 109.46 -179.098 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -89.26 -171.66 3.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.18 0.991 . . . . 0.0 110.502 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.4 m -56.42 143.53 34.44 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.691 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.99 -51.46 3.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.256 -0.903 . . . . 0.0 111.479 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.1 140.67 58.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.401 . . . . 0.0 110.093 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -160.01 -174.51 4.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.273 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -110.11 147.41 33.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' A' ' 20' ' ' ARG . 10.3 ttt-85 -88.87 164.1 15.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.553 ' H ' ' CD ' ' A' ' 21' ' ' LYS . 8.4 mptt -63.71 -19.41 64.92 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.94 -8.17 50.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.608 -0.683 . . . . 0.0 110.714 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.68 6.32 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -61.41 145.79 50.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.969 -1.312 . . . . 0.0 108.041 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 11' ' ' ARG . 72.2 m-85 -78.75 167.93 20.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.103 -0.998 . . . . 0.0 110.659 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.645 HD13 ' CE2' ' A' ' 40' ' ' TYR . 67.8 tp -152.01 132.56 13.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 50.9 t80 -132.92 162.76 30.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 25.0 tttt -137.34 137.1 38.55 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.034 -1.041 . . . . 0.0 110.873 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.513 ' CD2' ' OE1' ' A' ' 37' ' ' GLN . 13.8 p90 -149.95 -175.55 5.09 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.45 ' HA ' HE22 ' A' ' 37' ' ' GLN . 39.9 mm -109.17 131.88 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.257 -0.902 . . . . 0.0 109.287 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.92 178.38 6.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 0.0 110.047 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.505 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 14.8 t -63.01 0.36 0.58 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.054 -1.029 . . . . 0.0 110.881 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 6.6 m-85 -102.69 -10.47 19.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.4 59.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.0 pt-20 -80.17 150.7 71.73 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 108.395 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.76 135.61 21.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.632 1.555 . . . . 0.0 111.459 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.679 ' NE2' ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -132.74 165.68 23.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.508 ' HB3' HD11 ' A' ' 26' ' ' LEU . 48.5 m-85 -137.11 155.79 49.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -0.839 . . . . 0.0 109.304 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.56 ' O ' HD12 ' A' ' 26' ' ' LEU . 10.7 m -126.05 150.09 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.645 ' CE2' HD13 ' A' ' 26' ' ' LEU . 71.6 m-85 -123.01 156.89 33.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.8 t -171.46 152.07 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.096 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -95.61 9.32 40.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 109.654 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.47 156.01 45.79 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.224 -0.923 . . . . 0.0 109.507 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.507 ' CB ' ' HE ' ' A' ' 11' ' ' ARG . 59.6 tp -98.66 -38.63 9.04 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -120.26 173.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.53 49.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 0.0 110.452 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.0 p -86.04 -7.17 58.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -71.94 167.62 19.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.84 136.85 51.03 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.6 149.52 78.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 110.616 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.26 140.79 25.45 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.677 1.585 . . . . 0.0 111.377 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.57 5.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 109.561 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.09 -19.97 48.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.62 142.86 27.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.827 -1.396 . . . . 0.0 109.205 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -78.08 151.21 33.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 109.829 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 p30 -62.08 175.08 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.79 . . . . 0.0 109.764 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 15.3 t -172.46 -174.99 1.27 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.411 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 49.8 mm -98.97 127.44 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.013 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.454 ' OG ' ' C ' ' A' ' 44' ' ' LEU . 22.7 t -56.91 157.23 5.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.382 -0.824 . . . . 0.0 109.392 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.5 -51.69 66.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.987 -1.07 . . . . 0.0 109.986 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -47.79 -41.76 24.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.77 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.06 -39.69 65.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.923 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -65.36 -55.47 17.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.868 -1.145 . . . . 0.0 109.611 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 64' ' ' ILE . 1.6 mp -48.05 -58.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.6 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.08 -42.36 69.25 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.684 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.18 -42.43 62.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.822 . . . . 0.0 111.598 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.487 HD23 ' OH ' ' A' ' 29' ' ' TYR . 6.3 mp -70.56 -44.42 67.46 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.779 -1.2 . . . . 0.0 111.817 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -72.49 -33.65 67.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.614 -1.304 . . . . 0.0 110.524 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -77.15 -21.53 53.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.862 -1.149 . . . . 0.0 109.468 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -97.23 -43.26 7.43 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.289 -0.882 . . . . 0.0 110.256 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.505 ' CG2' ' H ' ' A' ' 32' ' ' SER . 76.6 mt -80.06 -7.29 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.513 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 71' ' ' ILE . 9.0 m80 -145.33 -173.06 4.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.203 -0.936 . . . . 0.0 108.832 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.787 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 45.7 mp0 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -81.66 163.79 22.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.065 -1.022 . . . . 0.0 109.671 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.588 ' NE ' ' N ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -83.45 155.39 23.44 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 6' ' ' ARG . 14.9 mtm-85 -141.22 160.51 39.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.158 -0.964 . . . . 0.0 110.575 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' CD2' ' A' ' 13' ' ' LEU . 93.6 m-20 -87.21 170.92 11.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -63.84 -3.55 2.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.881 -1.137 . . . . 0.0 109.063 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 -11.23 18.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.52 4.77 59.26 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.598 ' HG2' HH11 ' A' ' 11' ' ' ARG . 8.6 mtt-85 -85.91 130.29 34.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -1.113 . . . . 0.0 109.545 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.0 110.48 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -86.29 150.36 24.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -89.29 -179.33 5.84 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.687 -1.258 . . . . 0.0 110.789 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -53.46 154.51 3.44 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -39.46 2.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -76.46 167.8 21.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.275 . . . . 0.0 109.518 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 t -158.82 161.96 36.97 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.863 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -104.51 138.13 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.3 156.37 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.942 -1.099 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CG ' ' N ' ' A' ' 22' ' ' ASP . 10.2 ptmm? -53.52 -39.24 64.48 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.107 -0.995 . . . . 0.0 109.491 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 51.1 p30 -83.89 -30.82 26.08 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.184 -0.948 . . . . 0.0 110.41 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 135.05 -24.72 3.4 Favored Glycine 0 N--CA 1.505 3.272 0 O-C-N 120.81 -1.181 . . . . 0.0 112.576 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -57.46 147.25 27.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 120.15 1.975 . . . . 0.0 107.714 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -85.32 169.55 13.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -152.96 129.01 10.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.146 -0.971 . . . . 0.0 109.75 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.859 ' N ' HD12 ' A' ' 26' ' ' LEU . 87.1 t80 -131.02 162.35 29.99 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.549 -0.719 . . . . 0.0 109.216 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 36.0 tttt -122.66 135.22 54.53 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.531 -0.73 . . . . 0.0 110.048 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.532 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 6.0 p90 -141.61 162.93 34.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' O ' ' NE2' ' A' ' 72' ' ' HIS . 24.7 mm -103.53 130.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -178.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 3.8 m-20 -88.5 179.74 6.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.506 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 47.1 t -57.08 -3.94 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 111.372 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 46.3 m-85 -96.26 -4.79 41.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.075 . . . . 0.0 110.473 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 10.33 81.71 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -88.25 164.36 33.35 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 122.034 -0.686 . . . . 0.0 110.092 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.28 122.6 0.75 Allowed 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 121.823 1.682 . . . . 0.0 110.144 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -123.07 166.11 15.68 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.222 -0.924 . . . . 0.0 109.724 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -135.85 146.55 47.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.505 -0.747 . . . . 0.0 110.486 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -124.34 148.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -132.35 155.02 49.15 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.134 -0.979 . . . . 0.0 109.956 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -171.83 157.74 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.963 -1.085 . . . . 0.0 109.728 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -91.85 12.47 21.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.148 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 8.6 mtmp? -135.31 138.09 43.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.432 -0.792 . . . . 0.0 109.7 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.7 tp -88.46 -43.27 11.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.69 173.92 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.17 62.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.266 -0.896 . . . . 0.0 111.541 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 t -86.6 -10.59 53.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.72 -1.237 . . . . 0.0 111.466 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.87 176.37 3.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.662 -1.274 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.35 140.38 30.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.8 m -84.79 146.35 46.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 109.385 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.95 150.98 78.37 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.992 1.794 . . . . 0.0 111.698 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.42 143.67 2.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.567 -0.708 . . . . 0.0 110.393 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.97 -26.65 22.54 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -96.99 131.93 43.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.368 -1.078 . . . . 0.0 108.527 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -75.91 145.89 40.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.36 -0.837 . . . . 0.0 109.7 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 60.8 t0 -50.27 153.73 1.41 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.664 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 81.1 m -148.59 167.3 25.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.217 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.5 mt -87.97 133.1 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.199 -0.938 . . . . 0.0 110.354 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.6 p -62.81 157.7 20.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.819 . . . . 0.0 110.623 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 64' ' ' ILE . 7.7 mp -58.42 -52.46 65.52 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.841 0.829 . . . . 0.0 109.588 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -51.2 -45.32 61.8 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.461 -0.774 . . . . 0.0 110.154 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.31 -40.99 70.47 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 109.704 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 ttmp? -66.32 -41.83 89.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.942 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.49 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -59.4 -53.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.776 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.31 71.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.917 -1.115 . . . . 0.0 109.958 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -73.87 -42.57 60.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.972 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -68.0 -43.39 78.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.616 -1.302 . . . . 0.0 110.594 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -69.11 -39.68 78.79 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.245 -1.535 . . . . 0.0 110.49 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -82.88 -38.74 22.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.875 -1.14 . . . . 0.0 111.304 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.83 -29.07 60.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.085 . . . . 0.0 111.202 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' CG2' ' H ' ' A' ' 32' ' ' SER . 42.8 mm -86.2 -44.12 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.0 -1.062 . . . . 0.0 110.325 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.471 ' NE2' ' O ' ' A' ' 30' ' ' ILE . 13.8 m170 -87.92 159.73 18.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.95 -1.094 . . . . 0.0 109.307 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.6 t0 . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.165 -179.375 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -83.18 144.32 29.89 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.229 1.014 . . . . 0.0 110.958 -178.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -97.52 156.18 16.61 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -137.97 150.05 46.67 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.016 -1.052 . . . . 0.0 109.767 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -83.44 166.85 18.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.287 -0.883 . . . . 0.0 109.832 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 23.2 p30 -69.17 1.64 3.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.192 -0.943 . . . . 0.0 109.902 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 92.2 mtt180 -100.11 -52.68 3.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.84 -3.34 1.11 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.639 HH11 ' CG ' ' A' ' 11' ' ' ARG . 1.6 mtt-85 -89.29 130.06 35.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.459 -1.612 . . . . 0.0 110.171 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 mm -72.73 110.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.249 -0.907 . . . . 0.0 108.561 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -94.26 152.53 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 109.484 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 35.9 mmtt -89.0 -173.27 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.978 -1.077 . . . . 0.0 110.78 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 p -57.14 165.6 1.31 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.454 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.1 -44.07 1.04 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.366 -0.834 . . . . 0.0 111.56 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 12.2 mp0 -65.23 152.39 43.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.019 -1.283 . . . . 0.0 110.823 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -158.58 139.62 13.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.2 tt0 -100.0 129.31 46.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.192 -0.942 . . . . 0.0 109.891 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.708 ' NH1' HH21 ' A' ' 24' ' ' ARG . 49.2 mtp180 -89.27 166.19 13.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.431 -0.793 . . . . 0.0 110.656 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.88 -20.27 63.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 109.729 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -85.78 -17.38 35.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.993 . . . . 0.0 109.463 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.09 -22.69 32.61 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.708 HH21 ' NH1' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -63.83 146.81 53.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.742 -1.446 . . . . 0.0 109.413 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.401 ' OH ' ' NH1' ' A' ' 9' ' ' ARG . 71.8 m-85 -88.63 166.47 14.09 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.802 0.81 . . . . 0.0 109.845 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.617 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 20.8 tp -148.74 119.87 7.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 90.4 t80 -131.67 168.63 17.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.645 -0.659 . . . . 0.0 109.437 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 71.1 tttt -130.91 135.17 47.43 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.541 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 18.9 p90 -133.18 165.03 25.72 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.461 -0.774 . . . . 0.0 108.912 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.01 134.78 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.077 -1.014 . . . . 0.0 109.302 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 16.7 m-20 -83.27 156.67 22.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 71' ' ' ILE . 42.7 m -53.66 -8.59 0.16 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.893 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.3 -13.9 21.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.881 -1.137 . . . . 0.0 108.807 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.34 0.73 59.5 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 20.6 pt-20 -83.38 148.52 55.85 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.892 -1.358 . . . . 0.0 108.329 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -82.64 141.63 11.11 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.354 2.036 . . . . 0.0 113.198 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 18.3 mp0 -139.67 161.68 36.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.186 -0.946 . . . . 0.0 108.753 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -132.09 142.54 49.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -122.2 151.58 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.561 0.695 . . . . 0.0 109.904 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.617 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 46.9 m-85 -123.72 150.47 44.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -166.05 148.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.391 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -90.94 10.38 26.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 109.573 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -140.18 144.02 36.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.99 -42.79 10.35 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.35 167.57 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.05 -6.24 44.27 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.982 -1.073 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.8 p -88.7 -18.53 27.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.433 -1.417 . . . . 0.0 110.011 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.28 175.11 7.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.42 HH12 ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -138.83 145.73 40.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 50' ' ' VAL . 5.9 m -79.91 128.53 73.72 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.713 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.32 141.17 10.5 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.028 1.152 . . . . 0.0 110.327 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' N ' HH12 ' A' ' 49' ' ' ARG . . . -44.81 143.44 1.43 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.07 -32.26 7.69 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -91.88 140.66 29.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 108.546 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -76.16 155.62 34.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 44.1 p30 -52.66 155.55 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.254 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 56' ' ' ASP . 64.9 m -154.54 157.99 39.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -85.05 135.08 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.8 p -58.82 153.65 16.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.09 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -60.47 -52.03 66.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.951 -1.093 . . . . 0.0 109.928 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -46.95 -50.0 19.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.824 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -69.13 -34.09 74.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.248 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -69.84 -41.26 75.16 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.428 -0.795 . . . . 0.0 110.02 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.18 -50.04 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.243 -0.91 . . . . 0.0 109.358 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.33 79.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.986 -1.071 . . . . 0.0 109.819 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -71.62 -44.02 65.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.466 -0.771 . . . . 0.0 111.308 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.74 -32.9 74.5 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.524 -1.36 . . . . 0.0 111.701 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -70.41 -45.53 65.74 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.215 -1.553 . . . . 0.0 110.308 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -82.93 -13.49 55.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.524 -1.36 . . . . 0.0 112.035 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -95.03 -29.1 14.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.484 -1.385 . . . . 0.0 110.357 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.41 ' O ' ' OG ' ' A' ' 32' ' ' SER . 6.2 mm -79.73 91.71 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-O 121.914 0.864 . . . . 0.0 109.015 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -151.43 -56.28 0.15 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.76 179.557 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -84.83 -170.81 3.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.046 -1.034 . . . . 0.0 109.492 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 139.75 37.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 0.0 108.534 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -144.22 171.51 14.19 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.609 -0.682 . . . . 0.0 109.872 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.2 p30 -75.46 -179.66 4.71 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.753 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -67.99 -8.6 38.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.829 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -101.79 -22.97 14.26 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.779 -1.201 . . . . 0.0 111.029 -178.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 123.06 7.93 6.89 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 121.199 -0.938 . . . . 0.0 110.78 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.527 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 9.2 mtm180 -85.09 126.25 33.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.884 -1.362 . . . . 0.0 109.596 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.2 mm -71.56 105.53 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' H ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 pp -87.78 149.02 24.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -91.09 -175.14 4.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.04 0.924 . . . . 0.0 110.903 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.466 ' H ' HG23 ' A' ' 15' ' ' THR . 7.5 p -55.19 146.24 19.24 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.665 0.745 . . . . 0.0 111.481 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.3 -54.12 4.85 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.422 -0.799 . . . . 0.0 111.37 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 36.8 mp0 -60.69 145.87 47.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 109.644 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -160.83 149.28 16.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.071 . . . . 0.0 109.649 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -99.3 130.87 45.62 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.081 -1.012 . . . . 0.0 108.568 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -84.54 -171.24 3.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 0.0 109.605 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -75.32 -23.04 57.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.176 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -86.2 -15.02 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.19 -19.2 49.63 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -62.4 141.88 58.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.491 -1.594 . . . . 0.0 108.66 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -87.83 165.58 15.2 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.427 -0.796 . . . . 0.0 108.915 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.941 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -154.71 130.91 10.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -178.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.941 ' N ' HD22 ' A' ' 26' ' ' LEU . 71.6 t80 -131.23 168.6 17.22 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 53.1 tttt -136.83 140.01 42.13 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.58 173.35 11.73 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.34 -0.85 . . . . 0.0 109.513 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.1 mm -103.35 126.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.412 -0.805 . . . . 0.0 109.615 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.14 176.41 9.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.005 -1.06 . . . . 0.0 109.058 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.428 ' H ' HG22 ' A' ' 71' ' ' ILE . 55.8 p -64.09 0.59 0.89 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.042 -1.036 . . . . 0.0 111.203 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 14.4 m-85 -103.65 -15.89 15.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.107 -0.996 . . . . 0.0 109.463 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.65 -0.62 74.12 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -82.81 148.39 57.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.248 . . . . 0.0 109.299 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.06 124.44 9.09 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.489 1.459 . . . . 0.0 111.019 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -122.81 163.55 20.03 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -136.29 153.55 51.14 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.192 -0.943 . . . . 0.0 110.124 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.54 146.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -131.23 149.11 52.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.179 -0.951 . . . . 0.0 109.682 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.3 t -171.53 154.6 3.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.38 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -92.67 14.77 16.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.005 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.693 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 24.4 mtmm -130.91 138.51 49.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -93.38 -45.06 7.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.482 ' O ' ' OG ' ' A' ' 59' ' ' SER . 1.2 t -119.73 167.54 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.63 -17.57 64.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 110.664 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 p -86.89 -12.0 49.06 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.901 -1.124 . . . . 0.0 110.886 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -70.7 169.26 14.8 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.871 -1.143 . . . . 0.0 110.458 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -139.49 137.29 35.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.12 150.97 72.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 109.657 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.45 150.16 63.58 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.786 1.657 . . . . 0.0 111.049 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.86 146.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.3 -32.4 7.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -98.04 132.84 43.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -1.211 . . . . 0.0 109.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -74.95 147.91 40.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 109.182 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 60.0 p30 -51.82 152.06 3.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.114 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.693 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 35.6 m -146.78 164.07 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.47 133.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 110.823 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 56.3 m -58.19 166.95 1.43 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.412 0.625 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.467 HD12 ' CB ' ' A' ' 27' ' ' TYR . 4.4 mm? -63.68 -65.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.888 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -47.47 -34.45 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.502 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.94 -40.11 72.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.659 -1.275 . . . . 0.0 108.837 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -66.24 -44.02 84.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 110.245 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.5 mp -59.92 -45.12 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.134 -0.979 . . . . 0.0 110.677 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.62 81.65 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.745 -1.222 . . . . 0.0 110.981 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -77.85 -36.71 49.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.846 -1.159 . . . . 0.0 112.477 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.6 mt -67.53 -44.41 78.43 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.364 -1.46 . . . . 0.0 111.523 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -77.09 -36.22 55.9 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 110.985 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -73.26 -20.67 60.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.92 -1.112 . . . . 0.0 110.309 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -107.99 -52.9 2.7 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.253 -0.905 . . . . 0.0 111.239 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.428 HG22 ' H ' ' A' ' 32' ' ' SER . 7.9 mt -84.97 44.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.197 -0.939 . . . . 0.0 110.456 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -156.9 41.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.928 -1.108 . . . . 0.0 109.467 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.105 -0.997 . . . . 0.0 109.442 179.984 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -84.48 171.82 12.22 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.413 ' HD2' ' N ' ' A' ' 5' ' ' ARG . 0.7 OUTLIER -84.4 121.27 27.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.901 -1.124 . . . . 0.0 110.156 -178.883 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -139.7 173.4 11.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.522 -0.736 . . . . 0.0 109.612 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.0 p-10 -88.96 -176.9 5.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.083 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -64.78 -6.31 7.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 110.006 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 9' ' ' ARG . 52.9 mtt-85 -105.39 -16.88 14.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.172 -0.955 . . . . 0.0 110.318 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 101.65 19.01 16.7 Favored Glycine 0 N--CA 1.501 2.989 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.521 ' HG2' HH11 ' A' ' 11' ' ' ARG . 6.6 mtt-85 -86.03 140.18 30.5 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.77 -1.43 . . . . 0.0 109.168 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.78 103.24 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.525 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -99.4 149.97 22.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.388 -0.82 . . . . 0.0 109.065 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -89.02 -173.86 4.23 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.423 1.106 . . . . 0.0 111.785 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 m -59.4 140.0 56.55 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.229 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 -39.12 2.93 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.312 -0.867 . . . . 0.0 111.338 177.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -72.56 153.38 41.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.745 -1.444 . . . . 0.0 109.862 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -160.55 155.68 24.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -96.42 139.94 31.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -83.75 148.33 27.11 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.568 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -57.56 -18.9 21.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.61 -21.04 23.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.782 -0.573 . . . . 0.0 109.924 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.86 -35.59 4.01 Favored Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 24' ' ' ARG . 2.9 ptp180 -59.54 140.98 55.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.877 -1.366 . . . . 0.0 109.23 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -75.85 170.73 15.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.316 -0.865 . . . . 0.0 110.338 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 39' ' ' VAL . 62.9 tp -154.83 130.98 10.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.73 -0.606 . . . . 0.0 109.551 -179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -134.51 161.93 33.69 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -126.3 134.88 51.01 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.8 p90 -137.98 167.72 21.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.76 131.92 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 109.259 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 41.5 m-20 -82.09 -174.13 4.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.218 -0.926 . . . . 0.0 109.61 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.433 ' H ' HG22 ' A' ' 71' ' ' ILE . 70.1 m -72.32 -4.64 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.42 -0.8 . . . . 0.0 110.239 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 18.3 m-85 -99.59 -10.73 21.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.15 -0.968 . . . . 0.0 109.913 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.41 86.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.39 147.33 52.8 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.392 -1.063 . . . . 0.0 108.733 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.98 128.51 15.93 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.846 1.697 . . . . 0.0 110.522 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -127.87 164.69 21.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 109.011 -179.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.38 155.32 50.48 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.356 -0.84 . . . . 0.0 110.786 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.673 ' O ' HD12 ' A' ' 26' ' ' LEU . 2.9 m -128.86 152.72 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.652 ' CE2' HD13 ' A' ' 26' ' ' LEU . 78.5 m-85 -128.3 150.89 49.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.208 -0.933 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 t -169.08 146.4 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.469 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -88.31 3.55 49.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 109.289 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.66 ' HZ1' ' C ' ' A' ' 57' ' ' CYS . 24.4 mtmm -128.56 141.99 51.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.88 -49.59 6.35 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 46' ' ' ALA . 3.2 t -112.53 174.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -77.95 -11.92 59.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.62 -0.675 . . . . 0.0 110.669 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -87.25 -14.35 41.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.763 -1.211 . . . . 0.0 110.105 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.2 174.89 5.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 1.9 tmt_? -146.49 135.94 22.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.409 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 19.3 m -75.23 147.95 83.4 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.772 -1.205 . . . . 0.0 109.954 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.33 155.73 66.51 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.04 1.827 . . . . 0.0 111.764 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.18 146.98 2.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.55 -0.719 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.4 6.91 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -95.97 139.64 31.88 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.005 -1.291 . . . . 0.0 109.073 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 55' ' ' ARG . 1.4 ttt-85 -75.41 151.26 38.15 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.68 159.06 22.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.365 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.66 ' C ' ' HZ1' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -156.34 175.03 14.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.032 -179.848 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.81 135.38 25.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.524 -0.735 . . . . 0.0 110.68 -178.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.9 p -61.35 163.67 6.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 108.695 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.1 -51.98 40.19 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 111.149 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' NH1' ' HG2' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -44.27 -45.49 8.64 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.143 -0.973 . . . . 0.0 110.003 -178.853 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -68.58 -40.58 80.45 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 109.672 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -66.62 -44.14 82.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.986 -1.072 . . . . 0.0 110.516 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -56.93 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.91 -1.119 . . . . 0.0 110.318 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.07 70.29 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.74 -53.79 7.49 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -69.28 -41.28 77.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.996 -1.065 . . . . 0.0 110.144 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -69.63 -39.81 76.94 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -78.17 -24.57 47.2 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.907 -1.121 . . . . 0.0 111.068 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -100.03 -36.1 9.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.911 -1.118 . . . . 0.0 111.679 -178.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 32' ' ' SER . 3.9 mm -89.88 44.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.841 -1.162 . . . . 0.0 110.415 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -153.59 37.41 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.342 -1.474 . . . . 0.0 109.465 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.309 179.969 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 5.6 mp0 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -156.09 143.47 19.25 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -84.2 152.7 24.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 110.197 -179.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 6' ' ' ARG . 2.9 mtt-85 -134.94 -179.88 5.89 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 51.3 p-10 -74.4 -167.36 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.761 -1.212 . . . . 0.0 108.91 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.489 ' N ' ' OE1' ' A' ' 19' ' ' GLN . 11.7 m120 -68.61 -16.35 63.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.781 -1.2 . . . . 0.0 108.599 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' N ' ' CD ' ' A' ' 9' ' ' ARG . 9.2 mpt_? -101.3 -87.13 0.4 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -169.5 19.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.455 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 81.3 mtm180 -89.84 138.59 31.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.303 . . . . 0.0 109.704 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.9 mm -77.68 130.26 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.888 . . . . 0.0 109.98 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -93.6 150.64 20.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -87.88 170.87 10.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.957 -1.09 . . . . 0.0 109.513 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.0 m -58.11 137.17 57.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.455 -0.778 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.98 -24.81 24.88 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.943 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 44.1 mp0 -82.04 157.2 24.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.677 -1.484 . . . . 0.0 110.12 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 t -158.93 147.56 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 109.389 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 8' ' ' ASN . 41.7 tt0 -106.45 133.04 51.75 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -83.03 166.0 19.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 109.862 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HD3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.59 -16.49 48.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 108.643 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -86.9 -10.23 53.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.482 -0.761 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.31 -29.2 13.03 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.248 -0.907 . . . . 0.0 111.379 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -57.86 157.0 8.1 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.548 -1.56 . . . . 0.0 109.382 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.455 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 71.2 m-85 -100.41 166.91 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 109.42 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.484 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -152.79 141.29 20.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -135.26 149.23 49.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -114.88 135.42 54.22 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.253 -0.905 . . . . 0.0 110.792 -178.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.693 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.2 p90 -142.46 164.78 29.19 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.2 mt -107.96 139.62 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 33' ' ' PHE . 23.8 m-20 -81.79 159.93 23.68 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.935 -1.103 . . . . 0.0 109.222 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.7 m -58.2 -2.18 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 110.031 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 31' ' ' ASP . 88.1 m-85 -95.29 -15.43 23.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.044 -1.035 . . . . 0.0 108.59 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.07 -5.26 49.71 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.413 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 23.5 pt-20 -84.73 144.02 41.7 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.872 -1.369 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.69 139.83 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.534 2.156 . . . . 0.0 111.969 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.413 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 17.6 mp0 -136.8 172.75 12.54 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.108 -0.995 . . . . 0.0 109.402 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -137.01 139.51 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.51 154.27 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 66.9 m-85 -126.12 151.36 47.35 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.449 0.643 . . . . 0.0 109.273 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.8 t -168.22 136.57 2.29 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.013 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -87.58 12.9 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.189 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 53.0 mtmt -130.98 133.22 45.59 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.659 0.742 . . . . 0.0 109.574 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 66.9 tp -89.26 -43.44 10.97 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG22 HH12 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -111.63 175.39 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.48 -18.28 49.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.953 -1.092 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.2 p -93.58 7.29 45.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.679 -1.263 . . . . 0.0 110.955 -179.036 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.4 -179.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.611 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -142.1 116.79 9.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.13 -0.981 . . . . 0.0 109.196 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.47 149.45 51.88 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.204 -0.935 . . . . 0.0 110.839 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' LYS . 56.8 Cg_exo -49.58 134.42 33.12 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.208 1.272 . . . . 0.0 110.739 177.325 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.55 -23.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.848 -1.158 . . . . 0.0 109.791 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -25.4 73.65 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' PRO . 47.8 mmtt -103.93 133.93 48.06 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -78.99 152.65 30.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.087 . . . . 0.0 110.546 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -43.78 154.81 0.09 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.448 0.642 . . . . 0.0 109.826 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.498 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 61.4 m -149.73 167.59 26.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -86.96 128.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.141 -0.975 . . . . 0.0 108.779 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.6 p -58.64 167.64 1.43 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 110.443 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.78 -51.89 43.61 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.369 -0.832 . . . . 0.0 110.206 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.652 HH11 ' CG ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -47.07 -46.4 22.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 109.218 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -70.21 -39.65 75.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.512 -0.742 . . . . 0.0 110.19 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.0 -47.51 74.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.687 -1.258 . . . . 0.0 109.465 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.48 -56.69 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.21 76.97 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -77.29 -36.0 54.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.85 . . . . 0.0 111.945 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.693 HD12 ' CZ ' ' A' ' 29' ' ' TYR . 4.2 mm? -67.82 -41.41 83.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.542 -1.349 . . . . 0.0 110.178 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -76.98 -32.99 57.64 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.239 -1.538 . . . . 0.0 109.813 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 73' ' ' ASP . 37.4 ttpt -87.04 -39.81 15.29 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.165 -0.96 . . . . 0.0 112.654 -178.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.19 -17.2 60.93 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.777 -1.202 . . . . 0.0 111.548 -177.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 71' ' ' ILE . 36.5 mm -86.49 -7.7 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.784 -1.197 . . . . 0.0 110.67 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.61 -33.34 0.23 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.605 -1.309 . . . . 0.0 109.182 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 69' ' ' LYS . 38.9 t70 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.907 . . . . 0.0 109.728 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.651 ' N ' HH22 ' A' ' 6' ' ' ARG . 7.3 tp10 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 4' ' ' LYS . 13.7 ptpt -83.14 -160.07 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 -179.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -80.29 154.6 27.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.06 -1.025 . . . . 0.0 110.961 -177.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.651 HH22 ' N ' ' A' ' 3' ' ' GLU . 4.9 mtt-85 -138.98 -178.82 5.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.67 -0.644 . . . . 0.0 109.475 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -104.09 -167.66 1.39 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.755 . . . . 0.0 109.503 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 3.1 p30 -66.89 -16.86 64.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.28 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.593 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -97.6 -3.66 39.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.965 -1.084 . . . . 0.0 110.061 -179.422 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.85 90.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.533 HH11 ' CG ' ' A' ' 11' ' ' ARG . 2.6 mtt-85 -88.71 130.79 35.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.016 -1.285 . . . . 0.0 109.641 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.75 121.64 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 109.233 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.953 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -97.23 155.94 16.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -0.78 . . . . 0.0 108.948 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.07 179.42 6.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.871 -1.143 . . . . 0.0 110.111 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -56.81 152.47 12.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.729 -0.607 . . . . 0.0 110.295 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.44 -43.32 3.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.015 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' CD1' ' A' ' 44' ' ' LEU . 2.1 mt-10 -66.39 155.12 38.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.229 -1.16 . . . . 0.0 108.464 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 t -159.03 164.27 35.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.126 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -103.61 126.53 50.81 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 108.9 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -85.17 147.17 26.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.046 . . . . 0.0 108.947 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 1.3 mptt -49.26 -22.6 1.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -89.77 -26.74 20.44 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.799 -1.188 . . . . 0.0 110.821 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.62 -34.33 2.79 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 24' ' ' ARG . 0.1 OUTLIER -60.45 148.19 38.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.779 -1.424 . . . . 0.0 108.778 -179.753 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -86.47 168.71 13.5 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 27' ' ' TYR . 4.3 tt -145.12 122.95 11.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.349 -0.844 . . . . 0.0 109.536 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.655 ' N ' HD23 ' A' ' 26' ' ' LEU . 74.0 t80 -128.04 161.54 28.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 17.4 tttt -129.42 138.63 51.57 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.426 -0.796 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -140.42 162.82 34.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.1 mt -110.96 136.27 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -85.27 170.47 12.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.357 -0.84 . . . . 0.0 109.479 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.0 p -60.35 5.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 110.546 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 31' ' ' ASP . 37.3 m-85 -99.45 -17.68 17.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.039 -1.038 . . . . 0.0 109.43 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 -2.91 82.31 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -83.92 142.07 41.5 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.282 -1.128 . . . . 0.0 108.172 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.9 145.54 56.64 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.685 1.59 . . . . 0.0 111.124 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -140.07 153.97 46.92 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -129.56 148.69 51.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.044 -1.035 . . . . 0.0 109.892 -179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.14 142.92 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -117.22 160.91 20.32 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.1 t -168.74 152.46 5.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -93.78 7.55 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -143.65 149.09 36.77 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 51.1 tp -94.09 -42.99 8.71 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.65 158.01 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.683 -0.636 . . . . 0.0 109.452 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.36 -11.4 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.191 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.0 p -90.3 -6.91 54.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.039 -1.038 . . . . 0.0 110.129 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -70.71 179.36 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.97 -1.081 . . . . 0.0 110.009 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 49' ' ' ARG . 6.5 tpt180 -142.44 120.76 12.32 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 109.116 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.31 142.35 50.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.252 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -49.34 146.29 14.02 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.879 1.053 . . . . 0.0 110.503 178.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.56 -47.55 39.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.994 -1.067 . . . . 0.0 110.166 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.97 -21.02 4.85 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -102.51 139.71 37.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -1.17 . . . . 0.0 109.934 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.638 ' H ' ' CD ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.54 159.29 30.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 179.839 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 25.6 p-10 -66.39 164.25 16.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.16 171.68 15.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.62 133.05 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 110.17 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.7 p -58.82 152.58 18.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.066 179.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.27 -47.21 87.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.219 -0.925 . . . . 0.0 109.867 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -42.95 -45.07 4.88 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.08 -1.012 . . . . 0.0 109.819 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 97.5 mt-10 -72.29 -37.5 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -66.32 -42.51 88.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.693 -1.255 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.04 -53.5 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.668 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.87 93.03 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.15 -0.969 . . . . 0.0 110.116 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -72.33 -38.73 68.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.893 -1.129 . . . . 0.0 111.436 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.62 -46.4 72.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.576 -1.327 . . . . 0.0 110.094 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -74.45 -38.06 63.09 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 120.794 -1.191 . . . . 0.0 109.838 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 73' ' ' ASP . 29.0 ttmt -73.09 -30.1 63.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.839 -1.163 . . . . 0.0 110.114 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.35 -32.81 20.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.186 -0.946 . . . . 0.0 110.48 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 86.8 mt -86.74 -49.95 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.099 -1.001 . . . . 0.0 110.257 -179.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -88.44 64.23 7.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.931 -1.106 . . . . 0.0 109.399 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' O ' ' O ' ' A' ' 69' ' ' LYS . 89.3 m-20 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.924 -1.11 . . . . 0.0 109.476 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.497 0.665 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -88.3 -168.31 2.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.417 -0.802 . . . . 0.0 109.533 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -81.27 127.13 32.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.855 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 -129.81 135.47 48.46 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.544 -0.723 . . . . 0.0 109.526 -179.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -64.83 165.51 10.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.391 -0.818 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.441 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 26.0 p30 -63.17 -6.97 4.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.368 -0.832 . . . . 0.0 109.823 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -96.41 -75.79 0.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.205 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.95 -1.32 0.03 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.924 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.554 HH11 ' CG ' ' A' ' 11' ' ' ARG . 5.3 mtt-85 -85.59 133.18 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.469 . . . . 0.0 108.895 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.96 117.0 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.958 . . . . 0.0 109.385 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.8 151.42 22.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -88.89 173.78 8.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.337 -0.852 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 m -56.82 139.34 51.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.397 -0.815 . . . . 0.0 110.636 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.18 -42.35 2.27 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.24 150.6 43.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.807 -1.408 . . . . 0.0 109.539 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -157.03 140.0 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.441 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 53.9 tt0 -101.86 140.72 35.77 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.454 HH21 HD13 ' A' ' 26' ' ' LEU . 37.1 mtt-85 -91.19 173.13 8.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 110.425 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 1.5 mptt -64.16 -19.66 65.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -84.81 -9.81 57.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.1 -25.53 25.08 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 121.096 -1.002 . . . . 0.0 110.96 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -62.21 137.95 58.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.739 -1.447 . . . . 0.0 109.302 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.81 166.76 19.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 110.496 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 HH21 ' A' ' 20' ' ' ARG . 3.0 tt -153.51 138.76 17.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.696 . . . . 0.0 110.043 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -133.16 148.39 52.09 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -115.05 139.31 49.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.386 -0.821 . . . . 0.0 109.663 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.91 166.07 27.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 0.0 109.098 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -103.81 134.0 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.259 -0.901 . . . . 0.0 109.695 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -84.01 171.59 12.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.894 -1.128 . . . . 0.0 109.236 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -62.33 -0.13 0.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.568 -0.708 . . . . 0.0 111.367 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 39.2 m-85 -103.77 -21.59 13.66 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.901 -1.124 . . . . 0.0 110.255 -178.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.82 -1.91 38.8 Favored Glycine 0 N--CA 1.503 3.109 0 O-C-N 121.059 -1.026 . . . . 0.0 111.199 178.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -86.97 153.91 54.87 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.69 -1.476 . . . . 0.0 108.709 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -82.5 133.99 7.46 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.301 2.001 . . . . 0.0 112.796 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 3.7 mp0 -127.95 164.68 21.78 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.422 -0.798 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -137.49 147.35 45.18 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 156.22 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.34 154.9 44.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.458 -0.776 . . . . 0.0 110.065 -178.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -172.34 137.74 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.605 -0.684 . . . . 0.0 109.276 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -88.38 11.56 16.51 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -126.27 147.67 49.65 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.42 0.628 . . . . 0.0 109.78 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.1 tp -95.67 -47.22 6.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 47' ' ' THR . 35.5 m -122.15 -176.87 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.56 -15.87 58.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 111.109 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.424 ' H ' HG23 ' A' ' 45' ' ' VAL . 24.0 p -88.1 -10.03 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.711 -1.243 . . . . 0.0 110.234 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -75.85 166.78 23.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.978 . . . . 0.0 110.467 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.49 139.91 40.84 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -81.06 149.58 66.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.801 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.39 154.46 50.85 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.488 2.125 . . . . 0.0 111.338 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.13 144.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.63 -38.54 3.07 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.562 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 9.6 mptt -93.2 126.03 38.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -1.165 . . . . 0.0 108.175 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' HB3' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.5 155.67 33.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 110.109 -179.137 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -50.98 164.67 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.939 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 52.2 t -162.15 165.75 26.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.439 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 97.6 mt -83.93 126.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.59 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.5 p -54.37 157.62 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 108.925 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.54 -59.97 3.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 110.677 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -46.69 -39.93 12.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.115 . . . . 0.0 110.392 -178.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -71.5 -40.22 70.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.929 -1.107 . . . . 0.0 109.394 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -70.84 -41.81 70.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.78 -49.65 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.94 -1.1 . . . . 0.0 109.137 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.66 80.19 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.179 -0.95 . . . . 0.0 109.859 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.71 -53.5 13.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 111.07 -178.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.68 -49.19 41.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.631 -1.293 . . . . 0.0 110.442 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 72' ' ' HIS . 19.9 tt0 -68.1 -44.01 77.18 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 -176.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -75.59 -30.05 59.48 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.392 -1.442 . . . . 0.0 111.17 -178.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -75.0 -45.77 39.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.147 -0.971 . . . . 0.0 112.121 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 pt -87.18 -17.54 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.001 -1.062 . . . . 0.0 111.182 -177.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 68' ' ' GLN . 3.0 m-70 -153.22 154.43 34.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.027 -1.046 . . . . 0.0 109.526 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 C--N 1.303 -1.455 0 O-C-N 121.56 -0.712 . . . . 0.0 109.999 179.019 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.564 0.697 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -81.48 167.64 19.13 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.309 -0.869 . . . . 0.0 108.718 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -81.56 152.2 27.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.908 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.547 ' CG ' HH11 ' A' ' 6' ' ' ARG . 2.6 mtt-85 -141.72 161.56 37.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.325 -0.86 . . . . 0.0 108.969 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 58.3 p30 -101.26 178.15 4.73 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -62.05 -6.77 3.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.718 -1.239 . . . . 0.0 109.462 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.488 HH21 HH21 ' A' ' 11' ' ' ARG . 17.7 mmm180 -96.95 -12.12 23.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 86.73 10.05 73.57 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.313 178.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.598 HH11 ' CG ' ' A' ' 11' ' ' ARG . 2.9 mtt-85 -85.67 152.02 23.42 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.668 -1.489 . . . . 0.0 109.544 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -84.48 104.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 pp -92.77 146.43 23.65 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.936 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -88.78 -174.54 4.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.049 -1.032 . . . . 0.0 111.466 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 m -57.63 147.33 27.67 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.4 -44.82 3.41 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.51 149.06 50.66 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.995 -1.297 . . . . 0.0 109.555 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -157.21 155.1 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.491 ' OE1' ' CD1' ' A' ' 25' ' ' TYR . 5.2 tp60 -110.81 132.39 54.24 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.542 -0.724 . . . . 0.0 110.007 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.82 HH11 HH21 ' A' ' 24' ' ' ARG . 36.0 mtp180 -90.46 -177.41 5.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -67.67 -24.1 65.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.209 -179.229 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.51 -13.1 41.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.004 -1.06 . . . . 0.0 109.702 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.65 -14.46 59.09 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.345 -0.847 . . . . 0.0 111.393 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.82 HH21 HH11 ' A' ' 20' ' ' ARG . 2.1 ptt180 -64.46 141.03 58.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.444 -1.621 . . . . 0.0 109.348 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.491 ' CD1' ' OE1' ' A' ' 19' ' ' GLN . 71.5 m-85 -81.45 165.95 20.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.418 -0.802 . . . . 0.0 110.066 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.532 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 9.3 tp -153.85 125.81 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.43 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.473 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 69.0 t80 -130.72 170.15 14.72 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 33.1 tttm -139.76 142.24 36.77 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.931 -1.106 . . . . 0.0 111.173 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.58 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 43.5 p90 -149.17 -172.91 4.24 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.352 -0.843 . . . . 0.0 108.966 176.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -114.22 134.54 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.952 -1.092 . . . . 0.0 110.147 -178.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' CG ' HE21 ' A' ' 37' ' ' GLN . 5.0 m-20 -83.98 174.87 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.431 ' H ' HG22 ' A' ' 71' ' ' ILE . 25.4 t -66.6 -6.53 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.9 . . . . 0.0 108.808 178.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 12.0 m-85 -98.18 -4.76 34.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.773 . . . . 0.0 109.069 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.08 -1.11 86.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 pp20? -85.5 144.44 40.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 0.0 108.959 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.62 131.08 11.14 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.978 1.785 . . . . 0.0 112.146 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.668 ' NE2' ' H ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -129.4 172.1 11.85 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.964 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 19.0 m-85 -141.08 163.47 32.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 0.0 110.512 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.54 135.46 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.532 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 76.7 m-85 -122.49 143.54 49.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.531 -0.731 . . . . 0.0 110.01 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.6 t -171.7 157.64 4.72 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 178.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -91.19 10.18 28.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.544 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 34.1 mtmm -131.81 141.19 49.38 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.717 0.77 . . . . 0.0 110.152 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -94.58 -40.45 9.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.59 168.1 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.04 60.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.421 -0.799 . . . . 0.0 109.729 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.8 p -90.06 -5.52 56.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.165 -0.959 . . . . 0.0 110.314 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.95 172.15 9.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.924 -1.11 . . . . 0.0 109.366 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -142.15 133.65 26.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.135 -0.978 . . . . 0.0 109.255 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.4 150.0 62.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.301 -179.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 151.8 62.84 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.161 1.907 . . . . 0.0 111.213 178.506 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.84 153.32 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 0.0 110.481 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.21 5.77 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -95.43 139.38 31.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.059 -1.26 . . . . 0.0 109.572 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.521 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.84 164.62 25.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 109.349 -179.48 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -74.45 161.94 29.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.355 -0.841 . . . . 0.0 109.608 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.544 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 27.8 t -161.73 161.22 29.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.479 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 81.6 mt -82.42 136.34 23.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.021 -1.049 . . . . 0.0 109.227 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -59.19 176.04 0.26 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.53 -0.732 . . . . 0.0 110.123 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 60' ' ' LEU . 6.9 mp -77.2 -52.68 8.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.546 ' H ' ' CD ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -42.63 -44.41 4.22 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.182 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -71.84 -40.0 69.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -65.04 -40.38 94.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.709 -1.245 . . . . 0.0 109.884 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.19 -55.61 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.958 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.16 95.75 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.5 -1.375 . . . . 0.0 109.89 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.43 -45.28 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 110.652 -179.101 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.73 -43.5 68.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.815 -1.178 . . . . 0.0 110.255 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -72.1 -42.02 66.59 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.725 -0.609 . . . . 0.0 110.329 -177.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -77.34 -26.44 52.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.107 -0.996 . . . . 0.0 110.524 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -89.32 -46.58 8.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.917 -1.114 . . . . 0.0 110.924 -178.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 32' ' ' SER . 24.0 mt -83.89 60.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 109.641 -178.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.46 -171.16 3.48 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 t0 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.069 -1.02 . . . . 0.0 109.532 -179.763 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 42.4 p-10 -91.35 -177.08 4.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 109.772 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -63.09 -9.47 10.72 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.506 -0.746 . . . . 0.0 109.698 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.409 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 4.0 mmp_? -101.3 -71.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.994 -1.066 . . . . 0.0 110.02 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 169.09 7.08 0.03 OUTLIER Glycine 0 N--CA 1.497 2.703 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.949 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.566 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 67.0 mtm180 -87.98 136.49 32.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.644 -1.503 . . . . 0.0 109.066 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.3 mt -82.61 111.72 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -89.42 149.85 22.78 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -86.04 -179.71 6.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.803 -1.186 . . . . 0.0 110.97 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t -58.63 145.62 39.03 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.691 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.02 -40.1 2.81 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.328 -0.857 . . . . 0.0 111.189 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 27' ' ' TYR . 46.5 mp0 -72.07 152.18 42.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.709 -1.465 . . . . 0.0 109.997 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -154.67 142.38 19.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -110.27 132.43 54.18 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -89.5 169.87 11.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.313 -0.867 . . . . 0.0 109.347 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -12.6 41.79 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.534 -0.729 . . . . 0.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -87.65 -18.41 29.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.272 -0.893 . . . . 0.0 109.831 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.54 -23.85 25.46 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -64.86 137.89 58.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.424 . . . . 0.0 109.569 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.566 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -82.8 171.41 13.97 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.643 -0.661 . . . . 0.0 110.115 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 27' ' ' TYR . 2.1 tt -154.56 127.23 8.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.557 ' N ' HD23 ' A' ' 26' ' ' LEU . 75.9 t80 -132.78 163.19 29.6 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.249 -0.907 . . . . 0.0 109.058 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -131.52 137.05 48.35 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.323 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.72 133.13 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 33' ' ' PHE . 34.6 p30 -88.31 174.61 8.08 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.667 -0.646 . . . . 0.0 110.319 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 t -62.11 6.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 0.0 110.555 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 31' ' ' ASP . 19.9 m-85 -100.69 -16.31 17.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.98 -1.075 . . . . 0.0 108.432 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.61 -4.86 85.11 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.26 149.88 59.46 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.072 -1.252 . . . . 0.0 108.717 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.96 137.41 24.21 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.405 1.403 . . . . 0.0 109.786 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -135.21 137.63 42.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.915 -1.116 . . . . 0.0 109.274 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.61 145.23 40.74 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.518 -0.739 . . . . 0.0 110.172 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.0 157.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.527 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 55.6 m-85 -127.53 155.73 43.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -170.78 136.5 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.85 -1.156 . . . . 0.0 110.868 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -86.62 5.99 33.14 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -131.76 131.73 43.22 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.615 0.722 . . . . 0.0 110.098 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 tp -86.18 -42.78 13.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.75 174.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.93 -16.74 59.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.086 -1.008 . . . . 0.0 110.6 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.5 p -88.39 -4.91 58.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.849 -1.157 . . . . 0.0 110.596 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.565 ' CG ' HH12 ' A' ' 11' ' ' ARG . 73.2 m-20 -70.01 177.31 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.595 -1.316 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -139.6 138.08 35.88 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.08 144.07 50.32 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.49 -0.756 . . . . 0.0 111.044 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.0 143.92 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.449 2.099 . . . . 0.0 112.912 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.79 130.6 17.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -0.775 . . . . 0.0 110.072 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.84 59.71 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -92.22 135.24 34.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.013 -1.286 . . . . 0.0 109.061 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -75.24 161.27 29.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.314 -0.867 . . . . 0.0 110.189 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.55 158.86 3.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.57 -0.706 . . . . 0.0 110.23 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 9.3 t -147.31 158.0 43.8 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 87.1 mt -83.09 124.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.872 -1.143 . . . . 0.0 109.306 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.41 153.9 14.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.206 -0.934 . . . . 0.0 109.543 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.86 -53.45 57.8 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.611 -0.835 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -48.88 -44.65 40.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.885 -1.135 . . . . 0.0 109.043 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -72.33 -39.06 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 40' ' ' TYR . 11.0 ttmt -67.32 -49.86 62.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.977 -1.077 . . . . 0.0 109.444 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -50.34 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.27 -49.26 74.73 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 110.42 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -68.87 -39.75 79.66 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 111.701 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.31 -48.59 49.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.699 -1.251 . . . . 0.0 111.305 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.123 -0.985 . . . . 0.0 110.44 -178.61 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 37.6 p-10 -95.24 -170.81 2.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.371 -0.831 . . . . 0.0 109.59 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.444 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 70.1 m-80 -68.18 -11.57 59.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.849 . . . . 0.0 110.789 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -103.47 -23.27 13.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.028 -1.045 . . . . 0.0 109.907 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 109.41 19.27 8.48 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 24.3 mtt180 -84.71 124.59 31.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.131 -1.217 . . . . 0.0 109.47 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.7 mm -75.45 101.73 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.835 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -95.24 150.62 20.04 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -87.48 -171.81 3.63 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.0 111.45 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.431 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 66.2 p -54.06 149.95 8.68 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.0 -45.25 2.48 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 1.4 mp0 -69.22 131.84 45.55 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.563 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.3 m -152.7 152.35 31.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.287 -0.883 . . . . 0.0 108.775 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.444 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.1 tt0 -95.92 141.59 29.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.042 -1.037 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -88.11 163.03 16.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.718 -0.613 . . . . 0.0 109.376 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -62.71 -19.82 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.018 -1.051 . . . . 0.0 108.571 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.91 -13.59 44.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.913 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.31 -26.83 19.02 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 121.258 -0.901 . . . . 0.0 111.075 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -61.99 135.92 57.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.694 -1.474 . . . . 0.0 110.237 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH1' ' A' ' 11' ' ' ARG . 74.1 m-85 -80.57 168.28 19.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -161.04 147.38 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.0 -1.062 . . . . 0.0 109.298 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.978 ' N ' HD22 ' A' ' 26' ' ' LEU . 84.6 t80 -139.16 168.05 20.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 65.5 tttt -127.06 138.99 53.32 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.433 -0.792 . . . . 0.0 109.437 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.603 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 19.4 p90 -138.39 170.7 15.55 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mm -108.47 136.57 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.405 -0.809 . . . . 0.0 110.123 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.4 m-20 -78.47 161.82 26.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.22 -0.925 . . . . 0.0 108.649 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 t -59.79 -2.82 0.42 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 109.317 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.4 m-85 -101.53 -18.46 15.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.335 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 2.4 51.5 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 121.227 -0.921 . . . . 0.0 111.237 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -86.26 148.15 46.57 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.78 -1.424 . . . . 0.0 110.191 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 87.2 Cg_endo -76.99 128.32 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 122.94 2.427 . . . . 0.0 113.213 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.524 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -131.29 163.45 27.79 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -131.73 156.2 46.35 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.282 -0.886 . . . . 0.0 109.892 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.41 147.04 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -125.79 151.57 46.58 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.783 0.801 . . . . 0.0 109.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -172.27 145.47 1.72 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -87.79 23.79 1.92 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.951 -1.093 . . . . 0.0 108.281 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -137.37 137.56 38.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.593 -0.692 . . . . 0.0 110.539 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.0 tp -95.18 -42.33 8.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 47' ' ' THR . 18.2 m -126.86 147.49 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.15 -7.04 0.17 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 45' ' ' VAL . 30.8 p -89.82 -4.74 57.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.998 -1.064 . . . . 0.0 110.184 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.21 164.18 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.142 -0.974 . . . . 0.0 110.801 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.539 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -134.86 121.03 20.04 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.3 150.69 64.61 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.75 150.52 44.84 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.491 2.128 . . . . 0.0 111.69 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.83 147.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.83 -38.36 3.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -95.17 131.21 41.45 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.307 -1.114 . . . . 0.0 108.485 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -77.76 153.4 32.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.839 -1.163 . . . . 0.0 109.689 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.02 163.31 22.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.45 -0.781 . . . . 0.0 110.128 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 29.6 t -157.16 169.71 24.17 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.589 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.7 mt -82.42 136.82 22.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 94.5 p -55.85 154.31 7.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.149 -0.969 . . . . 0.0 109.311 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 61' ' ' ARG . 78.6 mt -62.01 -49.61 75.37 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.308 -0.87 . . . . 0.0 110.272 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 60' ' ' LEU . 30.5 mtt180 -46.65 -47.53 20.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.786 -1.196 . . . . 0.0 109.787 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -72.18 -34.83 68.72 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -68.71 -41.57 78.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 108.913 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.26 -52.54 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.45 -34.45 72.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -70.85 -35.33 72.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.424 -0.798 . . . . 0.0 111.535 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.603 HD12 ' CZ ' ' A' ' 29' ' ' TYR . 4.0 mm? -63.61 -39.93 95.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.821 -1.174 . . . . 0.0 110.658 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 . . . . . 0 C--N 1.293 -1.88 0 O-C-N 120.538 -1.351 . . . . 0.0 111.352 -177.881 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 6' ' ' ARG . 35.9 mtm-85 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -95.69 -163.88 1.1 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.082 -1.012 . . . . 0.0 109.85 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 13.4 p30 -67.07 -23.54 65.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -100.03 5.02 45.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 110.637 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.43 49.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -87.19 134.86 33.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.137 -1.214 . . . . 0.0 110.205 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.4 mm -84.44 97.1 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 108.773 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.78 146.02 24.47 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.039 -1.038 . . . . 0.0 109.708 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.79 178.59 6.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.122 -0.986 . . . . 0.0 109.732 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -57.26 147.02 26.61 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.532 0.682 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.55 -45.23 1.76 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 24.3 mp0 -72.41 156.62 38.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.106 -1.232 . . . . 0.0 109.802 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.8 m -157.75 140.91 15.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.534 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.4 tt0 -94.85 142.18 27.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -92.25 169.08 10.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.631 0.729 . . . . 0.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -63.48 -23.1 67.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.701 -0.624 . . . . 0.0 110.553 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -88.1 -17.49 30.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 0.0 110.133 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.39 -32.21 6.02 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -60.4 135.15 57.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.736 -1.449 . . . . 0.0 109.558 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.68 170.18 16.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 111.192 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.3 tp -152.03 121.66 6.93 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 82.3 t80 -125.14 174.66 7.91 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.236 -0.915 . . . . 0.0 108.57 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.576 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 75.1 tttt -128.06 121.77 30.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 109.779 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -124.3 158.47 32.49 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.96 150.02 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.467 ' CG ' ' NE2' ' A' ' 37' ' ' GLN . 69.1 m-20 -80.9 170.44 16.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 108.937 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.7 m -68.07 -2.64 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -96.96 -17.51 20.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.132 -0.98 . . . . 0.0 109.389 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.59 -4.41 32.71 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 20.9 pt-20 -85.34 145.67 43.08 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.882 -1.363 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 86.2 Cg_endo -78.57 146.97 21.94 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.645 2.23 . . . . 0.0 113.44 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.469 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.8 mp0 -142.3 178.35 7.63 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -133.95 152.9 52.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 0.0 109.531 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.578 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -129.92 158.58 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.451 -0.781 . . . . 0.0 109.33 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 36.6 m-85 -128.95 149.96 50.58 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.277 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -168.37 142.28 3.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 0.0 109.949 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -90.37 11.63 20.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -139.87 153.48 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 0.0 110.442 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 59' ' ' SER . 42.9 tp -99.25 -43.61 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.95 170.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.15 -15.58 59.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 0.0 110.886 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.2 p -86.57 -13.76 44.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.588 -1.32 . . . . 0.0 110.069 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -71.17 178.94 3.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.389 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.8 147.73 46.78 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.92 149.66 74.09 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.976 -1.077 . . . . 0.0 109.553 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -51.7 147.64 23.72 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.337 1.358 . . . . 0.0 111.432 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.24 141.18 11.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 -24.64 29.14 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -96.81 140.74 30.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.313 . . . . 0.0 109.356 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -74.45 153.28 39.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.807 -1.183 . . . . 0.0 109.148 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.31 163.32 0.41 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.181 -0.949 . . . . 0.0 110.09 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -148.38 160.12 43.33 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 99.0 mt -84.84 134.26 27.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 44.3 t -58.47 153.87 15.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.661 -0.65 . . . . 0.0 110.052 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -60.82 -53.13 61.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -49.87 -45.74 50.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.935 -1.103 . . . . 0.0 109.845 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.9 -29.9 66.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 108.675 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -72.39 -45.54 59.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.459 -0.775 . . . . 0.0 109.204 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.35 -55.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 0.0 110.252 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.06 93.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 0.0 110.647 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -68.74 -35.16 76.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 111.803 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.03 -41.78 86.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.569 -1.332 . . . . 0.0 111.755 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 . . . . . 0 C--N 1.293 -1.874 0 O-C-N 120.239 -1.538 . . . . 0.0 111.335 -177.383 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -70.34 175.24 4.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 0.0 110.264 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.521 HD22 ' CD ' ' A' ' 19' ' ' GLN . 79.9 m-20 -66.81 -12.4 58.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.476 -0.765 . . . . 0.0 109.931 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.435 ' NH1' ' HG3' ' A' ' 9' ' ' ARG . 7.7 mmm-85 -95.57 -77.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 0.0 109.349 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.96 3.7 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.216 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 55.9 mtm180 -88.14 125.27 34.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.732 -1.452 . . . . 0.0 108.869 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.3 mt -77.79 110.95 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.07 -1.019 . . . . 0.0 109.832 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.2 156.71 18.12 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -88.79 -176.84 5.36 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.816 -1.178 . . . . 0.0 110.775 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -54.63 161.65 1.42 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.801 0.81 . . . . 0.0 112.068 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.34 -19.26 1.89 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 40.4 mt-10 -86.92 150.03 24.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.266 . . . . 0.0 110.295 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.0 p -157.5 134.05 9.83 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.521 ' CD ' HD22 ' A' ' 8' ' ' ASN . 47.9 tt0 -99.2 125.8 44.86 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' CG ' HH11 ' A' ' 20' ' ' ARG . 1.0 OUTLIER -85.57 -174.13 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.816 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -72.48 -22.9 60.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 109.937 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.67 -10.97 57.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.89 -21.94 43.42 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -61.33 138.05 58.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.847 -1.384 . . . . 0.0 109.294 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 67.3 m-85 -80.54 166.72 20.9 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.252 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 24.3 tp -150.24 119.07 6.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 109.623 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -125.44 162.27 25.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -131.44 138.13 48.92 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.25 -0.906 . . . . 0.0 110.736 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.2 p90 -142.82 164.51 29.9 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.62 138.85 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.94 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.456 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 52.8 m-20 -87.37 -178.35 6.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.949 . . . . 0.0 110.4 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 p -66.91 -1.37 3.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.321 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 47.9 m-85 -98.58 -10.63 23.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.951 . . . . 0.0 108.713 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.45 -8.52 76.88 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -81.37 145.2 54.99 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.5 148.22 42.27 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.94 1.76 . . . . 0.0 112.717 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.1 mp0 -135.67 170.71 15.54 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.28 145.89 39.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.346 -0.846 . . . . 0.0 110.383 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.85 146.49 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.704 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 62.2 m-85 -128.91 151.11 50.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.597 -0.69 . . . . 0.0 109.596 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -171.66 146.19 2.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -88.83 11.42 17.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 108.51 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -123.57 140.99 52.44 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.555 -0.716 . . . . 0.0 110.226 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.79 -44.95 6.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.38 172.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -19.41 62.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.2 p -86.7 -1.98 58.15 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.703 -1.248 . . . . 0.0 110.788 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' OD1' ' NH1' ' A' ' 11' ' ' ARG . 76.0 m-20 -70.6 -174.22 0.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.585 -1.322 . . . . 0.0 109.334 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -148.75 130.53 15.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.043 -1.035 . . . . 0.0 109.454 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 15.0 m -80.97 130.07 64.91 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.83 -1.169 . . . . 0.0 109.272 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -48.87 148.05 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.188 1.259 . . . . 0.0 111.711 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.14 135.46 13.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.112 -0.992 . . . . 0.0 109.817 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.13 -32.66 6.68 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -92.33 136.47 33.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -1.165 . . . . 0.0 108.553 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.3 mmp_? -74.59 151.78 39.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.377 -0.827 . . . . 0.0 110.439 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -55.62 169.48 0.32 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 43.6 t -165.15 166.46 19.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.131 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 71.5 mt -83.6 125.48 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.015 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -56.69 156.0 6.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.337 -0.852 . . . . 0.0 109.638 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.456 ' O ' HD13 ' A' ' 64' ' ' ILE . 8.2 mp -56.13 -47.85 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 17' ' ' GLU . 5.0 mmp_? -53.25 -50.6 64.47 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.013 -1.054 . . . . 0.0 110.291 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.29 -36.68 61.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.753 -1.217 . . . . 0.0 110.806 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -65.97 -44.34 85.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.747 -1.22 . . . . 0.0 110.105 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.3 mp -60.68 -48.78 87.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.48 -42.71 74.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.93 -1.106 . . . . 0.0 109.974 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.27 -51.86 27.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 110.807 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.417 HD22 ' OH ' ' A' ' 29' ' ' TYR . 30.7 mt -68.27 -26.32 65.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 111.752 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 C--N 1.292 -1.912 0 O-C-N 120.804 -1.185 . . . . 0.0 112.745 -177.003 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 121.456 0.646 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -100.82 -176.47 3.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.732 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -66.29 -15.17 63.01 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.042 -1.036 . . . . 0.0 110.034 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.3 OUTLIER -95.39 -0.51 52.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 -178.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 0.45 86.45 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -84.57 137.04 33.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.107 -1.231 . . . . 0.0 109.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.6 mt -80.47 120.06 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.916 -1.115 . . . . 0.0 109.743 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -90.32 150.59 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 18.8 mtpp -87.09 -178.03 6.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.926 -1.109 . . . . 0.0 110.608 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 29.7 p -57.1 149.05 20.21 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 111.571 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.16 -30.37 2.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 15' ' ' THR . 43.1 mp0 -76.15 154.17 35.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.845 -1.385 . . . . 0.0 109.296 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -157.43 138.24 13.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.066 -1.022 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -99.37 134.34 42.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 20' ' ' ARG . 5.2 mmm-85 -87.54 176.02 7.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -21.33 63.56 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -83.52 -7.27 59.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.618 -0.676 . . . . 0.0 110.527 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.11 -28.46 13.84 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 120.97 -1.081 . . . . 0.0 111.068 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -57.13 154.33 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.853 -1.381 . . . . 0.0 109.616 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.63 169.85 9.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 109.731 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 tt -154.83 133.3 11.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.456 -0.777 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.96 146.41 49.08 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -118.92 136.38 54.09 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.653 -0.654 . . . . 0.0 110.606 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.551 ' C ' HD12 ' A' ' 30' ' ' ILE . 7.3 p90 -148.12 -171.9 3.94 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.365 -0.834 . . . . 0.0 110.287 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.551 HD12 ' C ' ' A' ' 29' ' ' TYR . 1.7 mp -106.64 129.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.9 p30 -86.47 -171.66 3.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.189 -0.944 . . . . 0.0 109.6 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.76 19.89 0.19 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.881 -1.137 . . . . 0.0 109.291 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 10.7 m-85 -118.29 -15.05 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.337 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.21 64.56 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.6 147.94 50.6 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.183 -1.186 . . . . 0.0 109.583 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.8 140.07 34.73 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.014 1.81 . . . . 0.0 112.36 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.682 HE21 ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.0 164.65 26.51 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 23.2 m-85 -128.65 141.41 51.35 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.17 -0.957 . . . . 0.0 109.271 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.85 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -122.52 154.89 37.26 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.702 0.763 . . . . 0.0 110.113 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -171.26 143.6 1.9 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.999 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -97.17 18.25 15.38 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.81 144.72 31.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.324 -0.86 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 59' ' ' SER . 45.1 tp -94.25 -43.92 8.21 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.24 167.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -12.55 61.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.488 -0.757 . . . . 0.0 111.261 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.0 m -86.79 -9.6 55.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.903 -1.123 . . . . 0.0 110.098 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.28 167.19 16.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -140.2 118.85 12.34 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.92 148.24 86.88 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.38 157.1 62.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.183 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.96 150.5 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.311 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.64 -41.62 2.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -98.13 132.04 44.0 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.493 -1.004 . . . . 0.0 108.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.469 ' CD ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.86 157.66 31.3 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.086 -1.009 . . . . 0.0 109.896 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -53.78 159.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.4 m -148.6 176.19 10.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 109.192 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.61 126.66 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 31.5 t -55.63 148.53 15.83 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.16 -0.963 . . . . 0.0 108.481 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 mt -58.52 -52.43 65.68 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.461 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 16.1 mmt180 -49.36 -37.24 24.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.704 -1.247 . . . . 0.0 108.989 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.35 -43.5 60.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.279 -0.888 . . . . 0.0 109.364 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -65.06 -44.36 89.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.494 -0.754 . . . . 0.0 109.613 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.09 -47.06 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.67 -46.58 88.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.099 -1.0 . . . . 0.0 109.851 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.47 -40.05 70.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.234 -0.916 . . . . 0.0 110.843 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.7 mt -66.4 -45.24 80.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 112.082 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.27 -1.519 . . . . 0.0 110.263 -178.517 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.6 mtm-85 . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 43.6 p-10 -76.83 -175.08 3.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.042 . . . . 0.0 109.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.58 -6.16 3.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.65 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -104.77 -81.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 0.0 109.404 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 177.72 2.81 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 17.5 ptt180 -86.96 132.03 33.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.082 -1.246 . . . . 0.0 108.584 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 131.86 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.46 163.01 16.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 175.98 7.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.098 -1.001 . . . . 0.0 109.783 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -60.96 130.32 45.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.859 -0.526 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.58 -37.29 3.42 Favored Glycine 0 N--CA 1.501 2.973 0 O-C-N 121.218 -0.926 . . . . 0.0 111.892 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 59.1 mp0 -72.62 150.58 42.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.638 -1.507 . . . . 0.0 110.265 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -155.8 148.39 23.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.316 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -104.8 132.93 50.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.963 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -85.42 170.9 12.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 109.632 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -68.68 -18.49 64.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.15 -21.31 36.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 110.359 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.53 3.86 Favored Glycine 0 N--CA 1.502 3.082 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -61.06 139.64 58.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.124 -1.221 . . . . 0.0 109.191 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 86.6 m-85 -85.73 170.3 12.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.835 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.604 HD13 ' CE2' ' A' ' 40' ' ' TYR . 41.4 tp -151.46 128.15 10.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -129.88 142.95 50.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.57 142.08 47.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.569 -0.707 . . . . 0.0 110.247 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.625 ' OH ' HD12 ' A' ' 67' ' ' LEU . 9.8 p90 -149.09 -171.41 3.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.0 109.53 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.11 134.85 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.261 -0.899 . . . . 0.0 110.221 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' OD2' ' OE1' ' A' ' 37' ' ' GLN . 12.5 m-20 -87.05 175.25 8.2 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.862 -1.149 . . . . 0.0 110.392 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 m -70.76 -2.71 15.58 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 11.0 m-85 -98.67 -11.59 21.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.589 -0.694 . . . . 0.0 109.357 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.79 -5.88 79.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.547 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.9 pt-20 -86.75 152.08 53.54 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.159 -1.201 . . . . 0.0 109.328 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.527 ' C ' HE21 ' A' ' 37' ' ' GLN . 95.3 Cg_endo -78.25 155.1 28.92 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.137 1.891 . . . . 0.0 112.441 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -148.86 160.14 43.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.217 -0.927 . . . . 0.0 109.235 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HB3' HD11 ' A' ' 26' ' ' LEU . 51.8 m-85 -136.66 148.97 47.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 26' ' ' LEU . 11.2 m -122.24 145.37 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.604 ' CE2' HD13 ' A' ' 26' ' ' LEU . 55.6 m-85 -116.03 151.51 35.36 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 t -169.64 145.54 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.28 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.72 9.07 36.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -132.32 133.64 44.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD11 ' NH2' ' A' ' 61' ' ' ARG . 35.1 tp -88.99 -42.96 11.47 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.67 151.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.42 -7.08 3.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.109 -0.995 . . . . 0.0 111.156 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.1 p -90.34 -11.8 39.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.749 -1.22 . . . . 0.0 109.774 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.62 172.49 11.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.181 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.33 135.03 33.34 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.24 147.39 60.53 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.745 -1.222 . . . . 0.0 110.451 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.61 145.7 71.02 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.13 1.887 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.72 144.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 110.573 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.12 -32.62 7.3 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -97.07 139.11 33.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.159 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.62 151.8 34.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -0.966 . . . . 0.0 109.771 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.7 150.53 15.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.141 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.7 p -147.32 161.98 39.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.046 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.69 126.81 40.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.0 m -56.33 160.94 2.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.157 -0.964 . . . . 0.0 108.801 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.04 -47.6 73.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.748 -1.22 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.596 ' NH2' HD11 ' A' ' 44' ' ' LEU . 5.1 mmt-85 -41.54 -53.01 3.58 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.401 -0.812 . . . . 0.0 110.28 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -69.01 -34.43 75.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.088 -1.008 . . . . 0.0 108.662 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -68.77 -41.87 78.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -50.15 -51.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.138 -0.976 . . . . 0.0 109.266 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.7 70.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.852 -1.155 . . . . 0.0 109.525 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.93 -44.87 60.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.91 . . . . 0.0 111.481 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.625 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.5 mm? -69.54 -44.06 71.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.23 -1.544 . . . . 0.0 110.899 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 . . . . . 0 N--CA 1.496 1.863 0 O-C-N 119.762 -1.836 . . . . 0.0 110.886 -178.513 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 121.444 0.64 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.57 -159.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.407 -0.808 . . . . 0.0 109.743 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.112 -0.992 . . . . 0.0 110.261 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -92.18 -86.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.041 . . . . 0.0 109.496 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.1 22.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.551 ' NH1' ' OD2' ' A' ' 48' ' ' ASP . 67.6 mtm180 -88.72 135.73 33.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.795 -1.415 . . . . 0.0 110.578 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.8 mm -76.37 114.46 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 140.45 33.14 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -86.39 179.01 6.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.963 -1.085 . . . . 0.0 111.028 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -52.13 155.12 2.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.418 0.628 . . . . 0.0 109.84 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.68 -44.75 2.06 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -70.28 147.17 50.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -1.231 . . . . 0.0 109.272 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -155.24 157.5 37.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.649 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.0 tp-100 -107.28 123.12 47.85 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.388 -0.82 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.539 ' NH2' ' OH ' ' A' ' 40' ' ' TYR . 18.3 mtt180 -83.62 169.49 15.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.201 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.877 . . . . 0.0 109.622 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' A' ' 24' ' ' ARG . 1.4 p30 -91.43 -26.58 18.78 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.97 -1.081 . . . . 0.0 109.98 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.42 -36.25 2.96 Favored Glycine 0 N--CA 1.505 3.295 0 O-C-N 121.268 -0.895 . . . . 0.0 111.443 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.531 ' NH2' ' OD2' ' A' ' 22' ' ' ASP . 3.3 ptt-85 -60.57 132.92 55.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.604 -1.527 . . . . 0.0 109.438 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 86.2 m-85 -87.04 168.93 12.86 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pp -147.4 138.22 23.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -125.31 156.97 37.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.662 -0.649 . . . . 0.0 109.452 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -117.68 138.97 51.64 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 16.7 p90 -148.83 -165.89 2.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.984 -1.072 . . . . 0.0 109.961 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.439 ' O ' ' CD2' ' A' ' 29' ' ' TYR . 1.4 mp -107.48 136.37 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 O-C-N 121.315 -0.866 . . . . 0.0 110.461 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.64 ' CG ' HE21 ' A' ' 37' ' ' GLN . 17.0 m-20 -80.56 173.01 13.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.006 -1.059 . . . . 0.0 109.494 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -9.59 10.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 11.5 m-85 -104.21 -6.76 20.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.471 -0.768 . . . . 0.0 110.824 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.26 -4.6 64.87 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.028 -1.045 . . . . 0.0 110.539 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.02 150.54 47.8 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.832 -1.393 . . . . 0.0 110.102 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.55 152.65 23.12 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.268 1.979 . . . . 0.0 113.554 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.64 HE21 ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -157.83 179.89 8.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.75 149.58 50.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.857 -1.152 . . . . 0.0 110.179 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.02 162.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.539 ' OH ' ' NH2' ' A' ' 20' ' ' ARG . 84.1 m-85 -137.0 153.83 50.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.256 -0.902 . . . . 0.0 110.767 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -168.23 149.75 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -86.97 3.68 44.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.337 -0.852 . . . . 0.0 109.302 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -131.95 153.13 50.61 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.392 -0.818 . . . . 0.0 109.459 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 59' ' ' SER . 19.5 tp -93.36 -51.14 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.348 0.594 . . . . 0.0 109.975 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.51 175.62 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.42 0.628 . . . . 0.0 110.5 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.86 63.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 111.095 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -85.16 -8.08 58.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.817 -1.177 . . . . 0.0 110.309 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 59.8 m-20 -74.46 174.38 9.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 109.819 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -139.68 149.51 43.76 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -80.85 138.81 49.99 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.269 -0.894 . . . . 0.0 109.934 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -46.18 140.82 10.47 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.923 1.749 . . . . 0.0 111.706 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.6 132.13 17.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.14 -30.75 6.6 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -94.54 145.5 24.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -1.083 . . . . 0.0 108.706 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HD3' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.6 150.66 34.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 108.726 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -49.53 162.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.01 -1.056 . . . . 0.0 109.845 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 38.2 t -154.78 173.64 16.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.155 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.473 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 5.9 mm -92.1 132.16 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.467 -0.77 . . . . 0.0 109.317 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 45.9 t -55.78 164.11 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.283 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 43' ' ' LYS . 4.5 mp -71.32 -57.48 4.43 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.521 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -45.82 -41.92 11.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -69.06 -41.88 77.02 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.34 -0.944 . . . . 0.0 108.877 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -67.16 -42.03 84.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.938 . . . . 0.0 109.954 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.76 -49.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.76 -1.213 . . . . 0.0 108.635 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.61 83.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.0 110.292 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -70.97 -43.12 68.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.89 . . . . 0.0 111.171 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.453 HD22 ' OH ' ' A' ' 29' ' ' TYR . 11.0 mt -67.66 -44.06 78.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 111.545 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 C--N 1.296 -1.744 0 O-C-N 120.815 -1.178 . . . . 0.0 110.539 -178.328 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.551 HH11 ' CG ' ' A' ' 6' ' ' ARG . 1.7 mtt-85 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -84.66 -171.66 3.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -66.96 -14.87 63.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.882 . . . . 0.0 109.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -95.04 -5.07 45.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -0.894 . . . . 0.0 108.911 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.82 58.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' CG ' ' A' ' 48' ' ' ASP . 17.9 mmt180 -90.67 142.12 28.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -1.183 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mm -82.55 119.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 108.004 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 13' ' ' LEU . 4.0 mp -90.75 145.06 25.11 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -87.6 179.28 6.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.052 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -57.52 136.74 56.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.256 -0.902 . . . . 0.0 110.036 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.27 -56.48 1.23 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -49.3 148.69 2.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 110.021 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -157.13 156.84 33.39 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -99.74 145.17 27.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.027 -1.046 . . . . 0.0 110.493 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -89.59 149.72 22.72 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.676 ' CD ' ' H ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -58.36 -20.57 44.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -89.15 -11.23 44.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 110.43 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.28 -35.0 5.24 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.56 HH21 ' HE1' ' A' ' 42' ' ' TRP . 2.4 ptp180 -59.12 143.96 47.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.412 . . . . 0.0 108.738 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -90.73 162.68 14.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.915 . . . . 0.0 110.183 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.501 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -147.33 140.42 25.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.666 0.746 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 39' ' ' VAL . 86.4 t80 -134.47 151.98 51.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -120.04 142.11 49.13 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.549 -0.719 . . . . 0.0 109.286 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -140.86 163.1 33.86 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.92 138.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.153 -0.967 . . . . 0.0 109.969 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' CG ' ' NE2' ' A' ' 37' ' ' GLN . 45.3 m-20 -84.12 161.68 20.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.6 p -63.24 -3.25 1.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -99.75 -15.96 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.379 -0.826 . . . . 0.0 109.085 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.32 56.89 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -80.59 156.29 73.22 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.499 -1.589 . . . . 0.0 107.125 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -93.53 141.08 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.563 1.508 . . . . 0.0 111.101 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.493 ' NE2' ' CG ' ' A' ' 31' ' ' ASP . 2.8 mp0 -130.02 154.64 47.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.539 -0.726 . . . . 0.0 109.126 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.2 147.89 52.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 27' ' ' TYR . 2.0 m -123.11 156.05 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.442 -0.786 . . . . 0.0 109.037 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 64.4 m-85 -129.9 156.12 44.93 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.427 -0.795 . . . . 0.0 109.696 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -174.31 146.31 1.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.592 -0.693 . . . . 0.0 109.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.56 ' HE1' HH21 ' A' ' 24' ' ' ARG . 54.7 m95 -90.46 3.49 53.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -123.77 142.5 51.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -92.42 -44.49 8.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.543 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 46' ' ' ALA . 2.1 t -121.7 174.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -72.74 -15.14 61.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -92.47 -8.52 44.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.049 -1.032 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.474 ' CG ' ' NH2' ' A' ' 11' ' ' ARG . 1.1 m-20 -72.54 168.84 17.75 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.278 -0.888 . . . . 0.0 109.805 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -134.73 144.64 47.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 50' ' ' VAL . 32.9 m -81.21 122.62 81.57 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.88 151.79 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.509 1.473 . . . . 0.0 112.025 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.85 139.58 7.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.56 -30.88 9.31 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 13.0 mptt -93.46 127.26 39.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -1.15 . . . . 0.0 108.242 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -78.01 149.74 33.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.579 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 53.1 t0 -40.06 147.03 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.789 -0.569 . . . . 0.0 109.902 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.5 p -153.66 164.86 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG2' ' CD ' ' A' ' 62' ' ' GLU . 20.3 mt -83.29 129.3 37.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.634 0.731 . . . . 0.0 110.032 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 92.4 p -60.84 173.14 0.8 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 63' ' ' LYS . 96.6 mt -83.92 -59.71 2.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.867 -1.146 . . . . 0.0 110.071 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' LEU . 37.6 mtt180 -40.01 -35.0 0.33 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' CD ' ' CG2' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -72.9 -40.89 65.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.736 -1.227 . . . . 0.0 108.582 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 60' ' ' LEU . 46.2 mttm -63.91 -46.46 84.72 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.505 -0.747 . . . . 0.0 109.719 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -53.44 -49.41 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.66 94.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -78.73 -44.18 24.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.06 -1.025 . . . . 0.0 112.501 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -66.71 -38.82 87.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.127 -1.608 . . . . 0.0 111.432 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--N 1.292 -1.892 0 O-C-N 120.477 -1.389 . . . . 0.0 110.612 -178.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.478 ' HG2' HD13 ' A' ' 12' ' ' ILE . 65.8 mtm180 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 39.4 p-10 -80.57 -169.23 2.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.76 HD21 ' NE2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -70.24 -21.11 63.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 108.831 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 9' ' ' ARG . 22.5 mmm-85 -95.81 1.89 53.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.457 -0.777 . . . . 0.0 110.42 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 82.51 20.64 61.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.543 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -86.97 149.29 24.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.344 . . . . 0.0 108.567 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.478 HD13 ' HG2' ' A' ' 6' ' ' ARG . 6.5 mm -90.6 119.37 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.422 -0.799 . . . . 0.0 109.174 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.794 HD22 ' N ' ' A' ' 13' ' ' LEU . 1.7 mm? -89.45 136.68 32.89 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 14' ' ' LYS . 8.9 mtmp? -86.38 -174.15 4.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.876 -1.14 . . . . 0.0 110.447 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 17' ' ' GLU . 8.8 m -51.55 138.99 21.29 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.753 -0.592 . . . . 0.0 110.206 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.04 -42.18 0.76 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 15' ' ' THR . 85.7 mt-10 -66.02 140.18 58.26 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.043 -1.269 . . . . 0.0 109.845 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 92.4 p -158.22 164.47 36.47 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.76 ' NE2' HD21 ' A' ' 8' ' ' ASN . 1.5 tm0? -92.8 150.44 20.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.888 -1.132 . . . . 0.0 109.393 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.485 ' NH1' ' CZ ' ' A' ' 24' ' ' ARG . 2.2 ttt180 -89.79 161.77 15.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.336 -0.852 . . . . 0.0 109.429 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -57.36 -30.06 64.55 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.906 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -84.92 -44.22 13.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 0.0 110.16 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.53 -31.81 1.02 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.485 ' CZ ' ' NH1' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -61.26 144.61 53.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.897 -1.355 . . . . 0.0 108.985 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -85.7 164.73 17.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.32 150.94 28.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 109.708 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.502 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 63.4 t80 -134.96 169.2 17.77 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 26.8 tttm -128.09 138.74 52.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.298 -0.876 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.434 ' C ' HD12 ' A' ' 30' ' ' ILE . 8.3 p90 -144.82 159.8 42.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.481 HD11 ' NZ ' ' A' ' 28' ' ' LYS . 1.4 mp -100.34 136.31 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.34 -0.85 . . . . 0.0 109.165 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 33' ' ' PHE . 54.8 m-20 -81.5 166.76 20.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.164 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -60.55 1.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -1.0 . . . . 0.0 111.068 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 9.6 m-85 -101.47 -21.17 14.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.924 -1.11 . . . . 0.0 108.557 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.52 39.12 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.565 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.1 pt-20 -84.82 150.13 55.26 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.912 -1.346 . . . . 0.0 109.961 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.51 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 85.3 Cg_endo -78.7 139.66 16.0 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.78 2.32 . . . . 0.0 113.527 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.565 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -137.88 161.33 36.9 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.28 -0.888 . . . . 0.0 108.827 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -132.11 150.1 52.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.25 151.05 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -126.45 155.03 42.88 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.333 -0.854 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.1 t -170.06 152.66 4.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.657 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -93.99 16.54 14.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 144.24 32.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' ' OG ' ' A' ' 59' ' ' SER . 21.5 tp -96.53 -44.49 7.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.41 HG12 ' NH1' ' A' ' 61' ' ' ARG . 15.7 m -119.79 153.93 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 121.547 0.689 . . . . 0.0 109.261 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.45 -11.75 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.72 . . . . 0.0 110.904 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 -8.28 39.17 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.73 -1.231 . . . . 0.0 111.222 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.0 166.36 21.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.903 -1.123 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 49' ' ' ARG . 4.0 tpt180 -128.24 124.01 35.61 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.469 -0.77 . . . . 0.0 109.093 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.41 142.22 40.21 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.847 . . . . 0.0 109.971 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -48.59 147.87 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.284 1.323 . . . . 0.0 110.823 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.23 -37.3 46.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.853 -1.154 . . . . 0.0 109.595 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.25 -31.24 56.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -98.35 135.16 40.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -1.161 . . . . 0.0 108.587 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -79.04 166.55 22.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 109.74 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -65.51 159.27 24.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.193 -0.942 . . . . 0.0 110.021 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.8 p -161.54 178.34 9.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.6 mt -87.48 134.12 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 21.9 t -61.62 161.39 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 109.883 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 64' ' ' ILE . 84.1 mt -64.8 -48.72 73.4 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.948 -1.095 . . . . 0.0 109.644 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -48.09 -51.39 24.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.793 -1.192 . . . . 0.0 109.133 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -70.01 -38.12 75.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.59 -45.62 86.18 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.712 -1.243 . . . . 0.0 109.149 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -48.49 -54.29 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -30.2 69.74 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.171 -0.956 . . . . 0.0 109.687 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.91 -42.91 76.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.148 -0.97 . . . . 0.0 111.542 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.4 mm? -69.21 -51.24 39.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.846 -1.159 . . . . 0.0 111.418 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 . . . . . 0 C--N 1.298 -1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 112.075 -177.134 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 53.6 p-10 -87.13 -165.5 1.31 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.884 -1.135 . . . . 0.0 109.996 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -66.67 -17.92 65.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.699 -0.625 . . . . 0.0 109.403 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' CG ' HH11 ' A' ' 9' ' ' ARG . 4.4 mtt-85 -103.98 -80.13 0.53 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.382 -0.824 . . . . 0.0 109.162 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -178.92 34.7 0.07 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -90.56 130.95 36.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -1.055 . . . . 0.0 110.178 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.6 mm -79.91 107.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.3 mp -88.29 157.49 18.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.93 -1.106 . . . . 0.0 110.481 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -87.82 170.48 11.15 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 m -52.75 138.63 28.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.141 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.73 -57.75 1.87 Allowed Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.111 -0.993 . . . . 0.0 110.74 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -51.56 141.88 15.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 110.081 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.2 m -152.21 149.81 29.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.617 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.4 tp-100 -95.26 137.99 33.56 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.256 -0.903 . . . . 0.0 109.727 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.632 ' NH1' ' NH2' ' A' ' 24' ' ' ARG . 4.7 mtp180 -81.84 -177.04 6.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -76.71 -24.97 53.09 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.825 -0.547 . . . . 0.0 110.042 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' OD2' ' NE ' ' A' ' 24' ' ' ARG . 38.6 p-10 -89.98 -28.53 19.06 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.753 -1.217 . . . . 0.0 111.407 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 19' ' ' GLN . . . 136.05 -26.24 3.13 Favored Glycine 0 N--CA 1.503 3.157 0 O-C-N 120.757 -1.214 . . . . 0.0 111.382 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.632 ' NH2' ' NH1' ' A' ' 20' ' ' ARG . 8.0 ptt180 -65.59 135.99 55.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.364 -1.668 . . . . 0.0 108.714 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.617 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 72.0 m-85 -72.67 173.55 8.84 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 40' ' ' TYR . 25.5 tp -152.4 126.89 9.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.5 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -129.4 151.87 49.57 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HZ3' ' C ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -124.55 135.03 52.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.33 -0.856 . . . . 0.0 110.055 -178.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.635 ' OH ' HD12 ' A' ' 67' ' ' LEU . 17.4 p90 -139.17 164.88 28.64 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.316 -0.865 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.428 HG13 ' NZ ' ' A' ' 28' ' ' LYS . 87.1 mt -105.41 137.71 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.357 -0.84 . . . . 0.0 109.0 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' CG ' ' A' ' 35' ' ' GLU . 5.0 p30 -83.39 175.39 9.88 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.143 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -66.2 6.06 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.936 -1.103 . . . . 0.0 110.882 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -102.36 -18.93 15.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.933 -1.105 . . . . 0.0 110.118 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.24 -9.4 45.96 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 121.11 -0.994 . . . . 0.0 110.651 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HG3' HE22 ' A' ' 37' ' ' GLN . 17.4 pt-20 -87.9 146.15 38.13 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.953 -1.322 . . . . 0.0 109.137 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.618 ' C ' HE21 ' A' ' 37' ' ' GLN . 95.2 Cg_endo -77.87 136.65 15.16 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.481 2.121 . . . . 0.0 112.679 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.679 HE21 ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -122.19 174.93 6.66 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.268 -0.895 . . . . 0.0 109.073 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.95 146.32 39.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.561 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -131.99 143.56 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.646 -0.659 . . . . 0.0 109.273 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' A' ' 26' ' ' LEU . 61.2 m-85 -124.15 160.0 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.518 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 153.8 5.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -98.09 14.81 26.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -140.8 146.94 38.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.089 -1.007 . . . . 0.0 109.136 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.7 tp -89.74 -49.3 6.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 109.123 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 m -118.97 171.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.95 -17.54 62.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.359 -0.838 . . . . 0.0 111.893 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.4 t -87.92 -4.86 58.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.626 -1.296 . . . . 0.0 110.629 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.7 -175.08 1.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 0.0 110.55 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -142.03 133.76 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.9 m -73.53 150.59 89.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.073 -1.017 . . . . 0.0 108.426 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.64 148.07 92.45 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.903 1.735 . . . . 0.0 111.723 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.95 143.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.411 -0.805 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.43 -29.03 10.17 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -94.87 143.08 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.317 . . . . 0.0 109.819 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 55' ' ' ARG . 8.1 ptt-85 -78.67 154.92 29.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.5 155.52 15.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.061 -1.024 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.1 m -149.11 177.85 9.24 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.0 mt -93.55 135.68 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.99 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 p -57.97 174.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 108.874 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 60' ' ' LEU . 4.3 mp -77.93 -54.25 6.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.868 -1.145 . . . . 0.0 110.234 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -47.01 -40.8 15.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.447 -0.783 . . . . 0.0 110.282 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -70.49 -38.46 74.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 66' ' ' GLU . 41.9 mttt -67.26 -50.52 60.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 108.767 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 63' ' ' LYS . 1.5 mp -40.0 -54.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.618 -0.676 . . . . 0.0 109.437 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.46 73.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 109.691 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 63' ' ' LYS . 11.0 tp10 -76.42 -41.66 46.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.396 -0.815 . . . . 0.0 111.738 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.6 mm? -62.79 -48.44 79.13 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.585 -1.322 . . . . 0.0 111.284 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 . . . . . 0 C--N 1.294 -1.81 0 O-C-N 121.009 -1.057 . . . . 0.0 111.045 -177.659 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 70.1 mtt180 . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 6' ' ' ARG . 67.7 m-20 -137.56 -103.72 0.19 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.363 -0.836 . . . . 0.0 112.378 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' A' ' 19' ' ' GLN . 72.9 m-20 -66.46 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -94.68 27.8 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.078 -1.014 . . . . 0.0 112.097 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.69 29.5 51.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -81.21 141.04 34.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.401 -1.058 . . . . 0.0 108.606 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.8 mm -86.21 98.36 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 109.681 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -91.57 151.5 20.7 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -89.56 -178.84 5.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.005 -1.059 . . . . 0.0 110.941 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 t -55.6 156.44 4.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.8 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.88 -36.62 3.26 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -79.65 159.76 26.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.886 -1.361 . . . . 0.0 110.174 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -160.41 166.33 29.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.892 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 8' ' ' ASN . 42.8 tt0 -104.22 148.01 26.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.552 HH21 HH11 ' A' ' 24' ' ' ARG . 9.3 mmm180 -90.76 168.59 11.63 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.713 0.768 . . . . 0.0 110.522 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -67.89 -27.51 66.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.393 -0.817 . . . . 0.0 109.606 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.5 p30 -94.99 -28.61 15.05 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.957 . . . . 0.0 110.949 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 136.5 -26.28 3.06 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.648 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.552 HH11 HH21 ' A' ' 20' ' ' ARG . 0.4 OUTLIER -60.0 145.87 44.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.375 -1.662 . . . . 0.0 109.256 -179.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -79.62 167.96 20.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.093 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.455 HD12 ' CE2' ' A' ' 40' ' ' TYR . 1.2 tt -153.02 129.92 10.98 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.873 0.844 . . . . 0.0 110.028 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 39' ' ' VAL . 92.1 t80 -136.42 154.19 50.87 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -127.3 143.62 51.2 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.007 -1.058 . . . . 0.0 110.05 -178.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.426 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 12.2 p90 -137.06 170.63 15.78 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.6 mm -99.88 135.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.15 -0.969 . . . . 0.0 109.799 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 33' ' ' PHE . 88.2 m-20 -81.71 162.98 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.187 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.1 p -64.1 0.74 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.2 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' ASP . 3.6 m-85 -100.66 -20.43 15.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.7 36.42 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.8 pt-20 -86.12 148.62 48.14 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.847 -1.384 . . . . 0.0 109.663 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.487 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 97.2 Cg_endo -83.65 142.45 10.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.947 1.765 . . . . 0.0 112.414 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.0 mp0 -130.2 167.78 17.88 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -134.57 143.45 47.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.394 -0.816 . . . . 0.0 110.267 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -113.06 156.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.455 ' CE2' HD12 ' A' ' 26' ' ' LEU . 95.0 m-85 -133.31 147.27 51.87 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 t -172.11 148.61 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.951 . . . . 0.0 109.615 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -91.54 16.25 10.81 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.342 -0.849 . . . . 0.0 108.856 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 47.6 mtmt -134.41 143.67 47.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.351 -0.843 . . . . 0.0 110.153 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -94.2 -44.08 8.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 46' ' ' ALA . 1.7 t -116.41 176.7 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-O 121.379 0.609 . . . . 0.0 109.438 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -79.53 -15.06 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 110.886 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.5 p -92.91 -14.34 27.73 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.791 -1.193 . . . . 0.0 111.453 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.17 169.73 11.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.713 -1.242 . . . . 0.0 110.481 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -123.58 147.92 46.86 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.517 0.675 . . . . 0.0 109.209 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.14 147.15 60.25 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.424 -0.797 . . . . 0.0 110.063 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.15 140.12 51.55 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.297 1.331 . . . . 0.0 110.834 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.94 149.0 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.886 -1.134 . . . . 0.0 109.588 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.17 -20.27 26.66 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HZ2' ' HB3' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -98.31 137.89 36.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -1.088 . . . . 0.0 108.991 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -76.22 167.8 21.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -60.15 161.91 6.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.423 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 77.0 m -151.19 151.58 32.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.1 mt -81.29 134.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.87 -1.144 . . . . 0.0 109.519 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 150.73 28.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 110.655 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.59 -64.72 0.73 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -41.58 -48.35 3.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.587 . . . . 0.0 111.73 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.45 -33.12 73.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.53 -1.356 . . . . 0.0 109.9 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -68.5 -42.19 78.93 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 109.745 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.81 -56.64 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.383 -0.823 . . . . 0.0 110.51 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.76 87.49 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.318 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -75.01 -28.75 60.62 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 111.477 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -70.25 -53.13 18.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.56 -1.338 . . . . 0.0 111.585 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 C--N 1.3 -1.582 0 O-C-N 120.256 -1.528 . . . . 0.0 109.589 -178.479 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.896 0.855 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 40.7 p-10 -93.8 -168.2 1.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.627 0.727 . . . . 0.0 110.378 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -66.27 -14.91 62.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.476 -0.765 . . . . 0.0 110.481 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -99.86 -13.58 19.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.352 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.26 14.98 39.89 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 48' ' ' ASP . 30.0 mtt180 -84.07 135.3 34.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.157 . . . . 0.0 109.323 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.8 mt -84.27 111.4 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 109.192 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 11' ' ' ARG . 4.8 mp -94.94 157.33 15.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -92.26 179.04 5.67 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.018 -1.051 . . . . 0.0 109.968 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.4 m -54.01 146.23 14.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.439 -0.788 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.08 -52.67 4.75 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -52.56 149.84 5.55 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.134 -1.215 . . . . 0.0 109.28 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 t -157.1 161.72 39.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.596 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.3 tp-100 -105.17 131.41 52.69 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 22' ' ' ASP . 21.3 ttt180 -89.53 162.5 15.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.373 -0.829 . . . . 0.0 109.362 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -66.07 -22.3 66.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 95.8 m-20 -84.75 -7.99 59.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.4 -0.813 . . . . 0.0 109.329 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.31 8.83 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -62.11 137.7 58.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.946 -1.326 . . . . 0.0 109.466 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.596 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 67.0 m-85 -80.41 173.15 12.88 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.512 -0.743 . . . . 0.0 109.548 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.673 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.2 tt -156.07 139.24 15.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.326 -0.858 . . . . 0.0 109.874 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -136.57 155.25 50.19 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.23 -0.919 . . . . 0.0 109.275 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -119.97 138.97 53.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.474 -0.766 . . . . 0.0 110.513 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.436 ' CE1' HD13 ' A' ' 67' ' ' LEU . 9.7 p90 -143.14 165.0 28.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.03 134.84 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 0.0 109.378 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 33' ' ' PHE . 72.1 m-20 -80.11 164.64 23.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 108.401 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.8 t -58.9 0.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.942 -1.099 . . . . 0.0 110.536 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.7 m-85 -101.73 -19.35 15.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.052 -1.03 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.08 46.02 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.529 ' C ' HE22 ' A' ' 37' ' ' GLN . 22.9 pt-20 -83.68 147.55 52.44 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.012 -1.287 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.502 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 55.7 Cg_endo -81.4 139.2 11.4 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.473 2.115 . . . . 0.0 113.249 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.529 HE22 ' C ' ' A' ' 35' ' ' GLU . 1.7 mp0 -137.5 159.86 40.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -132.14 145.02 51.1 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 149.1 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.443 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 78.5 m-85 -121.18 152.38 38.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.7 t -168.29 145.03 3.94 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 109.314 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.93 11.74 21.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.967 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -135.99 141.22 44.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.548 -0.72 . . . . 0.0 109.809 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.9 tp -89.65 -42.63 11.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.59 173.81 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.97 -14.35 59.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.047 -1.033 . . . . 0.0 110.598 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 p -91.27 -2.78 57.35 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 11' ' ' ARG . 80.5 m-20 -69.51 -174.43 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.661 -1.274 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -149.62 124.97 10.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.506 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 m -82.21 152.96 68.74 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.85 137.86 42.68 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 120.968 1.112 . . . . 0.0 109.978 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.86 -34.92 5.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.106 -0.996 . . . . 0.0 110.478 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.95 -22.27 62.23 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -99.48 140.83 33.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -1.122 . . . . 0.0 110.957 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 55' ' ' ARG . 2.0 ptt-85 -76.22 153.78 35.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.511 -0.743 . . . . 0.0 109.886 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.4 161.14 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 0.0 109.462 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.5 p -152.03 162.86 40.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.34 -0.85 . . . . 0.0 108.745 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.24 127.91 40.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.056 -1.027 . . . . 0.0 109.771 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.9 p -59.52 169.27 1.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.36 -0.837 . . . . 0.0 109.907 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -79.59 -58.53 3.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -41.45 -43.67 2.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 110.905 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -69.89 -41.38 74.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 0.0 109.433 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -67.99 -44.84 75.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 110.162 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.11 -60.69 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.914 -1.116 . . . . 0.0 109.203 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.01 63.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.942 . . . . 0.0 110.26 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -71.81 -39.04 70.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD13 ' CE1' ' A' ' 29' ' ' TYR . 64.7 mt -67.06 -54.54 20.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.867 -1.145 . . . . 0.0 111.889 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.347 -1.471 . . . . 0.0 109.478 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.381 0.61 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 11' ' ' ARG . 8.3 p-10 -88.6 -168.33 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.783 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -67.15 -11.88 58.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.533 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.638 ' CB ' HH12 ' A' ' 11' ' ' ARG . 0.3 OUTLIER -100.2 -73.39 0.64 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.908 -1.12 . . . . 0.0 110.047 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.18 0.86 0.05 OUTLIER Glycine 0 N--CA 1.501 3.012 0 C-N-CA 118.41 -1.852 . . . . 0.0 113.03 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.638 HH12 ' CB ' ' A' ' 9' ' ' ARG . 2.4 mtm-85 -84.46 114.64 22.07 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 119.95 -1.912 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.95 113.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.444 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -91.91 169.47 10.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.42 -0.8 . . . . 0.0 109.716 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -89.16 -177.16 5.35 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.27 1.033 . . . . 0.0 111.054 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 t -56.75 153.62 10.37 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.39 -41.43 1.15 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.792 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.86 136.52 56.96 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.938 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -159.24 154.24 25.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.254 -0.904 . . . . 0.0 108.621 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -109.02 140.93 41.88 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.022 -1.048 . . . . 0.0 110.217 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -84.71 177.21 8.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.571 -0.706 . . . . 0.0 110.022 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -71.54 -14.48 62.11 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -87.83 -20.14 26.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 109.837 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.24 -30.19 8.5 Favored Glycine 0 N--CA 1.501 3.019 0 O-C-N 121.227 -0.92 . . . . 0.0 111.204 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -63.38 140.68 58.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.546 -1.561 . . . . 0.0 109.679 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.47 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 90.8 m-85 -85.07 168.49 14.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.778 . . . . 0.0 109.87 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.765 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 11.9 tp -150.89 127.48 10.81 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.448 0.642 . . . . 0.0 109.576 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.421 ' N ' HD12 ' A' ' 26' ' ' LEU . 79.6 t80 -131.79 156.33 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -127.16 144.11 51.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -0.773 . . . . 0.0 109.861 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.484 ' C ' HD12 ' A' ' 30' ' ' ILE . 12.1 p90 -144.86 161.66 38.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.201 -0.937 . . . . 0.0 108.776 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' C ' ' A' ' 29' ' ' TYR . 1.4 mp -102.86 135.96 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.371 -0.83 . . . . 0.0 108.883 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 60.2 m-20 -81.74 174.26 11.52 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.288 -0.883 . . . . 0.0 109.186 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.4 t -65.58 -3.47 4.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 109.361 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -96.55 -11.32 25.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 108.91 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.6 -6.17 77.36 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.428 ' HG3' HE22 ' A' ' 37' ' ' GLN . 14.4 pt-20 -84.69 149.47 54.16 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.179 -1.189 . . . . 0.0 109.249 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 40.1 Cg_endo -82.89 136.51 8.22 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.589 2.193 . . . . 0.0 113.668 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.1 mp0 -125.67 164.9 19.61 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.4 149.09 51.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 109.698 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.8 142.68 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.765 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 49.1 m-85 -127.43 156.99 41.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.557 -0.714 . . . . 0.0 109.795 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.5 t -170.91 150.75 3.21 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.488 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -89.38 11.07 20.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 51.7 mtmt -135.64 139.87 44.1 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.501 0.667 . . . . 0.0 110.567 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -92.51 -39.28 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.27 155.36 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.23 -7.67 10.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.181 -0.95 . . . . 0.0 110.972 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.3 p -93.76 -10.47 34.12 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.7 -1.25 . . . . 0.0 111.887 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -71.15 -171.56 0.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.488 -1.382 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -141.99 151.8 42.84 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -79.35 149.69 72.69 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.963 -1.086 . . . . 0.0 109.307 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' ALA . 32.6 Cg_endo -82.09 -112.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.56 2.174 . . . . 0.0 114.498 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -55.0 -149.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.257 -0.902 . . . . 0.0 112.954 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.97 36.1 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 52' ' ' ALA . 11.9 mptt -89.26 130.99 35.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.112 -1.228 . . . . 0.0 108.818 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.06 159.07 28.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 109.978 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 23.1 p-10 -53.71 162.19 0.93 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.677 -0.639 . . . . 0.0 109.851 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 19.8 t -162.97 161.22 25.49 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.494 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 89.3 mt -82.83 137.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.9 p -61.13 159.06 12.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.32 -0.863 . . . . 0.0 109.854 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HA ' ' HZ3' ' A' ' 63' ' ' LYS . 97.2 mt -63.53 -49.1 74.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -45.82 -46.34 15.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.115 -0.99 . . . . 0.0 110.352 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -37.43 75.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.883 -1.136 . . . . 0.0 109.781 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HZ3' ' HA ' ' A' ' 60' ' ' LEU . 2.8 mtmp? -67.61 -44.68 77.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.856 -1.153 . . . . 0.0 110.202 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.5 -53.56 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.956 -1.09 . . . . 0.0 110.145 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.62 79.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.112 . . . . 0.0 110.133 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.19 -45.47 56.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.89 -1.131 . . . . 0.0 110.177 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.29 -44.12 65.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.025 -1.047 . . . . 0.0 110.008 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--N 1.289 -2.034 0 O-C-N 120.609 -1.307 . . . . 0.0 109.646 -178.338 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 121.388 0.613 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -98.5 -164.39 1.13 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.61 -0.681 . . . . 0.0 109.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.595 HD22 ' NE2' ' A' ' 19' ' ' GLN . 22.3 p30 -68.65 -12.74 61.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.115 -0.99 . . . . 0.0 110.599 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -96.07 -5.71 40.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.0 -1.063 . . . . 0.0 109.29 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.19 -1.67 69.04 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.281 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.541 HH22 ' CG ' ' A' ' 48' ' ' ASP . 6.8 ptm180 -82.78 136.46 34.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.734 -1.451 . . . . 0.0 109.316 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.8 mt -83.97 110.6 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.149 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.79 161.72 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 77.5 mttt -88.93 -174.3 4.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.842 -1.161 . . . . 0.0 110.831 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 15' ' ' THR . 1.2 t -55.79 162.23 1.86 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.67 -36.94 1.41 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 14' ' ' LYS . 9.5 mp0 -73.72 156.42 37.91 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.919 -1.342 . . . . 0.0 109.303 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -156.96 158.65 37.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 109.423 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.595 ' NE2' HD22 ' A' ' 8' ' ' ASN . 56.5 tt0 -97.05 134.74 40.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 108.735 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -86.47 160.99 18.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.891 -1.13 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.87 -36.49 62.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.584 -0.697 . . . . 0.0 109.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -82.14 -25.29 34.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.171 -0.955 . . . . 0.0 110.515 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.64 -26.9 5.06 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.17 -0.956 . . . . 0.0 110.744 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.699 HH21 ' HE1' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -59.74 148.5 34.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.356 -1.673 . . . . 0.0 108.307 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -87.44 164.42 16.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.232 -0.918 . . . . 0.0 109.187 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -147.74 137.75 22.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -131.6 161.48 32.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 29' ' ' TYR . 4.7 tmtm? -125.13 136.19 53.39 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.251 -0.906 . . . . 0.0 110.79 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 13.6 p90 -139.7 170.08 16.55 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.512 HD13 ' HZ1' ' A' ' 28' ' ' LYS . 5.9 mm -101.87 133.84 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.123 -0.986 . . . . 0.0 110.503 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -84.23 162.43 20.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -59.87 -3.98 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 21.8 m-85 -101.07 -15.27 17.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.03 -1.044 . . . . 0.0 109.622 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.31 0.32 58.32 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.984 -1.072 . . . . 0.0 111.064 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -83.9 150.56 59.08 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.837 -1.39 . . . . 0.0 109.682 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.503 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 88.8 Cg_endo -81.61 118.94 3.24 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.107 1.872 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.629 HE21 ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -115.05 163.02 16.21 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.72 142.03 44.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.24 150.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 85.4 m-85 -122.77 151.61 41.45 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.7 t -171.77 148.62 2.41 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.699 ' HE1' HH21 ' A' ' 24' ' ' ARG . 98.7 m95 -91.91 10.6 28.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 57' ' ' CYS . 29.8 mtmt -135.64 146.74 48.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.675 0.75 . . . . 0.0 110.179 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.412 HD23 ' HE ' ' A' ' 11' ' ' ARG . 60.8 tp -96.3 -40.07 9.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.15 161.23 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.61 -14.05 62.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.922 -1.111 . . . . 0.0 111.423 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -87.37 0.23 55.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.796 -1.19 . . . . 0.0 110.985 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.541 ' CG ' HH22 ' A' ' 11' ' ' ARG . 84.7 m-20 -72.49 -178.61 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.896 -1.127 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.42 121.18 13.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -75.79 146.29 79.5 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.492 -1.38 . . . . 0.0 109.957 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.82 155.58 62.16 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.031 . . . . 0.0 111.296 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.36 151.6 0.36 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 110.359 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.81 3.76 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -92.49 146.17 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -1.227 . . . . 0.0 108.913 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -78.08 -99.1 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 66.3 t0 -168.46 140.24 2.76 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.532 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 15.0 p -148.6 169.25 20.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.976 -1.077 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -82.69 139.0 18.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.497 -0.752 . . . . 0.0 110.326 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -60.72 169.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.33 -52.84 28.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -47.16 -47.76 23.7 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.724 -1.235 . . . . 0.0 110.114 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 68.3 mt-10 -71.49 -38.89 71.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.445 -1.409 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -65.75 -39.78 91.44 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 0.0 110.188 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.05 -44.41 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.377 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.19 90.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.955 -1.091 . . . . 0.0 110.782 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -71.34 -34.31 70.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.868 -1.145 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.88 -44.61 80.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.557 -1.339 . . . . 0.0 110.865 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.853 -1.154 . . . . 0.0 110.617 -178.721 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 29.3 p-10 -123.58 -169.57 1.97 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.208 -0.932 . . . . 0.0 109.936 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.715 ' ND2' HE21 ' A' ' 19' ' ' GLN . 68.9 m-80 -67.73 -21.37 65.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 110.077 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.57 -4.69 40.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.73 17.33 61.97 Favored Glycine 0 N--CA 1.497 2.738 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.07 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 11' ' ' ARG . 3.6 mtt-85 -86.04 138.58 31.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -1.112 . . . . 0.0 108.913 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.8 mm -82.57 116.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -88.9 147.09 24.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.092 -1.005 . . . . 0.0 108.574 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -90.53 -179.73 5.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.802 -1.187 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 m -55.68 148.09 17.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.545 -0.722 . . . . 0.0 110.396 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.04 -41.66 2.79 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' OE2' ' CZ ' ' A' ' 61' ' ' ARG . 95.2 mt-10 -78.09 158.43 29.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.909 -1.348 . . . . 0.0 110.067 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -158.21 154.56 27.51 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.815 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.715 HE21 ' ND2' ' A' ' 8' ' ' ASN . 61.2 tt0 -99.16 130.21 45.46 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.837 . . . . 0.0 110.123 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.9 168.86 16.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.338 -0.851 . . . . 0.0 110.472 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -69.04 -25.59 64.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.467 -0.771 . . . . 0.0 109.15 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -87.11 -12.76 46.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.91 -31.1 8.27 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -58.88 143.7 46.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.313 . . . . 0.0 108.777 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -78.88 165.67 23.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.37 -0.831 . . . . 0.0 109.854 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.5 tm? -149.35 121.23 8.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 89.3 t80 -130.3 161.05 32.1 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 46.8 tttt -120.27 131.87 55.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.759 -0.588 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -135.73 152.15 50.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.581 -0.699 . . . . 0.0 109.25 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.4 mp -98.69 133.75 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' OD2' ' CG ' ' A' ' 35' ' ' GLU . 44.9 p30 -82.64 173.12 12.22 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.011 0.91 . . . . 0.0 110.795 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 m -60.73 3.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.831 -0.543 . . . . 0.0 111.381 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 31' ' ' ASP . 30.1 m-85 -107.12 -22.82 12.51 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.895 -1.128 . . . . 0.0 109.312 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.76 34.36 Favored Glycine 0 N--CA 1.505 3.251 0 O-C-N 121.211 -0.931 . . . . 0.0 111.137 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.578 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.2 pt-20 -88.49 152.44 49.62 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.941 -1.329 . . . . 0.0 109.263 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.41 147.6 25.76 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.413 2.075 . . . . 0.0 113.305 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -144.53 166.59 24.72 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -135.4 153.85 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.243 -0.911 . . . . 0.0 109.561 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -130.51 157.36 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.718 . . . . 0.0 109.231 -179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 48.0 m-85 -135.21 144.78 47.13 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 t -169.45 155.01 5.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.035 . . . . 0.0 109.743 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CZ2' ' NZ ' ' A' ' 54' ' ' LYS . 96.1 m95 -93.98 5.54 51.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.137 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 43.9 mtmt -123.92 140.43 52.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.547 0.689 . . . . 0.0 110.158 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.38 -44.83 7.04 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 46' ' ' ALA . 9.0 t -122.38 178.91 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -78.56 -12.94 60.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.122 -0.986 . . . . 0.0 110.995 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.28 -10.69 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 109.944 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -74.42 168.13 20.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.034 -1.041 . . . . 0.0 109.815 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HB2' HH11 ' A' ' 49' ' ' ARG . 0.0 OUTLIER -144.73 136.06 25.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 108.904 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.12 148.56 71.61 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.807 . . . . 0.0 110.514 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.95 149.4 77.53 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.183 1.922 . . . . 0.0 111.845 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.54 146.17 1.11 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.71 0.766 . . . . 0.0 110.124 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.7 4.61 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' NZ ' ' CZ2' ' A' ' 42' ' ' TRP . 28.4 mmtp -95.56 135.22 37.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -73.09 152.62 41.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.759 . . . . 0.0 109.472 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -61.73 166.27 4.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 48.9 t -159.15 160.85 36.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -0.812 . . . . 0.0 109.108 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 85.5 mt -80.87 137.78 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.351 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.4 p -63.57 156.13 27.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.811 0.815 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.44 -55.45 33.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.585 -0.697 . . . . 0.0 109.838 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 15.7 mmt180 -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.243 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -72.07 -39.53 68.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.927 . . . . 0.0 110.273 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.12 -37.02 80.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.032 -1.042 . . . . 0.0 110.102 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.1 -50.66 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.099 -1.001 . . . . 0.0 110.729 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.95 -45.85 82.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.819 -1.176 . . . . 0.0 110.422 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.52 -41.73 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 0.0 111.676 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.38 -21.51 66.65 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.884 -1.76 . . . . 0.0 110.987 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 120.79 -1.194 . . . . 0.0 111.32 -179.221 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.853 0.835 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.76 ' CG ' HD22 ' A' ' 13' ' ' LEU . 30.8 m-20 -79.7 -179.79 7.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.714 HD22 ' NE2' ' A' ' 19' ' ' GLN . 12.5 p30 -66.96 -14.52 62.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.919 . . . . 0.0 111.259 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -98.75 14.93 26.96 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.049 . . . . 0.0 109.941 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.21 20.95 75.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -90.76 126.27 35.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -1.065 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.8 mt -77.52 95.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.015 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.6 pt? -87.37 156.11 19.74 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -92.0 -176.02 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.691 1.234 . . . . 0.0 110.773 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.1 m -57.91 144.08 40.45 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.14 -54.39 3.6 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.3 149.27 24.88 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.203 -1.175 . . . . 0.0 108.801 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -160.96 159.73 29.88 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 108.848 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.714 ' NE2' HD22 ' A' ' 8' ' ' ASN . 17.3 pt20 -97.14 140.86 31.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 109.652 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.75 -174.14 4.62 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.09 -29.86 55.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.309 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -89.94 -11.88 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 111.538 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.44 -28.08 7.69 Favored Glycine 0 N--CA 1.504 3.199 0 O-C-N 121.012 -1.055 . . . . 0.0 110.908 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.4 140.88 56.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.352 -1.675 . . . . 0.0 109.341 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -80.03 170.56 16.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.434 -0.791 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.598 HD13 ' CE2' ' A' ' 40' ' ' TYR . 64.4 tp -151.68 127.25 10.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.537 -0.727 . . . . 0.0 109.328 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -129.58 157.15 42.86 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tttm -127.06 143.7 51.22 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.381 -0.825 . . . . 0.0 110.289 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.627 ' OH ' HD22 ' A' ' 67' ' ' LEU . 4.1 p90 -151.88 -178.99 7.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.46 144.99 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.488 -0.758 . . . . 0.0 109.006 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 33' ' ' PHE . 90.6 m-20 -84.05 165.85 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.469 -0.769 . . . . 0.0 109.856 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -59.28 -0.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.584 -0.697 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 31' ' ' ASP . 18.8 m-85 -108.76 -13.95 14.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.473 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.51 -8.67 52.16 Favored Glycine 0 N--CA 1.502 3.068 0 O-C-N 121.045 -1.035 . . . . 0.0 110.871 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.8 pt-20 -81.68 149.94 65.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.825 -1.397 . . . . 0.0 109.129 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.534 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 59.0 Cg_endo -83.67 143.55 10.81 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.361 2.041 . . . . 0.0 112.67 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.534 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.4 mp0 -140.68 173.51 11.43 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.256 -0.903 . . . . 0.0 108.682 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HB3' HD11 ' A' ' 26' ' ' LEU . 89.8 m-85 -137.89 154.32 49.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.442 -0.786 . . . . 0.0 109.801 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.546 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.1 m -128.57 143.72 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.525 -0.735 . . . . 0.0 109.232 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CE2' HD13 ' A' ' 26' ' ' LEU . 43.5 m-85 -122.35 147.61 46.06 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -171.52 150.86 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.899 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -94.26 10.42 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -127.02 138.84 53.31 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.5 tp -93.02 -44.41 8.42 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.39 166.48 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -14.24 62.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.65 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.4 p -90.04 -6.01 56.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.725 -1.234 . . . . 0.0 111.305 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -70.96 160.56 32.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.68 -1.262 . . . . 0.0 109.417 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.82 126.22 39.39 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.303 -0.873 . . . . 0.0 108.91 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.68 150.1 75.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 110.032 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.4 151.16 80.71 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.834 1.689 . . . . 0.0 110.619 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.33 159.55 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -0.928 . . . . 0.0 109.859 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.04 -36.59 3.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -95.08 137.0 34.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.342 . . . . 0.0 109.64 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.2 mmp_? -79.87 150.38 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -0.982 . . . . 0.0 109.701 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -52.1 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.447 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 42.6 t -168.41 169.71 10.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.33 -0.856 . . . . 0.0 108.9 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.447 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 6.5 mm -84.55 122.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.4 p -58.88 158.84 7.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 64' ' ' ILE . 3.2 mm? -54.71 -49.88 69.66 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.732 -0.605 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -51.45 -47.65 63.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.926 -1.109 . . . . 0.0 110.178 -179.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.85 -43.68 67.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 0.0 110.892 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -65.85 -41.4 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.613 -1.305 . . . . 0.0 109.693 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -60.58 -36.58 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -51.51 69.15 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.018 -1.051 . . . . 0.0 110.087 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.4 -41.26 63.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.866 -1.146 . . . . 0.0 112.462 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.627 HD22 ' OH ' ' A' ' 29' ' ' TYR . 22.7 mt -68.05 -44.29 76.72 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.286 -1.509 . . . . 0.0 111.752 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 . . . . . 0 N--CA 1.497 1.889 0 O-C-N 120.893 -1.129 . . . . 0.0 111.569 -177.919 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.731 ' HE ' ' C ' ' A' ' 10' ' ' GLY . 33.4 mtp180 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' HB2' HH12 ' A' ' 11' ' ' ARG . 3.8 m-20 -130.98 -159.59 0.98 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.648 -0.658 . . . . 0.0 109.823 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.481 ' ND2' ' NE2' ' A' ' 19' ' ' GLN . 77.6 m-20 -63.29 -33.06 74.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.121 -0.987 . . . . 0.0 111.659 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HB2' ' NH1' ' A' ' 11' ' ' ARG . 15.1 mmt180 -96.03 8.28 44.13 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.017 -1.052 . . . . 0.0 112.09 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.731 ' C ' ' HE ' ' A' ' 6' ' ' ARG . . . 76.88 19.99 76.79 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.422 -1.424 . . . . 0.0 111.704 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.627 ' HG3' HH11 ' A' ' 11' ' ' ARG . 2.3 mtm-85 -94.19 144.95 25.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.495 . . . . 0.0 108.374 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.4 mt -85.56 117.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 108.879 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -84.99 144.69 28.14 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.423 -0.798 . . . . 0.0 109.46 -179.098 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -89.26 -171.66 3.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.18 0.991 . . . . 0.0 110.502 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.4 m -56.42 143.53 34.44 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.691 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.99 -51.46 3.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.256 -0.903 . . . . 0.0 111.479 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.1 140.67 58.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.401 . . . . 0.0 110.093 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -160.01 -174.51 4.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.273 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.481 ' NE2' ' ND2' ' A' ' 8' ' ' ASN . 4.1 tt0 -110.11 147.41 33.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 20' ' ' ARG . 10.3 ttt-85 -88.87 164.1 15.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.553 ' CD ' ' H ' ' A' ' 21' ' ' LYS . 8.4 mptt -63.71 -19.41 64.92 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.94 -8.17 50.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.608 -0.683 . . . . 0.0 110.714 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.68 6.32 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -61.41 145.79 50.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.969 -1.312 . . . . 0.0 108.041 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 11' ' ' ARG . 72.2 m-85 -78.75 167.93 20.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.103 -0.998 . . . . 0.0 110.659 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.645 HD13 ' CE2' ' A' ' 40' ' ' TYR . 67.8 tp -152.01 132.56 13.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 50.9 t80 -132.92 162.76 30.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 25.0 tttt -137.34 137.1 38.55 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.034 -1.041 . . . . 0.0 110.873 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.513 ' CD2' ' OE1' ' A' ' 37' ' ' GLN . 13.8 p90 -149.95 -175.55 5.09 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.45 ' HA ' HE22 ' A' ' 37' ' ' GLN . 39.9 mm -109.17 131.88 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.257 -0.902 . . . . 0.0 109.287 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.92 178.38 6.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 0.0 110.047 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 t -63.01 0.36 0.58 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.054 -1.029 . . . . 0.0 110.881 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 6.6 m-85 -102.69 -10.47 19.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.4 59.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.0 pt-20 -80.17 150.7 71.73 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 108.395 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.76 135.61 21.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.632 1.555 . . . . 0.0 111.459 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.679 ' NE2' ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -132.74 165.68 23.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.508 ' HB3' HD11 ' A' ' 26' ' ' LEU . 48.5 m-85 -137.11 155.79 49.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -0.839 . . . . 0.0 109.304 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.56 ' O ' HD12 ' A' ' 26' ' ' LEU . 10.7 m -126.05 150.09 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.645 ' CE2' HD13 ' A' ' 26' ' ' LEU . 71.6 m-85 -123.01 156.89 33.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.8 t -171.46 152.07 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.096 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -95.61 9.32 40.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 109.654 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.47 156.01 45.79 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.224 -0.923 . . . . 0.0 109.507 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.507 ' CB ' ' HE ' ' A' ' 11' ' ' ARG . 59.6 tp -98.66 -38.63 9.04 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -120.26 173.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.53 49.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 0.0 110.452 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.0 p -86.04 -7.17 58.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -71.94 167.62 19.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.84 136.85 51.03 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.6 149.52 78.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 110.616 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.26 140.79 25.45 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.677 1.585 . . . . 0.0 111.377 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.57 5.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 109.561 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.09 -19.97 48.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.62 142.86 27.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.827 -1.396 . . . . 0.0 109.205 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -78.08 151.21 33.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 109.829 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 p30 -62.08 175.08 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.79 . . . . 0.0 109.764 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 15.3 t -172.46 -174.99 1.27 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.411 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 49.8 mm -98.97 127.44 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.013 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.454 ' OG ' ' C ' ' A' ' 44' ' ' LEU . 22.7 t -56.91 157.23 5.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.382 -0.824 . . . . 0.0 109.392 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.5 -51.69 66.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.987 -1.07 . . . . 0.0 109.986 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -47.79 -41.76 24.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.77 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.06 -39.69 65.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.923 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -65.36 -55.47 17.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.868 -1.145 . . . . 0.0 109.611 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 64' ' ' ILE . 1.6 mp -48.05 -58.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.6 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.08 -42.36 69.25 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.684 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.18 -42.43 62.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.822 . . . . 0.0 111.598 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.487 HD23 ' OH ' ' A' ' 29' ' ' TYR . 6.3 mp -70.56 -44.42 67.46 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.779 -1.2 . . . . 0.0 111.817 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 120.614 -1.304 . . . . 0.0 110.524 -178.194 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 6' ' ' ARG . 14.9 mtm-85 . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.801 0.81 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' CD2' ' A' ' 13' ' ' LEU . 93.6 m-20 -87.21 170.92 11.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -63.84 -3.55 2.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.881 -1.137 . . . . 0.0 109.063 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 -11.23 18.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.52 4.77 59.26 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.598 HH11 ' HG2' ' A' ' 11' ' ' ARG . 8.6 mtt-85 -85.91 130.29 34.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -1.113 . . . . 0.0 109.545 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.0 110.48 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -86.29 150.36 24.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -89.29 -179.33 5.84 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.687 -1.258 . . . . 0.0 110.789 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -53.46 154.51 3.44 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -39.46 2.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -76.46 167.8 21.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.275 . . . . 0.0 109.518 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 t -158.82 161.96 36.97 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.863 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -104.51 138.13 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.3 156.37 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.942 -1.099 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CG ' ' N ' ' A' ' 22' ' ' ASP . 10.2 ptmm? -53.52 -39.24 64.48 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.107 -0.995 . . . . 0.0 109.491 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 51.1 p30 -83.89 -30.82 26.08 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.184 -0.948 . . . . 0.0 110.41 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 135.05 -24.72 3.4 Favored Glycine 0 N--CA 1.505 3.272 0 O-C-N 120.81 -1.181 . . . . 0.0 112.576 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -57.46 147.25 27.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 120.15 1.975 . . . . 0.0 107.714 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -85.32 169.55 13.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -152.96 129.01 10.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.146 -0.971 . . . . 0.0 109.75 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.859 ' N ' HD12 ' A' ' 26' ' ' LEU . 87.1 t80 -131.02 162.35 29.99 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.549 -0.719 . . . . 0.0 109.216 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 36.0 tttt -122.66 135.22 54.53 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.531 -0.73 . . . . 0.0 110.048 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.532 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 6.0 p90 -141.61 162.93 34.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mm -103.53 130.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 3.8 m-20 -88.5 179.74 6.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 t -57.08 -3.94 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 111.372 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 46.3 m-85 -96.26 -4.79 41.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.075 . . . . 0.0 110.473 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 10.33 81.71 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -88.25 164.36 33.35 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 122.034 -0.686 . . . . 0.0 110.092 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.28 122.6 0.75 Allowed 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 121.823 1.682 . . . . 0.0 110.144 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.599 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -123.07 166.11 15.68 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.222 -0.924 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -135.85 146.55 47.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.505 -0.747 . . . . 0.0 110.486 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -124.34 148.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -132.35 155.02 49.15 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.134 -0.979 . . . . 0.0 109.956 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -171.83 157.74 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.963 -1.085 . . . . 0.0 109.728 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -91.85 12.47 21.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.148 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 8.6 mtmp? -135.31 138.09 43.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.432 -0.792 . . . . 0.0 109.7 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.7 tp -88.46 -43.27 11.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.69 173.92 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.17 62.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.266 -0.896 . . . . 0.0 111.541 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 t -86.6 -10.59 53.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.72 -1.237 . . . . 0.0 111.466 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.87 176.37 3.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.662 -1.274 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.35 140.38 30.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.8 m -84.79 146.35 46.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 109.385 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.95 150.98 78.37 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.992 1.794 . . . . 0.0 111.698 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.42 143.67 2.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.567 -0.708 . . . . 0.0 110.393 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.97 -26.65 22.54 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -96.99 131.93 43.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.368 -1.078 . . . . 0.0 108.527 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -75.91 145.89 40.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.36 -0.837 . . . . 0.0 109.7 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 60.8 t0 -50.27 153.73 1.41 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.664 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 81.1 m -148.59 167.3 25.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.217 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.5 mt -87.97 133.1 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.199 -0.938 . . . . 0.0 110.354 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.6 p -62.81 157.7 20.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.819 . . . . 0.0 110.623 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 64' ' ' ILE . 7.7 mp -58.42 -52.46 65.52 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.841 0.829 . . . . 0.0 109.588 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -51.2 -45.32 61.8 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.461 -0.774 . . . . 0.0 110.154 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.31 -40.99 70.47 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 109.704 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' NZ ' ' CB ' ' A' ' 63' ' ' LYS . 2.1 ttmp? -66.32 -41.83 89.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.942 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.49 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -59.4 -53.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.776 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.31 71.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.917 -1.115 . . . . 0.0 109.958 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -73.87 -42.57 60.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.972 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -68.0 -43.39 78.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.616 -1.302 . . . . 0.0 110.594 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 . . . . . 0 C--N 1.294 -1.837 0 O-C-N 120.245 -1.535 . . . . 0.0 110.49 -178.822 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.514 0.673 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -83.44 166.85 18.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.287 -0.883 . . . . 0.0 109.832 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 23.2 p30 -69.17 1.64 3.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.192 -0.943 . . . . 0.0 109.902 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 92.2 mtt180 -100.11 -52.68 3.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.84 -3.34 1.11 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.639 ' CG ' HH11 ' A' ' 11' ' ' ARG . 1.6 mtt-85 -89.29 130.06 35.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.459 -1.612 . . . . 0.0 110.171 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 mm -72.73 110.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.249 -0.907 . . . . 0.0 108.561 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -94.26 152.53 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 109.484 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 35.9 mmtt -89.0 -173.27 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.978 -1.077 . . . . 0.0 110.78 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 p -57.14 165.6 1.31 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.454 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.1 -44.07 1.04 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.366 -0.834 . . . . 0.0 111.56 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 12.2 mp0 -65.23 152.39 43.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.019 -1.283 . . . . 0.0 110.823 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -158.58 139.62 13.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.2 tt0 -100.0 129.31 46.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.192 -0.942 . . . . 0.0 109.891 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.708 ' NH1' HH21 ' A' ' 24' ' ' ARG . 49.2 mtp180 -89.27 166.19 13.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.431 -0.793 . . . . 0.0 110.656 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.88 -20.27 63.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 109.729 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -85.78 -17.38 35.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.993 . . . . 0.0 109.463 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.09 -22.69 32.61 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.708 HH21 ' NH1' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -63.83 146.81 53.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.742 -1.446 . . . . 0.0 109.413 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.401 ' OH ' ' NH1' ' A' ' 9' ' ' ARG . 71.8 m-85 -88.63 166.47 14.09 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.802 0.81 . . . . 0.0 109.845 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.617 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 20.8 tp -148.74 119.87 7.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 90.4 t80 -131.67 168.63 17.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.645 -0.659 . . . . 0.0 109.437 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 71.1 tttt -130.91 135.17 47.43 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.541 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 18.9 p90 -133.18 165.03 25.72 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.461 -0.774 . . . . 0.0 108.912 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.01 134.78 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.077 -1.014 . . . . 0.0 109.302 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 16.7 m-20 -83.27 156.67 22.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.7 m -53.66 -8.59 0.16 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.893 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.3 -13.9 21.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.881 -1.137 . . . . 0.0 108.807 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.34 0.73 59.5 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 20.6 pt-20 -83.38 148.52 55.85 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.892 -1.358 . . . . 0.0 108.329 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 96.0 Cg_endo -82.64 141.63 11.11 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.354 2.036 . . . . 0.0 113.198 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.1 mp0 -139.67 161.68 36.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.186 -0.946 . . . . 0.0 108.753 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -132.09 142.54 49.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -122.2 151.58 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.561 0.695 . . . . 0.0 109.904 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.617 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 46.9 m-85 -123.72 150.47 44.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -166.05 148.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.391 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -90.94 10.38 26.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 109.573 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -140.18 144.02 36.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.99 -42.79 10.35 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.35 167.57 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.05 -6.24 44.27 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.982 -1.073 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.8 p -88.7 -18.53 27.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.433 -1.417 . . . . 0.0 110.011 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.28 175.11 7.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.42 HH12 ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -138.83 145.73 40.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 50' ' ' VAL . 5.9 m -79.91 128.53 73.72 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.713 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.32 141.17 10.5 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.028 1.152 . . . . 0.0 110.327 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' N ' HH12 ' A' ' 49' ' ' ARG . . . -44.81 143.44 1.43 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.07 -32.26 7.69 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -91.88 140.66 29.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 108.546 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -76.16 155.62 34.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 44.1 p30 -52.66 155.55 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.254 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 56' ' ' ASP . 64.9 m -154.54 157.99 39.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -85.05 135.08 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.8 p -58.82 153.65 16.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.09 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -60.47 -52.03 66.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.951 -1.093 . . . . 0.0 109.928 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -46.95 -50.0 19.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.824 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -69.13 -34.09 74.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.248 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -69.84 -41.26 75.16 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.428 -0.795 . . . . 0.0 110.02 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.18 -50.04 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.243 -0.91 . . . . 0.0 109.358 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.33 79.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.986 -1.071 . . . . 0.0 109.819 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -71.62 -44.02 65.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.466 -0.771 . . . . 0.0 111.308 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.74 -32.9 74.5 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.524 -1.36 . . . . 0.0 111.701 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 . . . . . 0 C--N 1.295 -1.783 0 O-C-N 120.215 -1.553 . . . . 0.0 110.308 -178.936 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 121.215 0.531 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.2 p30 -75.46 -179.66 4.71 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.753 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.464 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 61.8 m-80 -67.99 -8.6 38.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -101.79 -22.97 14.26 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.779 -1.201 . . . . 0.0 111.029 -178.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 123.06 7.93 6.89 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 121.199 -0.938 . . . . 0.0 110.78 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.527 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 9.2 mtm180 -85.09 126.25 33.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.884 -1.362 . . . . 0.0 109.596 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.2 mm -71.56 105.53 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' H ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 pp -87.78 149.02 24.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -91.09 -175.14 4.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.04 0.924 . . . . 0.0 110.903 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.466 ' H ' HG23 ' A' ' 15' ' ' THR . 7.5 p -55.19 146.24 19.24 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.665 0.745 . . . . 0.0 111.481 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.3 -54.12 4.85 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.422 -0.799 . . . . 0.0 111.37 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 36.8 mp0 -60.69 145.87 47.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 109.644 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -160.83 149.28 16.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.071 . . . . 0.0 109.649 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.464 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.8 tt0 -99.3 130.87 45.62 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.081 -1.012 . . . . 0.0 108.568 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -84.54 -171.24 3.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 0.0 109.605 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -75.32 -23.04 57.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.176 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -86.2 -15.02 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.19 -19.2 49.63 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -62.4 141.88 58.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.491 -1.594 . . . . 0.0 108.66 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -87.83 165.58 15.2 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.427 -0.796 . . . . 0.0 108.915 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.941 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -154.71 130.91 10.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -178.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.941 ' N ' HD22 ' A' ' 26' ' ' LEU . 71.6 t80 -131.23 168.6 17.22 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 53.1 tttt -136.83 140.01 42.13 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.58 173.35 11.73 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.34 -0.85 . . . . 0.0 109.513 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.1 mm -103.35 126.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.412 -0.805 . . . . 0.0 109.615 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.14 176.41 9.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.005 -1.06 . . . . 0.0 109.058 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.8 p -64.09 0.59 0.89 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.042 -1.036 . . . . 0.0 111.203 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 14.4 m-85 -103.65 -15.89 15.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.107 -0.996 . . . . 0.0 109.463 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.65 -0.62 74.12 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -82.81 148.39 57.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.248 . . . . 0.0 109.299 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.402 ' C ' HE21 ' A' ' 37' ' ' GLN . 61.3 Cg_endo -74.06 124.44 9.09 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.489 1.459 . . . . 0.0 111.019 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.487 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -122.81 163.55 20.03 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -136.29 153.55 51.14 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.192 -0.943 . . . . 0.0 110.124 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.54 146.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -131.23 149.11 52.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.179 -0.951 . . . . 0.0 109.682 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.3 t -171.53 154.6 3.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.38 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -92.67 14.77 16.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.005 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.693 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 24.4 mtmm -130.91 138.51 49.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -93.38 -45.06 7.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.482 ' O ' ' OG ' ' A' ' 59' ' ' SER . 1.2 t -119.73 167.54 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.63 -17.57 64.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 110.664 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 p -86.89 -12.0 49.06 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.901 -1.124 . . . . 0.0 110.886 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -70.7 169.26 14.8 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.871 -1.143 . . . . 0.0 110.458 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -139.49 137.29 35.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.12 150.97 72.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 109.657 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.45 150.16 63.58 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.786 1.657 . . . . 0.0 111.049 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.86 146.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.3 -32.4 7.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -98.04 132.84 43.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -1.211 . . . . 0.0 109.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -74.95 147.91 40.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 109.182 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 60.0 p30 -51.82 152.06 3.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.114 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.693 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 35.6 m -146.78 164.07 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.47 133.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 110.823 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 56.3 m -58.19 166.95 1.43 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.412 0.625 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.467 HD12 ' CB ' ' A' ' 27' ' ' TYR . 4.4 mm? -63.68 -65.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.888 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -47.47 -34.45 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.502 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.94 -40.11 72.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.659 -1.275 . . . . 0.0 108.837 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -66.24 -44.02 84.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 110.245 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.5 mp -59.92 -45.12 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.134 -0.979 . . . . 0.0 110.677 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.62 81.65 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.745 -1.222 . . . . 0.0 110.981 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -77.85 -36.71 49.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.846 -1.159 . . . . 0.0 112.477 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.6 mt -67.53 -44.41 78.43 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.364 -1.46 . . . . 0.0 111.523 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 110.985 -178.619 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 121.267 0.556 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.0 p-10 -88.96 -176.9 5.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.083 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -64.78 -6.31 7.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 110.006 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 9' ' ' ARG . 52.9 mtt-85 -105.39 -16.88 14.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.172 -0.955 . . . . 0.0 110.318 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 101.65 19.01 16.7 Favored Glycine 0 N--CA 1.501 2.989 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 11' ' ' ARG . 6.6 mtt-85 -86.03 140.18 30.5 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.77 -1.43 . . . . 0.0 109.168 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.78 103.24 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.525 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -99.4 149.97 22.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.388 -0.82 . . . . 0.0 109.065 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -89.02 -173.86 4.23 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.423 1.106 . . . . 0.0 111.785 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 m -59.4 140.0 56.55 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.229 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 -39.12 2.93 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.312 -0.867 . . . . 0.0 111.338 177.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -72.56 153.38 41.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.745 -1.444 . . . . 0.0 109.862 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -160.55 155.68 24.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -96.42 139.94 31.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -83.75 148.33 27.11 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.568 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -57.56 -18.9 21.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.61 -21.04 23.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.782 -0.573 . . . . 0.0 109.924 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.86 -35.59 4.01 Favored Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 24' ' ' ARG . 2.9 ptp180 -59.54 140.98 55.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.877 -1.366 . . . . 0.0 109.23 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -75.85 170.73 15.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.316 -0.865 . . . . 0.0 110.338 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 39' ' ' VAL . 62.9 tp -154.83 130.98 10.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.73 -0.606 . . . . 0.0 109.551 -179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -134.51 161.93 33.69 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -126.3 134.88 51.01 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.8 p90 -137.98 167.72 21.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.76 131.92 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 109.259 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 41.5 m-20 -82.09 -174.13 4.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.218 -0.926 . . . . 0.0 109.61 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -72.32 -4.64 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.42 -0.8 . . . . 0.0 110.239 -179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 18.3 m-85 -99.59 -10.73 21.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.15 -0.968 . . . . 0.0 109.913 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.41 86.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.39 147.33 52.8 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.392 -1.063 . . . . 0.0 108.733 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.98 128.51 15.93 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.846 1.697 . . . . 0.0 110.522 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.51 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -127.87 164.69 21.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 109.011 -179.106 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.38 155.32 50.48 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.356 -0.84 . . . . 0.0 110.786 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.673 ' O ' HD12 ' A' ' 26' ' ' LEU . 2.9 m -128.86 152.72 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.652 ' CE2' HD13 ' A' ' 26' ' ' LEU . 78.5 m-85 -128.3 150.89 49.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.208 -0.933 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 t -169.08 146.4 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.469 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -88.31 3.55 49.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 109.289 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.66 ' HZ1' ' C ' ' A' ' 57' ' ' CYS . 24.4 mtmm -128.56 141.99 51.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.88 -49.59 6.35 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 46' ' ' ALA . 3.2 t -112.53 174.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -77.95 -11.92 59.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.62 -0.675 . . . . 0.0 110.669 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -87.25 -14.35 41.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.763 -1.211 . . . . 0.0 110.105 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.2 174.89 5.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 1.9 tmt_? -146.49 135.94 22.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.409 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 19.3 m -75.23 147.95 83.4 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.772 -1.205 . . . . 0.0 109.954 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.33 155.73 66.51 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.04 1.827 . . . . 0.0 111.764 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.18 146.98 2.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.55 -0.719 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.4 6.91 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -95.97 139.64 31.88 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.005 -1.291 . . . . 0.0 109.073 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 55' ' ' ARG . 1.4 ttt-85 -75.41 151.26 38.15 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.68 159.06 22.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.365 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.66 ' C ' ' HZ1' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -156.34 175.03 14.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.032 -179.848 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.81 135.38 25.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.524 -0.735 . . . . 0.0 110.68 -178.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.9 p -61.35 163.67 6.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 108.695 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.1 -51.98 40.19 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 111.149 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' NH1' ' HG2' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -44.27 -45.49 8.64 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.143 -0.973 . . . . 0.0 110.003 -178.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -68.58 -40.58 80.45 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 109.672 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -66.62 -44.14 82.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.986 -1.072 . . . . 0.0 110.516 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -56.93 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.91 -1.119 . . . . 0.0 110.318 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.07 70.29 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.74 -53.79 7.49 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -69.28 -41.28 77.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.996 -1.065 . . . . 0.0 110.144 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.296 -1.75 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -177.731 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 6' ' ' ARG . 2.9 mtt-85 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 51.3 p-10 -74.4 -167.36 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.761 -1.212 . . . . 0.0 108.91 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.489 ' N ' ' OE1' ' A' ' 19' ' ' GLN . 95.6 m-20 -68.61 -16.35 63.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.781 -1.2 . . . . 0.0 108.599 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.45 ' N ' ' CD ' ' A' ' 9' ' ' ARG . 9.2 mpt_? -101.3 -87.13 0.4 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -169.5 19.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.455 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 81.3 mtm180 -89.84 138.59 31.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.303 . . . . 0.0 109.704 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.9 mm -77.68 130.26 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.888 . . . . 0.0 109.98 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -93.6 150.64 20.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -87.88 170.87 10.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.957 -1.09 . . . . 0.0 109.513 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.0 m -58.11 137.17 57.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.455 -0.778 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.98 -24.81 24.88 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.943 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 44.1 mp0 -82.04 157.2 24.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.677 -1.484 . . . . 0.0 110.12 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 t -158.93 147.56 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 109.389 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 8' ' ' ASN . 41.7 tt0 -106.45 133.04 51.75 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -83.03 166.0 19.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 109.862 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HD3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.59 -16.49 48.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 108.643 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -86.9 -10.23 53.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.482 -0.761 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.31 -29.2 13.03 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.248 -0.907 . . . . 0.0 111.379 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -57.86 157.0 8.1 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.548 -1.56 . . . . 0.0 109.382 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.455 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 71.2 m-85 -100.41 166.91 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 109.42 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.484 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -152.79 141.29 20.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -135.26 149.23 49.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -114.88 135.42 54.22 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.253 -0.905 . . . . 0.0 110.792 -178.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.693 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.2 p90 -142.46 164.78 29.19 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.2 mt -107.96 139.62 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 33' ' ' PHE . 23.8 m-20 -81.79 159.93 23.68 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.935 -1.103 . . . . 0.0 109.222 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.7 m -58.2 -2.18 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 110.031 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 31' ' ' ASP . 88.1 m-85 -95.29 -15.43 23.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.044 -1.035 . . . . 0.0 108.59 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.07 -5.26 49.71 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 23.5 pt-20 -84.73 144.02 41.7 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.872 -1.369 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.69 139.83 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.534 2.156 . . . . 0.0 111.969 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.4 mp0 -136.8 172.75 12.54 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.108 -0.995 . . . . 0.0 109.402 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -137.01 139.51 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.51 154.27 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 66.9 m-85 -126.12 151.36 47.35 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.449 0.643 . . . . 0.0 109.273 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.8 t -168.22 136.57 2.29 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.013 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -87.58 12.9 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.189 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 53.0 mtmt -130.98 133.22 45.59 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.659 0.742 . . . . 0.0 109.574 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 66.9 tp -89.26 -43.44 10.97 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.528 HG22 HH12 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -111.63 175.39 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.48 -18.28 49.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.953 -1.092 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.2 p -93.58 7.29 45.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.679 -1.263 . . . . 0.0 110.955 -179.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.4 -179.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.611 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -142.1 116.79 9.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.13 -0.981 . . . . 0.0 109.196 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.47 149.45 51.88 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.204 -0.935 . . . . 0.0 110.839 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' LYS . 56.8 Cg_exo -49.58 134.42 33.12 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.208 1.272 . . . . 0.0 110.739 177.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.55 -23.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.848 -1.158 . . . . 0.0 109.791 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -25.4 73.65 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' PRO . 47.8 mmtt -103.93 133.93 48.06 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -78.99 152.65 30.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.087 . . . . 0.0 110.546 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -43.78 154.81 0.09 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.448 0.642 . . . . 0.0 109.826 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.498 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 61.4 m -149.73 167.59 26.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -86.96 128.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.141 -0.975 . . . . 0.0 108.779 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.6 p -58.64 167.64 1.43 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 110.443 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.78 -51.89 43.61 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.369 -0.832 . . . . 0.0 110.206 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' A' ' 61' ' ' ARG . 0.0 OUTLIER -47.07 -46.4 22.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 109.218 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -70.21 -39.65 75.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.512 -0.742 . . . . 0.0 110.19 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.0 -47.51 74.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.687 -1.258 . . . . 0.0 109.465 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.48 -56.69 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.21 76.97 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -77.29 -36.0 54.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.85 . . . . 0.0 111.945 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.693 HD12 ' CZ ' ' A' ' 29' ' ' TYR . 4.2 mm? -67.82 -41.41 83.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.542 -1.349 . . . . 0.0 110.178 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 . . . . . 0 C--N 1.297 -1.705 0 O-C-N 120.239 -1.538 . . . . 0.0 109.813 -179.624 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.501 HH11 ' CG ' ' A' ' 6' ' ' ARG . 4.9 mtt-85 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -104.09 -167.66 1.39 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.755 . . . . 0.0 109.503 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 3.1 p30 -66.89 -16.86 64.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.28 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.593 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -97.6 -3.66 39.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.965 -1.084 . . . . 0.0 110.061 -179.422 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.85 90.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.533 ' CG ' HH11 ' A' ' 11' ' ' ARG . 2.6 mtt-85 -88.71 130.79 35.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.016 -1.285 . . . . 0.0 109.641 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.75 121.64 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 109.233 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.953 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -97.23 155.94 16.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -0.78 . . . . 0.0 108.948 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.07 179.42 6.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.871 -1.143 . . . . 0.0 110.111 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -56.81 152.47 12.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.729 -0.607 . . . . 0.0 110.295 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.44 -43.32 3.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' CD1' ' A' ' 44' ' ' LEU . 2.1 mt-10 -66.39 155.12 38.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.229 -1.16 . . . . 0.0 108.464 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 t -159.03 164.27 35.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.126 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.468 HE21 ' ND2' ' A' ' 8' ' ' ASN . 39.4 tt0 -103.61 126.53 50.81 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 108.9 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -85.17 147.17 26.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.046 . . . . 0.0 108.947 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 1.3 mptt -49.26 -22.6 1.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -89.77 -26.74 20.44 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.799 -1.188 . . . . 0.0 110.821 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.62 -34.33 2.79 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -60.45 148.19 38.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.779 -1.424 . . . . 0.0 108.778 -179.753 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -86.47 168.71 13.5 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 27' ' ' TYR . 4.3 tt -145.12 122.95 11.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.349 -0.844 . . . . 0.0 109.536 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.655 ' N ' HD23 ' A' ' 26' ' ' LEU . 74.0 t80 -128.04 161.54 28.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.424 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 17.4 tttt -129.42 138.63 51.57 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.426 -0.796 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -140.42 162.82 34.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.1 mt -110.96 136.27 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -85.27 170.47 12.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.357 -0.84 . . . . 0.0 109.479 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.0 p -60.35 5.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 110.546 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 31' ' ' ASP . 37.3 m-85 -99.45 -17.68 17.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.039 -1.038 . . . . 0.0 109.43 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 -2.91 82.31 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -83.92 142.07 41.5 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.282 -1.128 . . . . 0.0 108.172 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.5 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 50.4 Cg_endo -69.9 145.54 56.64 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.685 1.59 . . . . 0.0 111.124 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -140.07 153.97 46.92 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -129.56 148.69 51.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.044 -1.035 . . . . 0.0 109.892 -179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.14 142.92 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -117.22 160.91 20.32 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.1 t -168.74 152.46 5.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -93.78 7.55 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -143.65 149.09 36.77 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 51.1 tp -94.09 -42.99 8.71 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.65 158.01 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.683 -0.636 . . . . 0.0 109.452 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.36 -11.4 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.191 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.0 p -90.3 -6.91 54.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.039 -1.038 . . . . 0.0 110.129 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -70.71 179.36 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.97 -1.081 . . . . 0.0 110.009 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 49' ' ' ARG . 6.5 tpt180 -142.44 120.76 12.32 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 109.116 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.31 142.35 50.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.252 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -49.34 146.29 14.02 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.879 1.053 . . . . 0.0 110.503 178.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.56 -47.55 39.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.994 -1.067 . . . . 0.0 110.166 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.97 -21.02 4.85 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -102.51 139.71 37.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -1.17 . . . . 0.0 109.934 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.638 ' CD ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.54 159.29 30.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 179.839 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 25.6 p-10 -66.39 164.25 16.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.16 171.68 15.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.62 133.05 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 110.17 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.7 p -58.82 152.58 18.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.066 179.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.27 -47.21 87.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.219 -0.925 . . . . 0.0 109.867 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -42.95 -45.07 4.88 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.08 -1.012 . . . . 0.0 109.819 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 97.5 mt-10 -72.29 -37.5 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -66.32 -42.51 88.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.693 -1.255 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.04 -53.5 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.668 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.87 93.03 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.15 -0.969 . . . . 0.0 110.116 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -72.33 -38.73 68.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.893 -1.129 . . . . 0.0 111.436 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.62 -46.4 72.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.576 -1.327 . . . . 0.0 110.094 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 . . . . . 0 C--N 1.298 -1.63 0 O-C-N 120.794 -1.191 . . . . 0.0 109.838 179.874 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.499 0.666 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -64.83 165.51 10.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.391 -0.818 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.441 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 26.0 p30 -63.17 -6.97 4.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.368 -0.832 . . . . 0.0 109.823 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -96.41 -75.79 0.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.95 -1.32 0.03 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.924 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.554 ' CG ' HH11 ' A' ' 11' ' ' ARG . 5.3 mtt-85 -85.59 133.18 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.469 . . . . 0.0 108.895 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.96 117.0 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.958 . . . . 0.0 109.385 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.8 151.42 22.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -88.89 173.78 8.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.337 -0.852 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 m -56.82 139.34 51.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.397 -0.815 . . . . 0.0 110.636 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.18 -42.35 2.27 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.24 150.6 43.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.807 -1.408 . . . . 0.0 109.539 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -157.03 140.0 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.441 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 53.9 tt0 -101.86 140.72 35.77 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.454 HH21 HD13 ' A' ' 26' ' ' LEU . 37.1 mtt-85 -91.19 173.13 8.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 110.425 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 1.5 mptt -64.16 -19.66 65.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -84.81 -9.81 57.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.1 -25.53 25.08 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 121.096 -1.002 . . . . 0.0 110.96 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -62.21 137.95 58.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.739 -1.447 . . . . 0.0 109.302 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.81 166.76 19.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 110.496 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 HH21 ' A' ' 20' ' ' ARG . 3.0 tt -153.51 138.76 17.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.696 . . . . 0.0 110.043 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -133.16 148.39 52.09 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -115.05 139.31 49.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.386 -0.821 . . . . 0.0 109.663 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.91 166.07 27.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 0.0 109.098 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -103.81 134.0 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.259 -0.901 . . . . 0.0 109.695 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -84.01 171.59 12.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.894 -1.128 . . . . 0.0 109.236 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -62.33 -0.13 0.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.568 -0.708 . . . . 0.0 111.367 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 39.2 m-85 -103.77 -21.59 13.66 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.901 -1.124 . . . . 0.0 110.255 -178.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.82 -1.91 38.8 Favored Glycine 0 N--CA 1.503 3.109 0 O-C-N 121.059 -1.026 . . . . 0.0 111.199 178.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -86.97 153.91 54.87 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.69 -1.476 . . . . 0.0 108.709 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -82.5 133.99 7.46 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.301 2.001 . . . . 0.0 112.796 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 3.7 mp0 -127.95 164.68 21.78 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.422 -0.798 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -137.49 147.35 45.18 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 156.22 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.34 154.9 44.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.458 -0.776 . . . . 0.0 110.065 -178.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -172.34 137.74 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.605 -0.684 . . . . 0.0 109.276 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -88.38 11.56 16.51 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -126.27 147.67 49.65 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.42 0.628 . . . . 0.0 109.78 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.1 tp -95.67 -47.22 6.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 47' ' ' THR . 35.5 m -122.15 -176.87 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.56 -15.87 58.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 111.109 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.424 ' H ' HG23 ' A' ' 45' ' ' VAL . 24.0 p -88.1 -10.03 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.711 -1.243 . . . . 0.0 110.234 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -75.85 166.78 23.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.978 . . . . 0.0 110.467 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.49 139.91 40.84 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -81.06 149.58 66.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.801 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.39 154.46 50.85 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.488 2.125 . . . . 0.0 111.338 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.13 144.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.63 -38.54 3.07 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.562 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 9.6 mptt -93.2 126.03 38.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -1.165 . . . . 0.0 108.175 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' HB3' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.5 155.67 33.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 110.109 -179.137 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -50.98 164.67 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.939 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 52.2 t -162.15 165.75 26.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.439 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 97.6 mt -83.93 126.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.59 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.5 p -54.37 157.62 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 108.925 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.54 -59.97 3.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 110.677 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -46.69 -39.93 12.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.115 . . . . 0.0 110.392 -178.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -71.5 -40.22 70.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.929 -1.107 . . . . 0.0 109.394 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -70.84 -41.81 70.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.78 -49.65 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.94 -1.1 . . . . 0.0 109.137 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.66 80.19 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.179 -0.95 . . . . 0.0 109.859 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.71 -53.5 13.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 111.07 -178.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.68 -49.19 41.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.631 -1.293 . . . . 0.0 110.442 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 C--N 1.295 -1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 -176.499 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 6' ' ' ARG . 2.6 mtt-85 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 58.3 p30 -101.26 178.15 4.73 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -62.05 -6.77 3.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.718 -1.239 . . . . 0.0 109.462 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.488 HH21 HH21 ' A' ' 11' ' ' ARG . 17.7 mmm180 -96.95 -12.12 23.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 86.73 10.05 73.57 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.313 178.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 11' ' ' ARG . 2.9 mtt-85 -85.67 152.02 23.42 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.668 -1.489 . . . . 0.0 109.544 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -84.48 104.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 pp -92.77 146.43 23.65 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.936 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -88.78 -174.54 4.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.049 -1.032 . . . . 0.0 111.466 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 m -57.63 147.33 27.67 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.4 -44.82 3.41 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.51 149.06 50.66 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.995 -1.297 . . . . 0.0 109.555 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -157.21 155.1 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.491 ' OE1' ' CD1' ' A' ' 25' ' ' TYR . 5.2 tp60 -110.81 132.39 54.24 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.542 -0.724 . . . . 0.0 110.007 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.82 HH11 HH21 ' A' ' 24' ' ' ARG . 36.0 mtp180 -90.46 -177.41 5.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -67.67 -24.1 65.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.209 -179.229 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.51 -13.1 41.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.004 -1.06 . . . . 0.0 109.702 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.65 -14.46 59.09 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.345 -0.847 . . . . 0.0 111.393 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.82 HH21 HH11 ' A' ' 20' ' ' ARG . 2.1 ptt180 -64.46 141.03 58.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.444 -1.621 . . . . 0.0 109.348 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.491 ' CD1' ' OE1' ' A' ' 19' ' ' GLN . 71.5 m-85 -81.45 165.95 20.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.418 -0.802 . . . . 0.0 110.066 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.532 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 9.3 tp -153.85 125.81 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.473 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 69.0 t80 -130.72 170.15 14.72 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 33.1 tttm -139.76 142.24 36.77 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.931 -1.106 . . . . 0.0 111.173 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.58 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 43.5 p90 -149.17 -172.91 4.24 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.352 -0.843 . . . . 0.0 108.966 176.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -114.22 134.54 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.952 -1.092 . . . . 0.0 110.147 -178.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' CG ' HE21 ' A' ' 37' ' ' GLN . 5.0 m-20 -83.98 174.87 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 t -66.6 -6.53 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.9 . . . . 0.0 108.808 178.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 12.0 m-85 -98.18 -4.76 34.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.773 . . . . 0.0 109.069 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.08 -1.11 86.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 pp20? -85.5 144.44 40.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 0.0 108.959 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.62 131.08 11.14 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.978 1.785 . . . . 0.0 112.146 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.668 ' H ' ' NE2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -129.4 172.1 11.85 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.964 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 19.0 m-85 -141.08 163.47 32.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 0.0 110.512 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.54 135.46 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.532 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 76.7 m-85 -122.49 143.54 49.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.531 -0.731 . . . . 0.0 110.01 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.6 t -171.7 157.64 4.72 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 178.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -91.19 10.18 28.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.544 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 34.1 mtmm -131.81 141.19 49.38 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.717 0.77 . . . . 0.0 110.152 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -94.58 -40.45 9.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.59 168.1 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.04 60.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.421 -0.799 . . . . 0.0 109.729 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.8 p -90.06 -5.52 56.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.165 -0.959 . . . . 0.0 110.314 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.95 172.15 9.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.924 -1.11 . . . . 0.0 109.366 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -142.15 133.65 26.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.135 -0.978 . . . . 0.0 109.255 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.4 150.0 62.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.301 -179.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 151.8 62.84 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.161 1.907 . . . . 0.0 111.213 178.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.84 153.32 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 0.0 110.481 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.21 5.77 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -95.43 139.38 31.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.059 -1.26 . . . . 0.0 109.572 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.521 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.84 164.62 25.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 109.349 -179.48 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -74.45 161.94 29.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.355 -0.841 . . . . 0.0 109.608 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.544 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 27.8 t -161.73 161.22 29.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.479 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 81.6 mt -82.42 136.34 23.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.021 -1.049 . . . . 0.0 109.227 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -59.19 176.04 0.26 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.53 -0.732 . . . . 0.0 110.123 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 60' ' ' LEU . 6.9 mp -77.2 -52.68 8.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.546 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -42.63 -44.41 4.22 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.182 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -71.84 -40.0 69.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -65.04 -40.38 94.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.709 -1.245 . . . . 0.0 109.884 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.19 -55.61 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.958 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.16 95.75 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.5 -1.375 . . . . 0.0 109.89 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.43 -45.28 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 110.652 -179.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.73 -43.5 68.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.815 -1.178 . . . . 0.0 110.255 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 . . . . . 0 C--N 1.298 -1.665 0 O-C-N 121.725 -0.609 . . . . 0.0 110.329 -177.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.372 0.606 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 mtpt -152.67 90.15 1.46 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.441 ' CA ' ' HE ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -88.82 151.3 22.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 -179.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 mtm-85 -133.95 167.54 20.41 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.539 -0.726 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 42.4 p-10 -91.35 -177.08 4.75 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 109.772 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -63.09 -9.47 10.72 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.506 -0.746 . . . . 0.0 109.698 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.409 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 4.0 mmp_? -101.3 -71.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.994 -1.066 . . . . 0.0 110.02 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 169.09 7.08 0.03 OUTLIER Glycine 0 N--CA 1.497 2.703 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.949 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.566 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 67.0 mtm180 -87.98 136.49 32.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.644 -1.503 . . . . 0.0 109.066 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.3 mt -82.61 111.72 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -89.42 149.85 22.78 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -86.04 -179.71 6.81 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.803 -1.186 . . . . 0.0 110.97 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t -58.63 145.62 39.03 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.691 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.02 -40.1 2.81 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 121.328 -0.857 . . . . 0.0 111.189 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 27' ' ' TYR . 46.5 mp0 -72.07 152.18 42.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.709 -1.465 . . . . 0.0 109.997 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.3 t -154.67 142.38 19.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -110.27 132.43 54.18 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -89.5 169.87 11.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.313 -0.867 . . . . 0.0 109.347 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -12.6 41.79 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.534 -0.729 . . . . 0.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -87.65 -18.41 29.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.272 -0.893 . . . . 0.0 109.831 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.54 -23.85 25.46 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -64.86 137.89 58.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.78 -1.424 . . . . 0.0 109.569 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.566 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -82.8 171.41 13.97 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.643 -0.661 . . . . 0.0 110.115 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 27' ' ' TYR . 2.1 tt -154.56 127.23 8.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.423 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.557 ' N ' HD23 ' A' ' 26' ' ' LEU . 75.9 t80 -132.78 163.19 29.6 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.249 -0.907 . . . . 0.0 109.058 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -131.52 137.05 48.35 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.323 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.72 133.13 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 33' ' ' PHE . 34.6 p30 -88.31 174.61 8.08 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.667 -0.646 . . . . 0.0 110.319 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 t -62.11 6.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 0.0 110.555 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 31' ' ' ASP . 19.9 m-85 -100.69 -16.31 17.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.98 -1.075 . . . . 0.0 108.432 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.61 -4.86 85.11 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.26 149.88 59.46 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.072 -1.252 . . . . 0.0 108.717 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.96 137.41 24.21 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.405 1.403 . . . . 0.0 109.786 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -135.21 137.63 42.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.915 -1.116 . . . . 0.0 109.274 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -112.61 145.23 40.74 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.518 -0.739 . . . . 0.0 110.172 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -122.0 157.38 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.527 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 55.6 m-85 -127.53 155.73 43.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.463 -0.773 . . . . 0.0 109.172 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -170.78 136.5 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.85 -1.156 . . . . 0.0 110.868 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -86.62 5.99 33.14 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -131.76 131.73 43.22 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.615 0.722 . . . . 0.0 110.098 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 tp -86.18 -42.78 13.54 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.75 174.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.93 -16.74 59.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.086 -1.008 . . . . 0.0 110.6 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.5 p -88.39 -4.91 58.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.849 -1.157 . . . . 0.0 110.596 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.565 ' CG ' HH12 ' A' ' 11' ' ' ARG . 73.2 m-20 -70.01 177.31 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.595 -1.316 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -139.6 138.08 35.88 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.329 -0.857 . . . . 0.0 109.338 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.08 144.07 50.32 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.49 -0.756 . . . . 0.0 111.044 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.0 143.92 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.449 2.099 . . . . 0.0 112.912 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.79 130.6 17.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.459 -0.775 . . . . 0.0 110.072 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.88 -16.84 59.71 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -92.22 135.24 34.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.013 -1.286 . . . . 0.0 109.061 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -75.24 161.27 29.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.314 -0.867 . . . . 0.0 110.189 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.55 158.86 3.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.57 -0.706 . . . . 0.0 110.23 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 9.3 t -147.31 158.0 43.8 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 87.1 mt -83.09 124.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.872 -1.143 . . . . 0.0 109.306 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -58.41 153.9 14.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.206 -0.934 . . . . 0.0 109.543 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.86 -53.45 57.8 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.611 -0.835 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -48.88 -44.65 40.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.885 -1.135 . . . . 0.0 109.043 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -72.33 -39.06 68.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 40' ' ' TYR . 11.0 ttmt -67.32 -49.86 62.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.977 -1.077 . . . . 0.0 109.444 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.15 -50.34 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.27 -49.26 74.73 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 110.42 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -68.87 -39.75 79.66 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 111.701 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.31 -48.59 49.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.699 -1.251 . . . . 0.0 111.305 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -71.35 -37.74 71.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.123 -0.985 . . . . 0.0 110.44 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -74.08 -23.03 59.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.646 -1.284 . . . . 0.0 110.29 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -98.8 -51.41 3.9 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.172 -0.955 . . . . 0.0 110.827 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -81.37 13.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.079 -1.013 . . . . 0.0 109.373 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -151.65 37.14 0.58 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.585 -1.322 . . . . 0.0 109.011 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.42 -0.8 . . . . 0.0 109.638 179.793 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.881 ' N ' ' HZ2' ' A' ' 4' ' ' LYS . 77.7 mm-40 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.881 ' HZ2' ' N ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -152.61 -113.92 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.238 -0.913 . . . . 0.0 109.577 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.546 HH11 ' CG ' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -83.82 147.75 27.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.804 -1.185 . . . . 0.0 108.802 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -135.16 172.97 12.26 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.36 -0.837 . . . . 0.0 109.27 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 37.6 p-10 -95.24 -170.81 2.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.371 -0.831 . . . . 0.0 109.59 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 70.1 m-80 -68.18 -11.57 59.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.849 . . . . 0.0 110.789 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -103.47 -23.27 13.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.028 -1.045 . . . . 0.0 109.907 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 109.41 19.27 8.48 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 24.3 mtt180 -84.71 124.59 31.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.131 -1.217 . . . . 0.0 109.47 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.7 mm -75.45 101.73 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.835 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -95.24 150.62 20.04 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -87.48 -171.81 3.63 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.0 111.45 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.431 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 66.2 p -54.06 149.95 8.68 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.0 -45.25 2.48 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 1.4 mp0 -69.22 131.84 45.55 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.563 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.3 m -152.7 152.35 31.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.287 -0.883 . . . . 0.0 108.775 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.444 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.1 tt0 -95.92 141.59 29.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.042 -1.037 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -88.11 163.03 16.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.718 -0.613 . . . . 0.0 109.376 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -62.71 -19.82 64.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.018 -1.051 . . . . 0.0 108.571 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.91 -13.59 44.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.913 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.31 -26.83 19.02 Favored Glycine 0 N--CA 1.5 2.936 0 O-C-N 121.258 -0.901 . . . . 0.0 111.075 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -61.99 135.92 57.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.694 -1.474 . . . . 0.0 110.237 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH1' ' A' ' 11' ' ' ARG . 74.1 m-85 -80.57 168.28 19.09 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -161.04 147.38 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.0 -1.062 . . . . 0.0 109.298 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.978 ' N ' HD22 ' A' ' 26' ' ' LEU . 84.6 t80 -139.16 168.05 20.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.295 -0.878 . . . . 0.0 109.708 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 65.5 tttt -127.06 138.99 53.32 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.433 -0.792 . . . . 0.0 109.437 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.603 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 19.4 p90 -138.39 170.7 15.55 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mm -108.47 136.57 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.405 -0.809 . . . . 0.0 110.123 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.4 m-20 -78.47 161.82 26.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.22 -0.925 . . . . 0.0 108.649 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 t -59.79 -2.82 0.42 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 109.317 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.4 m-85 -101.53 -18.46 15.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.335 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 2.4 51.5 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 121.227 -0.921 . . . . 0.0 111.237 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -86.26 148.15 46.57 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 120.78 -1.424 . . . . 0.0 110.191 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 87.2 Cg_endo -76.99 128.32 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 122.94 2.427 . . . . 0.0 113.213 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.524 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -131.29 163.45 27.79 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -131.73 156.2 46.35 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.282 -0.886 . . . . 0.0 109.892 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.41 147.04 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -125.79 151.57 46.58 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.783 0.801 . . . . 0.0 109.751 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.5 t -172.27 145.47 1.72 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -87.79 23.79 1.92 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.951 -1.093 . . . . 0.0 108.281 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -137.37 137.56 38.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.593 -0.692 . . . . 0.0 110.539 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.0 tp -95.18 -42.33 8.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 47' ' ' THR . 18.2 m -126.86 147.49 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.15 -7.04 0.17 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 45' ' ' VAL . 30.8 p -89.82 -4.74 57.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.998 -1.064 . . . . 0.0 110.184 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.21 164.18 27.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.142 -0.974 . . . . 0.0 110.801 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.539 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -134.86 121.03 20.04 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.3 150.69 64.61 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.025 -1.047 . . . . 0.0 110.885 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.75 150.52 44.84 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.491 2.128 . . . . 0.0 111.69 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.83 147.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.111 -0.993 . . . . 0.0 109.666 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.83 -38.36 3.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -95.17 131.21 41.45 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.307 -1.114 . . . . 0.0 108.485 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -77.76 153.4 32.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.839 -1.163 . . . . 0.0 109.689 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.02 163.31 22.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.45 -0.781 . . . . 0.0 110.128 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 29.6 t -157.16 169.71 24.17 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.589 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 75.7 mt -82.42 136.82 22.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 109.174 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 94.5 p -55.85 154.31 7.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.149 -0.969 . . . . 0.0 109.311 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 61' ' ' ARG . 78.6 mt -62.01 -49.61 75.37 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.308 -0.87 . . . . 0.0 110.272 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 60' ' ' LEU . 30.5 mtt180 -46.65 -47.53 20.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.786 -1.196 . . . . 0.0 109.787 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -72.18 -34.83 68.72 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -68.71 -41.57 78.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 108.913 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.26 -52.54 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.45 -34.45 72.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -70.85 -35.33 72.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.424 -0.798 . . . . 0.0 111.535 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.603 HD12 ' CZ ' ' A' ' 29' ' ' TYR . 4.0 mm? -63.61 -39.93 95.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.821 -1.174 . . . . 0.0 110.658 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -70.96 -44.59 65.73 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 120.538 -1.351 . . . . 0.0 111.352 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.94 -14.86 58.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.577 -1.327 . . . . 0.0 111.369 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -89.04 -23.55 22.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.868 -1.145 . . . . 0.0 110.658 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 71' ' ' ILE . 6.2 mm -88.67 -4.59 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.001 -1.062 . . . . 0.0 109.402 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -150.33 149.82 30.62 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.04 -1.037 . . . . 0.0 110.047 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.561 -0.712 . . . . 0.0 110.095 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -85.32 -172.7 4.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.077 -1.015 . . . . 0.0 110.597 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.548 HH11 ' HG2' ' A' ' 5' ' ' ARG . 5.3 mtt-85 -87.66 162.0 17.35 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.474 0.654 . . . . 0.0 110.299 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 6' ' ' ARG . 35.9 mtm-85 -137.89 -179.31 5.69 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -95.69 -163.88 1.1 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.082 -1.012 . . . . 0.0 109.85 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 13.4 p30 -67.07 -23.54 65.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -100.03 5.02 45.07 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 110.637 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.43 49.8 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -87.19 134.86 33.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.137 -1.214 . . . . 0.0 110.205 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.4 mm -84.44 97.1 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 108.773 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.78 146.02 24.47 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.039 -1.038 . . . . 0.0 109.708 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.79 178.59 6.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.122 -0.986 . . . . 0.0 109.732 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -57.26 147.02 26.61 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.532 0.682 . . . . 0.0 111.324 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.55 -45.23 1.76 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 24.3 mp0 -72.41 156.62 38.87 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.106 -1.232 . . . . 0.0 109.802 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.8 m -157.75 140.91 15.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.534 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 36.4 tt0 -94.85 142.18 27.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -92.25 169.08 10.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.631 0.729 . . . . 0.0 109.452 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -63.48 -23.1 67.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.701 -0.624 . . . . 0.0 110.553 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -88.1 -17.49 30.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 0.0 110.133 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.39 -32.21 6.02 Favored Glycine 0 N--CA 1.501 2.994 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -60.4 135.15 57.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.736 -1.449 . . . . 0.0 109.558 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.68 170.18 16.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 111.192 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 39' ' ' VAL . 47.3 tp -152.03 121.66 6.93 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 82.3 t80 -125.14 174.66 7.91 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.236 -0.915 . . . . 0.0 108.57 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.576 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 75.1 tttt -128.06 121.77 30.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.331 -0.856 . . . . 0.0 109.779 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -124.3 158.47 32.49 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.96 150.02 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' HA ' HD11 ' A' ' 71' ' ' ILE . 69.1 m-20 -80.9 170.44 16.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.224 -0.922 . . . . 0.0 108.937 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.7 m -68.07 -2.64 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -96.96 -17.51 20.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.132 -0.98 . . . . 0.0 109.389 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.59 -4.41 32.71 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 20.9 pt-20 -85.34 145.67 43.08 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.882 -1.363 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 86.2 Cg_endo -78.57 146.97 21.94 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.645 2.23 . . . . 0.0 113.44 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.469 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.8 mp0 -142.3 178.35 7.63 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -133.95 152.9 52.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 0.0 109.531 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.578 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -129.92 158.58 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.451 -0.781 . . . . 0.0 109.33 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 36.6 m-85 -128.95 149.96 50.58 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.277 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -168.37 142.28 3.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.128 -0.982 . . . . 0.0 109.949 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -90.37 11.63 20.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -139.87 153.48 47.03 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 0.0 110.442 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 59' ' ' SER . 42.9 tp -99.25 -43.61 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.95 170.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.15 -15.58 59.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 0.0 110.886 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.2 p -86.57 -13.76 44.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.588 -1.32 . . . . 0.0 110.069 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -71.17 178.94 3.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 110.389 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.8 147.73 46.78 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.7 m -78.92 149.66 74.09 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.976 -1.077 . . . . 0.0 109.553 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -51.7 147.64 23.72 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.337 1.358 . . . . 0.0 111.432 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.24 141.18 11.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 -24.64 29.14 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -96.81 140.74 30.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.313 . . . . 0.0 109.356 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -74.45 153.28 39.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.807 -1.183 . . . . 0.0 109.148 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.31 163.32 0.41 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.181 -0.949 . . . . 0.0 110.09 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -148.38 160.12 43.33 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 99.0 mt -84.84 134.26 27.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 44.3 t -58.47 153.87 15.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.661 -0.65 . . . . 0.0 110.052 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -60.82 -53.13 61.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -49.87 -45.74 50.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.935 -1.103 . . . . 0.0 109.845 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -70.9 -29.9 66.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.712 -1.242 . . . . 0.0 108.675 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -72.39 -45.54 59.29 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.459 -0.775 . . . . 0.0 109.204 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.35 -55.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 0.0 110.252 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.06 93.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 0.0 110.647 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -68.74 -35.16 76.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 111.803 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.03 -41.78 86.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.569 -1.332 . . . . 0.0 111.755 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -67.06 -44.71 79.44 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 120.239 -1.538 . . . . 0.0 111.335 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -78.97 -3.11 43.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.777 -1.202 . . . . 0.0 111.514 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -109.14 -52.65 2.74 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.839 -1.163 . . . . 0.0 112.446 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.733 ' O ' HD12 ' A' ' 71' ' ' ILE . 2.0 pp -82.6 102.19 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.786 -1.196 . . . . 0.0 110.342 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 9.7 p-80 -156.52 15.84 0.31 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.648 -1.283 . . . . 0.0 109.66 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 109.526 -179.654 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 3' ' ' GLU . 1.2 pm0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -83.7 114.51 21.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.174 -0.954 . . . . 0.0 108.727 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -91.96 125.58 36.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.219 -0.926 . . . . 0.0 109.355 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -139.46 -178.38 5.36 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -70.34 175.24 4.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 0.0 110.264 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.521 HD22 ' CD ' ' A' ' 19' ' ' GLN . 79.9 m-20 -66.81 -12.4 58.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.476 -0.765 . . . . 0.0 109.931 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.435 ' NH1' ' HG3' ' A' ' 9' ' ' ARG . 7.7 mmm-85 -95.57 -77.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.847 -1.158 . . . . 0.0 109.349 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.96 3.7 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.216 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 55.9 mtm180 -88.14 125.27 34.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.732 -1.452 . . . . 0.0 108.869 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.3 mt -77.79 110.95 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.07 -1.019 . . . . 0.0 109.832 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.2 156.71 18.12 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -88.79 -176.84 5.36 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.816 -1.178 . . . . 0.0 110.775 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -54.63 161.65 1.42 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.801 0.81 . . . . 0.0 112.068 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.34 -19.26 1.89 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.531 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 40.4 mt-10 -86.92 150.03 24.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.266 . . . . 0.0 110.295 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.0 p -157.5 134.05 9.83 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.521 ' CD ' HD22 ' A' ' 8' ' ' ASN . 47.9 tt0 -99.2 125.8 44.86 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' CG ' HH11 ' A' ' 20' ' ' ARG . 1.0 OUTLIER -85.57 -174.13 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.816 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -72.48 -22.9 60.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.457 -0.777 . . . . 0.0 109.937 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.67 -10.97 57.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 109.699 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.89 -21.94 43.42 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -61.33 138.05 58.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.847 -1.384 . . . . 0.0 109.294 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 67.3 m-85 -80.54 166.72 20.9 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.252 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 24.3 tp -150.24 119.07 6.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 109.623 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -125.44 162.27 25.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -131.44 138.13 48.92 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.25 -0.906 . . . . 0.0 110.736 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.2 p90 -142.82 164.51 29.9 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.62 138.85 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.94 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 52.8 m-20 -87.37 -178.35 6.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.949 . . . . 0.0 110.4 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 p -66.91 -1.37 3.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.637 -0.665 . . . . 0.0 110.321 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 47.9 m-85 -98.58 -10.63 23.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.951 . . . . 0.0 108.713 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.45 -8.52 76.88 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -81.37 145.2 54.99 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.5 148.22 42.27 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.94 1.76 . . . . 0.0 112.717 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.1 mp0 -135.67 170.71 15.54 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -139.28 145.89 39.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.346 -0.846 . . . . 0.0 110.383 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.85 146.49 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.704 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 62.2 m-85 -128.91 151.11 50.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.597 -0.69 . . . . 0.0 109.596 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.9 t -171.66 146.19 2.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -88.83 11.42 17.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 108.51 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -123.57 140.99 52.44 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.555 -0.716 . . . . 0.0 110.226 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.79 -44.95 6.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.38 172.72 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -19.41 62.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.2 p -86.7 -1.98 58.15 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.703 -1.248 . . . . 0.0 110.788 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' OD1' ' NH1' ' A' ' 11' ' ' ARG . 76.0 m-20 -70.6 -174.22 0.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.585 -1.322 . . . . 0.0 109.334 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -148.75 130.53 15.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.043 -1.035 . . . . 0.0 109.454 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 15.0 m -80.97 130.07 64.91 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.83 -1.169 . . . . 0.0 109.272 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -48.87 148.05 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.188 1.259 . . . . 0.0 111.711 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.14 135.46 13.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.112 -0.992 . . . . 0.0 109.817 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.13 -32.66 6.68 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -92.33 136.47 33.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -1.165 . . . . 0.0 108.553 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.3 mmp_? -74.59 151.78 39.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.377 -0.827 . . . . 0.0 110.439 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -55.62 169.48 0.32 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 43.6 t -165.15 166.46 19.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.131 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 71.5 mt -83.6 125.48 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.015 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.9 p -56.69 156.0 6.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.337 -0.852 . . . . 0.0 109.638 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' O ' HD13 ' A' ' 64' ' ' ILE . 8.2 mp -56.13 -47.85 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.531 ' NH2' ' OE2' ' A' ' 17' ' ' GLU . 5.0 mmp_? -53.25 -50.6 64.47 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.013 -1.054 . . . . 0.0 110.291 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.29 -36.68 61.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.753 -1.217 . . . . 0.0 110.806 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -65.97 -44.34 85.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.747 -1.22 . . . . 0.0 110.105 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.3 mp -60.68 -48.78 87.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.179 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.48 -42.71 74.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.93 -1.106 . . . . 0.0 109.974 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -70.27 -51.86 27.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.607 -1.308 . . . . 0.0 110.807 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.417 HD22 ' OH ' ' A' ' 29' ' ' TYR . 30.7 mt -68.27 -26.32 65.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 111.752 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.98 -68.68 0.58 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 120.804 -1.185 . . . . 0.0 112.745 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 73' ' ' ASP . 16.1 ptmt -75.06 -39.1 61.13 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.611 -1.306 . . . . 0.0 112.844 -177.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -60.85 -33.49 73.15 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.458 -1.401 . . . . 0.0 109.369 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 71' ' ' ILE . 42.2 mm -85.76 -3.11 8.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.549 -0.719 . . . . 0.0 110.743 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -144.76 -59.98 0.36 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.934 -1.104 . . . . 0.0 109.673 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' LYS . 58.1 t0 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.129 -0.982 . . . . 0.0 109.317 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -82.64 168.55 17.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.059 -1.026 . . . . 0.0 109.439 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -80.95 151.81 28.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.671 -0.643 . . . . 0.0 110.446 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -134.92 166.63 22.56 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.527 -0.733 . . . . 0.0 109.93 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -100.82 -176.47 3.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.732 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -66.29 -15.17 63.01 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.042 -1.036 . . . . 0.0 110.034 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.3 OUTLIER -95.39 -0.51 52.48 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 -178.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 0.45 86.45 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -84.57 137.04 33.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.107 -1.231 . . . . 0.0 109.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.6 mt -80.47 120.06 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.916 -1.115 . . . . 0.0 109.743 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -90.32 150.59 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 18.8 mtpp -87.09 -178.03 6.16 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.926 -1.109 . . . . 0.0 110.608 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 29.7 p -57.1 149.05 20.21 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 111.571 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.16 -30.37 2.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 15' ' ' THR . 43.1 mp0 -76.15 154.17 35.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.845 -1.385 . . . . 0.0 109.296 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.0 m -157.43 138.24 13.23 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.066 -1.022 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -99.37 134.34 42.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 20' ' ' ARG . 5.2 mmm-85 -87.54 176.02 7.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -21.33 63.56 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -83.52 -7.27 59.56 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.618 -0.676 . . . . 0.0 110.527 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.11 -28.46 13.84 Favored Glycine 0 N--CA 1.501 2.977 0 O-C-N 120.97 -1.081 . . . . 0.0 111.068 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -57.13 154.33 10.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.853 -1.381 . . . . 0.0 109.616 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.63 169.85 9.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 0.0 109.731 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 tt -154.83 133.3 11.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.456 -0.777 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.96 146.41 49.08 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -118.92 136.38 54.09 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.653 -0.654 . . . . 0.0 110.606 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.551 ' C ' HD12 ' A' ' 30' ' ' ILE . 7.3 p90 -148.12 -171.9 3.94 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.365 -0.834 . . . . 0.0 110.287 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.551 HD12 ' C ' ' A' ' 29' ' ' TYR . 1.7 mp -106.64 129.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 33' ' ' PHE . 48.9 p30 -86.47 -171.66 3.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.189 -0.944 . . . . 0.0 109.6 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.76 19.89 0.19 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.881 -1.137 . . . . 0.0 109.291 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 10.7 m-85 -118.29 -15.05 9.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.337 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.21 64.56 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.6 147.94 50.6 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.183 -1.186 . . . . 0.0 109.583 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.8 140.07 34.73 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.014 1.81 . . . . 0.0 112.36 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.682 HE21 ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.0 164.65 26.51 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 23.2 m-85 -128.65 141.41 51.35 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.17 -0.957 . . . . 0.0 109.271 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.15 155.85 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -122.52 154.89 37.26 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.702 0.763 . . . . 0.0 110.113 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -171.26 143.6 1.9 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.999 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -97.17 18.25 15.38 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.81 144.72 31.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.324 -0.86 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 59' ' ' SER . 45.1 tp -94.25 -43.92 8.21 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.24 167.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.61 -12.55 61.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.488 -0.757 . . . . 0.0 111.261 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.0 m -86.79 -9.6 55.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.903 -1.123 . . . . 0.0 110.098 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.28 167.19 16.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -140.2 118.85 12.34 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.92 148.24 86.88 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 110.179 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.38 157.1 62.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.183 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.96 150.5 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.311 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.64 -41.62 2.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -98.13 132.04 44.0 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.493 -1.004 . . . . 0.0 108.931 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.469 ' CD ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.86 157.66 31.3 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.086 -1.009 . . . . 0.0 109.896 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -53.78 159.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.4 m -148.6 176.19 10.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 109.192 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -91.61 126.66 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 31.5 t -55.63 148.53 15.83 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.16 -0.963 . . . . 0.0 108.481 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 mt -58.52 -52.43 65.68 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.461 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 16.1 mmt180 -49.36 -37.24 24.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.704 -1.247 . . . . 0.0 108.989 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.35 -43.5 60.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.279 -0.888 . . . . 0.0 109.364 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -65.06 -44.36 89.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.494 -0.754 . . . . 0.0 109.613 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.09 -47.06 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.67 -46.58 88.61 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.099 -1.0 . . . . 0.0 109.851 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.47 -40.05 70.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.234 -0.916 . . . . 0.0 110.843 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 71' ' ' ILE . 40.7 mt -66.4 -45.24 80.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 112.082 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.42 -24.74 57.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.27 -1.519 . . . . 0.0 110.263 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -77.43 -39.75 45.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.08 -1.012 . . . . 0.0 110.725 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.86 -18.83 38.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.087 -1.008 . . . . 0.0 109.933 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.514 HD13 ' O ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -78.99 -36.65 18.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.702 -0.623 . . . . 0.0 109.751 -178.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -147.62 129.24 15.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.09 -1.006 . . . . 0.0 108.941 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.698 -0.627 . . . . 0.0 110.088 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.4 mtpp -82.54 168.87 16.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.4 -0.812 . . . . 0.0 110.003 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.4 ' HG2' ' NH1' ' A' ' 5' ' ' ARG . 8.2 ptt-85 -82.17 164.14 21.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.227 -0.92 . . . . 0.0 110.362 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 58.6 mtm-85 -138.76 160.22 40.2 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 43.6 p-10 -76.83 -175.08 3.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.042 . . . . 0.0 109.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -62.58 -6.16 3.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.65 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -104.77 -81.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 0.0 109.404 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 177.72 2.81 0.02 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.536 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 17.5 ptt180 -86.96 132.03 33.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.082 -1.246 . . . . 0.0 108.584 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 131.86 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.46 163.01 16.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.19 175.98 7.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.098 -1.001 . . . . 0.0 109.783 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.4 m -60.96 130.32 45.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.859 -0.526 . . . . 0.0 110.749 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.58 -37.29 3.42 Favored Glycine 0 N--CA 1.501 2.973 0 O-C-N 121.218 -0.926 . . . . 0.0 111.892 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 59.1 mp0 -72.62 150.58 42.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.638 -1.507 . . . . 0.0 110.265 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -155.8 148.39 23.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.316 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -104.8 132.93 50.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.963 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -85.42 170.9 12.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 109.632 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -68.68 -18.49 64.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.15 -21.31 36.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 110.359 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.53 3.86 Favored Glycine 0 N--CA 1.502 3.082 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -61.06 139.64 58.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.124 -1.221 . . . . 0.0 109.191 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.536 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 86.6 m-85 -85.73 170.3 12.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.835 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.604 HD13 ' CE2' ' A' ' 40' ' ' TYR . 41.4 tp -151.46 128.15 10.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -129.88 142.95 50.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.57 142.08 47.35 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.569 -0.707 . . . . 0.0 110.247 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.625 ' OH ' HD12 ' A' ' 67' ' ' LEU . 9.8 p90 -149.09 -171.41 3.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.516 -0.74 . . . . 0.0 109.53 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 mm -120.11 134.85 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.261 -0.899 . . . . 0.0 110.221 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' OD2' ' OE1' ' A' ' 37' ' ' GLN . 12.5 m-20 -87.05 175.25 8.2 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.862 -1.149 . . . . 0.0 110.392 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.644 ' H ' HD12 ' A' ' 71' ' ' ILE . 47.4 m -70.76 -2.71 15.58 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 11.0 m-85 -98.67 -11.59 21.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.589 -0.694 . . . . 0.0 109.357 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.79 -5.88 79.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.547 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.9 pt-20 -86.75 152.08 53.54 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.159 -1.201 . . . . 0.0 109.328 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.527 ' C ' HE21 ' A' ' 37' ' ' GLN . 95.3 Cg_endo -78.25 155.1 28.92 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.137 1.891 . . . . 0.0 112.441 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -148.86 160.14 43.52 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.217 -0.927 . . . . 0.0 109.235 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HB3' HD11 ' A' ' 26' ' ' LEU . 51.8 m-85 -136.66 148.97 47.69 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 26' ' ' LEU . 11.2 m -122.24 145.37 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.604 ' CE2' HD13 ' A' ' 26' ' ' LEU . 55.6 m-85 -116.03 151.51 35.36 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 t -169.64 145.54 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.28 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.72 9.07 36.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.328 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -132.32 133.64 44.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD11 ' NH2' ' A' ' 61' ' ' ARG . 35.1 tp -88.99 -42.96 11.47 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.67 151.75 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.42 -7.08 3.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.109 -0.995 . . . . 0.0 111.156 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.1 p -90.34 -11.8 39.6 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.749 -1.22 . . . . 0.0 109.774 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.62 172.49 11.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.181 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.33 135.03 33.34 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.24 147.39 60.53 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.745 -1.222 . . . . 0.0 110.451 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.61 145.7 71.02 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.13 1.887 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.72 144.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 110.573 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.12 -32.62 7.3 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -97.07 139.11 33.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.159 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.62 151.8 34.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -0.966 . . . . 0.0 109.771 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -56.7 150.53 15.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.141 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.7 p -147.32 161.98 39.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.046 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.2 mt -82.69 126.81 40.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.0 m -56.33 160.94 2.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.157 -0.964 . . . . 0.0 108.801 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.04 -47.6 73.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.748 -1.22 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' NH2' HD11 ' A' ' 44' ' ' LEU . 5.1 mmt-85 -41.54 -53.01 3.58 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.401 -0.812 . . . . 0.0 110.28 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -69.01 -34.43 75.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.088 -1.008 . . . . 0.0 108.662 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -68.77 -41.87 78.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -50.15 -51.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.138 -0.976 . . . . 0.0 109.266 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.7 70.98 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.852 -1.155 . . . . 0.0 109.525 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -72.93 -44.87 60.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.91 . . . . 0.0 111.481 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.625 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.5 mm? -69.54 -44.06 71.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.23 -1.544 . . . . 0.0 110.899 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -73.26 -18.01 61.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.762 -1.836 . . . . 0.0 110.886 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -79.46 -63.65 1.37 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.572 -1.33 . . . . 0.0 110.905 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.85 -27.78 31.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.505 -1.372 . . . . 0.0 107.824 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.644 HD12 ' H ' ' A' ' 32' ' ' SER . 36.7 mm -81.55 113.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.402 ' CD2' ' C ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -133.09 15.5 4.2 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.296 -177.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.3 t0 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 120.913 -1.117 . . . . 0.0 109.423 -179.533 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -155.28 -141.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -83.34 150.42 26.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.943 -1.098 . . . . 0.0 109.536 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -136.35 177.84 7.53 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.327 -0.858 . . . . 0.0 109.849 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.57 -159.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.407 -0.808 . . . . 0.0 109.743 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.64 -27.21 68.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.112 -0.992 . . . . 0.0 110.261 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -92.18 -86.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.041 . . . . 0.0 109.496 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.1 22.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.551 ' NH1' ' OD2' ' A' ' 48' ' ' ASP . 67.6 mtm180 -88.72 135.73 33.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.795 -1.415 . . . . 0.0 110.578 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.8 mm -76.37 114.46 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 140.45 33.14 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -86.39 179.01 6.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.963 -1.085 . . . . 0.0 111.028 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -52.13 155.12 2.02 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.418 0.628 . . . . 0.0 109.84 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.68 -44.75 2.06 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -70.28 147.17 50.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -1.231 . . . . 0.0 109.272 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -155.24 157.5 37.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.649 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.0 tp-100 -107.28 123.12 47.85 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.388 -0.82 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.539 ' NH2' ' OH ' ' A' ' 40' ' ' TYR . 18.3 mtt180 -83.62 169.49 15.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.201 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -17.1 63.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.877 . . . . 0.0 109.622 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' A' ' 24' ' ' ARG . 1.4 p30 -91.43 -26.58 18.78 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.97 -1.081 . . . . 0.0 109.98 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.42 -36.25 2.96 Favored Glycine 0 N--CA 1.505 3.295 0 O-C-N 121.268 -0.895 . . . . 0.0 111.443 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.531 ' NH2' ' OD2' ' A' ' 22' ' ' ASP . 3.3 ptt-85 -60.57 132.92 55.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.604 -1.527 . . . . 0.0 109.438 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 86.2 m-85 -87.04 168.93 12.86 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pp -147.4 138.22 23.53 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -125.31 156.97 37.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.662 -0.649 . . . . 0.0 109.452 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -117.68 138.97 51.64 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 16.7 p90 -148.83 -165.89 2.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.984 -1.072 . . . . 0.0 109.961 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.439 ' O ' ' CD2' ' A' ' 29' ' ' TYR . 1.4 mp -107.48 136.37 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 O-C-N 121.315 -0.866 . . . . 0.0 110.461 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.64 ' CG ' HE21 ' A' ' 37' ' ' GLN . 17.0 m-20 -80.56 173.01 13.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.006 -1.059 . . . . 0.0 109.494 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -9.59 10.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 109.681 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 11.5 m-85 -104.21 -6.76 20.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.471 -0.768 . . . . 0.0 110.824 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.26 -4.6 64.87 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.028 -1.045 . . . . 0.0 110.539 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.02 150.54 47.8 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.832 -1.393 . . . . 0.0 110.102 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.55 152.65 23.12 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.268 1.979 . . . . 0.0 113.554 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.64 HE21 ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -157.83 179.89 8.78 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.75 149.58 50.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.857 -1.152 . . . . 0.0 110.179 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.02 162.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.539 ' OH ' ' NH2' ' A' ' 20' ' ' ARG . 84.1 m-85 -137.0 153.83 50.56 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.256 -0.902 . . . . 0.0 110.767 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 t -168.23 149.75 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -86.97 3.68 44.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.337 -0.852 . . . . 0.0 109.302 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -131.95 153.13 50.61 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.392 -0.818 . . . . 0.0 109.459 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 59' ' ' SER . 19.5 tp -93.36 -51.14 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.348 0.594 . . . . 0.0 109.975 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.51 175.62 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.42 0.628 . . . . 0.0 110.5 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.86 63.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 111.095 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.0 p -85.16 -8.08 58.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.817 -1.177 . . . . 0.0 110.309 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 59.8 m-20 -74.46 174.38 9.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.779 -1.201 . . . . 0.0 109.819 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -139.68 149.51 43.76 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -80.85 138.81 49.99 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.269 -0.894 . . . . 0.0 109.934 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -46.18 140.82 10.47 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.923 1.749 . . . . 0.0 111.706 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.6 132.13 17.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.14 -30.75 6.6 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -94.54 145.5 24.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -1.083 . . . . 0.0 108.706 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HD3' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.6 150.66 34.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -0.982 . . . . 0.0 108.726 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -49.53 162.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.01 -1.056 . . . . 0.0 109.845 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 38.2 t -154.78 173.64 16.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.155 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.473 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 5.9 mm -92.1 132.16 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.467 -0.77 . . . . 0.0 109.317 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 45.9 t -55.78 164.11 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.283 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 43' ' ' LYS . 4.5 mp -71.32 -57.48 4.43 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.521 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -45.82 -41.92 11.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -69.06 -41.88 77.02 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.34 -0.944 . . . . 0.0 108.877 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -67.16 -42.03 84.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.938 . . . . 0.0 109.954 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.76 -49.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.76 -1.213 . . . . 0.0 108.635 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.61 83.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.0 110.292 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -70.97 -43.12 68.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.89 . . . . 0.0 111.171 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.453 HD22 ' OH ' ' A' ' 29' ' ' TYR . 11.0 mt -67.66 -44.06 78.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 111.545 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.438 ' O ' ' O ' ' A' ' 72' ' ' HIS . 32.6 mt-30 -71.99 -38.74 69.63 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.815 -1.178 . . . . 0.0 110.539 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -74.88 -42.0 58.7 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.407 -0.808 . . . . 0.0 110.59 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.05 -36.4 81.51 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.193 -0.942 . . . . 0.0 111.307 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.504 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 8.4 pt -82.44 -42.13 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.0 110.258 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 71' ' ' ILE . 77.9 m-70 -157.83 154.0 27.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.085 -1.01 . . . . 0.0 109.704 179.795 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -87.42 74.88 9.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -94.7 -148.03 0.27 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 110.02 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.551 HH11 ' CG ' ' A' ' 6' ' ' ARG . 1.7 mtt-85 -132.61 163.65 28.42 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -84.66 -171.66 3.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.272 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -66.96 -14.87 63.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.882 . . . . 0.0 109.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -95.04 -5.07 45.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -0.894 . . . . 0.0 108.911 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.16 21.82 58.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' NH2' ' CG ' ' A' ' 48' ' ' ASP . 17.9 mmt180 -90.67 142.12 28.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -1.183 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mm -82.55 119.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 108.004 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 13' ' ' LEU . 4.0 mp -90.75 145.06 25.11 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -87.6 179.28 6.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.052 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.6 m -57.52 136.74 56.74 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.256 -0.902 . . . . 0.0 110.036 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.27 -56.48 1.23 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -49.3 148.69 2.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 110.021 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -157.13 156.84 33.39 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -99.74 145.17 27.96 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.027 -1.046 . . . . 0.0 110.493 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -89.59 149.72 22.72 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.676 ' CD ' ' H ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -58.36 -20.57 44.83 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -89.15 -11.23 44.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.607 -0.683 . . . . 0.0 110.43 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.28 -35.0 5.24 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.56 HH21 ' HE1' ' A' ' 42' ' ' TRP . 2.4 ptp180 -59.12 143.96 47.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.8 -1.412 . . . . 0.0 108.738 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -90.73 162.68 14.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.915 . . . . 0.0 110.183 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -147.33 140.42 25.16 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.666 0.746 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 39' ' ' VAL . 86.4 t80 -134.47 151.98 51.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -120.04 142.11 49.13 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.549 -0.719 . . . . 0.0 109.286 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -140.86 163.1 33.86 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.92 138.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.153 -0.967 . . . . 0.0 109.969 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' CG ' ' NE2' ' A' ' 37' ' ' GLN . 45.3 m-20 -84.12 161.68 20.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.6 p -63.24 -3.25 1.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -99.75 -15.96 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.379 -0.826 . . . . 0.0 109.085 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.32 56.89 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -80.59 156.29 73.22 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 120.499 -1.589 . . . . 0.0 107.125 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -93.53 141.08 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.563 1.508 . . . . 0.0 111.101 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.493 ' NE2' ' CG ' ' A' ' 31' ' ' ASP . 2.8 mp0 -130.02 154.64 47.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.539 -0.726 . . . . 0.0 109.126 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.2 147.89 52.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 27' ' ' TYR . 2.0 m -123.11 156.05 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.442 -0.786 . . . . 0.0 109.037 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 64.4 m-85 -129.9 156.12 44.93 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.427 -0.795 . . . . 0.0 109.696 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -174.31 146.31 1.08 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.592 -0.693 . . . . 0.0 109.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.56 ' HE1' HH21 ' A' ' 24' ' ' ARG . 54.7 m95 -90.46 3.49 53.73 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -123.77 142.5 51.03 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -92.42 -44.49 8.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 108.543 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 46' ' ' ALA . 2.1 t -121.7 174.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -72.74 -15.14 61.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -92.47 -8.52 44.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.049 -1.032 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.474 ' CG ' ' NH2' ' A' ' 11' ' ' ARG . 1.1 m-20 -72.54 168.84 17.75 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.278 -0.888 . . . . 0.0 109.805 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -134.73 144.64 47.86 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 50' ' ' VAL . 32.9 m -81.21 122.62 81.57 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.88 151.79 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.509 1.473 . . . . 0.0 112.025 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.85 139.58 7.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.56 -30.88 9.31 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 13.0 mptt -93.46 127.26 39.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -1.15 . . . . 0.0 108.242 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -78.01 149.74 33.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.579 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 53.1 t0 -40.06 147.03 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.789 -0.569 . . . . 0.0 109.902 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.5 p -153.66 164.86 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG2' ' CD ' ' A' ' 62' ' ' GLU . 20.3 mt -83.29 129.3 37.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.634 0.731 . . . . 0.0 110.032 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 92.4 p -60.84 173.14 0.8 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 63' ' ' LYS . 96.6 mt -83.92 -59.71 2.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.867 -1.146 . . . . 0.0 110.071 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' LEU . 37.6 mtt180 -40.01 -35.0 0.33 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 111.606 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' CD ' ' CG2' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -72.9 -40.89 65.15 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.736 -1.227 . . . . 0.0 108.582 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 60' ' ' LEU . 46.2 mttm -63.91 -46.46 84.72 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.505 -0.747 . . . . 0.0 109.719 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -53.44 -49.41 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.66 94.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -78.73 -44.18 24.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.06 -1.025 . . . . 0.0 112.501 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -66.71 -38.82 87.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.127 -1.608 . . . . 0.0 111.432 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -70.67 -50.07 40.5 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 120.477 -1.389 . . . . 0.0 110.612 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.31 -14.64 58.87 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.762 -1.211 . . . . 0.0 112.13 -178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -84.27 -13.12 53.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.282 -1.511 . . . . 0.0 110.505 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 mm -85.63 -37.75 12.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.106 -0.996 . . . . 0.0 109.399 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.5 m170 -85.41 -175.69 5.79 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.115 -0.991 . . . . 0.0 109.554 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -84.66 149.48 25.79 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -82.68 140.61 33.03 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.905 -1.122 . . . . 0.0 109.436 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.478 ' HG2' HD13 ' A' ' 12' ' ' ILE . 65.8 mtm180 -140.29 173.96 10.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.284 -0.885 . . . . 0.0 109.216 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 39.4 p-10 -80.57 -169.23 2.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.76 HD21 ' NE2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -70.24 -21.11 63.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 108.831 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 9' ' ' ARG . 22.5 mmm-85 -95.81 1.89 53.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.457 -0.777 . . . . 0.0 110.42 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 82.51 20.64 61.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.543 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 mtt180 -86.97 149.29 24.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.344 . . . . 0.0 108.567 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.478 HD13 ' HG2' ' A' ' 6' ' ' ARG . 6.5 mm -90.6 119.37 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.422 -0.799 . . . . 0.0 109.174 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.794 HD22 ' N ' ' A' ' 13' ' ' LEU . 1.7 mm? -89.45 136.68 32.89 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 14' ' ' LYS . 8.9 mtmp? -86.38 -174.15 4.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.876 -1.14 . . . . 0.0 110.447 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 17' ' ' GLU . 8.8 m -51.55 138.99 21.29 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.753 -0.592 . . . . 0.0 110.206 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.04 -42.18 0.76 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 15' ' ' THR . 85.7 mt-10 -66.02 140.18 58.26 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.043 -1.269 . . . . 0.0 109.845 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 92.4 p -158.22 164.47 36.47 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.76 ' NE2' HD21 ' A' ' 8' ' ' ASN . 1.5 tm0? -92.8 150.44 20.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.888 -1.132 . . . . 0.0 109.393 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' NH1' ' CZ ' ' A' ' 24' ' ' ARG . 2.2 ttt180 -89.79 161.77 15.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.336 -0.852 . . . . 0.0 109.429 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -57.36 -30.06 64.55 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.906 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -84.92 -44.22 13.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.939 -1.1 . . . . 0.0 110.16 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.53 -31.81 1.02 Allowed Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.844 -1.169 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' CZ ' ' NH1' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -61.26 144.61 53.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.897 -1.355 . . . . 0.0 108.985 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -85.7 164.73 17.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.32 150.94 28.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 109.708 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.502 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 63.4 t80 -134.96 169.2 17.77 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 26.8 tttm -128.09 138.74 52.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.298 -0.876 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.434 ' C ' HD12 ' A' ' 30' ' ' ILE . 8.3 p90 -144.82 159.8 42.3 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.481 HD11 ' NZ ' ' A' ' 28' ' ' LYS . 1.4 mp -100.34 136.31 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.34 -0.85 . . . . 0.0 109.165 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 33' ' ' PHE . 54.8 m-20 -81.5 166.76 20.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.164 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -60.55 1.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.101 -1.0 . . . . 0.0 111.068 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 9.6 m-85 -101.47 -21.17 14.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.924 -1.11 . . . . 0.0 108.557 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.76 -3.52 39.12 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.565 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.1 pt-20 -84.82 150.13 55.26 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.912 -1.346 . . . . 0.0 109.961 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 85.3 Cg_endo -78.7 139.66 16.0 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.78 2.32 . . . . 0.0 113.527 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.565 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -137.88 161.33 36.9 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.28 -0.888 . . . . 0.0 108.827 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -132.11 150.1 52.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.53 -0.731 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.25 151.05 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -126.45 155.03 42.88 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.333 -0.854 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.1 t -170.06 152.66 4.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.657 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -93.99 16.54 14.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 144.24 32.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' ' OG ' ' A' ' 59' ' ' SER . 21.5 tp -96.53 -44.49 7.14 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.41 HG12 ' NH1' ' A' ' 61' ' ' ARG . 15.7 m -119.79 153.93 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 121.547 0.689 . . . . 0.0 109.261 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.45 -11.75 1.4 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.72 . . . . 0.0 110.904 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 -8.28 39.17 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.73 -1.231 . . . . 0.0 111.222 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.0 166.36 21.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.903 -1.123 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 49' ' ' ARG . 4.0 tpt180 -128.24 124.01 35.61 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.469 -0.77 . . . . 0.0 109.093 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.0 m -84.41 142.22 40.21 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.847 . . . . 0.0 109.971 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -48.59 147.87 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.284 1.323 . . . . 0.0 110.823 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.23 -37.3 46.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.853 -1.154 . . . . 0.0 109.595 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.25 -31.24 56.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -98.35 135.16 40.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -1.161 . . . . 0.0 108.587 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -79.04 166.55 22.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.028 -1.045 . . . . 0.0 109.74 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -65.51 159.27 24.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.193 -0.942 . . . . 0.0 110.021 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.8 p -161.54 178.34 9.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.6 mt -87.48 134.12 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 44' ' ' LEU . 21.9 t -61.62 161.39 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.502 -0.749 . . . . 0.0 109.883 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 64' ' ' ILE . 84.1 mt -64.8 -48.72 73.4 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.948 -1.095 . . . . 0.0 109.644 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -48.09 -51.39 24.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.793 -1.192 . . . . 0.0 109.133 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -70.01 -38.12 75.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -64.59 -45.62 86.18 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.712 -1.243 . . . . 0.0 109.149 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -48.49 -54.29 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -30.2 69.74 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.171 -0.956 . . . . 0.0 109.687 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.91 -42.91 76.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.148 -0.97 . . . . 0.0 111.542 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.4 mm? -69.21 -51.24 39.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.846 -1.159 . . . . 0.0 111.418 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -71.37 -35.25 71.05 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 112.075 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -76.42 -21.44 55.96 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.328 -1.483 . . . . 0.0 111.29 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -82.17 -47.02 13.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.727 -1.233 . . . . 0.0 111.597 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 pt -86.53 -42.43 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.016 . . . . 0.0 111.05 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.37 -39.51 12.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.241 -0.912 . . . . 0.0 109.212 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.553 -0.717 . . . . 0.0 110.4 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 3' ' ' GLU . 11.2 mp0 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.84 152.89 22.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.098 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -84.45 138.56 32.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.062 -1.024 . . . . 0.0 109.164 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -143.79 173.14 11.94 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 53.6 p-10 -87.13 -165.5 1.31 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.884 -1.135 . . . . 0.0 109.996 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -66.67 -17.92 65.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.699 -0.625 . . . . 0.0 109.403 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' CG ' HH11 ' A' ' 9' ' ' ARG . 4.4 mtt-85 -103.98 -80.13 0.53 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.382 -0.824 . . . . 0.0 109.162 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -178.92 34.7 0.07 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -90.56 130.95 36.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -1.055 . . . . 0.0 110.178 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.6 mm -79.91 107.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 13' ' ' LEU . 1.3 mp -88.29 157.49 18.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.93 -1.106 . . . . 0.0 110.481 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -87.82 170.48 11.15 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 m -52.75 138.63 28.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.141 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.73 -57.75 1.87 Allowed Glycine 0 N--CA 1.497 2.765 0 O-C-N 121.111 -0.993 . . . . 0.0 110.74 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -51.56 141.88 15.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 110.081 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.2 m -152.21 149.81 29.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.617 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.4 tp-100 -95.26 137.99 33.56 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.256 -0.903 . . . . 0.0 109.727 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.632 ' NH1' ' NH2' ' A' ' 24' ' ' ARG . 4.7 mtp180 -81.84 -177.04 6.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -76.71 -24.97 53.09 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.825 -0.547 . . . . 0.0 110.042 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' OD2' ' NE ' ' A' ' 24' ' ' ARG . 38.6 p-10 -89.98 -28.53 19.06 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.753 -1.217 . . . . 0.0 111.407 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' O ' ' OE1' ' A' ' 19' ' ' GLN . . . 136.05 -26.24 3.13 Favored Glycine 0 N--CA 1.503 3.157 0 O-C-N 120.757 -1.214 . . . . 0.0 111.382 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.632 ' NH2' ' NH1' ' A' ' 20' ' ' ARG . 8.0 ptt180 -65.59 135.99 55.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.364 -1.668 . . . . 0.0 108.714 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.617 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 72.0 m-85 -72.67 173.55 8.84 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.61 -0.681 . . . . 0.0 109.231 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 40' ' ' TYR . 25.5 tp -152.4 126.89 9.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.5 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -129.4 151.87 49.57 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HZ3' ' C ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -124.55 135.03 52.83 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.33 -0.856 . . . . 0.0 110.055 -178.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.635 ' OH ' HD12 ' A' ' 67' ' ' LEU . 17.4 p90 -139.17 164.88 28.64 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.316 -0.865 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.428 HG13 ' NZ ' ' A' ' 28' ' ' LYS . 87.1 mt -105.41 137.71 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.357 -0.84 . . . . 0.0 109.0 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' CG ' ' A' ' 35' ' ' GLU . 5.0 p30 -83.39 175.39 9.88 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.372 -0.83 . . . . 0.0 109.143 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -66.2 6.06 0.45 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.936 -1.103 . . . . 0.0 110.882 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -102.36 -18.93 15.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.933 -1.105 . . . . 0.0 110.118 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.24 -9.4 45.96 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 121.11 -0.994 . . . . 0.0 110.651 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HG3' HE22 ' A' ' 37' ' ' GLN . 17.4 pt-20 -87.9 146.15 38.13 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.953 -1.322 . . . . 0.0 109.137 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.618 ' C ' HE21 ' A' ' 37' ' ' GLN . 95.2 Cg_endo -77.87 136.65 15.16 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.481 2.121 . . . . 0.0 112.679 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.679 HE21 ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -122.19 174.93 6.66 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.268 -0.895 . . . . 0.0 109.073 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.95 146.32 39.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.315 -0.866 . . . . 0.0 110.561 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -131.99 143.56 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.646 -0.659 . . . . 0.0 109.273 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CE2' HD13 ' A' ' 26' ' ' LEU . 61.2 m-85 -124.15 160.0 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.674 -0.641 . . . . 0.0 109.518 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 153.8 5.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -98.09 14.81 26.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -140.8 146.94 38.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.089 -1.007 . . . . 0.0 109.136 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.7 tp -89.74 -49.3 6.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 109.123 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 m -118.97 171.37 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.95 -17.54 62.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.359 -0.838 . . . . 0.0 111.893 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.4 t -87.92 -4.86 58.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.626 -1.296 . . . . 0.0 110.629 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.7 -175.08 1.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.099 . . . . 0.0 110.55 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -142.03 133.76 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.9 m -73.53 150.59 89.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.073 -1.017 . . . . 0.0 108.426 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.64 148.07 92.45 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.903 1.735 . . . . 0.0 111.723 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.95 143.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.411 -0.805 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.43 -29.03 10.17 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -94.87 143.08 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.317 . . . . 0.0 109.819 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 55' ' ' ARG . 8.1 ptt-85 -78.67 154.92 29.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.5 155.52 15.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.061 -1.024 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.1 m -149.11 177.85 9.24 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.0 mt -93.55 135.68 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.99 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.5 p -57.97 174.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 108.874 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 60' ' ' LEU . 4.3 mp -77.93 -54.25 6.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.868 -1.145 . . . . 0.0 110.234 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -47.01 -40.8 15.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.447 -0.783 . . . . 0.0 110.282 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -70.49 -38.46 74.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 66' ' ' GLU . 41.9 mttt -67.26 -50.52 60.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 108.767 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 63' ' ' LYS . 1.5 mp -40.0 -54.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.618 -0.676 . . . . 0.0 109.437 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.37 -32.46 73.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 109.691 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 63' ' ' LYS . 11.0 tp10 -76.42 -41.66 46.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.396 -0.815 . . . . 0.0 111.738 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD12 ' OH ' ' A' ' 29' ' ' TYR . 4.6 mm? -62.79 -48.44 79.13 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.585 -1.322 . . . . 0.0 111.284 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -73.01 -35.38 66.8 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.009 -1.057 . . . . 0.0 111.045 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -79.0 -27.77 43.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.949 -1.094 . . . . 0.0 112.608 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -96.2 -27.42 15.03 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.667 -1.27 . . . . 0.0 111.127 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 67' ' ' LEU . 4.4 mm -85.06 73.47 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.965 -1.084 . . . . 0.0 109.779 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -156.45 -42.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 108.93 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.549 -0.72 . . . . 0.0 109.318 -179.538 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.303 0.573 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.11 44.24 1.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.129 -0.982 . . . . 0.0 108.885 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -85.58 155.95 20.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.971 -1.08 . . . . 0.0 109.309 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 70.1 mtt180 -138.01 160.51 39.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.299 -0.875 . . . . 0.0 109.327 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 6' ' ' ARG . 67.7 m-20 -137.56 -103.72 0.19 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.363 -0.836 . . . . 0.0 112.378 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' A' ' 19' ' ' GLN . 72.9 m-20 -66.46 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -94.68 27.8 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.078 -1.014 . . . . 0.0 112.097 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.69 29.5 51.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -81.21 141.04 34.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.401 -1.058 . . . . 0.0 108.606 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.8 mm -86.21 98.36 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 109.681 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -91.57 151.5 20.7 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -89.56 -178.84 5.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.005 -1.059 . . . . 0.0 110.941 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 t -55.6 156.44 4.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.8 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.88 -36.62 3.26 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -79.65 159.76 26.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.886 -1.361 . . . . 0.0 110.174 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.0 t -160.41 166.33 29.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.892 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 8' ' ' ASN . 42.8 tt0 -104.22 148.01 26.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.552 HH21 HH11 ' A' ' 24' ' ' ARG . 9.3 mmm180 -90.76 168.59 11.63 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.713 0.768 . . . . 0.0 110.522 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -67.89 -27.51 66.73 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.393 -0.817 . . . . 0.0 109.606 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.5 p30 -94.99 -28.61 15.05 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.957 . . . . 0.0 110.949 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 136.5 -26.28 3.06 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 119.927 -1.13 . . . . 0.0 111.648 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.552 HH11 HH21 ' A' ' 20' ' ' ARG . 0.4 OUTLIER -60.0 145.87 44.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.375 -1.662 . . . . 0.0 109.256 -179.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -79.62 167.96 20.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.093 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.455 HD12 ' CE2' ' A' ' 40' ' ' TYR . 1.2 tt -153.02 129.92 10.98 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.873 0.844 . . . . 0.0 110.028 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 39' ' ' VAL . 92.1 t80 -136.42 154.19 50.87 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -127.3 143.62 51.2 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.007 -1.058 . . . . 0.0 110.05 -178.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.426 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 12.2 p90 -137.06 170.63 15.78 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.6 mm -99.88 135.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.15 -0.969 . . . . 0.0 109.799 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 33' ' ' PHE . 88.2 m-20 -81.71 162.98 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.187 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.1 p -64.1 0.74 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.2 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' ASP . 3.6 m-85 -100.66 -20.43 15.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.41 -6.7 36.42 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.8 pt-20 -86.12 148.62 48.14 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 120.847 -1.384 . . . . 0.0 109.663 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.487 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 97.2 Cg_endo -83.65 142.45 10.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.947 1.765 . . . . 0.0 112.414 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.0 mp0 -130.2 167.78 17.88 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -134.57 143.45 47.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.394 -0.816 . . . . 0.0 110.267 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -113.06 156.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.455 ' CE2' HD12 ' A' ' 26' ' ' LEU . 95.0 m-85 -133.31 147.27 51.87 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 t -172.11 148.61 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.951 . . . . 0.0 109.615 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -91.54 16.25 10.81 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.342 -0.849 . . . . 0.0 108.856 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 47.6 mtmt -134.41 143.67 47.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.351 -0.843 . . . . 0.0 110.153 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.3 tp -94.2 -44.08 8.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 46' ' ' ALA . 1.7 t -116.41 176.7 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-O 121.379 0.609 . . . . 0.0 109.438 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -79.53 -15.06 58.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.513 -0.742 . . . . 0.0 110.886 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.5 p -92.91 -14.34 27.73 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.791 -1.193 . . . . 0.0 111.453 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.17 169.73 11.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.713 -1.242 . . . . 0.0 110.481 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -123.58 147.92 46.86 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.517 0.675 . . . . 0.0 109.209 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.14 147.15 60.25 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.424 -0.797 . . . . 0.0 110.063 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.15 140.12 51.55 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.297 1.331 . . . . 0.0 110.834 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -47.94 149.0 1.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.886 -1.134 . . . . 0.0 109.588 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.17 -20.27 26.66 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HZ2' ' HB3' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -98.31 137.89 36.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -1.088 . . . . 0.0 108.991 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -76.22 167.8 21.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -60.15 161.91 6.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.423 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 77.0 m -151.19 151.58 32.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.1 mt -81.29 134.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.87 -1.144 . . . . 0.0 109.519 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 150.73 28.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.594 -0.691 . . . . 0.0 110.655 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.59 -64.72 0.73 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -41.58 -48.35 3.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.587 . . . . 0.0 111.73 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.45 -33.12 73.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.53 -1.356 . . . . 0.0 109.9 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -68.5 -42.19 78.93 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 109.745 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.81 -56.64 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.383 -0.823 . . . . 0.0 110.51 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.76 87.49 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.983 -1.073 . . . . 0.0 110.318 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -75.01 -28.75 60.62 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 111.477 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -70.25 -53.13 18.23 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.56 -1.338 . . . . 0.0 111.585 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -69.01 -27.26 65.53 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.256 -1.528 . . . . 0.0 109.589 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -78.96 -23.31 44.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.189 -0.944 . . . . 0.0 110.298 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -99.15 -18.44 17.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.893 -1.129 . . . . 0.0 111.135 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 71' ' ' ILE . 4.7 mm -87.96 69.48 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.038 -1.039 . . . . 0.0 110.642 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -158.18 13.52 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.021 . . . . 0.0 109.009 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.601 179.704 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -149.08 161.16 42.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 5' ' ' ARG . 27.2 mtm-85 -82.09 140.38 33.88 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -138.57 169.61 17.48 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.896 0.855 . . . . 0.0 110.756 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 40.7 p-10 -93.8 -168.2 1.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.627 0.727 . . . . 0.0 110.378 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -66.27 -14.91 62.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.476 -0.765 . . . . 0.0 110.481 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -99.86 -13.58 19.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.034 -1.041 . . . . 0.0 110.352 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.26 14.98 39.89 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 48' ' ' ASP . 30.0 mtt180 -84.07 135.3 34.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.157 . . . . 0.0 109.323 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.8 mt -84.27 111.4 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 109.192 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 11' ' ' ARG . 4.8 mp -94.94 157.33 15.95 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -92.26 179.04 5.67 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.018 -1.051 . . . . 0.0 109.968 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.4 m -54.01 146.23 14.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.439 -0.788 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.08 -52.67 4.75 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -52.56 149.84 5.55 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.134 -1.215 . . . . 0.0 109.28 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 t -157.1 161.72 39.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.596 ' NE2' ' CE1' ' A' ' 25' ' ' TYR . 5.3 tp-100 -105.17 131.41 52.69 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 22' ' ' ASP . 21.3 ttt180 -89.53 162.5 15.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.373 -0.829 . . . . 0.0 109.362 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -66.07 -22.3 66.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 109.583 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 95.8 m-20 -84.75 -7.99 59.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.4 -0.813 . . . . 0.0 109.329 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.31 8.83 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -62.11 137.7 58.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.946 -1.326 . . . . 0.0 109.466 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.596 ' CE1' ' NE2' ' A' ' 19' ' ' GLN . 67.0 m-85 -80.41 173.15 12.88 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.512 -0.743 . . . . 0.0 109.548 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.673 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.2 tt -156.07 139.24 15.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.326 -0.858 . . . . 0.0 109.874 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -136.57 155.25 50.19 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.23 -0.919 . . . . 0.0 109.275 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -119.97 138.97 53.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.474 -0.766 . . . . 0.0 110.513 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.436 ' CE1' HD13 ' A' ' 67' ' ' LEU . 9.7 p90 -143.14 165.0 28.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.03 134.84 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 0.0 109.378 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 33' ' ' PHE . 72.1 m-20 -80.11 164.64 23.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 108.401 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.457 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 17.8 t -58.9 0.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.942 -1.099 . . . . 0.0 110.536 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 31' ' ' ASP . 4.7 m-85 -101.73 -19.35 15.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.052 -1.03 . . . . 0.0 109.978 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.55 -2.08 46.02 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' C ' HE22 ' A' ' 37' ' ' GLN . 22.9 pt-20 -83.68 147.55 52.44 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.012 -1.287 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 55.7 Cg_endo -81.4 139.2 11.4 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.473 2.115 . . . . 0.0 113.249 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.529 HE22 ' C ' ' A' ' 35' ' ' GLU . 1.7 mp0 -137.5 159.86 40.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -132.14 145.02 51.1 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 149.1 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.443 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 78.5 m-85 -121.18 152.38 38.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.7 t -168.29 145.03 3.94 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.351 -0.843 . . . . 0.0 109.314 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.93 11.74 21.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.967 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -135.99 141.22 44.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.548 -0.72 . . . . 0.0 109.809 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.9 tp -89.65 -42.63 11.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.59 173.81 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.97 -14.35 59.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.047 -1.033 . . . . 0.0 110.598 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 p -91.27 -2.78 57.35 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 11' ' ' ARG . 80.5 m-20 -69.51 -174.43 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.661 -1.274 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -149.62 124.97 10.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.799 . . . . 0.0 109.506 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 m -82.21 152.96 68.74 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.85 137.86 42.68 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 120.968 1.112 . . . . 0.0 109.978 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.86 -34.92 5.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.106 -0.996 . . . . 0.0 110.478 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.95 -22.27 62.23 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -99.48 140.83 33.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -1.122 . . . . 0.0 110.957 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 55' ' ' ARG . 2.0 ptt-85 -76.22 153.78 35.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.511 -0.743 . . . . 0.0 109.886 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -50.4 161.14 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.503 -0.748 . . . . 0.0 109.462 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.5 p -152.03 162.86 40.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.34 -0.85 . . . . 0.0 108.745 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.24 127.91 40.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.056 -1.027 . . . . 0.0 109.771 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.9 p -59.52 169.27 1.32 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.36 -0.837 . . . . 0.0 109.907 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.8 mt -79.59 -58.53 3.15 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -41.45 -43.67 2.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 110.905 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -69.89 -41.38 74.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 0.0 109.433 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -67.99 -44.84 75.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 110.162 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.11 -60.69 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.914 -1.116 . . . . 0.0 109.203 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.01 63.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.942 . . . . 0.0 110.26 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -71.81 -39.04 70.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -0.981 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD13 ' CE1' ' A' ' 29' ' ' TYR . 64.7 mt -67.06 -54.54 20.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.867 -1.145 . . . . 0.0 111.889 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -68.52 -35.16 77.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.347 -1.471 . . . . 0.0 109.478 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -74.54 -27.96 60.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.033 -1.042 . . . . 0.0 110.932 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -99.66 -29.55 12.61 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.701 -1.25 . . . . 0.0 110.807 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.457 ' CG2' ' H ' ' A' ' 32' ' ' SER . 5.6 mm -82.38 -60.88 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.925 -1.109 . . . . 0.0 108.076 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 68' ' ' GLN . 21.0 t-80 -96.35 125.71 41.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.073 -1.017 . . . . 0.0 109.224 -178.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' N ' ' CD ' ' A' ' 3' ' ' GLU . 3.5 pm0 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.516 0.674 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -151.51 -167.02 2.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.235 -0.916 . . . . 0.0 108.913 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -93.6 137.17 33.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.513 -0.742 . . . . 0.0 109.481 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -138.58 159.8 41.19 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.457 -0.777 . . . . 0.0 109.84 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 11' ' ' ARG . 8.3 p-10 -88.6 -168.33 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.783 . . . . 0.0 108.932 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -67.15 -11.88 58.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.533 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.638 ' CB ' HH12 ' A' ' 11' ' ' ARG . 0.3 OUTLIER -100.2 -73.39 0.64 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.908 -1.12 . . . . 0.0 110.047 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.18 0.86 0.05 OUTLIER Glycine 0 N--CA 1.501 3.012 0 C-N-CA 118.41 -1.852 . . . . 0.0 113.03 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.638 HH12 ' CB ' ' A' ' 9' ' ' ARG . 2.4 mtm-85 -84.46 114.64 22.07 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 119.95 -1.912 . . . . 0.0 108.835 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.95 113.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.444 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -91.91 169.47 10.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.42 -0.8 . . . . 0.0 109.716 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -89.16 -177.16 5.35 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.27 1.033 . . . . 0.0 111.054 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 t -56.75 153.62 10.37 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.39 -41.43 1.15 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.354 -0.927 . . . . 0.0 110.792 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.86 136.52 56.96 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.938 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -159.24 154.24 25.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.254 -0.904 . . . . 0.0 108.621 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -109.02 140.93 41.88 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.022 -1.048 . . . . 0.0 110.217 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -84.71 177.21 8.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.571 -0.706 . . . . 0.0 110.022 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -71.54 -14.48 62.11 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -87.83 -20.14 26.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 109.837 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.24 -30.19 8.5 Favored Glycine 0 N--CA 1.501 3.019 0 O-C-N 121.227 -0.92 . . . . 0.0 111.204 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -63.38 140.68 58.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.546 -1.561 . . . . 0.0 109.679 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.47 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 90.8 m-85 -85.07 168.49 14.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.778 . . . . 0.0 109.87 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.765 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 11.9 tp -150.89 127.48 10.81 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.448 0.642 . . . . 0.0 109.576 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.421 ' N ' HD12 ' A' ' 26' ' ' LEU . 79.6 t80 -131.79 156.33 46.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -127.16 144.11 51.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -0.773 . . . . 0.0 109.861 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.484 ' C ' HD12 ' A' ' 30' ' ' ILE . 12.1 p90 -144.86 161.66 38.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.201 -0.937 . . . . 0.0 108.776 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' C ' ' A' ' 29' ' ' TYR . 1.4 mp -102.86 135.96 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.371 -0.83 . . . . 0.0 108.883 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 60.2 m-20 -81.74 174.26 11.52 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.288 -0.883 . . . . 0.0 109.186 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 71' ' ' ILE . 44.4 t -65.58 -3.47 4.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 109.361 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -96.55 -11.32 25.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 108.91 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.6 -6.17 77.36 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.428 ' HG3' HE22 ' A' ' 37' ' ' GLN . 14.4 pt-20 -84.69 149.47 54.16 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.179 -1.189 . . . . 0.0 109.249 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 40.1 Cg_endo -82.89 136.51 8.22 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.589 2.193 . . . . 0.0 113.668 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.1 mp0 -125.67 164.9 19.61 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.4 149.09 51.83 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.275 -0.89 . . . . 0.0 109.698 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -129.8 142.68 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.765 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 49.1 m-85 -127.43 156.99 41.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.557 -0.714 . . . . 0.0 109.795 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.5 t -170.91 150.75 3.21 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.488 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -89.38 11.07 20.22 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 51.7 mtmt -135.64 139.87 44.1 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.501 0.667 . . . . 0.0 110.567 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -92.51 -39.28 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.27 155.36 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.23 -7.67 10.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.181 -0.95 . . . . 0.0 110.972 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.3 p -93.76 -10.47 34.12 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.7 -1.25 . . . . 0.0 111.887 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -71.15 -171.56 0.59 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.488 -1.382 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -141.99 151.8 42.84 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -79.35 149.69 72.69 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.963 -1.086 . . . . 0.0 109.307 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 52' ' ' ALA . 32.6 Cg_endo -82.09 -112.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.56 2.174 . . . . 0.0 114.498 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -55.0 -149.76 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.257 -0.902 . . . . 0.0 112.954 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.97 36.1 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 52' ' ' ALA . 11.9 mptt -89.26 130.99 35.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.112 -1.228 . . . . 0.0 108.818 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.06 159.07 28.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 109.978 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 23.1 p-10 -53.71 162.19 0.93 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.677 -0.639 . . . . 0.0 109.851 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.494 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 19.8 t -162.97 161.22 25.49 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.494 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 89.3 mt -82.83 137.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.9 p -61.13 159.06 12.53 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.32 -0.863 . . . . 0.0 109.854 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HA ' ' HZ3' ' A' ' 63' ' ' LYS . 97.2 mt -63.53 -49.1 74.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -45.82 -46.34 15.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.115 -0.99 . . . . 0.0 110.352 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.22 -37.43 75.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.883 -1.136 . . . . 0.0 109.781 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HZ3' ' HA ' ' A' ' 60' ' ' LEU . 2.8 mtmp? -67.61 -44.68 77.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.856 -1.153 . . . . 0.0 110.202 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.5 -53.56 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.956 -1.09 . . . . 0.0 110.145 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.62 79.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.92 -1.112 . . . . 0.0 110.133 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.19 -45.47 56.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.89 -1.131 . . . . 0.0 110.177 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.29 -44.12 65.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.025 -1.047 . . . . 0.0 110.008 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -68.12 -36.94 80.54 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 120.609 -1.307 . . . . 0.0 109.646 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -85.79 -26.73 25.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.128 -0.982 . . . . 0.0 111.363 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -93.77 -26.11 17.12 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.628 -1.295 . . . . 0.0 111.325 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 32' ' ' SER . 44.1 mm -83.33 -29.96 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.665 -1.272 . . . . 0.0 109.013 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -85.28 -127.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 109.761 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -150.8 123.85 8.76 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.2 ttm-85 -83.68 148.51 27.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.262 -0.898 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -133.17 166.05 23.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.586 -0.697 . . . . 0.0 110.11 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -98.5 -164.39 1.13 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.61 -0.681 . . . . 0.0 109.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.595 HD22 ' NE2' ' A' ' 19' ' ' GLN . 22.3 p30 -68.65 -12.74 61.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.115 -0.99 . . . . 0.0 110.599 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -96.07 -5.71 40.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.0 -1.063 . . . . 0.0 109.29 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.19 -1.67 69.04 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.281 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.541 HH22 ' CG ' ' A' ' 48' ' ' ASP . 6.8 ptm180 -82.78 136.46 34.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.734 -1.451 . . . . 0.0 109.316 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.8 mt -83.97 110.6 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.149 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.79 161.72 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 77.5 mttt -88.93 -174.3 4.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.842 -1.161 . . . . 0.0 110.831 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 15' ' ' THR . 1.2 t -55.79 162.23 1.86 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.212 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.67 -36.94 1.41 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 14' ' ' LYS . 9.5 mp0 -73.72 156.42 37.91 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.919 -1.342 . . . . 0.0 109.303 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -156.96 158.65 37.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 109.423 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.595 ' NE2' HD22 ' A' ' 8' ' ' ASN . 56.5 tt0 -97.05 134.74 40.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.127 -0.983 . . . . 0.0 108.735 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -86.47 160.99 18.84 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.891 -1.13 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.87 -36.49 62.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.584 -0.697 . . . . 0.0 109.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -82.14 -25.29 34.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.171 -0.955 . . . . 0.0 110.515 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.64 -26.9 5.06 Favored Glycine 0 N--CA 1.499 2.842 0 O-C-N 121.17 -0.956 . . . . 0.0 110.744 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.699 HH21 ' HE1' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -59.74 148.5 34.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.356 -1.673 . . . . 0.0 108.307 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -87.44 164.42 16.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.232 -0.918 . . . . 0.0 109.187 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -147.74 137.75 22.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.571 -0.706 . . . . 0.0 109.262 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -131.6 161.48 32.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 29' ' ' TYR . 4.7 tmtm? -125.13 136.19 53.39 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.251 -0.906 . . . . 0.0 110.79 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 13.6 p90 -139.7 170.08 16.55 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.512 HD13 ' HZ1' ' A' ' 28' ' ' LYS . 5.9 mm -101.87 133.84 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.123 -0.986 . . . . 0.0 110.503 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -84.23 162.43 20.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -59.87 -3.98 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 21.8 m-85 -101.07 -15.27 17.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.03 -1.044 . . . . 0.0 109.622 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.31 0.32 58.32 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.984 -1.072 . . . . 0.0 111.064 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -83.9 150.56 59.08 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.837 -1.39 . . . . 0.0 109.682 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 88.8 Cg_endo -81.61 118.94 3.24 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.107 1.872 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.629 HE21 ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -115.05 163.02 16.21 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.72 142.03 44.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.24 150.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 85.4 m-85 -122.77 151.61 41.45 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.7 t -171.77 148.62 2.41 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.699 ' HE1' HH21 ' A' ' 24' ' ' ARG . 98.7 m95 -91.91 10.6 28.11 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 57' ' ' CYS . 29.8 mtmt -135.64 146.74 48.17 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.675 0.75 . . . . 0.0 110.179 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.412 HD23 ' HE ' ' A' ' 11' ' ' ARG . 60.8 tp -96.3 -40.07 9.33 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.3 m -125.15 161.23 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.61 -14.05 62.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.922 -1.111 . . . . 0.0 111.423 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.8 p -87.37 0.23 55.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.796 -1.19 . . . . 0.0 110.985 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.541 ' CG ' HH22 ' A' ' 11' ' ' ARG . 84.7 m-20 -72.49 -178.61 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.896 -1.127 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.42 121.18 13.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -75.79 146.29 79.5 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.492 -1.38 . . . . 0.0 109.957 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.82 155.58 62.16 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.031 . . . . 0.0 111.296 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.36 151.6 0.36 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.423 -0.798 . . . . 0.0 110.359 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.81 3.76 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -92.49 146.17 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -1.227 . . . . 0.0 108.913 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -78.08 -99.1 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 66.3 t0 -168.46 140.24 2.76 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.532 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 15.0 p -148.6 169.25 20.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.976 -1.077 . . . . 0.0 109.1 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -82.69 139.0 18.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.497 -0.752 . . . . 0.0 110.326 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.0 p -60.72 169.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.33 -52.84 28.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.465 -0.772 . . . . 0.0 109.671 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -47.16 -47.76 23.7 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.724 -1.235 . . . . 0.0 110.114 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 68.3 mt-10 -71.49 -38.89 71.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.445 -1.409 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -65.75 -39.78 91.44 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 0.0 110.188 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.05 -44.41 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.377 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.19 90.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.955 -1.091 . . . . 0.0 110.782 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -71.34 -34.31 70.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.868 -1.145 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.88 -44.61 80.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.557 -1.339 . . . . 0.0 110.865 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -75.66 -29.28 59.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.853 -1.154 . . . . 0.0 110.617 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -77.57 -27.14 51.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.654 -1.279 . . . . 0.0 110.17 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -80.09 -38.92 30.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.175 -0.953 . . . . 0.0 110.912 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' A' ' 72' ' ' HIS . 6.5 pt -91.5 -44.28 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.134 -0.979 . . . . 0.0 111.03 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.435 ' N ' ' CG1' ' A' ' 71' ' ' ILE . 0.3 OUTLIER -91.57 105.08 17.48 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.075 -1.016 . . . . 0.0 108.457 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.235 -0.916 . . . . 0.0 109.33 -179.856 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -82.42 149.3 27.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.514 HH11 ' CG ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -85.45 142.2 29.4 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.116 -0.99 . . . . 0.0 110.878 -178.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -146.13 161.63 39.76 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 11' ' ' ARG . 29.3 p-10 -123.58 -169.57 1.97 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.208 -0.932 . . . . 0.0 109.936 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.715 ' ND2' HE21 ' A' ' 19' ' ' GLN . 68.9 m-80 -67.73 -21.37 65.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.457 -0.777 . . . . 0.0 110.077 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.57 -4.69 40.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.73 17.33 61.97 Favored Glycine 0 N--CA 1.497 2.738 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.07 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 11' ' ' ARG . 3.6 mtt-85 -86.04 138.58 31.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -1.112 . . . . 0.0 108.913 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.8 mm -82.57 116.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -88.9 147.09 24.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.092 -1.005 . . . . 0.0 108.574 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -90.53 -179.73 5.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.802 -1.187 . . . . 0.0 109.833 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.0 m -55.68 148.09 17.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.545 -0.722 . . . . 0.0 110.396 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.04 -41.66 2.79 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' OE2' ' CZ ' ' A' ' 61' ' ' ARG . 95.2 mt-10 -78.09 158.43 29.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.909 -1.348 . . . . 0.0 110.067 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -158.21 154.56 27.51 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.815 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.715 HE21 ' ND2' ' A' ' 8' ' ' ASN . 61.2 tt0 -99.16 130.21 45.46 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.837 . . . . 0.0 110.123 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.9 168.86 16.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.338 -0.851 . . . . 0.0 110.472 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -69.04 -25.59 64.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.467 -0.771 . . . . 0.0 109.15 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -87.11 -12.76 46.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.91 -31.1 8.27 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -58.88 143.7 46.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.313 . . . . 0.0 108.777 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -78.88 165.67 23.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.37 -0.831 . . . . 0.0 109.854 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.5 tm? -149.35 121.23 8.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 89.3 t80 -130.3 161.05 32.1 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 46.8 tttt -120.27 131.87 55.09 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.759 -0.588 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -135.73 152.15 50.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.581 -0.699 . . . . 0.0 109.25 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.4 mp -98.69 133.75 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' OD2' ' CG ' ' A' ' 35' ' ' GLU . 44.9 p30 -82.64 173.12 12.22 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.011 0.91 . . . . 0.0 110.795 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 m -60.73 3.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.831 -0.543 . . . . 0.0 111.381 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 31' ' ' ASP . 30.1 m-85 -107.12 -22.82 12.51 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.895 -1.128 . . . . 0.0 109.312 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.76 34.36 Favored Glycine 0 N--CA 1.505 3.251 0 O-C-N 121.211 -0.931 . . . . 0.0 111.137 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.578 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 13.2 pt-20 -88.49 152.44 49.62 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.941 -1.329 . . . . 0.0 109.263 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.41 147.6 25.76 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.413 2.075 . . . . 0.0 113.305 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 1.6 mp0 -144.53 166.59 24.72 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -135.4 153.85 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.243 -0.911 . . . . 0.0 109.561 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -130.51 157.36 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.552 -0.718 . . . . 0.0 109.231 -179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 48.0 m-85 -135.21 144.78 47.13 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 t -169.45 155.01 5.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.035 . . . . 0.0 109.743 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CZ2' ' NZ ' ' A' ' 54' ' ' LYS . 96.1 m95 -93.98 5.54 51.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.137 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 43.9 mtmt -123.92 140.43 52.98 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.547 0.689 . . . . 0.0 110.158 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.38 -44.83 7.04 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 46' ' ' ALA . 9.0 t -122.38 178.91 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -78.56 -12.94 60.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.122 -0.986 . . . . 0.0 110.995 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.28 -10.69 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 109.944 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -74.42 168.13 20.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.034 -1.041 . . . . 0.0 109.815 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HB2' HH11 ' A' ' 49' ' ' ARG . 0.0 OUTLIER -144.73 136.06 25.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 108.904 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.12 148.56 71.61 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.807 . . . . 0.0 110.514 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.95 149.4 77.53 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.183 1.922 . . . . 0.0 111.845 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.54 146.17 1.11 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.71 0.766 . . . . 0.0 110.124 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.14 -35.7 4.61 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' NZ ' ' CZ2' ' A' ' 42' ' ' TRP . 28.4 mmtp -95.56 135.22 37.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -73.09 152.62 41.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.759 . . . . 0.0 109.472 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -61.73 166.27 4.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 48.9 t -159.15 160.85 36.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.4 -0.812 . . . . 0.0 109.108 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 85.5 mt -80.87 137.78 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 109.351 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 97.4 p -63.57 156.13 27.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.811 0.815 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.44 -55.45 33.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.585 -0.697 . . . . 0.0 109.838 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 15.7 mmt180 -49.16 -47.87 45.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.243 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -72.07 -39.53 68.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.927 . . . . 0.0 110.273 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -68.12 -37.02 80.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.032 -1.042 . . . . 0.0 110.102 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.1 -50.66 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.099 -1.001 . . . . 0.0 110.729 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.95 -45.85 82.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.819 -1.176 . . . . 0.0 110.422 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 36.4 mt-10 -71.52 -41.73 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 0.0 111.676 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.38 -21.51 66.65 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 119.884 -1.76 . . . . 0.0 110.987 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -78.82 -72.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.79 -1.194 . . . . 0.0 111.32 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -76.8 -4.2 42.31 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.155 -0.966 . . . . 0.0 113.31 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 66' ' ' GLU . 43.5 t0 -93.71 -48.83 6.14 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.195 -1.566 . . . . 0.0 112.56 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.485 ' CG1' ' O ' ' A' ' 71' ' ' ILE . 1.4 pt -80.81 103.99 8.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 122.859 1.314 . . . . 0.0 110.204 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.22 135.5 9.05 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.113 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.1 t0 . . . . . 0 N--CA 1.497 1.913 0 O-C-N 120.886 -1.134 . . . . 0.0 109.635 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -84.89 146.24 27.39 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -83.47 129.05 34.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.07 -1.018 . . . . 0.0 108.977 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 -141.29 157.34 45.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.405 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.76 ' CG ' HD22 ' A' ' 13' ' ' LEU . 30.8 m-20 -79.7 -179.79 7.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.714 HD22 ' NE2' ' A' ' 19' ' ' GLN . 12.5 p30 -66.96 -14.52 62.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.919 . . . . 0.0 111.259 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -98.75 14.93 26.96 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.049 . . . . 0.0 109.941 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.21 20.95 75.48 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -90.76 126.27 35.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -1.065 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.8 mt -77.52 95.66 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.015 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.6 pt? -87.37 156.11 19.74 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -92.0 -176.02 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.691 1.234 . . . . 0.0 110.773 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.1 m -57.91 144.08 40.45 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.79 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.14 -54.39 3.6 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.3 149.27 24.88 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.203 -1.175 . . . . 0.0 108.801 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -160.96 159.73 29.88 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 108.848 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.714 ' NE2' HD22 ' A' ' 8' ' ' ASN . 17.3 pt20 -97.14 140.86 31.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 109.652 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.75 -174.14 4.62 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -77.09 -29.86 55.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.309 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -89.94 -11.88 40.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 111.538 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.44 -28.08 7.69 Favored Glycine 0 N--CA 1.504 3.199 0 O-C-N 121.012 -1.055 . . . . 0.0 110.908 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.4 140.88 56.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.352 -1.675 . . . . 0.0 109.341 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -80.03 170.56 16.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.434 -0.791 . . . . 0.0 109.538 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.598 HD13 ' CE2' ' A' ' 40' ' ' TYR . 64.4 tp -151.68 127.25 10.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.537 -0.727 . . . . 0.0 109.328 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -129.58 157.15 42.86 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tttm -127.06 143.7 51.22 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.381 -0.825 . . . . 0.0 110.289 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.627 ' OH ' HD22 ' A' ' 67' ' ' LEU . 4.1 p90 -151.88 -178.99 7.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.46 144.99 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.488 -0.758 . . . . 0.0 109.006 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 33' ' ' PHE . 90.6 m-20 -84.05 165.85 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.469 -0.769 . . . . 0.0 109.856 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -59.28 -0.43 0.14 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.584 -0.697 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 31' ' ' ASP . 18.8 m-85 -108.76 -13.95 14.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.473 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.51 -8.67 52.16 Favored Glycine 0 N--CA 1.502 3.068 0 O-C-N 121.045 -1.035 . . . . 0.0 110.871 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 12.8 pt-20 -81.68 149.94 65.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.825 -1.397 . . . . 0.0 109.129 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.534 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 59.0 Cg_endo -83.67 143.55 10.81 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.361 2.041 . . . . 0.0 112.67 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.534 ' NE2' ' C ' ' A' ' 36' ' ' PRO . 1.4 mp0 -140.68 173.51 11.43 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.256 -0.903 . . . . 0.0 108.682 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HB3' HD11 ' A' ' 26' ' ' LEU . 89.8 m-85 -137.89 154.32 49.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.442 -0.786 . . . . 0.0 109.801 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.546 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.1 m -128.57 143.72 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.525 -0.735 . . . . 0.0 109.232 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CE2' HD13 ' A' ' 26' ' ' LEU . 43.5 m-85 -122.35 147.61 46.06 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -171.52 150.86 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.899 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -94.26 10.42 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -127.02 138.84 53.31 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.377 -0.827 . . . . 0.0 110.202 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.5 tp -93.02 -44.41 8.42 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.39 166.48 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -14.24 62.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.65 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.4 p -90.04 -6.01 56.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.725 -1.234 . . . . 0.0 111.305 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -70.96 160.56 32.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.68 -1.262 . . . . 0.0 109.417 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.82 126.22 39.39 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.303 -0.873 . . . . 0.0 108.91 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.68 150.1 75.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 110.032 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.4 151.16 80.71 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.834 1.689 . . . . 0.0 110.619 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.33 159.55 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -0.928 . . . . 0.0 109.859 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.04 -36.59 3.45 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -95.08 137.0 34.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.342 . . . . 0.0 109.64 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.2 mmp_? -79.87 150.38 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -0.982 . . . . 0.0 109.701 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -52.1 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.447 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 42.6 t -168.41 169.71 10.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.33 -0.856 . . . . 0.0 108.9 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.447 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 6.5 mm -84.55 122.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.425 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.4 p -58.88 158.84 7.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 64' ' ' ILE . 3.2 mm? -54.71 -49.88 69.66 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.732 -0.605 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -51.45 -47.65 63.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.926 -1.109 . . . . 0.0 110.178 -179.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.85 -43.68 67.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 0.0 110.892 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -65.85 -41.4 91.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.613 -1.305 . . . . 0.0 109.693 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -60.58 -36.58 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -51.51 69.15 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.018 -1.051 . . . . 0.0 110.087 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.4 -41.26 63.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.866 -1.146 . . . . 0.0 112.462 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.627 HD22 ' OH ' ' A' ' 29' ' ' TYR . 22.7 mt -68.05 -44.29 76.72 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.286 -1.509 . . . . 0.0 111.752 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.38 -30.15 68.07 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.893 -1.129 . . . . 0.0 111.569 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' C ' ' N ' ' A' ' 71' ' ' ILE . 49.6 mtmt -76.84 -39.37 51.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.278 -1.514 . . . . 0.0 108.801 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -55.11 -11.26 0.66 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.427 ' N ' ' C ' ' A' ' 69' ' ' LYS . 15.7 mm -79.91 106.3 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.91 168.26 26.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.434 -0.791 . . . . 0.0 109.908 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.451 -0.78 . . . . 0.0 109.318 -179.131 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -147.09 124.46 11.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.286 -0.884 . . . . 0.0 108.907 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 133.98 34.02 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.731 ' HE ' ' C ' ' A' ' 10' ' ' GLY . 33.4 mtp180 -141.13 -169.25 2.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.222 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' HB2' HH12 ' A' ' 11' ' ' ARG . 3.8 m-20 -130.98 -159.59 0.98 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.648 -0.658 . . . . 0.0 109.823 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.481 ' ND2' ' NE2' ' A' ' 19' ' ' GLN . 77.6 m-20 -63.29 -33.06 74.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.121 -0.987 . . . . 0.0 111.659 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HB2' ' NH1' ' A' ' 11' ' ' ARG . 15.1 mmt180 -96.03 8.28 44.13 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.017 -1.052 . . . . 0.0 112.09 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.731 ' C ' ' HE ' ' A' ' 6' ' ' ARG . . . 76.88 19.99 76.79 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.422 -1.424 . . . . 0.0 111.704 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.627 ' HG3' HH11 ' A' ' 11' ' ' ARG . 2.3 mtm-85 -94.19 144.95 25.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.659 -1.495 . . . . 0.0 108.374 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.4 mt -85.56 117.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 108.879 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -84.99 144.69 28.14 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.423 -0.798 . . . . 0.0 109.46 -179.098 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -89.26 -171.66 3.34 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.18 0.991 . . . . 0.0 110.502 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.4 m -56.42 143.53 34.44 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.691 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.99 -51.46 3.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.256 -0.903 . . . . 0.0 111.479 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.1 140.67 58.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.819 -1.401 . . . . 0.0 110.093 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -160.01 -174.51 4.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.273 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.481 ' NE2' ' ND2' ' A' ' 8' ' ' ASN . 4.1 tt0 -110.11 147.41 33.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.419 -0.801 . . . . 0.0 109.402 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 20' ' ' ARG . 10.3 ttt-85 -88.87 164.1 15.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.553 ' CD ' ' H ' ' A' ' 21' ' ' LYS . 8.4 mptt -63.71 -19.41 64.92 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.94 -8.17 50.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.608 -0.683 . . . . 0.0 110.714 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.68 6.32 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -61.41 145.79 50.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.969 -1.312 . . . . 0.0 108.041 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 11' ' ' ARG . 72.2 m-85 -78.75 167.93 20.48 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.103 -0.998 . . . . 0.0 110.659 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.645 HD13 ' CE2' ' A' ' 40' ' ' TYR . 67.8 tp -152.01 132.56 13.87 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 50.9 t80 -132.92 162.76 30.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 25.0 tttt -137.34 137.1 38.55 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.034 -1.041 . . . . 0.0 110.873 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.513 ' CD2' ' OE1' ' A' ' 37' ' ' GLN . 13.8 p90 -149.95 -175.55 5.09 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.45 ' HA ' HE22 ' A' ' 37' ' ' GLN . 39.9 mm -109.17 131.88 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.257 -0.902 . . . . 0.0 109.287 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.92 178.38 6.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 0.0 110.047 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.505 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 14.8 t -63.01 0.36 0.58 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.054 -1.029 . . . . 0.0 110.881 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 6.6 m-85 -102.69 -10.47 19.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.4 59.32 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 15.0 pt-20 -80.17 150.7 71.73 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 108.395 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.76 135.61 21.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.632 1.555 . . . . 0.0 111.459 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.679 ' NE2' ' N ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -132.74 165.68 23.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.508 ' HB3' HD11 ' A' ' 26' ' ' LEU . 48.5 m-85 -137.11 155.79 49.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -0.839 . . . . 0.0 109.304 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.56 ' O ' HD12 ' A' ' 26' ' ' LEU . 10.7 m -126.05 150.09 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.645 ' CE2' HD13 ' A' ' 26' ' ' LEU . 71.6 m-85 -123.01 156.89 33.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.8 t -171.46 152.07 3.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.096 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -95.61 9.32 40.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 109.654 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.47 156.01 45.79 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.224 -0.923 . . . . 0.0 109.507 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.507 ' CB ' ' HE ' ' A' ' 11' ' ' ARG . 59.6 tp -98.66 -38.63 9.04 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -120.26 173.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.53 49.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 0.0 110.452 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.0 p -86.04 -7.17 58.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 0.0 110.182 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -71.94 167.62 19.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.17 -0.956 . . . . 0.0 109.428 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.84 136.85 51.03 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.6 149.52 78.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 110.616 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.26 140.79 25.45 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.677 1.585 . . . . 0.0 111.377 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.01 141.57 5.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 109.561 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.09 -19.97 48.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.62 142.86 27.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.827 -1.396 . . . . 0.0 109.205 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -78.08 151.21 33.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 109.829 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 p30 -62.08 175.08 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.79 . . . . 0.0 109.764 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 15.3 t -172.46 -174.99 1.27 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.411 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 49.8 mm -98.97 127.44 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.013 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.454 ' OG ' ' C ' ' A' ' 44' ' ' LEU . 22.7 t -56.91 157.23 5.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.382 -0.824 . . . . 0.0 109.392 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.5 -51.69 66.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.987 -1.07 . . . . 0.0 109.986 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -47.79 -41.76 24.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.77 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.06 -39.69 65.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.927 -1.108 . . . . 0.0 109.923 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -65.36 -55.47 17.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.868 -1.145 . . . . 0.0 109.611 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 64' ' ' ILE . 1.6 mp -48.05 -58.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.6 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.08 -42.36 69.25 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.684 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -73.18 -42.43 62.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.822 . . . . 0.0 111.598 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.487 HD23 ' OH ' ' A' ' 29' ' ' TYR . 6.3 mp -70.56 -44.42 67.46 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.779 -1.2 . . . . 0.0 111.817 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -72.49 -33.65 67.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.614 -1.304 . . . . 0.0 110.524 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -77.15 -21.53 53.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.862 -1.149 . . . . 0.0 109.468 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -97.23 -43.26 7.43 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.289 -0.882 . . . . 0.0 110.256 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.505 ' CG2' ' H ' ' A' ' 32' ' ' SER . 76.6 mt -80.06 -7.29 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.513 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 71' ' ' ILE . 9.0 m80 -145.33 -173.06 4.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.203 -0.936 . . . . 0.0 108.832 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.787 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.458 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 45.7 mp0 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -81.66 163.79 22.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.065 -1.022 . . . . 0.0 109.671 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.588 ' N ' ' NE ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -83.45 155.39 23.44 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 6' ' ' ARG . 14.9 mtm-85 -141.22 160.51 39.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.158 -0.964 . . . . 0.0 110.575 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' CD2' ' A' ' 13' ' ' LEU . 93.6 m-20 -87.21 170.92 11.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -63.84 -3.55 2.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.881 -1.137 . . . . 0.0 109.063 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.91 -11.23 18.38 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.52 4.77 59.26 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.598 HH11 ' HG2' ' A' ' 11' ' ' ARG . 8.6 mtt-85 -85.91 130.29 34.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -1.113 . . . . 0.0 109.545 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.0 110.48 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -86.29 150.36 24.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -89.29 -179.33 5.84 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.687 -1.258 . . . . 0.0 110.789 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 m -53.46 154.51 3.44 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -39.46 2.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -76.46 167.8 21.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.275 . . . . 0.0 109.518 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 t -158.82 161.96 36.97 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.863 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -104.51 138.13 41.34 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -89.3 156.37 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.942 -1.099 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CG ' ' N ' ' A' ' 22' ' ' ASP . 10.2 ptmm? -53.52 -39.24 64.48 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.107 -0.995 . . . . 0.0 109.491 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 51.1 p30 -83.89 -30.82 26.08 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.184 -0.948 . . . . 0.0 110.41 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 135.05 -24.72 3.4 Favored Glycine 0 N--CA 1.505 3.272 0 O-C-N 120.81 -1.181 . . . . 0.0 112.576 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -57.46 147.25 27.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 120.15 1.975 . . . . 0.0 107.714 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -85.32 169.55 13.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.069 -1.019 . . . . 0.0 110.153 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -152.96 129.01 10.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.146 -0.971 . . . . 0.0 109.75 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.859 ' N ' HD12 ' A' ' 26' ' ' LEU . 87.1 t80 -131.02 162.35 29.99 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.549 -0.719 . . . . 0.0 109.216 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 36.0 tttt -122.66 135.22 54.53 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.531 -0.73 . . . . 0.0 110.048 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.532 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 6.0 p90 -141.61 162.93 34.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' O ' ' NE2' ' A' ' 72' ' ' HIS . 24.7 mm -103.53 130.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.193 -0.942 . . . . 0.0 109.549 -178.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 3.8 m-20 -88.5 179.74 6.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.506 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 47.1 t -57.08 -3.94 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 111.372 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 46.3 m-85 -96.26 -4.79 41.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.981 -1.075 . . . . 0.0 110.473 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.28 10.33 81.71 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -88.25 164.36 33.35 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 122.034 -0.686 . . . . 0.0 110.092 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.28 122.6 0.75 Allowed 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 121.823 1.682 . . . . 0.0 110.144 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.599 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -123.07 166.11 15.68 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.222 -0.924 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -135.85 146.55 47.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.505 -0.747 . . . . 0.0 110.486 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -124.34 148.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -132.35 155.02 49.15 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.134 -0.979 . . . . 0.0 109.956 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.1 t -171.83 157.74 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.963 -1.085 . . . . 0.0 109.728 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -91.85 12.47 21.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 109.148 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 8.6 mtmp? -135.31 138.09 43.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.432 -0.792 . . . . 0.0 109.7 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.7 tp -88.46 -43.27 11.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.69 173.92 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.72 -19.17 62.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.266 -0.896 . . . . 0.0 111.541 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 t -86.6 -10.59 53.6 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.72 -1.237 . . . . 0.0 111.466 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.87 176.37 3.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.662 -1.274 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.35 140.38 30.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.8 m -84.79 146.35 46.13 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 109.385 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.95 150.98 78.37 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.992 1.794 . . . . 0.0 111.698 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.42 143.67 2.46 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.567 -0.708 . . . . 0.0 110.393 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.97 -26.65 22.54 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -96.99 131.93 43.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.368 -1.078 . . . . 0.0 108.527 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -75.91 145.89 40.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.36 -0.837 . . . . 0.0 109.7 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 57' ' ' CYS . 60.8 t0 -50.27 153.73 1.41 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.664 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 81.1 m -148.59 167.3 25.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 109.217 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.5 mt -87.97 133.1 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.199 -0.938 . . . . 0.0 110.354 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.6 p -62.81 157.7 20.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.39 -0.819 . . . . 0.0 110.623 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 64' ' ' ILE . 7.7 mp -58.42 -52.46 65.52 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.841 0.829 . . . . 0.0 109.588 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -51.2 -45.32 61.8 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.461 -0.774 . . . . 0.0 110.154 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.31 -40.99 70.47 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 109.704 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' NZ ' ' CB ' ' A' ' 63' ' ' LYS . 2.1 ttmp? -66.32 -41.83 89.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.942 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.49 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.4 mp -59.4 -53.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.776 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.31 71.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.917 -1.115 . . . . 0.0 109.958 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -73.87 -42.57 60.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.972 -179.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 mt -68.0 -43.39 78.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.616 -1.302 . . . . 0.0 110.594 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -69.11 -39.68 78.79 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.245 -1.535 . . . . 0.0 110.49 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -82.88 -38.74 22.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.875 -1.14 . . . . 0.0 111.304 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.83 -29.07 60.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.085 . . . . 0.0 111.202 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' CG2' ' H ' ' A' ' 32' ' ' SER . 42.8 mm -86.2 -44.12 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.0 -1.062 . . . . 0.0 110.325 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.471 ' NE2' ' O ' ' A' ' 30' ' ' ILE . 13.8 m170 -87.92 159.73 18.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.95 -1.094 . . . . 0.0 109.307 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.6 t0 . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.303 -0.873 . . . . 0.0 109.165 -179.375 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -83.18 144.32 29.89 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.229 1.014 . . . . 0.0 110.958 -178.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -97.52 156.18 16.61 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -137.97 150.05 46.67 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.016 -1.052 . . . . 0.0 109.767 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -83.44 166.85 18.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.287 -0.883 . . . . 0.0 109.832 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 23.2 p30 -69.17 1.64 3.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.192 -0.943 . . . . 0.0 109.902 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' NH1' ' OH ' ' A' ' 25' ' ' TYR . 92.2 mtt180 -100.11 -52.68 3.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.84 -3.34 1.11 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.639 ' CG ' HH11 ' A' ' 11' ' ' ARG . 1.6 mtt-85 -89.29 130.06 35.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.459 -1.612 . . . . 0.0 110.171 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 mm -72.73 110.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.249 -0.907 . . . . 0.0 108.561 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -94.26 152.53 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 109.484 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 35.9 mmtt -89.0 -173.27 4.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.978 -1.077 . . . . 0.0 110.78 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.8 p -57.14 165.6 1.31 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.454 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.1 -44.07 1.04 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.366 -0.834 . . . . 0.0 111.56 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' OE2' ' CD1' ' A' ' 27' ' ' TYR . 12.2 mp0 -65.23 152.39 43.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.019 -1.283 . . . . 0.0 110.823 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 t -158.58 139.62 13.05 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.2 tt0 -100.0 129.31 46.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.192 -0.942 . . . . 0.0 109.891 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.708 ' NH1' HH21 ' A' ' 24' ' ' ARG . 49.2 mtp180 -89.27 166.19 13.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.431 -0.793 . . . . 0.0 110.656 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.88 -20.27 63.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 109.729 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -85.78 -17.38 35.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -0.993 . . . . 0.0 109.463 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.09 -22.69 32.61 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.708 HH21 ' NH1' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -63.83 146.81 53.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.742 -1.446 . . . . 0.0 109.413 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.401 ' OH ' ' NH1' ' A' ' 9' ' ' ARG . 71.8 m-85 -88.63 166.47 14.09 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.802 0.81 . . . . 0.0 109.845 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.617 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 20.8 tp -148.74 119.87 7.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 28' ' ' LYS . 90.4 t80 -131.67 168.63 17.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.645 -0.659 . . . . 0.0 109.437 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' O ' ' CE2' ' A' ' 27' ' ' TYR . 71.1 tttt -130.91 135.17 47.43 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.541 ' CE2' ' OD1' ' A' ' 31' ' ' ASP . 18.9 p90 -133.18 165.03 25.72 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.461 -0.774 . . . . 0.0 108.912 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.8 mm -103.01 134.78 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.077 -1.014 . . . . 0.0 109.302 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' OD1' ' CE2' ' A' ' 29' ' ' TYR . 16.7 m-20 -83.27 156.67 22.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 71' ' ' ILE . 42.7 m -53.66 -8.59 0.16 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.893 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.3 -13.9 21.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.881 -1.137 . . . . 0.0 108.807 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.34 0.73 59.5 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 20.6 pt-20 -83.38 148.52 55.85 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.892 -1.358 . . . . 0.0 108.329 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' C ' ' NE2' ' A' ' 37' ' ' GLN . 96.0 Cg_endo -82.64 141.63 11.11 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.354 2.036 . . . . 0.0 113.198 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.1 mp0 -139.67 161.68 36.95 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.186 -0.946 . . . . 0.0 108.753 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -132.09 142.54 49.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.233 -0.917 . . . . 0.0 109.783 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -122.2 151.58 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.561 0.695 . . . . 0.0 109.904 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.617 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 46.9 m-85 -123.72 150.47 44.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -166.05 148.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.391 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -90.94 10.38 26.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 109.573 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -140.18 144.02 36.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.99 -42.79 10.35 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.35 167.57 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.05 -6.24 44.27 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.982 -1.073 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.8 p -88.7 -18.53 27.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.433 -1.417 . . . . 0.0 110.011 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.28 175.11 7.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.42 HH12 ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -138.83 145.73 40.39 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 50' ' ' VAL . 5.9 m -79.91 128.53 73.72 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.713 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -46.32 141.17 10.5 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.028 1.152 . . . . 0.0 110.327 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' N ' HH12 ' A' ' 49' ' ' ARG . . . -44.81 143.44 1.43 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.07 -32.26 7.69 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -91.88 140.66 29.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 108.546 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -76.16 155.62 34.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 44.1 p30 -52.66 155.55 2.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.254 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 56' ' ' ASP . 64.9 m -154.54 157.99 39.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -85.05 135.08 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.168 -0.957 . . . . 0.0 110.207 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.8 p -58.82 153.65 16.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.09 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.7 mt -60.47 -52.03 66.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.951 -1.093 . . . . 0.0 109.928 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -46.95 -50.0 19.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.824 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -69.13 -34.09 74.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.248 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -69.84 -41.26 75.16 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.428 -0.795 . . . . 0.0 110.02 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.18 -50.04 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.243 -0.91 . . . . 0.0 109.358 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.33 79.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.986 -1.071 . . . . 0.0 109.819 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -71.62 -44.02 65.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.466 -0.771 . . . . 0.0 111.308 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.8 mt -66.74 -32.9 74.5 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.524 -1.36 . . . . 0.0 111.701 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -70.41 -45.53 65.74 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.215 -1.553 . . . . 0.0 110.308 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -82.93 -13.49 55.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.524 -1.36 . . . . 0.0 112.035 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -95.03 -29.1 14.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.484 -1.385 . . . . 0.0 110.357 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.41 ' O ' ' OG ' ' A' ' 32' ' ' SER . 6.2 mm -79.73 91.71 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-O 121.914 0.864 . . . . 0.0 109.015 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -151.43 -56.28 0.15 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.76 179.557 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -84.83 -170.81 3.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.046 -1.034 . . . . 0.0 109.492 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 139.75 37.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.113 -0.992 . . . . 0.0 108.534 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -144.22 171.51 14.19 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.609 -0.682 . . . . 0.0 109.872 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.2 p30 -75.46 -179.66 4.71 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.753 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 61.8 m-80 -67.99 -8.6 38.73 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.829 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -101.79 -22.97 14.26 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.779 -1.201 . . . . 0.0 111.029 -178.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 123.06 7.93 6.89 Favored Glycine 0 N--CA 1.503 3.165 0 O-C-N 121.199 -0.938 . . . . 0.0 110.78 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.527 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 9.2 mtm180 -85.09 126.25 33.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.884 -1.362 . . . . 0.0 109.596 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.2 mm -71.56 105.53 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' H ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 pp -87.78 149.02 24.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.372 -0.83 . . . . 0.0 109.193 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -91.09 -175.14 4.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.04 0.924 . . . . 0.0 110.903 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.466 ' H ' HG23 ' A' ' 15' ' ' THR . 7.5 p -55.19 146.24 19.24 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.665 0.745 . . . . 0.0 111.481 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.3 -54.12 4.85 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.422 -0.799 . . . . 0.0 111.37 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 36.8 mp0 -60.69 145.87 47.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 109.644 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -160.83 149.28 16.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.071 . . . . 0.0 109.649 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.464 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 48.8 tt0 -99.3 130.87 45.62 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.081 -1.012 . . . . 0.0 108.568 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -84.54 -171.24 3.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 0.0 109.605 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -75.32 -23.04 57.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.176 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -86.2 -15.02 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.502 -0.749 . . . . 0.0 109.516 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.19 -19.2 49.63 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -62.4 141.88 58.12 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.491 -1.594 . . . . 0.0 108.66 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 75.6 m-85 -87.83 165.58 15.2 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.427 -0.796 . . . . 0.0 108.915 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.941 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -154.71 130.91 10.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.548 -178.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.941 ' N ' HD22 ' A' ' 26' ' ' LEU . 71.6 t80 -131.23 168.6 17.22 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 53.1 tttt -136.83 140.01 42.13 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.58 173.35 11.73 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.34 -0.85 . . . . 0.0 109.513 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.1 mm -103.35 126.14 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.412 -0.805 . . . . 0.0 109.615 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.14 176.41 9.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.005 -1.06 . . . . 0.0 109.058 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.428 ' H ' HG22 ' A' ' 71' ' ' ILE . 55.8 p -64.09 0.59 0.89 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.042 -1.036 . . . . 0.0 111.203 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 14.4 m-85 -103.65 -15.89 15.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.107 -0.996 . . . . 0.0 109.463 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.65 -0.62 74.12 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -82.81 148.39 57.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.248 . . . . 0.0 109.299 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.402 ' C ' HE21 ' A' ' 37' ' ' GLN . 61.3 Cg_endo -74.06 124.44 9.09 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.489 1.459 . . . . 0.0 111.019 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.487 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -122.81 163.55 20.03 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -136.29 153.55 51.14 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.192 -0.943 . . . . 0.0 110.124 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.54 146.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -131.23 149.11 52.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.179 -0.951 . . . . 0.0 109.682 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.3 t -171.53 154.6 3.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.38 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -92.67 14.77 16.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.385 -0.822 . . . . 0.0 109.005 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.693 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 24.4 mtmm -130.91 138.51 49.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -93.38 -45.06 7.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.482 ' O ' ' OG ' ' A' ' 59' ' ' SER . 1.2 t -119.73 167.54 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.63 -17.57 64.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 110.664 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 p -86.89 -12.0 49.06 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.901 -1.124 . . . . 0.0 110.886 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -70.7 169.26 14.8 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.871 -1.143 . . . . 0.0 110.458 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -139.49 137.29 35.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.4 m -80.12 150.97 72.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 109.657 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.45 150.16 63.58 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.786 1.657 . . . . 0.0 111.049 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -45.86 146.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.3 -32.4 7.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -98.04 132.84 43.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -1.211 . . . . 0.0 109.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -74.95 147.91 40.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 109.182 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 60.0 p30 -51.82 152.06 3.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.114 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.693 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 35.6 m -146.78 164.07 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.47 133.91 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 110.823 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 45' ' ' VAL . 56.3 m -58.19 166.95 1.43 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.412 0.625 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.467 HD12 ' CB ' ' A' ' 27' ' ' TYR . 4.4 mm? -63.68 -65.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.888 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -47.47 -34.45 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.502 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.94 -40.11 72.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.659 -1.275 . . . . 0.0 108.837 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -66.24 -44.02 84.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 110.245 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.5 mp -59.92 -45.12 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.134 -0.979 . . . . 0.0 110.677 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.62 81.65 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.745 -1.222 . . . . 0.0 110.981 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -77.85 -36.71 49.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.846 -1.159 . . . . 0.0 112.477 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.6 mt -67.53 -44.41 78.43 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.364 -1.46 . . . . 0.0 111.523 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -77.09 -36.22 55.9 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.978 -1.076 . . . . 0.0 110.985 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -73.26 -20.67 60.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.92 -1.112 . . . . 0.0 110.309 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -107.99 -52.9 2.7 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.253 -0.905 . . . . 0.0 111.239 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.428 HG22 ' H ' ' A' ' 32' ' ' SER . 7.9 mt -84.97 44.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.197 -0.939 . . . . 0.0 110.456 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -156.9 41.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.928 -1.108 . . . . 0.0 109.467 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.105 -0.997 . . . . 0.0 109.442 179.984 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -84.48 171.82 12.22 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.413 ' HD2' ' N ' ' A' ' 5' ' ' ARG . 0.7 OUTLIER -84.4 121.27 27.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.901 -1.124 . . . . 0.0 110.156 -178.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -139.7 173.4 11.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.522 -0.736 . . . . 0.0 109.612 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 55.0 p-10 -88.96 -176.9 5.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.083 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -64.78 -6.31 7.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 110.006 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 9' ' ' ARG . 52.9 mtt-85 -105.39 -16.88 14.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.172 -0.955 . . . . 0.0 110.318 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 101.65 19.01 16.7 Favored Glycine 0 N--CA 1.501 2.989 0 O-C-N 121.108 -0.995 . . . . 0.0 110.76 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 11' ' ' ARG . 6.6 mtt-85 -86.03 140.18 30.5 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.77 -1.43 . . . . 0.0 109.168 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.78 103.24 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.525 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -99.4 149.97 22.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.388 -0.82 . . . . 0.0 109.065 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -89.02 -173.86 4.23 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.423 1.106 . . . . 0.0 111.785 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.9 m -59.4 140.0 56.55 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.229 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 -39.12 2.93 Favored Glycine 0 N--CA 1.499 2.844 0 O-C-N 121.312 -0.867 . . . . 0.0 111.338 177.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -72.56 153.38 41.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.745 -1.444 . . . . 0.0 109.862 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.9 t -160.55 155.68 24.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -96.42 139.94 31.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -83.75 148.33 27.11 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.568 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -57.56 -18.9 21.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.355 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.61 -21.04 23.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.782 -0.573 . . . . 0.0 109.924 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.86 -35.59 4.01 Favored Glycine 0 N--CA 1.503 3.135 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 24' ' ' ARG . 2.9 ptp180 -59.54 140.98 55.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.877 -1.366 . . . . 0.0 109.23 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -75.85 170.73 15.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.316 -0.865 . . . . 0.0 110.338 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 39' ' ' VAL . 62.9 tp -154.83 130.98 10.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.73 -0.606 . . . . 0.0 109.551 -179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -134.51 161.93 33.69 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -126.3 134.88 51.01 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 31' ' ' ASP . 5.8 p90 -137.98 167.72 21.2 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.76 131.92 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 109.259 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 29' ' ' TYR . 41.5 m-20 -82.09 -174.13 4.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.218 -0.926 . . . . 0.0 109.61 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.433 ' H ' HG22 ' A' ' 71' ' ' ILE . 70.1 m -72.32 -4.64 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.42 -0.8 . . . . 0.0 110.239 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 18.3 m-85 -99.59 -10.73 21.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.15 -0.968 . . . . 0.0 109.913 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.41 86.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.39 147.33 52.8 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.392 -1.063 . . . . 0.0 108.733 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.98 128.51 15.93 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.846 1.697 . . . . 0.0 110.522 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.51 HE21 ' CA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -127.87 164.69 21.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 109.011 -179.106 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.38 155.32 50.48 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.356 -0.84 . . . . 0.0 110.786 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.673 ' O ' HD12 ' A' ' 26' ' ' LEU . 2.9 m -128.86 152.72 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.652 ' CE2' HD13 ' A' ' 26' ' ' LEU . 78.5 m-85 -128.3 150.89 49.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.208 -0.933 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.6 t -169.08 146.4 3.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.469 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -88.31 3.55 49.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 109.289 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.66 ' HZ1' ' C ' ' A' ' 57' ' ' CYS . 24.4 mtmm -128.56 141.99 51.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.88 -49.59 6.35 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 46' ' ' ALA . 3.2 t -112.53 174.33 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -77.95 -11.92 59.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.62 -0.675 . . . . 0.0 110.669 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.5 p -87.25 -14.35 41.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.763 -1.211 . . . . 0.0 110.105 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -70.2 174.89 5.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 50' ' ' VAL . 1.9 tmt_? -146.49 135.94 22.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.409 ' O ' ' NH1' ' A' ' 49' ' ' ARG . 19.3 m -75.23 147.95 83.4 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.772 -1.205 . . . . 0.0 109.954 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.33 155.73 66.51 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.04 1.827 . . . . 0.0 111.764 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.18 146.98 2.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.55 -0.719 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.76 -31.4 6.91 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -95.97 139.64 31.88 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.005 -1.291 . . . . 0.0 109.073 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 55' ' ' ARG . 1.4 ttt-85 -75.41 151.26 38.15 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.268 -0.895 . . . . 0.0 109.504 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.68 159.06 22.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.365 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.66 ' C ' ' HZ1' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -156.34 175.03 14.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.032 -179.848 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.7 mt -88.81 135.38 25.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.524 -0.735 . . . . 0.0 110.68 -178.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.9 p -61.35 163.67 6.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 108.695 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.1 -51.98 40.19 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 111.149 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' NH1' ' HG2' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -44.27 -45.49 8.64 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.143 -0.973 . . . . 0.0 110.003 -178.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -68.58 -40.58 80.45 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 109.672 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -66.62 -44.14 82.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.986 -1.072 . . . . 0.0 110.516 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -56.93 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.91 -1.119 . . . . 0.0 110.318 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.07 70.29 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -76.74 -53.79 7.49 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.524 -0.735 . . . . 0.0 110.606 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -69.28 -41.28 77.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.996 -1.065 . . . . 0.0 110.144 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -69.63 -39.81 76.94 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -78.17 -24.57 47.2 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.907 -1.121 . . . . 0.0 111.068 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -100.03 -36.1 9.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.911 -1.118 . . . . 0.0 111.679 -178.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 32' ' ' SER . 3.9 mm -89.88 44.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.841 -1.162 . . . . 0.0 110.415 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -153.59 37.41 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.342 -1.474 . . . . 0.0 109.465 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.309 179.969 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 3' ' ' GLU . 5.6 mp0 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -156.09 143.47 19.25 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -84.2 152.7 24.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 110.197 -179.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 6' ' ' ARG . 2.9 mtt-85 -134.94 -179.88 5.89 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 51.3 p-10 -74.4 -167.36 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.761 -1.212 . . . . 0.0 108.91 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.489 ' N ' ' OE1' ' A' ' 19' ' ' GLN . 95.6 m-20 -68.61 -16.35 63.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.781 -1.2 . . . . 0.0 108.599 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' N ' ' CD ' ' A' ' 9' ' ' ARG . 9.2 mpt_? -101.3 -87.13 0.4 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . -169.5 19.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.455 ' NH2' ' OH ' ' A' ' 25' ' ' TYR . 81.3 mtm180 -89.84 138.59 31.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.303 . . . . 0.0 109.704 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.9 mm -77.68 130.26 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.888 . . . . 0.0 109.98 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -93.6 150.64 20.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -87.88 170.87 10.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.957 -1.09 . . . . 0.0 109.513 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.0 m -58.11 137.17 57.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.455 -0.778 . . . . 0.0 110.047 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.98 -24.81 24.88 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.943 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 44.1 mp0 -82.04 157.2 24.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.677 -1.484 . . . . 0.0 110.12 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 t -158.93 147.56 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 109.389 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 8' ' ' ASN . 41.7 tt0 -106.45 133.04 51.75 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -83.03 166.0 19.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 109.862 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HD3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.59 -16.49 48.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 108.643 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -86.9 -10.23 53.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.482 -0.761 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.31 -29.2 13.03 Favored Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.248 -0.907 . . . . 0.0 111.379 178.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -57.86 157.0 8.1 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.548 -1.56 . . . . 0.0 109.382 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.455 ' OH ' ' NH2' ' A' ' 11' ' ' ARG . 71.2 m-85 -100.41 166.91 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 109.42 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.484 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -152.79 141.29 20.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.739 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -135.26 149.23 49.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -114.88 135.42 54.22 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.253 -0.905 . . . . 0.0 110.792 -178.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.693 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.2 p90 -142.46 164.78 29.19 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.2 mt -107.96 139.62 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 33' ' ' PHE . 23.8 m-20 -81.79 159.93 23.68 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.935 -1.103 . . . . 0.0 109.222 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.7 m -58.2 -2.18 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 110.031 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 31' ' ' ASP . 88.1 m-85 -95.29 -15.43 23.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.044 -1.035 . . . . 0.0 108.59 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.07 -5.26 49.71 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 23.5 pt-20 -84.73 144.02 41.7 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.872 -1.369 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.69 139.83 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.534 2.156 . . . . 0.0 111.969 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 2.4 mp0 -136.8 172.75 12.54 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.108 -0.995 . . . . 0.0 109.402 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -137.01 139.51 41.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.51 154.27 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CZ ' HD12 ' A' ' 26' ' ' LEU . 66.9 m-85 -126.12 151.36 47.35 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.449 0.643 . . . . 0.0 109.273 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.8 t -168.22 136.57 2.29 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.013 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -87.58 12.9 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 109.189 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 57' ' ' CYS . 53.0 mtmt -130.98 133.22 45.59 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.659 0.742 . . . . 0.0 109.574 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 66.9 tp -89.26 -43.44 10.97 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG22 HH12 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -111.63 175.39 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.48 -18.28 49.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.953 -1.092 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.2 p -93.58 7.29 45.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.679 -1.263 . . . . 0.0 110.955 -179.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.4 -179.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.611 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -142.1 116.79 9.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.13 -0.981 . . . . 0.0 109.196 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.47 149.45 51.88 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.204 -0.935 . . . . 0.0 110.839 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' LYS . 56.8 Cg_exo -49.58 134.42 33.12 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.208 1.272 . . . . 0.0 110.739 177.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.55 -23.56 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.848 -1.158 . . . . 0.0 109.791 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -25.4 73.65 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' PRO . 47.8 mmtt -103.93 133.93 48.06 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -78.99 152.65 30.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.087 . . . . 0.0 110.546 -179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -43.78 154.81 0.09 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.448 0.642 . . . . 0.0 109.826 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.498 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 61.4 m -149.73 167.59 26.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -86.96 128.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.141 -0.975 . . . . 0.0 108.779 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.6 p -58.64 167.64 1.43 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 110.443 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.78 -51.89 43.61 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.369 -0.832 . . . . 0.0 110.206 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' A' ' 61' ' ' ARG . 0.0 OUTLIER -47.07 -46.4 22.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 109.218 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -70.21 -39.65 75.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.512 -0.742 . . . . 0.0 110.19 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.0 -47.51 74.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.687 -1.258 . . . . 0.0 109.465 179.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mp -46.48 -56.69 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.21 76.97 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -77.29 -36.0 54.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.85 . . . . 0.0 111.945 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.693 HD12 ' CZ ' ' A' ' 29' ' ' TYR . 4.2 mm? -67.82 -41.41 83.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.542 -1.349 . . . . 0.0 110.178 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -76.98 -32.99 57.64 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.239 -1.538 . . . . 0.0 109.813 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 73' ' ' ASP . 37.4 ttpt -87.04 -39.81 15.29 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.165 -0.96 . . . . 0.0 112.654 -178.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.19 -17.2 60.93 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.777 -1.202 . . . . 0.0 111.548 -177.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.486 ' O ' HG22 ' A' ' 71' ' ' ILE . 36.5 mm -86.49 -7.7 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.784 -1.197 . . . . 0.0 110.67 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.61 -33.34 0.23 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.605 -1.309 . . . . 0.0 109.182 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 69' ' ' LYS . 38.9 t70 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.907 . . . . 0.0 109.728 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.651 ' N ' HH22 ' A' ' 6' ' ' ARG . 7.3 tp10 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 4' ' ' LYS . 13.7 ptpt -83.14 -160.07 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 -179.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -80.29 154.6 27.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.06 -1.025 . . . . 0.0 110.961 -177.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.651 HH22 ' N ' ' A' ' 3' ' ' GLU . 4.9 mtt-85 -138.98 -178.82 5.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.67 -0.644 . . . . 0.0 109.475 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -104.09 -167.66 1.39 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.493 -0.755 . . . . 0.0 109.503 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.538 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 3.1 p30 -66.89 -16.86 64.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.28 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.593 HH11 ' HG2' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -97.6 -3.66 39.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.965 -1.084 . . . . 0.0 110.061 -179.422 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.03 4.85 90.47 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.533 ' CG ' HH11 ' A' ' 11' ' ' ARG . 2.6 mtt-85 -88.71 130.79 35.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.016 -1.285 . . . . 0.0 109.641 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.75 121.64 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.981 -1.074 . . . . 0.0 109.233 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.953 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -97.23 155.94 16.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -0.78 . . . . 0.0 108.948 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.07 179.42 6.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.871 -1.143 . . . . 0.0 110.111 -179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -56.81 152.47 12.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.729 -0.607 . . . . 0.0 110.295 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.44 -43.32 3.2 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' CD1' ' A' ' 44' ' ' LEU . 2.1 mt-10 -66.39 155.12 38.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.229 -1.16 . . . . 0.0 108.464 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 t -159.03 164.27 35.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.126 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.468 HE21 ' ND2' ' A' ' 8' ' ' ASN . 39.4 tt0 -103.61 126.53 50.81 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.418 -0.801 . . . . 0.0 108.9 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -85.17 147.17 26.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.046 . . . . 0.0 108.947 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 1.3 mptt -49.26 -22.6 1.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 110.405 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -89.77 -26.74 20.44 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.799 -1.188 . . . . 0.0 110.821 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.62 -34.33 2.79 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -60.45 148.19 38.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.779 -1.424 . . . . 0.0 108.778 -179.753 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -86.47 168.71 13.5 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 27' ' ' TYR . 4.3 tt -145.12 122.95 11.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.349 -0.844 . . . . 0.0 109.536 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.655 ' N ' HD23 ' A' ' 26' ' ' LEU . 74.0 t80 -128.04 161.54 28.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 17.4 tttt -129.42 138.63 51.57 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.426 -0.796 . . . . 0.0 110.329 -179.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -140.42 162.82 34.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.1 mt -110.96 136.27 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -85.27 170.47 12.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.357 -0.84 . . . . 0.0 109.479 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.0 p -60.35 5.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 110.546 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 31' ' ' ASP . 37.3 m-85 -99.45 -17.68 17.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.039 -1.038 . . . . 0.0 109.43 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 -2.91 82.31 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -83.92 142.07 41.5 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.282 -1.128 . . . . 0.0 108.172 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.5 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 50.4 Cg_endo -69.9 145.54 56.64 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.685 1.59 . . . . 0.0 111.124 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -140.07 153.97 46.92 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -129.56 148.69 51.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.044 -1.035 . . . . 0.0 109.892 -179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.14 142.92 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -117.22 160.91 20.32 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.1 t -168.74 152.46 5.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -93.78 7.55 44.45 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -143.65 149.09 36.77 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.309 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 51.1 tp -94.09 -42.99 8.71 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 m -121.65 158.01 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.683 -0.636 . . . . 0.0 109.452 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.36 -11.4 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.407 -0.808 . . . . 0.0 110.191 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.0 p -90.3 -6.91 54.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.039 -1.038 . . . . 0.0 110.129 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -70.71 179.36 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.97 -1.081 . . . . 0.0 110.009 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 49' ' ' ARG . 6.5 tpt180 -142.44 120.76 12.32 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 109.116 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.31 142.35 50.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.252 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -49.34 146.29 14.02 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.879 1.053 . . . . 0.0 110.503 178.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.56 -47.55 39.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.994 -1.067 . . . . 0.0 110.166 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.97 -21.02 4.85 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -102.51 139.71 37.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -1.17 . . . . 0.0 109.934 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.638 ' CD ' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.54 159.29 30.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 179.839 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 25.6 p-10 -66.39 164.25 16.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.173 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.16 171.68 15.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.62 133.05 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 110.17 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.7 p -58.82 152.58 18.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.066 179.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.27 -47.21 87.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.219 -0.925 . . . . 0.0 109.867 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -42.95 -45.07 4.88 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.08 -1.012 . . . . 0.0 109.819 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 97.5 mt-10 -72.29 -37.5 68.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -66.32 -42.51 88.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.693 -1.255 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.04 -53.5 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 0.0 109.668 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.0 -41.87 93.03 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.15 -0.969 . . . . 0.0 110.116 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -72.33 -38.73 68.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.893 -1.129 . . . . 0.0 111.436 -178.805 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.62 -46.4 72.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.576 -1.327 . . . . 0.0 110.094 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -74.45 -38.06 63.09 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 120.794 -1.191 . . . . 0.0 109.838 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 73' ' ' ASP . 29.0 ttmt -73.09 -30.1 63.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.839 -1.163 . . . . 0.0 110.114 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.35 -32.81 20.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.186 -0.946 . . . . 0.0 110.48 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 86.8 mt -86.74 -49.95 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.099 -1.001 . . . . 0.0 110.257 -179.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -88.44 64.23 7.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.931 -1.106 . . . . 0.0 109.399 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' O ' ' O ' ' A' ' 69' ' ' LYS . 89.3 m-20 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.924 -1.11 . . . . 0.0 109.476 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.497 0.665 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -88.3 -168.31 2.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.417 -0.802 . . . . 0.0 109.533 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -81.27 127.13 32.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.855 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 -129.81 135.47 48.46 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.544 -0.723 . . . . 0.0 109.526 -179.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -64.83 165.51 10.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.391 -0.818 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.441 ' ND2' ' OE1' ' A' ' 19' ' ' GLN . 26.0 p30 -63.17 -6.97 4.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.368 -0.832 . . . . 0.0 109.823 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -96.41 -75.79 0.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.167 -0.958 . . . . 0.0 110.155 -179.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.95 -1.32 0.03 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.924 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.554 ' CG ' HH11 ' A' ' 11' ' ' ARG . 5.3 mtt-85 -85.59 133.18 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.469 . . . . 0.0 108.895 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.96 117.0 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.958 . . . . 0.0 109.385 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.8 151.42 22.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.42 -0.8 . . . . 0.0 109.72 -179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -88.89 173.78 8.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.337 -0.852 . . . . 0.0 109.565 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.8 m -56.82 139.34 51.47 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.397 -0.815 . . . . 0.0 110.636 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.18 -42.35 2.27 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.24 150.6 43.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.807 -1.408 . . . . 0.0 109.539 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -157.03 140.0 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.441 ' OE1' ' ND2' ' A' ' 8' ' ' ASN . 53.9 tt0 -101.86 140.72 35.77 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.454 HH21 HD13 ' A' ' 26' ' ' LEU . 37.1 mtt-85 -91.19 173.13 8.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.441 -0.787 . . . . 0.0 110.425 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 1.5 mptt -64.16 -19.66 65.46 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -84.81 -9.81 57.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.1 -25.53 25.08 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 121.096 -1.002 . . . . 0.0 110.96 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -62.21 137.95 58.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.739 -1.447 . . . . 0.0 109.302 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.81 166.76 19.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 110.496 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 HH21 ' A' ' 20' ' ' ARG . 3.0 tt -153.51 138.76 17.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.586 -0.696 . . . . 0.0 110.043 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -133.16 148.39 52.09 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -115.05 139.31 49.97 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.386 -0.821 . . . . 0.0 109.663 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.91 166.07 27.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 0.0 109.098 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -103.81 134.0 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.259 -0.901 . . . . 0.0 109.695 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -84.01 171.59 12.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.894 -1.128 . . . . 0.0 109.236 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 m -62.33 -0.13 0.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.568 -0.708 . . . . 0.0 111.367 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 33' ' ' PHE . 39.2 m-85 -103.77 -21.59 13.66 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.901 -1.124 . . . . 0.0 110.255 -178.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.82 -1.91 38.8 Favored Glycine 0 N--CA 1.503 3.109 0 O-C-N 121.059 -1.026 . . . . 0.0 111.199 178.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 5.5 pt-20 -86.97 153.91 54.87 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.69 -1.476 . . . . 0.0 108.709 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -82.5 133.99 7.46 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.301 2.001 . . . . 0.0 112.796 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 35' ' ' GLU . 3.7 mp0 -127.95 164.68 21.78 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.422 -0.798 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -137.49 147.35 45.18 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 156.22 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.34 154.9 44.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.458 -0.776 . . . . 0.0 110.065 -178.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -172.34 137.74 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.605 -0.684 . . . . 0.0 109.276 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -88.38 11.56 16.51 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -126.27 147.67 49.65 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.42 0.628 . . . . 0.0 109.78 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.1 tp -95.67 -47.22 6.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 47' ' ' THR . 35.5 m -122.15 -176.87 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.56 -15.87 58.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 111.109 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.424 ' H ' HG23 ' A' ' 45' ' ' VAL . 24.0 p -88.1 -10.03 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.711 -1.243 . . . . 0.0 110.234 -178.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -75.85 166.78 23.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.978 . . . . 0.0 110.467 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.49 139.91 40.84 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 m -81.06 149.58 66.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.801 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.39 154.46 50.85 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.488 2.125 . . . . 0.0 111.338 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.13 144.43 1.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.63 -38.54 3.07 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.562 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 9.6 mptt -93.2 126.03 38.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -1.165 . . . . 0.0 108.175 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' HB3' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.5 155.67 33.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 110.109 -179.137 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -50.98 164.67 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.939 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 58' ' ' ILE . 52.2 t -162.15 165.75 26.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.439 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 97.6 mt -83.93 126.46 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.59 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.5 p -54.37 157.62 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 108.925 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.54 -59.97 3.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 110.677 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -46.69 -39.93 12.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.916 -1.115 . . . . 0.0 110.392 -178.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -71.5 -40.22 70.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.929 -1.107 . . . . 0.0 109.394 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -70.84 -41.81 70.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.78 -49.65 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.94 -1.1 . . . . 0.0 109.137 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.66 80.19 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.179 -0.95 . . . . 0.0 109.859 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.71 -53.5 13.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.935 -1.103 . . . . 0.0 111.07 -178.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.68 -49.19 41.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.631 -1.293 . . . . 0.0 110.442 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 72' ' ' HIS . 19.9 tt0 -68.1 -44.01 77.18 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 -176.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -75.59 -30.05 59.48 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.392 -1.442 . . . . 0.0 111.17 -178.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -75.0 -45.77 39.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.147 -0.971 . . . . 0.0 112.121 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 pt -87.18 -17.54 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.001 -1.062 . . . . 0.0 111.182 -177.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 68' ' ' GLN . 3.0 m-70 -153.22 154.43 34.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.027 -1.046 . . . . 0.0 109.526 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 C--N 1.303 -1.455 0 O-C-N 121.56 -0.712 . . . . 0.0 109.999 179.019 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.564 0.697 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -81.48 167.64 19.13 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.309 -0.869 . . . . 0.0 108.718 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -81.56 152.2 27.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.908 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 6' ' ' ARG . 2.6 mtt-85 -141.72 161.56 37.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.325 -0.86 . . . . 0.0 108.969 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 58.3 p30 -101.26 178.15 4.73 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -62.05 -6.77 3.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.718 -1.239 . . . . 0.0 109.462 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.488 HH21 HH21 ' A' ' 11' ' ' ARG . 17.7 mmm180 -96.95 -12.12 23.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 86.73 10.05 73.57 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.313 178.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 11' ' ' ARG . 2.9 mtt-85 -85.67 152.02 23.42 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.668 -1.489 . . . . 0.0 109.544 179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -84.48 104.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 pp -92.77 146.43 23.65 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.936 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -88.78 -174.54 4.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.049 -1.032 . . . . 0.0 111.466 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 m -57.63 147.33 27.67 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.4 -44.82 3.41 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.51 149.06 50.66 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.995 -1.297 . . . . 0.0 109.555 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -157.21 155.1 30.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.491 ' OE1' ' CD1' ' A' ' 25' ' ' TYR . 5.2 tp60 -110.81 132.39 54.24 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.542 -0.724 . . . . 0.0 110.007 -179.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.82 HH11 HH21 ' A' ' 24' ' ' ARG . 36.0 mtp180 -90.46 -177.41 5.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -67.67 -24.1 65.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.209 -179.229 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -88.51 -13.1 41.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.004 -1.06 . . . . 0.0 109.702 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.65 -14.46 59.09 Favored Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.345 -0.847 . . . . 0.0 111.393 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.82 HH21 HH11 ' A' ' 20' ' ' ARG . 2.1 ptt180 -64.46 141.03 58.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.444 -1.621 . . . . 0.0 109.348 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.491 ' CD1' ' OE1' ' A' ' 19' ' ' GLN . 71.5 m-85 -81.45 165.95 20.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.418 -0.802 . . . . 0.0 110.066 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.532 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 9.3 tp -153.85 125.81 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.473 ' CG ' ' N ' ' A' ' 28' ' ' LYS . 69.0 t80 -130.72 170.15 14.72 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 33.1 tttm -139.76 142.24 36.77 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.931 -1.106 . . . . 0.0 111.173 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.58 ' CD1' ' OE1' ' A' ' 37' ' ' GLN . 43.5 p90 -149.17 -172.91 4.24 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.352 -0.843 . . . . 0.0 108.966 176.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -114.22 134.54 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.952 -1.092 . . . . 0.0 110.147 -178.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' CG ' HE21 ' A' ' 37' ' ' GLN . 5.0 m-20 -83.98 174.87 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.516 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.431 ' H ' HG22 ' A' ' 71' ' ' ILE . 25.4 t -66.6 -6.53 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.9 . . . . 0.0 108.808 178.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 12.0 m-85 -98.18 -4.76 34.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.773 . . . . 0.0 109.069 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.08 -1.11 86.06 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 pp20? -85.5 144.44 40.31 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.328 -1.101 . . . . 0.0 108.959 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.62 131.08 11.14 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.978 1.785 . . . . 0.0 112.146 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.668 ' H ' ' NE2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -129.4 172.1 11.85 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.964 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 19.0 m-85 -141.08 163.47 32.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 0.0 110.512 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.54 135.46 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.532 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 76.7 m-85 -122.49 143.54 49.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.531 -0.731 . . . . 0.0 110.01 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.6 t -171.7 157.64 4.72 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 178.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -91.19 10.18 28.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.544 ' NZ ' ' H ' ' A' ' 57' ' ' CYS . 34.1 mtmm -131.81 141.19 49.38 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.717 0.77 . . . . 0.0 110.152 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -94.58 -40.45 9.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.59 168.1 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.04 60.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.421 -0.799 . . . . 0.0 109.729 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 81.8 p -90.06 -5.52 56.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.165 -0.959 . . . . 0.0 110.314 -179.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.95 172.15 9.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.924 -1.11 . . . . 0.0 109.366 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -142.15 133.65 26.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.135 -0.978 . . . . 0.0 109.255 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.4 150.0 62.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.301 -179.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 151.8 62.84 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.161 1.907 . . . . 0.0 111.213 178.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -44.84 153.32 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 0.0 110.481 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.21 5.77 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -95.43 139.38 31.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.059 -1.26 . . . . 0.0 109.572 -179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.521 HH11 ' CG ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -77.84 164.62 25.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 109.349 -179.48 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -74.45 161.94 29.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.355 -0.841 . . . . 0.0 109.608 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.544 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 27.8 t -161.73 161.22 29.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.479 ' N ' ' SG ' ' A' ' 57' ' ' CYS . 81.6 mt -82.42 136.34 23.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.021 -1.049 . . . . 0.0 109.227 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.9 p -59.19 176.04 0.26 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.53 -0.732 . . . . 0.0 110.123 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 60' ' ' LEU . 6.9 mp -77.2 -52.68 8.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.375 -0.828 . . . . 0.0 109.979 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.546 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -42.63 -44.41 4.22 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.182 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -71.84 -40.0 69.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -65.04 -40.38 94.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.709 -1.245 . . . . 0.0 109.884 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.19 -55.61 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.958 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -43.16 95.75 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.5 -1.375 . . . . 0.0 109.89 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.43 -45.28 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 110.652 -179.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.73 -43.5 68.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.815 -1.178 . . . . 0.0 110.255 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -72.1 -42.02 66.59 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.725 -0.609 . . . . 0.0 110.329 -177.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -77.34 -26.44 52.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.107 -0.996 . . . . 0.0 110.524 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -89.32 -46.58 8.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.917 -1.114 . . . . 0.0 110.924 -178.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 32' ' ' SER . 24.0 mt -83.89 60.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 109.641 -178.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.46 -171.16 3.48 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 t0 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.069 -1.02 . . . . 0.0 109.532 -179.763 . . . . . . . . 0 0 . 1 stop_ save_